>ACMA_LACLA.1 [58,439]  Q9CIT4 Probable N-acetylmuramidase p
ATNSTEAFIESIAASAKPVADSNGLYPSVMIAQAILESNWGSSQLSRAPYYNLFGIQGTY
QGKSVVFKTQEYLNGKWVTKDMPFRVYPSFNQSFQDNAYVLKTTNFGNGPYYAKAWRANA
ATYQAATAALTGKYATDPNYGASLNRIISQYNLTRFDGASSAGTSNSGGSTATNTNNNSN
TSSTTYTVKSGDTLWGISQKYGISVAQIQSANNLKSTVIYIGQKLVLTTSSSSSNTNSST
SSGNSAGTTTPTTSVTPAKPASQTTIKVKSGDTLWGLSVKYKTTIAQLKSWNHLNSDTIF
IGQNLIVSQSAGSSSSSTGSSSASTSSTSNSSAASNTSIHKVVKGDTLWGLSQKSGSPIA
SIKAWNHLSSDTILIGQYLRIK
>ACMA_LACLC.1 [58,437]  Q48603 Probable N-acetylmuramidase p
ATNSSEVFIESIAASAKPVADANGLYPSVMIAQAILESNWGSSQLSRAPYYNLFGIQGTY
QGKSVVFKTQEYLNGKWVTKDMPFRVYPSFNQSFQDNAYVLKTTNFGNGPYYAKAWRANA
ATYQDATAALTGRYATDPSYGASLNRIISQYNLTRFDGASSAGNTNSGGSTTTITNNNSG
TNSSSTTYTVKSGDTLWGISQRYGISVAQIQSANNLKSTIIYIGQKLVLTGSASSTNSGG
SNNSASTTPTTSVTPAKPTSQTTVKVKSGDTLWALSVKYKTSIAQLKSWNHLSSDTIYIG
QNLIVSQSAAASNPSTGSGSTATNNSNSTSSNSNASIHKVVKGDTLWGLSQKSGSPIASI
KAWNHLSSDTILIGQYLRIK
>ACTA_LISMO.1 [30,639]  P33379 Actin-assembly inducing prote
ATDSEDSSLNTDEWEEEKTEEQPSEVNTGPRYETAREVSSRDIKELEKSNKVRNTNKADL
IAMLKEKAEKGPNINNNNSEQTENAAINEEASGADRPAIQVERRHPGLPSDSAAEIKKRR
KAIASSDSELESLTYPDKPTKVNKKKVAKESVADASESDLDSSMQSADESSPQPLKANQQ
PFFPKVFKKIKDAGKWVRDKIDENPEVKKAIVDKSAGLIDQLLTKKKSEEVNASDFPPPP
TDEELRLALPETPMLLGFNAPATSEPSSFEFPPPPTDEELRLALPETPMLLGFNAPATSE
PSSFEFPPPPTEDELEIIRETASSLDSSFTRGDLASLRNAINRHSQNFSDFPPIPTEEEL
NGRGGRPTSEEFSSLNSGDFTDDENSETTEEEIDRLADLRDRGTGKHSRNAGFLPLNPFA
SSPVPSLSPKVSKISAPALISDITKKTPFKNPSQPLNVFNKKTTTKTVTKKPTPVKTAPK
LAELPATKPQETVLRENKTPFIEKQAETNKQSINMPSLPVIQKEATESDKEEMKPQTEEK
MVEESESANNANGKNRSAGIEEGKLIAKSAEDEKAKEEPGNHTTLILAMLAIGVFSLGAF
IKIIQLRKNN
>ADCA_STRP3.1 [1,515]  Q8K847 Zinc-binding protein adcA prec
MKKKILLMMSLISVFFAWQLTQAKQVLAEGKVKVVTTFYPVYEFTKGIVGNDGDVSMLMK
AGTEPHDFEPSTKDIKKIQDADAFVYMDDNMETWVSDVKKSLTSKKVTIVKGTGNMLLVA
GVGHDHHHEEADKKHEHNKHSEEGHNHAFDPHVWLSPYRSITVVENIRDSLSKAYPEKAE
NFKANAATYIEKLKELDKDYTAALSDAKQKSFVTQHAAFGYMALDYGLNQISINGVIPDA
EPSAKRIATLSKYVKKYGIKYIYFEENASSKVAKTLAKEAGVKAAVLSPLEGLTEKEMKA
GQDYFTVMRKNLETLRLTTDVAGKEILPEKDTTKTVYNGYFKDKEVKDRQLSDWSGSWQS
VYPYLQDGTLDQVWDYKAKKSKGKMTAAEYKDYYTTGYKTDVEQIKINGKKKTMTFVRNG
EKKTFTYTYAGKEILTYPKGNRGVRFMFEAKEPNAGEFKYVQFSDHAIAPEKAEHFHLYW
GGDSQEKLHKELEHWPTYYGSDLSGREIAQEINAH
>ADCA_STRP8.1 [1,515]  Q8P1N2 Zinc-binding protein adcA prec
MKKKILLMMSLISVFFAWQLTQAKQVLAEGKVKVVTTFYPVYEFTKGVIGNDGDVSMLMK
AGTEPHDFEPSTKDIKKIQDADAFVYMDDNMETWVSDVKKSLTSKKVTIVKGTGNMLLVA
GAGHDHHHEDADKKHEHNKHSEEGHNHAFDPHVWLSPYRSITVVENIRDSLSKAYPEKAE
NFKANAATYIEKLKELDKDYTAALSDAKQKSFVTQHAAFGYMALDYGLNQISINGVTPDA
EPSAKRIATLSKYVKKYGIKYIYFEENASSKVAKTLAKEAGVKAAVLSPLEGLTKKEMKA
GQDYFTVMRKNLETLRLTTDVAGKEILPEKDTTKTVYNGYFKDKEVKDRQLSDWSGSWQS
VYPYLQDGTLDQVWDYKAKKSKGKMTAAEYKDYYTTGYKTDVEQIKINGKKKTMTFVRNG
EKKTFTYTYAGKEILTYPKGNRGVRFMFEAKEPNAGEFKYVQFSDHAIAPEKAEHFHLYW
GGDSQEKLHKELEHWPTYYGSDLSGREIAQEINAH
>ADCA_STRPN.1 [19,501]  O05703 Zinc-binding lipoprotein adcA
CSNQKQADGKLNIVTTFYPVYEFTKQVAGDTANVELLIGAGTEPHEYEPSAKAVAKIQDA
DTFVYENENMETWVPKLLDTLDKKKVKTIKATGDMLLLPGGEEEEGDHDHGEEGHHHEFD
PHVWLSPVRAIKLVEHIRDSLSADYPDKKETFEKNAAAYIEKLQALDKAYAEGLSQAKQK
SFVTQHAAFNYLALDYGLKQVAISGLSPDAEPSAARLAELTEYVKKNKIAYIYFEENASQ
ALANTLSKEAGVKTDVLNPLESLTEEDTKAGENYISVMEKNLKALKQTTDQEGPAIEPEK
AEDTKTVQNGYFEDAAVKDRTLSDYAGNWQSVYPFLEDGTFDQVFDYKAKLTGKMTQAEY
KAYYTKGYHTDVTKINITDNTMEFVQGGQSKKYTYKYVGKKILTYKKGNRGVRFLFEATD
ADAGQFKYVQFSDHNVAPVKAEHFHIFFGGTSQEALFEEMDNWPTYYPDNLSGQEIAQEM
LAH
>ADCA_STRPY.1 [1,515]  Q9A0L9 Zinc-binding protein adcA prec
MKKKILLMMSLISVFFAWQLTQAKQVLAEGKVKVVTTFYPVYEFTKGVIGNDGDVFMLMK
AGTEPHDFEPSTKDIKKIQDADAFVYMDDNMETWVSDVKKSLTSKKVTIVKGTGNMLLVA
GAGHDHPHEDADKKHEHNKHSEEGHNHAFDPHVWLSPYRSITVVENIRDSLSKAYPEKAE
NFKANAATYIEKLKELDKDYTAALSDAKQKSFVTQHAAFGYMALDYGLNQISINGVTPDA
EPSAKRIATLSKYVKKYGIKYIYFEENASSKVAKTLAKEAGVKAAVLSPLEGLTEKEMKA
GQDYFTVMRKNLETLRLTTDVAGKEILPEKDTTKTVYNGYFKDKEVKDRQLSDWSGSWQS
VYPYLQDGTLDQVWDYKAKKSKGKMTAAEYKDYYTTGYKTDVEQIKINGKKKTMTFVRNG
EKKTFTYTYAGKEILTYPKGNRGVRFMFEAKEADAGEFKYVQFSDHAIAPEKAKHFHLYW
GGDSQEKLHKELEHWPTYYGSDLSGREIAQEINAH
>ADCA_STRR6.1 [19,501]  Q8CWN2 Zinc-binding lipoprotein adcA
CSNQKQADGKLNIVTTFYPVYEFTKQVAGDTANVELLIGAGTEPHEYEPSAKAVAKIQDA
DTFVYENENMETWVPKLLDTLDKKKVKTIKATGDMLLLPGGEEEEGDHDHGEEGHHHEFD
PHVWLSPVRAIKLVEHIRDSLSADYPDKKETFEKNAAAYIEKLQSLDKAYAEGLSQAKQK
SFVTQHAAFNYLALDYGLKQVAISGLSPDAEPSAARLAELTEYVKKNKIAYIYFEENASQ
ALANTLSKEAGVKTDVLNPLESLTEEDTKAGENYISVMEKNLKALKQTTDQEGPAIEPEK
AEDTKTVQNGYFEDAAVKDRTLSDYAGNWQSVYPFLEDGTFDQVFDYKAKLTGKMTQAEY
KAYYTKGYQTDVTKINITDNTMEFVQGGQSKKYTYKYVGKKILTYKKGNRGVRFLFEATD
ADAGQFKYVQFSDHNIAPVKAEHFHIFFGGTSQETLFEEMDNWPTYYPDNLSGQEIAQEM
LAH
>ADP1_MYCGA.1 [31,1122]  Q49379 Adhesin P1 precursor (Cytadh
KPNNLKPVNQVGEMNSQGQSNLLEKARRWRNSNFTSLSIDGTNPGALVLTGSKSISRIDL
YGNVIWTFDPGNTNDLTGKVGFYDANNKLTAFSGDVSFNVSDLSSKTVVEATQDQEDPNV
FYLLLMPDAAVQQEQKTKDQVFENYFMSDAPAAGDTSAEGSATPAGGGSGSSAAGGGAVA
PAAASSTARLVEEGNSAGMGTMTPTASTSETVIDYNSDQNKIPKPKTLLDSSESSESING
GRTYANINTQKNLQGVIVKVNENLFNSENPFAVENMAFIKPKDMVDNYPSTWTQGSANGK
MTNVLQFYKHDNPNAVNNRFYRAKYYPKRLETQTTTPLIDSSFSPYEHPEWYEGNQFVMP
WMQYITNLGGLYAKDGMVYLFGGNGTWVNNESALSIGVFRTKFENRTAEAPGNTKTVGYP
YGILLSAISFDATRNGLALAAPALGQDVGYHFVPRLAVGGVSSPRGANGNIFLGSAITWG
TNGGNFLDTKWHSPAVIEDAPTTFITVNSSGVLQNSGSQQSTSTPMPNSNGNESIPYRWT
NSYDYNSVRFAALISKPAGGNTKQVESLFTTALKLDTLNSLPNKFTQENNIFFSYAMLDG
RQWSLGTRKDSTWLTTNTINNFTYNTQQQLASTAAGENANPRNILNALTTAKGFDRRDIG
NVDILYSNNTNKFTYYYQVGGAITTWPEVQVNYKTSANITYYNLTRTDFGSTTPATQDAN
TVSSKLNGAYLSSTGDQQGWYNGSIYVKKASFTPSSQGYTWQDFKGLTTTASNAVISNWT
KAGYSIRPDDDTVFSVSKIPFEKEITAAVNVRSLDSYYVQLNGETSVNTVARVSPDSSAL
TLNPKRITNPLMNRDNVIGQGAFISRNDIPSSFFENKINDIVTTEADGTEVLDSKYINSI
YRYTPPQNNPHIRLRLLVIDRSRATNDFIKLLPQVLVDGEYVAVPQANSVFVSDQEFTGF
DALPGYVLPVAISIPIIIIALALALGLGIGIPMSQNRKMLKQGFAISNKKVDILTTAVGS
VFKQIINRTSVTNIKKTPQMLQANKKDGASSPSKPSAPAAKKPTGPTKPSAPGAKPTAPA
KPKAPAPTKKIE
>ADP1_MYCGE.1 [31,1444]  P20796 Adhesin P1 precursor (Cytadh
YFLFNQNKQRSSVSNFAYQPKQLSVKHQQAVDETLTPWTWNNNNFSSLKITGENPGSFGL
VRSQNDNLNISSVTKNSSDDNLKYLNAVEKYLDGQQNFAIRRYDNNGRALYDINLAKMEN
PSTVQRGLNGEPIFDPFKGFGLTGNAPTDWNEIKGKVPVEVVQSPHSPNLYFVLLVPKVA
LEYHNLNNQVVKESLEVKATQSSFNPTQRLQKDSPVKDSSKQGEKLSETTASSMSSGMAT
STRAKALKVEVERGSQSDSLLKNDFAKKPLKHKNSSGEVKLEAEKEFTEAWKPLLTTDQI
AREKGMGATVVSFYDAPYSENHTAFGLVDHIDPKKMVENYPPSWKTPKWNHHGIWDYNAR
NLLLQTTGFFNPRRHPEWFDEGQAKADNTSPGFKVGDTDHKKDGFKKNSSSPIALPFEAY
FANIGNMVAIGNSVFIFGGNGHATKMFTTNPLSIGVFRIKYTDNFSKSSVTGWPYAVLFG
GLINPQTNGLKDLPLGTNRWFEYVPRMAVSGVKWVGNQLVLAGTLTMGDTATVPRLKYDQ
LEKHLNLVAQGQGLLREDLQIFTPYGWANRPDIPVGAWLQDEMGSKFGPHYFLNNPDIQD
NVNNDTVEALISSYKNTDKLKHVYPYRYSGLYAWQLFNWSNKLTNTPLSANFVNENSYAP
NSLFAAILNEDLLTGLSDKIFYGKENEFAENEADRFNQLLSLNPNPNTNWARYLNVVQRF
TTGPNLDSSTFDQFLDFLPWIGNGKPFSNSPSPSTSASSSTPLPTFSNINVGVKSMITQH
LNKENTRWVFIPNFSPDIWTGAGYRVQSANQKNGIPFEQVKPSNNSTPFDPNSDDNKVTP
SGGSSKPTTYPALPNSISPTSDWINALTFTNKNNPQRNQLLLRSLLGTIPVLINKSGDSN
DQFNKDSEQKWDKTETNEGNLPGFGEVNGLYNAALLHTYGFFGTNTNSTDPKIGFKADSS
SSSSSTLVGSGLNWTSQDVGNLVVINDTSFGFQLGGWFITFTDFIRPRTGYLGITLSSLQ
DQTIIWADQPWTSFKGSYLDSDGTPKSLWDPTALKSLPNSSTTYDTNPTLSPSFQLYQPN
KVKAYQTTNTYNKLIEPVDATSAATNMTSLLKLLTTKNIKAKLGKGTASSQGNNNGGGVS
QTINTITTTGNISEGLKEETSIQAETLKKFFDSKQNNKSEIGIGDSTFTKMDGKLTGVVS
TPLVNLINGQGATSDSDTEKISFKPGNQIDFNRLFTLPVTELFDPNTMFVYDQYVPLLVN
LPSGFDQASIRLKVISYSVENQTLGVRLEFKDPQTQQFIPVLNASSTGPQTVFQPFNQWA
DYVLPLIVTVPIVVIILSVTLGLTIGIPMHRNKKALQAGFDLSNKKVDVLTKAVGSVFKE
IINRTGISNAPKKLKQATPTKPTPKTPPKPPVKQ
>ADP1_MYCPN.1 [60,1627]  P11311 Adhesin P1 precursor (Cytadh
NAINPRLTPWTYRNTSFSSLPLTGENPGAWALVRDNSAKGITAGSGSQQTTYDPTRTEAA
LTASTTFALRRYDLAGRALYDLDFSKLNPQTPTRDQTGQITFNPFGGFGLSGAAPQQWNE
VKNKVPVEVAQDPSNPYRFAVLLVPRSVVYYEQLQRGLGLPQQRTESGQNTSTTGAMFGL
KVKNAEADTAKSNEKLQGAEATGSSTTSGSGQSTQRGGSSGDTKVKALKIEVKKKSDSED
NGQLQLEKNDLANAPIKRSEESGQSVQLKADDFGTALSSSGSGGNSNPGSPTPWRPWLAT
EQIHKDLPKWSASILILYDAPYARNRTAIDRVDHLDPKAMTANYPPSWRTPKWNHHGLWD
WKARDVLLQTTGFFNPRRHPEWFDGGQTVADNEKTGFDVDNSENTKQGFQKEADSDKSAP
IALPFEAYFANIGNLTWFGQALLVFGGNGHVTKSAHTAPLSIGVFRVRYNATGTSATVTG
WPYALLFSGMVNKQTDGLKDLPFNNNRWFEYVPRMAVAGAKFVGRELVLAGTITMGDTAT
VPRLLYDELESNLNLVAQGQGLLREDLQLFTPYGWANRPDLPIGAWSSSSSSSHNAPYYF
HNNPDWQDRPIQNVVDAFIKPWEDKNGKDDAKYIYPYRYSGMWAWQVYNWSNKLTDQPLS
ADFVNENAYQPNSLFAAILNPELLAALPDKVKYGKENEFAANEYERFNQKLTVAPTQGTN
WSHFSPTLSRFSTGFNLVGSVLDQVLDYVPWIGNGYRYGNNHRGVDDITAPQTSAGSSSG
ISTNTSGSRSFLPTFSNIGVGLKANVQATLGGSQTMITGGSPRRTLDQANLQLWTGAGWR
NDKASSGQSDENHTKFTSATGMDQQGQSGTSAGNPDSLKQDNISKSGDSLTTQDGNAIDQ
QEATNYTNLPPNLTPTADWPNALSFTNKNNAQRAQLFLRGLLGSIPVLVNRSGSDSNKFQ
ATDQKWSYTDLHSDQTKLNLPAYGEVNGLLNPALVETYFGNTRAGGSGSNTTSSPGIGFK
IPEQNNDSKATLITPGLAWTPQDVGNLVVSGTTVSFQLGGWLVTFTDFVKPRAGYLGLQL
TGLDASDATQRALIWAPRPWAAFRGSWVNRLGRVESVWDLKGVWADQAQSDSQGSTTTAT
RNALPEHPNALAFQVSVVEASAYKPNTSSGQTQSTNSSPYLHLVKPKKVTQSDKLDDDLK
NLLDPNQVRTKLRQSFGTDHSTQPQPQSLKTTTPVFGTSSGNLSSVLSGGGAGGGSSGSG
QSGVDLSPVEKVSGWLVGQLPSTSDGNTSSTNNLAPNTNTGNDVVGVGRLSESNAAKMND
DVDGIVRTPLAELLDGEGQTADTGPQSVKFKSPDQIDFNRLFTHPVTDLFDPVTMLVYDQ
YIPLFIDIPASVNPKMVRLKVLSFDTNEQSLGLRLEFFKPDQDTQPNNNVQVNPNNGDFL
PLLTASSQGPQTLFSPFNQWPDYVLPLAITVPIVVIVLSVTLGLAIGIPMHKNKQALKAG
FALSNQKVDVLTKAVGSVFKEIINRTGISQAPKRLKQTSAAKPGAPRPPVPPKPGAPKPP
VQPPKKPA
>ADP2_MYCGA.1 [27,1122]  Q9REM8 Adhesin P1 precursor (Cytadh
VSGAKPNNLKPVNQVGEMNSQGQSNLLEKARRWRNSNFTSLSIDGTNPGALVLTGSKSIS
RIDLYGNVIWTFDPGNTNDLTGKVGFYDANNRLTAFSGDVPFNVSDLSSKTVVEATQDQE
DPNVFYLLLIPDAAVQQEQKTKDQVFENYFMSDAPATGDTSAEGSATPAGGGSSSSAAGG
GAVAPAAASSTARLVEEGNSAGMGTMTPTASTSETVIDYNSDQNKIPKPKTLLDSSESSE
SINGGRTYANINTQNNLQGVIVKVNENLFNSENPFAVENMAFIKPKDMVDNYPSTWTQGS
ANGKMTNVLQFYKHDNPNAVNNRFYRAKYYPKRLETQTTTPLIDSSFSPYEHPEWYEDNQ
FVMPWMQYITNLGGLYAKDGMVYLFGGNGTWVNNESALSIGVFRTKFENRTAEAPGNTKT
VGYPYGILLSAISFDATRNGLALAPASLGQDVGYHFVPRLAVGGVSSPRGANGNIFLGSA
ITWGTNGGNFLDTKWHSPAVIEDAPTTFVTVNSSGALQNSGNPQPTSTPMPNSNGNESIP
YRWTNSYDYNSVRFAALISKPAGGNTKQVESLFTTALKLDTLNSLPNKFTQENNIFFSYA
MLDGRQWSLGTRKDSAWLTTNTINNFTYNTQQQLASTVAGENANPRNILNALTTAKGFDR
RDIGNVVYTYSNNTNKFTYYYQVGGAITTWPEVQVNYKTSANITYYNLTRTDFGSTTPAT
QDANTVSSKLNGAYLSSTGDQQGWYNGSIYVKKASFTPSSQGYTWQDFKGLTTTASNAVI
SNWTKAGYSIRPDDDTVFNVSKIPFEKEITAAVNVRSLDSYYVQLNGETSVNTVARVSPD
SSALALNPNRITNPLMNRDNVIGQGAFISRNDIPSSFFENKINDIVTTEADGKEVLDSKY
INSIYRYTPPQNNPDIRLRLLVIDRSRATNDFIKLLPQVLVDGEYVAVPQANSVFVSDQE
FTGFDALPGYVLPVAISIPIIIIALALALGLGIGIPMSQNRKMLKQGFAISNKKVDILTT
AVGSVFKQIINRTSVTNIKKTPQMLQANKKDGASSPSKPSAPAAKKPAGPTKPSAPGAKP
TAPAKPKAPAPTKKIE
>ALDC_BACBR.1 [26,285]  P23616 Alpha-acetolactate decarboxyl
TTATVPAPPAKQESKPAVAANPAPKNVLFQYSTINALMLGQFEGDLTLKDLKLRGDMGLG
TINDLDGEMIQMGTKFYQIDSTGKLSELPESVKTPFAVTTHFEPKEKTTLTNVQDYNQLT
KMLEEKFENKNVFYAVKLTGTFKMVKARTVPKQTRPYPQLTEVTKKQSEFEFKNVKGTLI
GFYTPNYAAALNVPGFHLHFITEDKTSGGHVLNLQFDNANLEISPIHEFDVQLPHTDDFA
HSDLTQVTTSQVHQAESERK
>ALE1_STACP.1 [36,362]  O05156 Glycyl-glycine endopeptidase 
STKVDAPKVEQEAPAKADAPKVEQEAPAKADAPKVEQEAPAKVDAPKVEQEAPAKVDAPK
VEQEAPAKADAPKVEQKRTFVREAAQSNHSASWLNNYKKGYGYGPYPLGINGGNHYGVDF
FMNVGTPVRAISDGKIVEAGWTNYGGGNEIGLVENDGVHRQWYMHLSKFNVKVGDRVKAG
QIIGWSGSTGYSTAPHLHFQRMTNSFSNNTAQDPMPFLKSAGYGSNSTSSSNNNGYKTNK
YGTLYKSESASFTANTDIITRLTGPFRSMPQSGVLRKGLTIKYDEVMKQDGHVWVGYNTN
SGKRVYLPVRTWNESTGELGPLWGTIK
>ALIA_STRPN.1 [23,660]  P35592 Oligopeptide-binding protein 
CSGSGSSTKGEKTFSYIYETDPDNLNYLTTAKAATANITSNVVDGLLENDRYGNFVPSMA
EDWSVSKDGLTYTYTIRKDAKWYTSEGEEYAAVKAQDFVTGLKYAADKKSDALYLVQESI
KGLDAYVKGEIKDFSQVGIKALDEQTVQYTLNKPESFWNSKTTMGVLAPVNEEFLNSKGD
DFAKATDPSSLLYNGPYLLKSIVTKSSVEFAKNPNYWDKDNVHVDKVKLSFWDGQDTSKP
AENFKDGSLTAARLYPTSASFAELEKSMKDNIVYTQQDSITYLVGTNIDRQSYKYTSKTS
DEQKASTKKALLNKDFRQAIAFGFDRTAYASQLNGQTGASKILRNLFVPPTFVQADGKNF
GDMVKEKLVTYGDEWKDVNLADSQDGLYNPEKAKAEFAKAKSALQAEGVQFPIHLDMPVD
QTATTKVQRVQSMKQSLEATLGADNVIIDIQQLQKDEVNNITYFAENAAGEDWDLSDNVG
WGPDFADPSTYLDIIKPSVGESTKTYLGFDSGEDNVAAKKVGLYDYEKLVTEAGDETTDV
AKRYDKYAAAQAWLTDSALIIPTTSRTGRPILSKMVPFTIPFALSGNKGTSEPVLYKYLE
LQDKAVTVDEYQKAQEKWMKEKEESNKKAQEDLAKHVK
>ALIB_STRPN.1 [25,652]  Q51933 Oligopeptide-binding protein 
CGNSSTASKTYNYVYSSDPSSLNYLAENRAATSDIVANLVDGLLENDQYGNIIPSLAEDW
TVSQDGLTYTYKLRKDAKWFTSEGEEYAPVTAQDFVTGLQYAADKKSEALYLVQDSVAGL
DDYITGKTSDFSTVGVKALDDQTVQYTLVKPELYWNSKTLATILFPVNADFLKSKGDDFG
KADPSSILYNGPFLMKALVSKSAIEYKKNPNYWDAKNVFVDDVKLTYYDGSDQESLERNF
TAGAYTTARLFPNSSSYEGIKEKYKNNIIYSMQNSTSYFFNFNLDRKSYNYTSKTSDIEK
KSTQEAVLNKNFRQAINFAFDRTSYGAQSEGKEGATKILRNLVVPPNFVSIKGKDFGEVV
ASKMVNYGKEWQGINFADGQDPYYNPEKAKAKFAEAKKELEAKGVQFPIHLDKTVEVTDK
VGIQGVSSIKQSIESVLGSDNVVIDIQQLTSDEFDSSGYFAQTAAQKDYDLYHGGWGPDY
QDPSTYLDIFNTNSGGFLQNLGLEPGEANDKAKAVGLDVYTQMLEEANKEQDPAKRYEKY
ADIQAWLIDSSLVLPSVSRGGTPSLRRTVPFAAAYGLTGTKGVESYKYLKVQDKIVTTDE
YAKAREKWLKEKEESNKKAQEELAKHVK
>ALYS_ENTFA.1 [54,737]  P37710 Autolysin precursor (EC 3.2.1
TEEQPTNAEVAQAPTTETGLVETPTTETTPGTTEQPTTDSSTTTESTTESSKETPTTPST
EQPTADSTTPVESGTTDSSVAEITPVAPSATESEAAPAVTPDDEVKVPEARVASAQTFSA
LSPTQSPSEFIAELARCAQPIAQANDLYASVMMAQAIVESGWGASTLSKAPNYNLFGIKG
SYNGQSVYMDTWEYLNGKWLVKKEPFRKYPSYMESFQDNAHVLKTTSFQAGVYYYAGAWK
SNTSSYRDATAWLTGRYATDPSYNAKLNNVITAYNLTQYDTPSSGGNTGGGTVNPGTGGS
NNQSGTNTYYTVKSGDTLNKIAAQYGVSVANLRSWNGISGDLIFVGQKLIVKKGASGNTG
GSGSGGSNNNQSGTNTYYTVKSGDTLNKIAAQYGVSVANLRSWNGISGDLIFVGQKLIVK
KGASGNTGGSNNGGSNNNQSGTNTYYTIKSGDTLNKIAAQYGVSVANLRSWNGISGDLIF
AGQKIIVKKGTSGNTGGSSNGGSNNNQSGTNTYYTIKSGDTLNKISAQFGVSVANLQAWN
NISGSLIFAGQKIIVKKGANSGSTNTNKPTNNGGGATTSYTIKSGDTLNKISAQFGVSVA
NLRSWNGIKGDLIFAGQTIIVKKGASAGGNASSTNSASGKRHTVKSGDSLWGLSMQYGIS
IQKIKQLNGLSGDTIYIGQTLKVG
>AMIA_STRPN.1 [23,659]  P18791 Oligopeptide-binding protein 
CSSSKSSDSSAPKAYGYVYTADPETLDYLISSKNSTTVVTSNGIDGLFTNDNYGNLAPAV
AEDWEVSKDGLTYTYKIRKGVKWFTSDGEEYAEVTAKDFVNGLKHAADKKSEAMYLAENS
VKGLADYLSGTSTDFSTVGVKAVDDYTLQYTLNQPEPFWNSKLTYSIFWPLNEEFETSKG
SDFAKPTDPTSLLYNGPFLLKGLTAKSSVEFVKNEQYWDKENVHLDTINLAYYDGSDQES
LERNFTSGAYSYARLYPTSSNYSKVAEEYKDNIYYTQSGSGIAGLGVNIDRQSYNYTSKT
TDSEKVATKKALLNKDFRQALNFALDRSAYSAQINGKDGAALAVRNLFVKPDFVSAGEKT
FGDLVAAQLPAYGDEWKGVNLADGQDGLFNADKAKAEFAKAKKALEADGVQFPIHLDVPV
DQASKNYISRIQSFKQSVETVLGVENVVVDIQQMTSDEFLNITYYAANASSEDWDVSGGV
SWGPDYQDPSTYLDILKTTSSETTKTYLGFDNPNSPSVVQVGLKEYDKLVDEAARETSDL
NVRYEKYAAAQAWLTDSSLFIPAMASSGAAPVLSRIVPFTGASAQTGSKGSDVYFKYLKS
QDKVVTKEEYEKAREKWLKEKAESNEKAQKELASHVK
>AMP_ONYPE.1 [33,233]   Q7M1T6 Antigenic membrane protein pr
DDKLDLNTLECKDALELTAADAADAEKVVKQWKVQNTSLNAKVTKDSVKVAVADNKVTVT
PADGDAGKALSGSKILNLVGVCELNKLTLGTEKKLTLTVKDGKVDAEAGLKALKEAGAKV
PATVNKDDVTFTVGKDDNANKVTVKAVDGKTTVSGQVVFEFTVAKTPWYKTVWFLTLVAV
VVVAAVAGGVFFFVKKNKKNK
>AMT6_BACS7.1 [34,518]  P19571 Glucan 1,4-alpha-maltohexaosi
HHNGTNGTMMQYFEWYLPNDGNHWNRLNSDASNLKSKGITAVWIPPAWKGASQNDVGYGA
YDLYDLGEFNQKGTVRTKYGTRSQLQAAVTSLKNNGIQVYGDVVMNHKGGADATEMVRAV
EVNPNNRNQEVTGEYTIEAWTRFDFPGRGNTHSSFKWRWYHFDGVDWDQSRRLNNRIYKF
RGHGKAWDWEVDTENGNYDYLMYADIDMDHPEVVNELRNWGVWYTNTLGLDGFRIDAVKH
IKYSFTRDWINHVRSATGKNMFAVAEFWKNDLGAIENYLQKTNWNHSVFDVPLHYNLYNA
SKSGGNYDMRNIFNGTVVQRHPSHAVTFVDNHDSQPEEALESFVEEWFKPLAYALTLTRE
QGYPSVFYGDYYGIPTHGVPAMRSKIDPILEARQKYAYGKQNDYLDHHNIIGWTREGNTA
HPNSGLATIMSDGAGGSKWMFVGRNKAGQVWSDITGNRTGTVTINADGWGNFSVNGGSVS
IWVNK
>AMYB_BACCE.1 [31,546]  P36924 Beta-amylase precursor (EC 3.
AVNGKGMNPDYKAYLMAPLKKIPEVTNWETFENDLRWAKQNGFYAITVDFWWGDMEKNGD
QQFDFSYAQRFAQSVKNAGMKMIPIISTHQCGGNVGDDCNVPIPSWVWNQKSDDSLYFKS
ETGTVNKETLNPLASDVIRKEYGELYTAFAAAMKPYKDVIAKIYLSGGPAGELRYPSYTT
SDGTGYPSRGKFQAYTEFAKSKFRLWVLNKYGSLNEVNKAWGTKLISELAILPPSDGEQF
LMNGYLSMYGKDYLEWYQGILENHTKLIGELAHNAFDTTFQVPIGAKIAGVHWQYNNPTI
PHGAEKPAGYNDYSHLLDAFKSAKLDVTFTCLEMTDKGSYPEYSMPKTLVQNIATLANEK
GIVLNGENALSIGNEEEYKRVAEMAFNYNFAGFTLLRYQDVMYNNSLMGKFKDLLGVTPV
MQTIVVKNVPTTIGDTVYITGNRAELGSWDTKQYPIQLYYDSHSNDWRGNVVLPAERNIE
FKAFIKSKDGTVKSWQTIQQSWNPVPLKTTSHTSSW
>AMYB_BACCI.1 [37,575]  P06547 Beta-amylase precursor (EC 3.
AVAGDFQVSVMGPLAKVTDWNSFKNQLTTLKNNGVYAITTDVWWGYVESAGDNQFDWSYY
KTYADTVKQAGLKWVPIISTHRCGGNVGDDCNIPLPSWLWSKGSADEMQFKDESGYVNNE
SLSPFWSGVGKQYDELYASFAQNFSAYKDMIPKIYLSGGPSGELRYPSYYPAAGWSYPAR
GKFQVYTETAKSAFRTAMTTKYGSLDKINAAWGTNLTSMSQISPPTDSDGFYTGGGYNIT
YGKDFLSWYQSVLENHLGVIGAAAHKNFDPVFGVRIGAKISGIHWQMNNPSMPHSAEHAG
GYYDYNRLIQKFKDTDLDLTFTALEMYDSGTAPNYSLPSTLVDTVSSIANSKGVRLNGEN
ALPTGGSGFQKIEEKITRFGYNGFTLLRINNIVNSDGSPTAEMSSFKNYVIKHAKPAGDG
GGNPVNSVTIYYKKGFNSPYIHYRPAGGTWTDVPGVKMPDSEISGYAKITLDIGSASQLE
AAFNDGNNQWDSNNMRNYFFSPGTSTYIPGTNGTAGSIQAGPPITSSDFQALPAYEMSI
>AMYB_BACFI.1 [37,468]  P96513 Beta-amylase precursor (EC 3.
VADDIQASVMGPLAKINDWGSFKKQLQTLKNNGVYAITTDVWWGYVESAGDNQFDWSYYK
TYADAVKEAGLKWVPIISTHKCGGNVGDDCNIPLPSWLSSKGSADEMQFKDESGYANNEA
LSPLWSGTGKQYDELYASFAQNFAGYKSIIPKIYLSGGPSGELRYPSYYPAAGWSYPGRG
KFQAYTETAKNAFRTAMNDKYGSLDKINTAWGTKLTSLSQINPPTDGDGFYTNGGYNSAY
GKDFLSWYQSVLEKHLGVIGAAAHKNFDSVFGVRIGAKISGLHWQMNNPAMPHSTEQAGG
YYDYNRLIQKFKDADLDLTFTCLEMSDSGTAPNYSLPSTLVDTVSSIANAKGVRLNGENA
LQTGGSGFQKIEEKITKFGYHGFTLLRINNLVNNDGSPTGELSGFKQYIISKAKPDNNGG
TGNKVTIYYKKG
>AMYB_PAEPO.1 [36,1196]  P21543 Beta/alpha-amylase precursor
AVADDFQASVMGPLAKINDWGSFKKQLQTLKNNGVYAITTDVWWGYVESAGDNQFDWSYY
KTYANAVKEAGLKWVPIISTHKCGGNVGDDCNIPLPSWLSSKGSADEMQFKDESGYANSE
ALSPLWSGTGKQYDELYASFAENFAGYKSIIPKIYLSGGPSGELRYPSYYPAAGWSYPGR
GKFQAYTETAKNAFRTAMNDKYGSLDKINAAWGTKLTSLSQINPPTDGDGFYTNGGYNSA
YGKDFLSWYQSVLEKHLGVIGAAAHKNFDSVFGVRIGAKISGLHWQMNNPAMPHGTEQAG
GYYDYNRLIQKFKDADLDLTFTCLEMSDSGTAPNYSLPSTLVDTVSSIANAKGVRLNGEN
ALPTGGSGFQKIEEKITKFGYHGFTLLRINNLVNNDGSPTGELSGFKQYIISKAKPDNNG
GTGNKVTIYYKKGFNSPYIHYRPAGGSWTAAPGVKMQDAEISGYAKITVDIGSASQLEAA
FNDGNNNWDSNNTKNYSFSTGTSTYTPGNSGNAGTITSGAPAGANPGDGGGTTNKVTVYY
KKGFNSPYIHYRPAGGSWTAAPGVKMQDAEISGYAKITVDIGSASQLEAAFNDGNNNWDS
NNTKNYLFSTGTSTYTPGSNGAAGTIRTGAPSGSVLSVVTSTYATDLNEVTGPIQTEKLS
GVSLNVSTSTYAPNSNGVEVTAQTEAPSGAFTSMDLGTLSNPTSLNTDWSKQSIYFIMTD
RFSNGDPSNDNYGGFNSNNSDQRKWHGGDFQGIINKLDYIKNMGFTAIWITPVTMQKSEY
AYHGYHTYDFYAVDGHLGTMDKLQELVRKAHDKNIAVMVDVVVNHTGDFQPGNGFAKAPF
DKADWYHHNGDITDGDYNSNNQWKIENGDVAGLDDLNHENPATANELKNWIKWLLNETGI
DGLRLDTVKHVPKGFLKDFDQAANTFTMGEIFHGDPAYVGDYTRYLDAALDFPMYYTIKD
VFGHDQSMRKIKDRYSDDRYYRDAQTNGVFIDNHDVKRFLNDASGKPGANYDKWPQLKAA
LGFTLTSRGIPIIYQGTEQGYSGGDDPANRENMNFNANHDLYQYIAKLNYVRNNHPALQN
GSQREKWVDDSFYSFQRSKNGDEAIVFINNSWNSQTRTIGNFDNLSNGTRLTNQLSNDSV
QINNGSITVTLAPKEVKVFTK
>AMYB_THETU.1 [33,551]  P19584 Beta-amylase, thermophilic pr
SIAPNFKVFVMGPLEKVTDFNAFKDQLITLKNNGVYGITTDIWWGYVENAGENQFDWSYY
KTYADTVRAAGLKWVPIMSTHACGGNVGDTVNIPIPSWVWTKDTQDNMQYKDEAGNWDNE
AVSPWYSGLTQLYNEFYSSFASNFSSYKDIITKIYISGGPSGELRYPSYNPSHGWTYPGR
GSLQCYSKAAITSFQNAMKSKYGTIAAVNSAWGTSLTDFSQISPPTDGDNFFTNGYKTTY
GNDFLTWYQSVLTNELANIASVAHSCFDPVFNVPIGAKIAGVHWLYNSPTMPHAAEYCAG
YYNYSTLLDQFKASNLAMTFTCLEMDDSNAYVSPYYSAPMTLVHYVANLANNKGIVHNGE
NALAISNNNQAYVNCANELTGYNFSGFTLLRLSNIVNSDGSVTSEMAPFVINIVTLTPNG
TIPVTFTINNATTYYGQNVYIVGSTSDLGNWNTTYARGPASCPNYPTWTITLNLLPGEQI
QFKAVKIDSSGNVTWEGGSNHTYTVPTSGTGSVTITWQN
>AMYG_CLOS0.1 [22,702]  P29761 Glucoamylase precursor (EC 3.
CSNNVSSIKIDRFNNISAVNGPGEEDTWASAQKQGVGTANNYVSKVWFTLANGAISEVYY
PTIDTADVKEIKFIVTDGKSFVSDETKDTISKVEKFTDKSLGYKLVNTDKKGRYRITKEI
FTDVKRNSLIMKAKFEALEGSIHDYKLYLAYDPHIKNQGSYNEGYVIKANNNEMLMAKRD
NVYTALSSNIGWKGYSIGYYKVNDIMTDLDENKQMTKHYDSARGNIIEGAEIDLKKNSQF
EIVLSFGNSEDEAVKASIETLSENYDSLKSAYIDEWEKYCNSLNNFNGKANSLYYNSMMI
LKASEDKTNKGAYIASLSIPWGDGQGDDNTGGYHLVWSRDLYHVANAFIAAGDVDSANRS
LDYLAKVVKDNGMIPQNTWISGKPYWTGIQLDEQADPIILSYRLRRYDLYDSLVKPLADF
IIKMGPKTGQERWEEIGGYSPATMAAEVAGLTCAAYIAEQNKDYESAQKYQEKADNWQKL
IDNLTYTEHGPLENGQYYIRIAGLPDPNADFTISIANGGGVYDQKEIVDPSFLELVRLGV
KSPDDPKILNTLRVVDSTIKVDTPKGPSWYRYNHDGYGEPSKTELYHGAGKGRLWPLLTG
ERGMYEIAAGKDATPYLKAMENFANEGGIISEQVWEDTGLPTDSASPLNWAHAEYVVLFP
SNIEHKVLDMPDIVYKRYVAK
>AMYM_BACST.1 [34,719]  P19531 Maltogenic alpha-amylase prec
SSSASVKGDVIYQIIIDRFYDGDTTNNNPAKSYGLYDPTKSKWKMYWGGDLEGVRQKLPY
LKQLGVTTIWLSPVLDNLDTLAGTDNTGYHGYWTRDFKQIEEHFGNWTTFDTLVNDAHQN
GIKVIVDFVPNHSTPFKANDSTFAEGGALYNNGTYMGNYFDDATKGYFHHNGDISNWDDR
YEAQWKNFTDPAGFSLADLSQENGTIAQYLTDAAVQLVAHGADGLRIDAVKHFNSGFSKS
LADKLYQKKDIFLVGEWYGDDPGTANHLEKVRYANNSGVNVLDFDLNTVIRNVFGTFTQT
MYDLNNMVNQTGNEYKYKENLITFIDNHDMSRFLSVNSNKANLHQALAFILTSRGTPSIY
YGTEQYMAGGNDPYNRGMMPAFDTTTTAFKEVSTLAGLRRNNAAIQYGTTTQRWINNDVY
IYERKFFNDVVLVAINRNTQSSYSISGLQTALPNGSYADYLSGLLGGNGISVSNGSVASF
TLAPGAVSVWQYSTSASAPQIGSVAPNMGIPGNVVTIDGKGFGTTQGTVTFGGVTATVKS
WTSNRIEVYVPNMAAGLTDVKVTAGGVSSNLYSYNILSGTQTSVVFTVKSAPPTNLGDKI
YLTGNIPELGNWSTDTSGAVNNAQGPLLAPNYPDWFYVFSVPAGKTIQFKFFIKRADGTI
QWENGSNHVATTPTGATGNITVTWQN
>AMY_BACAM.1 [32,514]   P00692 Alpha-amylase precursor (EC 3
VNGTLMQYFEWYTPNDGQHWKRLQNDAEHLSDIGITAVWIPPAYKGLSQSDNGYGPYDLY
DLGEFQQKGTVRTKYGTKSELQDAIGSLHSRNVQVYGDVVLNHKAGADATEDVTAVEVNP
ANRNQETSEEYQIKAWTDFRFPGRGNTYSDFKWHWYHFDGADWDESRKISRIFKFRGEGK
AWDWEVSSENGNYDYLMYADVDYDHPDVVAETKKWGIWYANELSLDGFRIDAAKHIKFSF
LRDWVQAVRQATGKEMFTVAEYWQNNAGKLENYLNKTSFNQSVFDVPLHFNLQAASSQGG
GYDMRRLLDGTVVSRHPEKAVTFVENHDTQPGQSLESTVQTWFKPLAYAFILTRESGYPQ
VFYGDMYGTKGTSPKEIPSLKDNIEPILKARKEYAYGPQHDYIDHPDVIGWTREGDSSAA
KSGLAALITDGPGGSKRMYAGLKNAGETWYDITGNRSDTVKIGSDGWGEFHVNDGSVSIY
VQK
>AMY_BACCI.1 [29,528]   P08137 Alpha-amylase precursor (EC 3
APATSVSNKQNFSTDVIYQIVTDRFVDGNTANNPAGSAYDATCSTNLKLYCGGDWQGIMN
KINDGYFTGMGITALWISQPVENIYSVINYSGVNNTAYHGYWARDFKKTNPAFGSMTDFA
NLISAAHSRNIKVVIDFAPNHTSPAMETNASFGENGKLYDNGTLLGGYTGDTNGYFHHNG
GTDFSTLKNGIYKNLYDLADLNHNNSTIDTYFKNAIRLWLDMGIDGIRVDAVKHMPFGWQ
KNWMSSIYSYKPVFTFGEWFLGTNETDANNTYFANESGMSLLDFRFSQKVRQVFRDGSDT
MYGLDSMLSSTAADYYSVNDQVTFLDNHDMDRFQVSGANGRKLEQALALTLTSRGVPAIY
YGTEQYMTGNGDPNNRAKMSSFSTSTTAYNVISKLAPLRKSNPAIAYGTTQQRWINNDVY
IYERKFGNNVAVVAINKNLTSSYSIAGLNTSLPSGTYTDVLANSLSGNSITVGSSGAVNT
FTLQAGGEASGLTRRRQRLR
>AMY_BACLI.1 [30,512]   P06278 Alpha-amylase precursor (EC 3
ANLNGTLMQYFEWYMPNDGQHWKRLQNDSAYLAEHGITAVWIPPAYKGTSQADVGYGAYD
LYDLGEFHQKGTVRTKYGTKGELQSAIKSLHSRDINVYGDVVINHKGGADATEDVTAVEV
DPADRNRVISGEHRIKAWTHFHFPGRGSTYSDFKWHWYHFDGTDWDESRKLNRIYKFQGK
AWDWEVSNENGNYDYLMYADIDYDHPDVAAEIKRWGTWYANELQLDGFRLDAVKHIKFSF
LRDWVNHVREKTGKEMFTVAEYWQNDLGALENYLNKTNFNHSVFDVPLHYQFHAASTQGG
GYDMRKLLNSTVVSKHPLKAVTFVDNHDTQPGQSLESTVQTWFKPLAYAFILTRESGYPQ
VFYGDMYGTKGDSQREIPALKHKIEPILKARKQYAYGAQHDYFDHHDIVGWTREGDSSVA
NSGLAALITDGPGGAKRMYVGRQNAGETWHDITGNRSEPVVINSEGWGEFHVNGGSVSIY
VQR
>AMY_BACME.1 [28,520]   P20845 Alpha-amylase precursor (EC 3
VHKGKAPTADKNGVFYEVYVNSFYDANKDGHGDLKGLTQKLDYLNDGNSHTKNDLQVNGI
WMMPVNPSPSYHKYDVTDYYNIDPQYGNLQDFRKLMKEADKRDVKVIMDLVVNHTSSEHP
WFQAALKDKNSKYRDYYIWADKNTDLNEKGSWGQQVWHKAPNGEYFYGTFWEGMPDLNYD
NPEVRKEMINVGKFWLKQGVDGFRLDAALHIFKGQTPEGAKKNILWWNEFRDAMKKENPN
VYLTGEVWDQPEVVAPYYQSLDSLFNFDLAGKIVSSVKAGNDQGIATAAAATDELFKSYN
PNKIDGIFLTNHDQNRVMSELSGDVNKAKSAASILLTLPGNPYIYYGEEIGMTGEKPDEL
IREPFRWYEGNGIGQTSWETPVYNKGGNGVSVEAQTKQKDSLLNHYREMIRVRQQHEELV
KGTLQSISVDSKEVVAYSRTYKGKSISVYHNISNQPVKVSVAAKGNLIFASEKGAKKVKN
QLVIPANRTVLIK
>AMY_BACST.1 [35,549]   P06279 Alpha-amylase precursor (EC 3
AAPFNGTMMQYFEWYLPDDGTLWTKVANEANNLSSLGITALWLPPAYKGTSRSDVGYGVY
DLYDLGEFNQKGAVRTKYGTKAQYLQAIQAAHAAGMQVYADVVFDHKGGADGTEWVDAVE
VNPSDRNQEISGTYQIQAWTKFDFPGRGNTYSSFKWRWYHFDGVDWDESRKLSRIYKFRG
IGKAWDWEVDTENGNYDYLMYADLDMDHPEVVTELKSWGKWYVNTTNIDGFRLDAVKHIK
FSFFPDWLSDVRSQTGKPLFTVGEYWSYDINKLHNYIMKTNGTMSLFDAPLHNKFYTASK
SGGTFDMRTLMTNTLMKDQPTLAVTFVDNHDTEPGQALQSWVDPWFKPLAYAFILTRQEG
YPCVFYGDYYGIPQYNIPSLKSKIDPLLIARRDYAYGTQHDYLDHSDIIGWTREGVTEKP
GSGLAALITDGPGGSKWMYVGKQHAGKVFYDLTGNRSDTVTINSDGWGEFKVNGGSVSVW
VPRKTTVSTIAWSITTRPWTDEFVRWTEPRLVAWP
>AMY_BACSU.1 [28,660]   P00691 Alpha-amylase precursor (EC 3
PAAASAETANKSNELTAPSIKSGTILHAWNWSFNTLKHNMKDIHDAGYTAIQTSPINQVK
EGNQGDKSMSNWYWLYQPTSYQIGNRYLGTEQEFKEMCAAAEEYGIKVIVDAVINHTTSD
YAAISNEVKSIPNWTHGNTQIKNWSDRWDVTQNSLLGLYDWNTQNTQVQSYLKRFLDRAL
NDGADGFRFDAAKHIELPDDGSYGSQFWPNITNTSAEFQYGEILQDSASRDAAYANYMDV
TASNYGHSIRSALKNRNLGVSNISHYASDVSADKLVTWVESHDTYANDDEESTWMSDDDI
RLGWAVIASRSGSTPLFFSRPEGGGNGVRFPGKSQIGDRGSALFEDQAITAVNRFHNVMA
GQPEELSNPNGNNQIFMNQRGSHGVVLANAGSSSVSINTATKLPDGRYDNKAGAGSFQVN
DGKLTGTINARSVAVLYPDDIAKAPHVFLENYKTGVTHSFNDQLTITLRADANTTKAVYQ
INNGPDDRRLRMEINSQSEKEIQFGKTYTIMLKGTNSDGVTRTEKYSFVKRDPASAKTIG
YQNPNHWSQVNAYIYKHDGSRVIELTGSWPGKPMTKNADGIYTLTLPADTDTTNAKVIFN
NGSAQVPGQNQPGFDYVLNGLYNDSGLSGSLPH
>AMY_BUTFI.1 [34,976]   P30269 Alpha-amylase precursor (EC 3
MESNDALVLDETKENTESATDASSNEASDAEADNDTDEAITDASSKELSAENDGASESDS
SFDEYDHTALPETDEITVTAAGELSTAKAELYTLAPREAREADNSLVTRDSIHDGAILHA
FCWSFNTIADNMADIADAGYTAVQTSPINECLSTNPGMNLHGPDGMWYYHYQPTDWVIGN
YQLGSRDEFKHMCDVADEYGVAVIVDILPNHTTPSTGSIAKALMEAAGGSDALYHATGKI
GGGYTDRLELTYYSMGGLPDVDTENTGFQQYFYEFLKDCVYLGADGFRIDTAKHISLPDD
PVPSDYSDAGRNTFYPNMREALNEYSEEVGTKSYDELFVYGEVLQGTNDRLAAYQQYIGG
TTASNYGSSLRSALSSGNLSVNRLLDYQIYDDTAYGSTYTADTEKLVTWVESHDNYMNDS
ESCWKSIDDDMVIMGWSIIAARDAGTPLFFSRPNNSSAENPYGDNLIGAAGSPIYKAPEV
KAVNLFREKMGEADEYLSNPGGNIQTLMIERYNDTVQGAVIVNAAQTRTTISTETHLSDG
IYPDQVEGSNSVFLVKDGVLSGSVEGEGVVVLSEKMDGTGKVVSFYNNKNWNGVVARVDN
AEETLDTIDENDGWFQVTVLDDEFTIRFESADGKEVSPEFQITAESGTFATPDSSELYYS
KAEAEEGLGIHTYPVYFFNTENWGSVYTYGWLDGGAQLFGGWPGTVAVNEGSGWYRADVK
TTGEITAFNLIFNNGNGIQTVNVEGITPDSKDIYLAVDAEKSNGQLIVNRYEDKESAEKA
LGVSGSYTTAYFYNTEGWDKVCAYTWGATALGDWPGKELTQDEDGWYSVVLPAGPSEDLN
IIFNNGNNGKQTNDMKISDMKYRFILNNGISYQKYGSKKDAMEAIAGAGDVTYETVYFYN
EKADDANWKNVYLYVFGGTDGEYNNLVGTWPGKLMEKEEDSNG
>AMY_CLOAB.1 [35,760]   P23671 Alpha-amylase precursor (EC 3
AKVMTYSSENRELPENTKDGVMLHAFDWSFNNIKKELPSIAAAGYKAVQVSPVQGTKSNS
TNSSDWWLLYQPTNQAIGNAQLGSYDDFKSLCSEAKNYGISIVVDVVMNHMANNGNDDEV
ASEVDPSFKDPSLYHHNGQCTDWNNRQDVTQEGIGMPDLNTQSSAVQSKAITFLNQCVDA
GATGFRFDAAKHIETDLGLDANKSWSGNYWENVLGSLHNKSNLYIYGEVLQDGKVDNISA
YESFMNVEASAYDGSLRGAIKSGDLTNAQGMGGLDSNKCVDMLETHDEYEHNESKDLTDW
QRKAGWAIAASRAGSVPLFFDRPTGNIGSEGDALWKDSDVVAVNEFHNAMAGQNEYLRLQ
NNNKAMIIERGSKGAVIVNEGDSFNLNTPTNLEDGNYDNHGSATDSLTVSQGRMTGTVPA
NSIIVIYNKNSNPGSDRVTLSEQAAKAGDSVTITYDAGTTALKDASNVNLYWGYDGFSAA
TSKAMTSLGDNKWQTTITVPKEVTKNVNFSFTDGTSWDNNNGANWNIPLASNYLPHAGYK
VDYDSSNLVSGNNFTIYYNGNLANSSNVSLHWGVNGWSNMQNLAMVKDSNGFWEATIAIP
ASSNTLNFCFTNGSSWDNNNNNNWTLNTWSSVPKVQVTPAPEACKQISVYYNGSLASSAS
NITLHWGCNGFTSPQDINMVKQADGRWLANITLPSGCYNVNMAFKDQSGTWDNNNSNNYN
FSSTNN
>ANCA_CLOTM.1 [30,447]  Q06848 Cellulosome anchoring protein
QTNTIEIIIGNVKARPGDRIEVPVSLKNVPDKGIVSSDFVIEYDSKLFKVIELKAGDIVE
NPSESFSYNVVEKDEIIAVLYLEETGLGIEAIRTDGVFFTIVMEVSKDVKPGISPIKFES
FGATADNDMNEMTPKLVEGKVEIIEASAPEATPTPGSTAGSGAGGGTGSSGSGQPSATPT
PTATEKPSTTPKTTEQPHEDIPQSGGTGEHAPFLKGYPGGLFKPENNITRAEAAVIFAKL
LGADENSAGKNSSITFKDLKDSHWAAWAIKYVTEQNLFGGYPDGTFMPDKSITRAEFATV
TYKFLEKLGKIEQGTDVKTQLKDIEGHWAQKYIETLVAKGYIKGYPDETFRPQASIKRAE
SVALINRSLERGPLNGAVLEFTDVPVNYWAYKDIAEGVIYHSYKIDENGQEVMVEKLD
>APPA_BACSU.1 [24,543]  P42061 Oligopeptide-binding protein 
CSGSKSSNSSAKKSAGKPQQGGDLVVGSIGEPTLFNSLYSTDDASTDIENMLYSFLTKTD
EKLNVKLSLAESIKELDGGLAYDVKIKKGVKFHDGKELTADDVVFTYSVPLSKDYKGERG
STYEMLKSVEKKGDYEVLFKLKYKDGNFYNNALDSTAILPKHILGNVPIADLEENEFNRK
KPIGSGPFKFKEWKQGQYIKLEANDDYFEGRPYLDTVTYKVIPDANAAEAQLQAGDINFF
NVPATDYKTAEKFNNLKIVTDLALSYVYIGWNEKNELFKDKKVRQALTTALDRESIVSQV
LDGDGEVAYIPESPLSWNYPKDIDVPKFEYNEKKAKQMLAEAGWKDTNGDGILDKDGKKF
SFTLKTNQGNKVREDIAVVVQEQLKKIGIEVKTQIVEWSALVEQMNPPNWDFDAMVMGWS
LSTFPDQYDIFHSSQIKKGLNYVWYKNAEADKLMKDAKSISDRKQYSKEYEQIYQKIAED
QPYTFLYYPNNHMAMPENLEGYKYHPKRDLYNIEKWWLAK
>APU_THEET.1 [32,1481]   P38939 Amylopullulanase precursor (
ETDTAPAIANVVGDFQSKIGDSDWNINSDKTVMTYKGNGFYEFTTPVALPAGDYEYKVAL
NHSWEGGGVPSQGNLSLHLDSDSVVTFYYNYNTSSVTDSTKYTPIPEEKLPRIVGTIQSA
IGAGDDWKPETSTAIMRDYKFNNVYEYTANVPKRYYEFKVTLGPSWDINYGLNGEQNGPN
IPLNVAYDTKITFYYDSVSHNIWTDYNPPLTGPDNNIYYDDLKHDTHDPFFRFAFGAIKT
GDTVTLRIQAKNHDLESAKISYWDDIKKTRTEVPMYKIGQSPDGQYEYWEVKLSFDYPTR
IWYYFILKDGTKTAYYGDNDEQLGGVGKATDTVNKDFELTVYDKNLDTPDWMKGAVMYQI
FPDRFYNGDPLNDRLKEYSRGFDPVEYHDDWYDLPDNPNDKDKPGYTGDGIWNNDFFGGD
LQGINDKLDYLKNLGISVIYLNPIFQSPSNHRYDTTDYTKIDELLGDLDTFKTLMKEAHA
RGIKVILDGVFNHTSDDSIYFDRYGKYLDNELGAYQAWKQGDQSKSPYGDWYEIKPDGTY
EGWWGFDSLPVIRQINGSEYNVKSWADFIINNPNAISKYWLNPDGDKDAGADGWRLDVAN
EIAHDFWVHFRAAINTVKPNAPMIAELWGDASLDLLGDSFNSVMNYLFRNAVIDFILDKQ
FDDGNVVHNPIDAAKLDQRLMSIYERYPLPVFYSTMNLLGSHDTMRILTVFGYNSANENQ
NSQEAKDLAVKRLKLAAILQMGYPGMPSIYYGDEAGQSGGKDPDNRRTFSWGREDKDLQD
FFKKVVNIRNENQVLKTGDLETLYANGDVYAFGRRIINGKDVFGNSYPDSVAIVVINKGE
AKSVQIDTTKFVRDGVAFTDALSGKTYTVRDGQIVVEVVALDGAILISDPGQNLTAPQPI
TDLKAVSGNGQVDLSWSAVDRAVSYNIYRSTVKGGLYEKIASNVTQITYIDTDVTNGLKY
VYSVTAVDSDGNESALSNEVEAYPAFSIGWAGNMNQVDTHVIGVNNPVEVYAEIWAEGLT
DKPGQGENMIAQLGYRYIGDGGQDATRNKVEGVEINKDWTWVDARYVGDSGNNDKYMAKF
VPDMVGTWEYIMRFSSNQGQDWTYTKGPDGKTDEAKQFIVVPSNDVEPPTALGLQQPGIE
SSRVTLNWSLSTDNVAIYGYEIYKSLSETGPFVKIATVADTVYNYVDTDVVNGKVYYYKV
VAVDTSFNRTASNIVKATPDIIPIKVIFNVTVPDYTPDDGANIAGNFHDAFWNPSAHQMT
KTGPNTYSITLTLNEGTQLEYKYARGSWDKVEKGEYGEEIANRKITVVNQGSNTMVVNDT
VQRWRDLPIYIYSPKDNTTVDANTNEIEIKGNTYKGAKVTINDESFVQQENGVFTKVVPL
EYGVNTTKIHVEPSGDKNNELTKDITITVIREEPVQEKEPTPTPESEPAPMPEPQPTPTP
EPQPSAIMAL
>APU_THESA.1 [36,1279]   P36905 Amylopullulanase precursor (
ADNASVVANIVGDFQDQLGDSNWNIDSNITIMQYVGNGLYEFTTPTQLKAGSYQYKVALN
HSWNGGGVPSQGNLTLNLTNDSYVTFWFDYNTQSVTDSTKYTPISNDKLPRLVGTIQSAI
GAGKDWDPGTSTAIMIDDNFDNVYSYTAHIPKGDYQYKVTLGNTWAENYGANGVQDGSNI
QLSVANDADITFFYDANTHNIWTNYSPTLTGLDNNIYYDDLKHDTHDPFFRNPFGAIKVG
QTVTLRIQAKNHDLESARISYWDDINKTRTELPMTRIGESPDGNYEYWEIKLSFDHPTRI
WYYFILKDGTKTAYYGDNDDQLGGLGKATDTVNKDFELTVYDKNFDTNDWMKGAVMYQIF
PDRFYNGDTSNDHAKTLSRGNDPIEFHNDWNDLPDNPNNAGTPGYTGDGIWSNDFFGGDL
KGIDDKLDYLKGLGVSVIYLNPIFESPSNHKYDTADYTKIDEMFGTTQDFEKLMSDAHAK
GINIILDGVFNHTSDDSIYFNRYGKYPDLGAYQDWKDGNQSLSPYGDWYTINSDGTYECW
WGYDSLPVIKSLNGSEYNVTSWANFIINDKNAISKYWLNPDENLNDGADGWRLDVENEVA
HDFWTHFRDAINTVKPEAPMIAENWGDASLDLLGDSFNSVMNYQFRNDIIDFLIGQSFDD
GNGQHNPIDAAKLDQRLMSIYERYPLPAFYSTMNLLGSHDTMSILTVFGYNSADPNENSD
AAKRLAEQKLKLATILQMGYPGMADIYYGDEAGVSGGKDPDDRRTFPWGNEDTALQDFFK
NVSSIRNNNQVLKTGDLETLYAQNDVYAIGRRIINGKDAFGNSYPDSAAIVAINRSNSDQ
QITIDTTKFLRDGVAFKDLINGDKSYTINGGQITINIPAMSGVMLISDDGQDLTAPQVPS
NVVATSGNGKVDLSWSQSDGATGYNIYRSSVEGGLYEKIASNVTGTTFEDTNVTNGLKYV
YAISAVDELGNESEMSIDTVAYPAYPIGWVGNLTQVVDNHVISVSNPTEDIYAEVWADGL
TNSTGQGPNMIAQLGYKYVGGTVNDSVYGSVYNSVYGVDDSDFTWVNAQYVGDIGNNDQY
KASLHLINRSMGYLMRFSDNQGQSWTTTDTLSFYVVPSDDLIKPTAPILNQPGVESSRVS
LTWSPSTDNVGIYNYEIYRSDGGTFNKIATVSNEVYNYVDTSVINGTTYSYKVVAADPSF
NRTESNVVTIKPDVVPIKVTFNVTVPDYTPNSVNLAGTFPNATW
>APU_THETU.1 [36,1861]   P38536 Amylopullulanase precursor (
ADNASVVANIVGEFQDQLGDSNWNIDSNITIMQYMGNGLYEFTTPTQLKAGSYQYKVALN
HSWDGGGVPSQGNLTLNLANDSYVTFWFDYNTQSVTDSTKYTPIANDKLPRLVGTIQSAI
GAGNDWKPETSTAIMTDDNFDNVYSYTAHVPKGDYQYKVTLGNTWDENYGANGVKDGSNI
QINVTNDADITFYYDANTHNIWTNYSPILTGLDNNIYYDDLKHDTHDSFFRNPFGAVKVD
QTVTLRIQAKNHDLESARISYWDDINKIRIELPMTRIGESPDGNFEYWEIKLSFDHPTRI
WYYFILKDGTKTAYYGDNDDQLGGVGKATDTVNKDFELTVYDKNFDTPDWMKGAVMYQIF
PDRFYNGDTSNDHAKTLSRGNDPIEFHNNWNDLPDNPNNAGTPGYTGDGIWSNDFFGDLK
GIDDKLDYLKGLGVSVIYLNPIFESPSNHKYDTADYTKIDEMFGTTQDFEKLMSDAHAKG
IKIILDGVFNHTSDDSIYFNRYGKYPGLGAYQAWKEGNQSLSPYGDWYTINSDGTYECWW
GYDSLPVIKSLNGSEYNVTSWANFIINDENAISKYWLNPDGNLNDGADGWRLDVENEVAH
DFWTHFRNAINTVKFEAPMIAENWGDASLDLLGDSFNSVMNYQFRNDIIDFLIGQSFDDG
NGQHNPIDAAKLDQRLMSIYERYPLPAFYSTMNLLGSHDTMRILTVFGYNSADPNENSDA
AKQLAEQKLKLATILQMGYPGMADIYYGDEAGVSGGKDPDDRRTFPWGNEDTTLQDFFKN
ISSIRNNNQVLKTGDLETLYAQNDVYAIGRRIINGKDAFGTSYPDSAAIVAINRSKSDKQ
IAIDTTKFLRDGVTFKDLINNNVSYSISNGQIVIDVPAMSGVMLISDDGQDLTAPQAPSN
VVVTSGNGKVDLSWLQSDGATGYNIYRSSVEGGLYEKIASNVTETTFEDANVTNGLKYVY
AISAIDELGNESGISNDAVAYPAYPIGWVGNLTQVSDNHIIGVDKPTEDIYAEVWADGLT
NSTGQGPNMIAQLGYKYVSGTVYDSVYGSVYNSVYGVDDSGFTWVNAQYVGDIGNNDQYK
ASFTPDKIGQWEYLMRFSDNQGQDWITTSTLSFYVVPSDDLIKPTAPYLNQPGTESSRVS
LTWNPSTDNVGIYDYEIYRSDGGTFNKIATVSNEVYNYIDTSVINGVTYNYKVVAVDLSF
NRTESNVVTIKPDVVPIKVIFNVTVPDYTPDAVNLAGTFPNATWDPSAQQMTKIDNNTYS
ITLTLDEGTQIEYKYARGSWDKVEKDEYGNEFASNRKVTIVNQGNNEMTINDTVYRWRDI
PIFIYSPSSNMTVDSNISTMEVKGNTYKGAKVTINGDSFVQDKNGVFTKDVSLNYGVNKI
KIHVEPNDGSVYGNDQGRITELTKDIEIDVIRQENNSGSGTGNNNTSTSGSNSSSTGSGS
TGSTSITSNISNTSNTSNTIGVITKNGNVITLTLDAGKAKDLIVNSKDKKVVFDITTIGE
GQQKVVQISKDILDTSAANGKDIVIKSDNASIALTKDALNQNQIQNGVNVSIKDNGKPNV
TNYVSLSNVVDITISGISGNVTLAKPVEVTLNISKANDPRKVAVYYYNPTTNQWEYVGGK
VDASSGTITFNATHFSQYAAFEYDKTFNDIKDNWAKDVIEVLASRHIVEGMTDTQYEPNK
TVTRAEFTAMILRLLNIKDETYSGEFSDVKSGDWYANAIEAAYKAGIIEGDGKNARPNDS
ITREEMTAIAMRAYEMLTQYKEENIGATTFSDDKSISDWARNVVANAAKLGIVNGEPNNV
FAPKGNATRAEAAAIIYGLLEKSGNI
>APU_THETY.1 [32,1475]   P16950 Amylopullulanase precursor (
ETDTAPAIANVVGNFQSKLGDSDWNINSDKTIMTYKGNGFYEFTTPVALPAGDYEYKVAL
NHSWEGGGVPSQGNLSFHLDSDSVVTFYYNYNTSSITDSTKYTPIPEDKLPRLVGTIQPA
IGAGDDWKPETSTAIMRDYKFNNVYEYTANVPKGNYEFKVTLGPSWDINYGLNGEQNGPN
IPLNVAYDTKITFYYDSVSHNIWTDYNPPLTGPDNNIYYDDLRHDTHDPFFRSPFGAIKT
GDTVTLRIQAKNHDIESAKISYWDDIKKTRIEVPMYRIGQSPDGKYEYWEVKLSFDHPTR
IWYYFILKDGTKTAYYGDNDEQLGGVGKATDTENKDFELTVYDKNLDTPDWMKGSVMYQI
FPDRFFNGDSSNDHLKKYSRGFDPVEYHSNWYELPDNPNDKNKLGYTGDGIWSNDFFGGD
LKGIDDKLDYLKSLGISVIYLNPIFQSPSNHRYDTTDYTKIDELLGDLSTFKKLMEDAHA
KGIKVILDGVFNHTSDDSIYFDRYGKYLNTGVLGAYQAWKQGDQSKSPYGDWYEIKPDGT
YEGWWGFDSLPVIRQINGSEYNVKSWADFIINNPNAISKYWLNPDGDKNVGADGWRLDVA
NEVAHDFWVHFRGAINTVKPNAPMVAENWNDASLDLLGDSFNSVMNYLFRNAVIDFILDK
SFDDGNVVHNPIDAAKLDQRLMSIYERYPLPVFYSTMNLLGSHDTMRILTVFGYNSADEN
QNSQAAKDLAVKRLKLAAILQMGYPGMPSIYYGDEAGQSGGKDPDNRRTFPWGREDTDLQ
TFFKKVVNIRNENQVLKTGDLETLYANGDVYAFGRRIINGKDTFGKSYPDSVAIVVINKG
DAKQVSIDTTKFIRDGVAFTDALSGKTYTVQDGKIVVEVGSMDGAILISDTGQNLTAPQP
ITDLKAVSGNGKVDLSWSVVDKAVSYNIYRSTVKGGLYEKIASNVTQITYTDTEVTNGLK
YVYAVTAVDNDGNESALSNEVEAYPAFPIGWAGNMNQVNTHVIGVNNPVEVYAEVWAQGL
TDKPGQGENMIAQLGYRYIGDTVGDAVYNAVYNKVEGVEISKDWTWVDAQYVGDSGNNDK
YMAKFVPDMVGTWEYIMRFSSNQGHDWTYTKGPDGKTDEAKQFTVVPSNDVETPTAPVLQ
QPGIESSRVTLNWSPSADDVAIFGYEIYKSSSETGPFIKIATVSDSVYNYVDTDVVNGNV
YYYKVVAVDTSYNRTASNTVKATPDIIPIKVTFNVTIPDYTPDDGVNIAGNFPDAFWNPN
ANQMTKAGSNTYSITLTLNEGTQIEYKYARGSWDKVEKGEYGNEIDNRKITVVNQGSNTM
VVNDTVQRWRDVPIYIYSPKDKTIVDANTSEIEIKGNTYKGAKVTINDESFVQQENGVFT
KVVPLEYGVNTIKIHVEPSGDKNNELTKDITITVTREKPARRQNLLLLHQQKQQNHLKKY
HKAK
>ARAN_BACHD.1 [21,445]  Q9KEE7 Probable arabinose-binding pr
CGGSSSSSSDADETSVIGDDIEGATELIFWTFAGQHVDLFEDAVVSWNEEFPDRPIKLVA
ETYPFDQMHNNLLLALQSGSGAPDLADIEVSRFPNFLQGVPQLLPMNDHVEPVIDKFVEA
RFNLYAKDGEYYGIPTHVGASVMYYNKEIMDEAGVDIESIETWDDYVEAGKQVVERTGKV
MTTVPTDDYLPMFQMVSQRGSDFFDENGNLTLDTQENIEVLQFLYDLIYVHEIAELTPGG
QPHAEEYYQYMNDGNVASMAMPIWYMGRFLDNMPDLAGKMLIQPLPAWEEGGFRSAGMGG
TGTVVTNQTDHEELAKDFLAYAKISEKANEKLWTILGFDPPRWDVWDNPVFQEDNDFYQF
FGENIFEVLLDVRDEINSINISQYTPSVANEFSTNIFNDVLRQQTHTPEEALKKAQETIE
ANMQQ
>ARAN_BACSU.1 [22,433]  P94528 Probable arabinose-binding pr
CSAEKSSGKSGETELTFWTFSGLHEQFYVEMVKEWNKKYPDRKIKLNTVVYPYGQMHDNL
SISLIAGEGVPDIADVELARFSNFLKGSDIPLADLTPLIEKDRDKFVEARLTLYSKNGKL
YGLDTHVGTTVMFYNMDVMKKAGVNPDDIKTWDDYHKAGQKVRKVTGKPMGTVETNDSAT
FLSMISQQNSGYFDKNGKLILNNDTNVKTLQYLKDMINDKTMIPAPGGGHHSEEYYGFMN
QGGAASVLMPIWYMGRFIDYMPDLKGKIAIRPLPAWKEGGDRSAGLGGTATVVPKQSKHV
ELAKEFLAFAKGSEEGNKKLWSVLGFDPLRWDVWSSKELKEKNKYTDYFQNGTGIFSVLL
DIKDEINPIYLHEDFAKASDLVNRSVLFDALKSQQKTPKQALDRAAGELKQK
>ARC3_CLOLM.1 [46,250]  Q46134 Mono-ADP-ribosyltransferase C
PYADSFKEFTNIDEARAWGDKQFAKYKLSSSEKNALTIYTRNAARINGPLRANQGNTNGL
PADIRKEVEQIDKSFTKMQTPENIILFRGDDPGYLGPDFENTILNRDGTINKAVFEQVKL
RFKGKDRKEYGYISTSLVNGSAFAGRPIITKFKVLDGSKAGYIEPISTFKGQLEVLLPRS
STYTISDMQIAPNNKQIIITALLKR
>ARP4_STRPY.1 [42,386]  P13050 IgA receptor precursor. - Str
AEIKKPQADSAWNWPKEYNALLKENEELKVEREKYLSYADDKEKDPQYRALMGENQDLRK
REGQYQDKIEELEKERKEKQERQEQLERQYQIEADKHYQEQQKKHQQEQQQLEAEKQKLA
KDKQISDASRQGLSRDLEASRAAKKELEAEHQKLKEEKQISDASRQGLSRDLEASREAKK
KVEADLAALTAEHQKLKEDKQISDASRQGLSRDLEASREAKKKVEADLAEANSKLQALEK
LNKELEEGKKLSEKEKAELQARLEAEAKALKEQLAKQAEELAKLKGNQTPNAKVAPQANR
SRSAMTQQKRTLPSTGETANPFFTAAAATVMVSAGMLALKRKEEN
>ASA1_ENTFA.1 [44,1296]  P17953 Aggregation substance precur
AELDTQPGTTTVQPDNPDPQVGSTTPKTAVTEEATVQKDTTSQPTKVEEVASEKNGAEQS
SATPNDTTNAQQPTVGAEKSAQEQPVVSPETTNEPLGQPTEVAPAENEANKSTSIPKEFE
TPDVDKAVDEAKKDPNITVVEKPAEDLGNVSSKDLAAKEKEVDQLQKEQAKKIAQQAAEL
KAKNEKIAKENAEIAAKNKAEKERYEKEVAEYNKHKNENGYVAKPVNKTLIFDREATKNS
KVVSVKAAEYIDAKKLTDKHKDKKLLISMLSVDSSGLTTKDSKKAHFYYNNGAGGTLVVL
HKNQPVTITYGNLNASYLGKKIASAEFQYTVKATPDSKGRLNAFLHDDPVATIVYGINID
PRTKKAGAEIEMLVRFFGEDGKEILPTKENPFVFSGASLNSRGENITYEFVKVGNTDTVH
EINGSKVARHGNKVYSKTDIDVGTNGISISDWEAVQGKEYIGATVISTPNRIKFTFGNEI
VNNPGYDGNSMWFAFNTDLKAKSITPYQEKGRPKQPEKATIEFNRYKANVVPVLVPNKEV
TDGQKNINDLNVKRGDSLQYIVTGDTTELAKVDPKTVTKQGIRDTFDAEKVTIDLSKVKV
YQADASLNEKDLKAVAAAINSGKAKDVTASYDLHLDQNTVTAMMKTNADDSVVLAMGYKY
LLVLPFVVKNVEGDFENTAVQLTNDGETVTNTVINHVPGSNPSKDVKADKNGTVGSVSLH
DKDIPLQTKIYYEVKSSERPANYGGITEEWGMNDVLDTTHDRFTGKWHAITNYDLKVGDK
TLKAGTDISAYILLENKDNKDLTFTMNQALLAALNEGSNKVGKQAWSVYLEVERIKTGDV
ENTQTENYNKELVRSNTVVTHTPDDPKPTKAVHNKKGEDINHGKVARGDVLSYEMTWDLK
GYDKDFAFDTVDLATGVSFFDDYDETKVTPIKDLLRVKDSKGEDITNQFTISWDDAKGTV
TISAKDPQAFILAHGGQELRVTLPTKVKANVSGDVYNLAEQNTFGQRIKTNTVVNHIPKV
NPKKDVVIKVGDKQSQNGATIKLGEKFFYEFTSSDIPAEYAGIVEEWSISDKLDVKHDKF
SGQWSVFANSTFVLADGTKVNKGDDISKLFTMTFEQGVVKITASQAFLDAMNLKENKNVA
HSWKAFIGVERIAAGDVYNTIEESFNNEKIKTNTVVTHTPEKPQTPPEKTVIVPPTPKTP
QAPVEPLVVEKASVVPELPQTGEKQNVLLTVAGSLAAMLGLAGLGFKRRKETK
>ATL_STAAU.1 [30,1256]   P52081 Bifunctional autolysin precu
AETTQDQTTNKNVLDSNKVKATTEQAKAEVKNPTQNISGTQVYQDPAIVQPKTANNKTGN
AQVSQKVDTAQVNGDTRANQSATTNNTQPVAKSTSTTAPKTNTNVTNAGYSLVDDEDDNS
ENQINPELIKSAAKPAALETQYKTAAPKAATTSAPKAKTEATPKVTTFSASAQPRSVAAT
PKTSLPKYKPQVNSSINDYICKNNLKAPKIEEDYTSYFPKYAYRNGVGRPEGIVVHDTAN
DRSTINGEISYMKNNYQNAFVHAFVDGDRIIETAPTDYLSWGVGAVGNPRFINVEIVHTH
DYASFARSMNNYADYAATQLQYYGLKPDSAEYDGNGTVWTHYAVSKYLGGTDHADPHGYL
RSHNYSYDQLYDLINEKYLIKMGKVAPWGTQSTTTPTTPSKPTTPSKPSTGKLTVAANNG
VAQIKPTNSGLYTTVYDKTGKATNEVQKTFAVSKTATLGNQKFYLVQDYNSGNKFGWVKE
GDVVYNTAKSPVNVNQSYSIKPGTKLYTVPWGTSKQVAGSVSGSGNQTFKASKQQQIDKS
IYLYGSVNGKSGWVSKAYLVDTAKPTPTPTPKPSTPTTNNKLTVSSLNGVAQINAKNNGL
FTTVYDKTGKPTKEVQKTFAVTKEASLGGNKFYLVKDYNSPTLIGWVKQGDVIYNNAKSP
VNVMQTYTVKPGTKLYSVPWGTYKQEAGAVSGTGNQTFKATKQQQIDKSIYLFGTVNGKS
GWVSKAYLAVPAAPKKAVAQPKTAVKAYTVTKPQTTQTVSKIAQVKPNNTGIRASVYEKT
AKNGAKYADRTFYVTKERAHGNETYVLLNNTSHNIPLGWFNVKDLNVQNLGKEVKTTQKY
TVNKSNNGLSMVPWGTKNQVILTGNNIAQGTFNATKQVSVGKDVYLYGTINNRTGWVNAK
DLTAPTAVKPTTSAAKDYNYTYVIKNGNGYYYVTPNSDTAKYSLKAFNEQPFAVVKEQVI
NGQTWYYGKLSNGKLAWIKSTDLAKELIKYNQTGMTLNQVAQIQAGLQYKPQVQRVPGKW
TDAKFNDVKHAMDTKRLAQDPALKYQFLRLDQPQNISIDKINQFLKGKGVLENQGAAFNK
AAQMYGINEVYLISHALLETGNGTSQLAKGADVVNNKVVTNSNTKYHNVFGIAAYDNDPL
REGIKYAKQAGWDTVSKAIVGGAKFIGNSYVKAGQNTLYKMRWNPAHPGTHQYATDVDWA
NINAKIIKGYYDKIGEVGKYFDIPQYK
>ATPF_MYCGA.1 [26,198]  P33256 ATP synthase B chain precurso
CSIPEELQAKTIVNEFFPNFWVFVAHTIALSIIILLGIFLLWKPTKRFLAKRSELIQAEI
NNANEIKKQAQFLLDNAKKQKQNAELQAREIINLATNQAYRLKNDLETDAKRKANRIIEN
AHAEIIKQESILKRELEGRIVDVALEATSTLIQKNVAKEDHERLVNELLRNLD
>ATPF_MYCGE.1 [28,208]  P47643 ATP synthase B chain precurso
CTENVREIKSSSVINELFPNFWVFITHLLAFFILLTLMIFLFWKPTQRFLNNRKNLLEAQ
IKQANELEKQARNLLEESNQRHEKALIVSKEIVDQANYEALQLKSEIEKTANRQANLMIF
QARQEIEKERRSLKEQSIKESVELAMLAAQELILKKIDQKSDREFIDKFIRDLEANETED
D
>ATPF_MYCPN.1 [28,207]  Q50327 ATP synthase B chain precurso
CTENVKEIKSESVINELFPNLWVFLAHLLAFVILLFLLLFLFWKPTQKFLNQRKALLEEQ
VNQANSLEQQAQALLQQANQRHENSLVVAKEIVDQANYEALQLKSEIEKKANRQANLMIF
QARQEIEKEKRLIQEQSLKESVELAMLAAKELIIKKVDVKADKAFIEEFIRELEAEDDHD
>AURE_STAAU.1 [28,509]  P81177 Zinc metalloproteinase aureol
SDTNHKPATSDINFEITQKSDAVKALKELPKSENVKNHYQDYSVTDVKTDKKGFTHYTLQ
PSVDGVHAPDKEVKVHADKSGKVVLINGDTDAKKVKPTNKVTLSKDEAADKAFNAVKIDK
NKAKNLQDDVIKENKVEIDGDSNKYIYNIELITVTPEISHWKVKIDADTGAVVEKTNLVK
EAAATGTGKGVLGDTKDININSIDGGFSLEDLTHQGKLSAYNFNDQTGQATLITNEDENF
VKDDQRAGVDANYYAKQTYDYYKNTFGRESYDNHGSPIVSLTHVNHYGGQDNRNNAAWIG
DKMIYGDGDGRTFTNLSGANDVVAHELTHGVTQETANLEYKDQSGALNESFSDVFGYFVD
DEDFLMGEDVYTPGKEGDALRSMSNPEQFGQPSHMKDYVYTEKDNGGVHTNSGIPNKAAY
NVIQAIGKSKSEQIYYRALTEYLTSNSNFKDCKDALYQAAKDLYDEQTAEQVYEAWNEVG
VE
>BAG_STRAG.1 [38,1164]   P27951 IgA FC receptor precursor (B
SELVKDDSVKTTEVAAKPYPSMAQTDQGNNSSSSELETTKMEIPTTDIKKAVEPVEKTAG
ETSATDTGKREKQLQQWKNNLKNDVDNTILSHEQKNEFKTKIDETNDSDALLELENQFNE
TNRLLHIKQHEEVEKDKKAKQQKTLKQSDTKVDLSNIDKELNHQKSQVEKMAEQKGITNE
DKDSMLKKIEDIRKQAQQADKKEDAEVKVREELGKLFSSTKAGLDQEIQEHVKKETSSEE
NTQKVDEHYANSLQNLAQKSLEELDKATTNEQATQVKNQFLENAQKLKEIQPLIKETNVK
LYKAMSESLEQVEKELKHNSEANLEDLVAKSKEIVREYEGKLNQSKNLPELKQLEEEAHS
KLKQVVEDFRKKFKTSEQVTPKKRVKRDLAANENNQQKIELTVSPENITVYEGEDVKFTV
TAKSDSKTTLDFSDLLTKYNPSVSDRISTNYKTNTDNHKIAEITIKNLKLNESQTVTLKA
KDDSGNVVEKTFTITVQKKEEKQVPKTPEQKDSKTEEKVPQEPKSNDKNQLQELIKSAQQ
ELEKLEKAIKELMEQPEIPSNPEYGIQKSIWESQKEPIQEAITSFKKIIGDSSSKYYTEH
YFNKYKSDFMNYQLHAQMEMLTRKVVQYMNKYPDNAEIKKIFESDMKRTKEDNYGSLEND
ALKGYFEKYFLTPFNKIKQIVDDLDKKVEQDQPAPIPENSEMDQAKEKAKIAVSKYMSKV
LDGVHQHLQKKNNSKIVDLFKELEAIKQQTIFDIDNAKTEVEIDNLVHDAFSKMNATVAK
FQKGLETNTPETPDTPKIPELPQAPDTPQAPDTPHVPESPKAPEAPRVPESPKTPEAPHV
PESPKAPEAPRVPESPKTPEAPHVPESPKTPEAPKIPEPPKTPDVPKLPDVPKLPDVPKL
PDAPKLPDGLNKVGQAVFTSTDGNTKVTVVFDKPTDADKLHLKEVTTKELADKIAHKTGG
GTVRVFDLSLSKGGKETHVNGERTVRLALGQTGSDVHVYHVKENGDLERIPSKVENGQVV
FKTNHFSLFAIKTLSKDQNVTPPKQTKPSTQGSQVEIAESQTGKFQSKAANHKALATGNE
TVAKGNPTSTTEKKLPYTGVASNLVLEIMGLLGLIGTSFIAMKRRKS
>BDBA_BACSU.1 [26,137]  O31987 Disulfide bond formation prot
SEKPFYNDINLTQYQKEVDSKKPKFIYVYETSCPPCQEIKPELNEVIKKEKLKVQALNIE
EKENYNTEFLDKYNLNKTPTILYYKDGKEKDRLEGYRSASQIEKFFDKNGDR
>BDBD_BACAN.1 [29,217]  Q81YT8 Probable disulfide bond forma
IINDKKDKGNEMFAYSTQQSLGKDDAPVKVVEFGDFKCPACRTWDVTVLPRLKEEYIDKG
KVQLYFINFPFIGKDSDLGAAAGEAIYKQDQDSFWIFYDEIYQSQKKDTEEWITEELLLN
IVKEKLPKIDVEQFKKDLHSKEIKEKVRKDSDRAQKLKVQGAPSVYVNGNLANPDFDSLK
KAIDKELKK
>BDBD_BACCR.1 [26,216]  Q81I73 Probable disulfide bond forma
YSIINDKKDKGNEMFAYSTQQSLGKDDAPVKVVEFGDFKCPACRTWDVTVLPRLKEEYID
KGKVQLYFINFPFIGKDSDLGAAAGEAIYKQDKDSFWIFYDEIYQNQKKDTEEWITEDLL
LSIVKEKLPKVDVEQFKKDLHSKDIKEKVSKDSDRAQKLKVQGAPSVYVNGNLANPDFDS
MKKAIDKELKK
>BDBD_BACSU.1 [37,222]  O32218 Disulfide bond formation prot
NDAVSGQPSIKGQPVLGKDDAPVTVVEFGDYKCPSCKVFNSDIFPKIQKDFIDKGDVKFS
FVNVMFHGKGSRLAALASEEVWKEDPDSFWDFHEKLFEKQPDTEQEWVTPGLLGDLAKST
TKIKPETLKENLDKETFASQVEKDSDLNQKMNIQATPTIYVNDKVIKNFADYDEIKETIE
KELKGK
>BDB_BACBR.1 [28,118]   Q44856 Disulfide bond formation prot
SSQDSKIVYVFSDSCGYCQTFRPTLETVLQEYPQTSVERLDIREERDLKEALRLGAEATP
TIFVVRDGTVMDKLEGDVAEAVLRSFFQKKS
>BLA1_BACCE.1 [44,306]  P10424 Beta-lactamase, type I precur
HKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQN
STKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPK
GYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNI
LTEWMKGNATGDKLIRAGVPTDWVDADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKD
EKEATYDNQLIKEAAEVVIDAIK
>BLA1_BACMY.1 [44,306]  P28018 Beta-lactamase, type I precur
HKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQN
SIDTLNEVIKFTKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPK
GYEKALRQIGDRVTMSDRFETELNEAIPGDIRDTSTAKAIASNLKAFTVGNALPAEKRKI
LTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKD
EKEATYDNQLIAEAPEVIVKSLK
>BLA2_BAC17.1 [31,257]  P10425 Beta-lactamase II precursor (
SQKVEQIVIKNETGTISISQLNKNVWVHTELGYFNGEAVPSNGLVLNTSKGLVLVDSSWD
NKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGITALKERGIKAHSTALTAELAKKSGY
EEPLGDLQTVTNLKFGNTKVETFYPGKGHTEDNIVVWLPQYQILAGGCLVKSAEAKNLGN
VADAYVNEWSTSIENMLKRYRNINLVVPGHGKVGDKGLLLHTLDLLK
>BLA2_BACCE.1 [31,257]  P04190 Beta-lactamase II precursor (
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>BLA3_BACCE.1 [30,316]  P06548 Beta-lactamase III precursor 
CSNSNTQSESNKQTNQTNQVKQENKRNHAFAKLEKEYNAKLGIYALDTSTNQTVAYHADD
RFAFASTSKSLAVGALLRQNSIEALDERITYTRKDLSNYNPITEKHVDTGMTLKELADAS
VRYSDSTAHNLILKKLGGPSAFEKILREMGDTVTNSERFEPELNEVNPGETHDTSTPKAI
AKTLQSFTLGTVLPSEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDI
AIIWPPNKKPIVLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK
>BLAB_BACCE.1 [30,256]  P14488 Beta-lactamase II precursor (
ERTVEHKVIKNETGTISISQLNKNVWVHTELGYFSGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGMKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQSVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYQILAGGCLVKSASSKDLGN
VADAYVNEWSTSIENVLKRYGNINLVVPGHGEVGDRGLLLHTLDLLK
>BLAC_BACAM.1 [35,306]  Q44674 Beta-lactamase precursor (EC 
EAKSIENTKMTSCITNQKFVQLEKKFDARLGVYAIDTGSNKTIAYRPNERFAYASTYKVL
AAAAVLKQKPIEKLNDVIRYTKEDLVTYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNI
LLQQLGGPKGFEKSLKQIGDHVTKADRFETDLNSAIPGDIRDTSTAKALATDLKAFTLGN
TLTTDKRTILTDWMRGNATGDELIRAGAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPI
VLAILTKRFTKDAEYDNALIAEAAKVALDDLK
>BLAC_BACCE.1 [28,306]  P00809 Beta-lactamase, type I precur
FTGESLQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRPNERF
AFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLVDYSPVTEKHVDTGMKLGEIAEAAVR
SSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSNRFETELNEAIPGDIRDTSTAKAIAT
NLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGIPTDWVVGDKSGAGSYGTRNDIAV
VWPPNSAPIIVLISSKDEKEAIYNDQLIAEATKVIVKGS
>BLAC_BACLI.1 [27,307]  P00808 Beta-lactamase precursor (EC 
CANNQTNASQPAEKNEKTEMKDDFAKLEEQFDAKLGIFALDTGTNRTVAYRPDERFAFAS
TIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYNPITEKHVDTGMTLKELADASLRYSDN
AAQNLILKQIGGPESLKKELRKIGDEVTNPERFEPELNEVNPGETQDTSTARALVTSLRA
FALEDKLPSEKRELLIDWMKRNTTGDALIRAGVPDGWEVADKTGAASYGTRNDIAIIWPP
KGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVMKALNMNGK
>BLAC_BACSU.1 [35,306]  P39824 Beta-lactamase precursor (EC 
EAKSIEDTNMASCITNKKFVQLEKKFDARLGVYAIDIGSNKTIAYRPNERFAYASTYKVL
AAAAVLKKNSIEKLNEVIHYSKDDLVTYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNI
LLQQLGGPKGFEKSLKQIGDHVTKAKRFETDLNSAIPGDIRDTSTAKALATDLKAFTLDN
TLTTDKRMILTDWMRGNATGDELIRAGAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPI
VVAILSNRFTKDANYDNALIAEAAKVVLNDLK
>BLAC_BACTU.1 [29,309]  Q45726 Beta-lactamase, type I precur
FTGGALQVEAKQKTGQVKHKNQATHKEFSQLEKKFDARVGVYAIDTGTNQTISYRSNERF
AFASTYKALAAGVLLQQNSIDTLNEVITFTKEDLVDYSPVTEKHVDTGMKLGEIAEAAVR
SSDNTAGNILFNKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKRIAT
NLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAI
VWPPNRAPIIIAILSSKDEKEASYDNQLIAEATEVIVKALK
>BLAC_STAAU.1 [25,281]  P00807 Beta-lactamase precursor (EC 
KELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNK
KVHINKDDIVAYSPILEKYVGKDITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLK
ELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLN
NKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDK
PNDKLISETAKSVMKEF
>BOFC_BACSU.1 [31,170]  O05391 BofC protein precursor (Bypas
AEVEHYEPLQVHVQLEKVYLDGDVSIEHKHEKVFSMDDFWAAYAGWTLVEQKKGYVLFRK
QMDDISPLSKVNGYIGVSDNGVISTFHGRPEPASEPIQSFFQIDLERLESHMQKNLLKGI
PFRTKAEFEDVIEHMKTYSG
>BSN1_BACSU.1 [25,289]  Q03091 Extracellular ribonuclease pr
SAGAPADTNLYSRLAVSTAGGTTLFPQTSSAVITPSADTETYYKEASGKSGTALKSALHR
IISGHTKLSYSQVWNALKETDEDPANPNNVILLYTQESRAKSKNGGSVGDWNREHVWAKS
HGNFGTAAGPGTDIHHLRPADVQVNSARGNMDFDNGGSEYPKAPGNYYDGDSWEPRDEVK
GDVARMLFYMAVRYEGGDGYPDLELNDKTGNGSAPYMGKLSVLLKWNKQDPVDSKEKRRN
EIIYEDYQHNRNPFIDHPEWADEIW
>BSN2_BACSU.1 [27,288]  O32150 Extracellular ribonuclease pr
SAQTTLSLNDRLASSPSGTGSLLSLAAPAAPYADTDTYYEGAEGKTGDSLKSTLHRIISG
HTMLSYSEVWNALKETDEDPRNPNNVILLYTNESRSKNLNGGNVGDWNREHVWAKSHGDF
GTSKGPGTDIHHLRPADVQVNSARGNMDFDNGGTEYAKAPGNYYDGDSWEPRDDVKGDVA
RMLFYMAVRYEGDDGYPDLELNDKTGNGSAPYHGKQSVLLEWNKQDPVDDRERKRNEIIY
EKYQHNRNPFIDHPEWADEIWP
>C551_BACP3.1 [19,111]  Q56247 Cytochrome c-551 precursor (C
CGGGGDNAGEKNGGSNGGGDTAAAAEQIFKQNCASCHGQDLSGGVGPNLQKVGSKYSKDE
IKNIIANGRGAMPAGIIKGEDADKVAEWLAAKK
>CBPA_CLOCL.1 [29,1848]  P38058 Cellulose binding protein A 
ATSSMSVEFYNSNKSAQTNSITPIIKITNTSDSDLNLNDVKVRYYYTSDGTQGQTFWCDH
AGALLGNSYVDNTSKVTANFVKETASPTSTYDTYVEFGFASGRATLKKGQFITIQGRITK
SDWSNYTQTNDYSFDASSSTPVVNPKVTGYIGGAKVLGTAPGPDVPSSIINPTSATFDKN
VTKQADVKTTMTLNGNTFKTITDANGTALNASTDYSVSGNDVTISKAYLAKQSVGTTTLN
FNFSAGNPQKLVITVVDTPVEAVTATIGKVQVNAGETVAVPVNLTKVPAAGLATIELPLT
FDSASLEVVSITAGDIVLNPSVNFSSTVSGSTIKLLFLDDTLGSQLITKDGVFATITFKA
KAITGTTAKVTSVKLAGTPVVGDAQLQEKPCAVNPGTVTINPIDNRMQISVGTATVKAGE
IAAVPVTLTSVPSTGIATAEAQVSFDATLLEVASVTAGDIVLNPTVNFSYTVNGNVIKLL
FLDDTLGSQLISKDGVFVTINFKAKAVTSTVTTPVTVSGTPVFADGTLAEVQSKTAAGSV
TINIGDPILEPTISPVTATFDKKAPADVATTMTLNGYTFNGITGLTTSDYSISGNVVKIS
QAYLAKQPVGDLTLTFNFSNGNKTATAKLVVSIKDAPKTVTATVGTATVNAGETVAVPVT
LSNVSGISTAELQLSFDATLLEVVSITAGDIVLNPSVNFSSVVNGSTIKLLFLDDTLGSQ
LISKDGVFATINFKAKSVTSTVTTPVKVSGTPVFADGTLAELSYETVAGSVTINAIGPVK
TVTATVGTATVKSGETVAVPVTLSNVPGIATAELQLSFDATLLEVASITVGDIVLNPSVN
FSSVVNGSTIKLLFLDDTLGSQLISKDGVLATINFKAKTVTSTVTTPVAVSGTPVFADGT
LAELQSKTVAGSVTIEPSQPVKTVTATVGTATVKSGETVAVPVTLSNVPGIATAELQVGF
DATLLEVASITVGDIVLNPSVNFSSVVNGSTIKLLFLDDTLGSQLISKDGVLATINFKAK
TVTSKVTTPVAVSGTPVFADGTLAELNMKTVAGSVTIEPSQPVKTVTATVGTATVKSGET
VAVPVTLSNVPGIATAELQVGFDATLLEVASITVGDIVLNPSVNFSSVVNGSTIKLLFLD
DTLGSQLISKDGVLATINFKAKTVTSKVTTPVAVSGTPVFADGTLAELKYETVAGSVTIE
PSQPVKTVTATVGTATGKVGETVAVPVTLSNVPGIATAEVQVGFDATLLEVASITAGDIV
LNPSVNFSSVVNGSTIKILFLDDTLGSQLISKDGVFATINFKIKAVPSTGTTPVAISGTP
VFADGTLAEVQYKTVAGSVTIAAADIKAVKATVGTATGKAGDTVAVPVTLSNVSGIATVE
LQLSFDATLLEVASITAGDIVLNPSVNFSSVVNGSTIKILFLDDTLGSQLISKDGVFATV
NFKVKSTATNSAVTPVTVSGTPVFADGTLAELKSESAAGRLTILPTVIIVDSTVAPTAVT
FDKANQADAAITMTLNGNTFSAIKNGTATLVKGTDYTVSENVVTISKAYLAKQTGTVTLE
FVFDKGNSAKVVVAVKEIQIVNSTITPVVATFEKTAAKQADVVVTMSLNGNTFSAIKNGT
TTLVKGTDYTISGSTVTISKAYLATLADGSATLEFVFNQGASAKLRLTIVPAVVDPVVTD
FAVKIDKVSAAAGSTVKVPVSLINVSKVGNVCVAEYKISFDSSVLTYVGTTAGTSIKNPA
VNFSSQLNGNTITLLFFDNTIGNELITADGQFATIEFKVNAAATSGTTAEVKVATISSFA
DASLTEITKVATVNGSVKVS
>CBPT_THEVU.1 [24,424]  P29068 Carboxypeptidase T precursor 
FSQNIENPSIFDLGIKLYKIDGVSTKEQRSAIASTGAAIEEVGKDYVKVLATPSEAKQIK
QKGFTATVDTSLTTQDFPSYDSGYHNYNEMVNKINTVASNYPNIVKKFSIGKSYEGRELW
AVKISDNVGTDENEPEVLYTALHHAREHLTVEMALYTLDLFTQNYNLDSRITNLVNNREI
YIVFNINPDGGEYDISSGSYKSWRKNRQPNSGSSYVGTDLNRNYGYKWGCCGGSSGSPSS
ETYRGRSAFSAPETAAMRDFINSRVVGGKQQIKTLITFHTYSELILYPYGYTYTDVPSDM
TQDDFNVFKTMANTMAQTNGYTPQQASDLYITDGDMTDWAYGQHKIFAFTFEMYPTSYNP
GFYPPDEVIGRETSRNKEAVLYVAEKADCPYSVIGKSCSTK
>CDG1_PAEMA.1 [28,714]  P04830 Cyclomaltodextrin glucanotran
SPDTSVDNKVNFSTDVIYQIVTDRFADGDRTNNPAGDAFSGDRSNLKLYFGGDWQGIIDK
INDGYLTGMGVTALWISQPVENITSVIKYSGVNNTSYHGYWARDFKQTNDAFGDFADFQN
LIDTAHAHNIKVVIDFAPNHTSPADRDNPGFAENGGMYDNGSLLGAYSNDTAGLFHHNGG
TDFSTIEDGIYKNLYDLADINHNNNAMDAYFKSAIDLWLGMGVDGIRFDAVKHMPFGWQK
SFVSSIYGGDHPVFTFGEWYLGADQTDGDNIKFANESGMNLLDFEYAQEVREVFRDKTET
MKDLYEVLASTESQYDYINNMVTFIDNHDMDRFQVAGSGTRATEQALALTLTSRGVPAIY
YGTEQYMTGDGDPNNRAMMTSFNTGTTAYKVIQALAPLRKSNPAIAYGTTTERWVNNDVL
IIERKFGSSAALVAINRNSSAAYPISGLLSSLPAGTYSDVLNGLLNGNSITVGSGGAVTN
FTLAAGGTAVWQYTAPETSPAIGNVGPTMGQPGNIVTIDGRGFGGTAGTVYFGTTAVTGS
GIVSWEDTQIKAVIPKVAAGKTGVSVKTSSGTASNTFKSFNVLTGDQVTVRFLVNQANTN
YGTNVYLVGNAAELGSWDPNKAIGPMYNQVIAKYPSWYYDVSVPAGTKLDFKFIKKGGGT
VTWEGGGNHTYTTPASGVGTVTVDWQN
>CDG2_PAEMA.1 [28,713]  P31835 Cyclomaltodextrin glucanotran
SPDTSVNNKLNFSTDTVYQIVTDRFVDGNSANNPTGAAFSSDHSNLKLYFGGDWQGITNK
INDGYLTGMGITALWISQPVENITAVINYSGVNNTAYHGYWPRDFKKTNAAFGSFTDFSN
LIAAAHSHNIKVVMDFAPNHTNPASSTDPSFAENGALYNNGTLLGKYSNDTAGLFHHNGG
TDFSTTESGIYKNLYDLADINQNNNTIDSYLKESIQLWLNLGVDGIRFDAVKHMPQGWQK
SYVSSIYSSANPVFTFGEWFLGPDEMTQDNINFANQSGMHLLDFAFAQEIREVFRDKSET
MTDLNSVISSTGSSYNYINNMVTFIDNHDMDRFQQAGASTRPTEQALAVTLTSRGVPAIY
YGTEQYMTGNGDPNNRGMMTGFDTNKTAYKVIKALAPLRKSNPALAYGSTTQRWVNSDVY
VYERKFGSNVALVAVNRSSTTAYPISGALTALPNGTYTDVLGGLLNGNSITVNGGTVSNF
TLAAGGTAVWQYTTTESSPIIGNVGPTMGKPGNTITIDGRGFGTTKNKVTFGTTAVTGAN
IVSWEDTEIKVKVPNVAAGNTAVTVTNAAGTTSAAFNNFNVLTADQVTVRFKVNNATTAL
GQNVYLTGNVAELGNWTAANAIGPMYNQVEASYPTWYFDVSVPANTALQFKFIKVNGSTV
TWEGGNNHTFTSPSSGVATVTVDWQN
>CDGT_BAC11.1 [28,713]  P30921 Cyclomaltodextrin glucanotran
APDTSVSNKQNFSTDVIYQIFTDRFSDGNPANNPTGPAFDGTCTNLRLYCGGDWQGIINK
INDGYLTGMGVTAIWISQPVENIYSVINYSGVNNTAYHGYWARDFKKTNPAYGTIADFQN
LIAAAHAKNIKVIIDFAPNHTSPASLDQPSFAENGKLYNNGRDEGGYTNDTHNLFHHNGG
TDFSTTENGIYKNLYDLADLNHNNSTVDTYLKDAIKMWLDLGIDGIRMDAVKHMPFGWQK
SFMATVNNYKPVFTFGEWFLGVNEVSAENHKFANVSGMSLLDFRFAQKVRQVFKDNTDNM
YGLKSMLEGSATDYAQMEDQVTFIDNHDMERFHNNSANRRKLEQALAFTLTSRGVPAIYY
GTEQYMSGGNDPDNRARIPSFSTTTTAYQVSKKLAPLRKSNPAIAYGTTQERWINNDVLI
YERKFGNNVAVIAVNRNVNTSASITGLVTSLPAGSYTDVLGGLLNGNNLTVGSGGSASIF
TLAAGGTAVWQYTTAVTAPTIGHVGPMMAKPGAAVTIDGRGFGATKGTVYFGTTAVTGAN
ITAWEDTQIKVKIPAVAGGVYNIKIANSAGTSSNVHDNFEVLSGDQVSVRFVVNNATTAL
GQNVYLAGSVSELGNWDPAKAIGPLYNQVIYQYPTWYYDVTVPAGKTIEFKFLKKQGSTV
TWEGGSNHTFTAPTSGTATINVNWQP
>CDGT_BACCI.1 [35,718]  P30920 Cyclomaltodextrin glucanotran
DPDTAVTNKQSFSTDVIYQVFTDRFLDGNPSNNPTGAAYDATCSNLKLYCGGDWQGLINK
INDNYFSDLGVTALWISQPVENIFATINYSGVTNTAYHGYWARDFKKTNPYFGTMADFQN
LITTAHAKGIKIVIDFAPNHTSPAMETDTSFAENGRLYDNGTLVGGYTNDTNGYFHHNGG
SDFSSLENGIYKNLYDLADFNHNNATIDKYFKDAIKLWLDMGVDGIRVDAVKHMPLGWQK
SWMSSIYAHKPVFTFGEWFLGSAASDADNTDFANKSGMSLLDFRFNSAVRNVFRDNTSNM
YALDSMINSTATDYNQVNDQVTFIDNHDMDRFKTSAVNNRRLEQALAFTLTSRGVPAIYY
GTEQYLTGNGDPDNRAKMPSFSKSTTAFNVISKLAPLRKSNPAIAYGSTQQRWINNDVYV
YERKFGKSVAVVAVNRNLSTSASITGLSTSLPTGSYTDVLGGVLNGNNITSTNGSINNFT
LAAGATAVWQYTTAETTPTIGHVGPVMGKPGNVVTIDGRGFGSTKGTVYFGTTAVTGAAI
TSWEDTQIKVTIPSVAAGNYAVKVAASGVNSNAYNNFTILTGDQVTVRFVVNNASTTLGQ
NLYLTGNVAELGNWSTGSTAIGPAFNQVIHQYPTWYYDVSVPAGKQLEFKFFKKNGSTIT
WESGSNHTFTTPASGTATVTVNWQ
>CDGT_BACLI.1 [35,718]  P14014 Cyclomaltodextrin glucanotran
DADTAVTNKQNFSTDVIYQVFTDRFLDGNPSNNPTGAAFDGTCSNLKLYCGGDWQGLVNK
INDNYFSDLGVTALWISQPVENIFATINYSGVTNTAYHGYWARDFKKTNPYFGTMTDFQN
LVTTAHAKGIKIIIDFAPNHTSPAMETDTSFAENGKLYDNGNLVGGYTNDTNGYFHHNGG
SDFSTLENGIYKNLYDLADLNHNNSTIDTYFKDAIKLWLDMGVDGIRVDAVKHMPQGWQK
NWMSSIYAHKPVFTFGEWFLGSAAPDADNTDFANESGMSLLDFRFNSAVRNVFRDNTSNM
YALDSMLTATAADYNQVNDQVTFIDNHDMDRFKTSAVNNRRLEQALAFTLTSRGVPAIYY
GTEQYLTGNGDPDNRGKMPSFSKSTTAFNVISKLAPLRKSNPAIAYGSTQQRWINNDVYI
YERKFGKSVAVVAVNRNLTTPTSITNLNTSLPSGTYTDVLGGVLNGNNITSSGGNISSFT
LAAGATAVWQYTASETTPTIGHVGPVMGKPGNVVTIDGRGFGSAKGTVYFGTTAVTGSAI
TSWEDTQIKVTIPPVAGGDYAVKVAANGVNSNAYNDFTILSGDQVSVRFVINNATTALGE
NIYLTGNVSELGNWTTGAASIGPAFNQVIHAYPTWYYDVSVPAGKQLEFKFFKKNGATIT
WEGGSNHTFTTPTSGTATVTINWQ
>CDGT_BACOH.1 [30,704]  P27036 Cyclomaltodextrin glucanotran
DVTNKVNYTRDVIYQIVTDRFSDGDPSNNPTGAIYSQDCSDLHKYCGGDWQGIIDKINDG
YLTDLGITAIWISQPVENVYALHPSGYTSYHGYWARDYKRTNPFYGDFSDFDRLMDTAHS
NGIKVIMDFTPNHSSPALETDPSYAENGAVYNDGVLIGNYSNDPNNLFHHNGGTDFSSYE
DSIYRNLYDLADYDLNNTVMDQYLKESIKLWLDKGIDGIRVDAVKHMSEGWQTSLMSDIY
AHEPVFTFGEWFLGSGEVDPQNHHFANESGMSLLDFQFGQTIRDVLMDGSSNWYDFNEMI
ASTEEDYDEVIDQVTFIDNHDMSRFSFEQSSNRHTDIALAVLLTSRGVPTIYYGTEQYLT
GGNDPENRKPMSDFDRTTNSYQIISTLASLRQNNPALGYGNTSERWINSDVYIYERSFGD
SVVLTAVNSGDTSYTINNLNTSLPQGQYTDELQQLLDGNEITVNSNGAVDSFQLSANGVS
VWQITEEHASPLIGHVGPMMGKHGNTVTITGEGFGDNEGSVLFDSDFSDVLSWSDTKIEV
SVPDVTAGHYDISVVNAGDSQSPTYDKFEVLTGDQVSIRFAVNNATTSLGTNLYMVGNVN
ELGNWDPDQAIGPMFNQVMYQYPTWYYDISVPAEENLEYKFIKKDSSGNVVWESGNNHTY
TTPATGTDTVLVDWQ
>CDGT_BACS0.1 [28,713]  P05618 Cyclomaltodextrin glucanotran
APDTSVSNKQNFSTDVIYQIFTDRFSDGNPANNPTGAAFDGSCTNLRLYCGGDWQGIINK
INDGYLTGMGITAIWISQPVENIYSVINYSGVNNTAYHGYWARDFKKTNPAYGTMQDFKN
LIDTAHAHNIKVIIDFAPNHTSPASSDDPSFAENGRLYDNGNLLGGYTNDTQNLFHHYGG
TDFSTIENGIYKNLYDLADLNHNNSSVDVYLKDAIKMWLDLGVDGIRVDAVKHMPFGWQK
SFMATINNYKPVFTFGEWFLGVNEISPEYHQFANESGMSLLDFRFAQKARQVFRDNTDNM
YGLKAMLEGSEVDYAQVNDQVTFIDNHDMERFHTSNGDRRKLEQALAFTLTSRGVPAIYY
GSEQYMSGGNDPDNRARLPSFSTTTTAYQVIQKLAPLRKSNPAIAYGSTHERWINNDVII
YERKFGNNVAVVAINRNMNTPASITGLVTSLRRASYNDVLGGILNGNTLTVGAGGAASNF
TLAPGGTAVWQYTTDATTPIIGNVGPMMAKPGVTITIDGRGFGSGKGTVYFGTTAVTGAD
IVAWEDTQIQVKIPAVPGGIYDIRVANAAGAASNIYDNFEVLTGDQVTVRFVINNATTAL
GQNVFLTGNVSELGNWDPNNAIGPMYNQVVYQYPTWYYDVSVPAGQTIEFKFLKKQGSTV
TWEGGANRTFTTPTSGTATVNVNWQP
>CDGT_BACS2.1 [30,703]  P31746 Cyclomaltodextrin glucanotran
DVTNKVNYSKDVIYQIVTDRFSDGNPGNNPSGAIFSQNCIDLHKYCGGDWQGIIDKINDG
YLTDLGITALWISQPVENVYALHPSGYTSYHGYWARDYKKTNPYYGNFDDFDRLMSTAHS
NGIKVIMDFTPNHSSPALETNPNYVENGAIYDNGALLGNYSNDQQNLFHHNGGTDFSSYE
DSIYRNLYDLADYDLNNTVMDQYLKESIKFWLDKGIDGIRVDAVKHMSEGWQTSLMSEIY
SHKPVFTFGEWFLGSGEVDPQNHHFANESGMSLLDFQFGQTIRNVLKDRTSNWYDFNEMI
TSTEKEYNEVIDQVTFIDNHDMSRFSVGSSSNRQTDMALAVLLTSRGVPTIYYGTEQYVT
GGNDPENRKPLKTFDRSTNSYQIISKLASLRQTNSALGYGTTTERWLNEDIYIYERTFGN
SIVLTAVNSSNSNQTITNLNTSLPQGNYTDELQQRLDGNTITVNANGAVNSFQLRANSVA
VWQVSNPSTSPLIGQVGPMMGKAGNTITVSGEGFGDERGSVLFDSTSSEIISWSNTKISV
KVPNVAGGYYDLSVVTAANIKSPTYKEFEVLSGNQVSVRFGVNNATTSPGTNLYIVGNVN
ELGNWDADKAIGPMFNQVMYQYPTWYYDISVPAGKNLEYKYIKKDQNGNVVWQSGNNRTY
TSPTTGTDTVMINW
>CDGT_BACS3.1 [28,712]  P09121 Cyclomaltodextrin glucanotran
APDTSVSNKQNFSTDVIYQIFTDRFSDGNPANNPTGAAFDGSCTNLRLYCGGDWQGIINK
INDGYLTGMGITAIWISQPVENIYSVINYSGVHNTAYHGYWARDFKKTNPAYGTMQDFKN
LIDTAHAHNIKVIIDFAPNHTSPASSDDPSFAENGRLYDNGNLLGGYTNDTQNLFHHYGG
TDFSTIENGIYKNLYDLADLNHNNSSVDVYLKDAIKMWLDLGVDGIRVDAVKHMPFGWQK
SFMSTINNYKPVFNFGEWFLGVNEISPEYHQFANESGMSLLDFPFAQKARQVFRDNTDNM
YGLKAMLEGSEVDYAQVNDQVTFIDNHDMERFHTSNGDRRKLEQALAFTLTSRGVPAIYY
GSEQYMSGGNDPDNRARIPSFSTTTTAYQVIQKLAPLRKSNPAIAYGSTQERWINNDVII
YERKFGNNVAVVAINRNMNTPASITGLVTSLPQGSYNDVLGGILNGNTLTVGAGGAASNF
TLAPGGTAVWQYTTDATAPINGNVGPMMAKAGVTITIDGRASARQGTVYFGTTAVTGADI
VAWEDTQIQVKILRVPGGIYDIRVANAAGAASNIYDNFEVLTGDQVTVRFVINNATTALG
QNVFLTGNVSELGNWDPNNAIGPMYNQVVYQYPTWYYDVSVPAGQTIEFKFLKKQGSTVT
WEGGANRTFTTPTSGTATVNVNWQP
>CDGT_BACS8.1 [28,713]  P17692 Cyclomaltodextrin glucanotran
APDTSVSNKQNFSTDVIYQIFTDRFSDGNPANNPTGAAFDGTCTNLRLYCGGDWQGIINK
INDGYLTGMGVTAIWISQPVENIYSIINYSGVNNTAYHGYWARDFKKTNPAYGTIADFQN
LIAAAHAKNIKVIIDFAPNHTSPASSDQPSFAENGRLYDNGTLLGGYTNDTQNLFHHNGG
TDFSTTENGIYKNLYDLADLNHNNSTSDVYLKDAIKMWLDLGIDGIRMDAVKHMPFGWQK
SFMAAVNNYKPVFTFGEWFLGVNEVGPENHKFANESGMSLLDFRFAQKVRQVFRDNTDNM
YGLKAMLEGSAADYAQVDDQVTFIDNHDMERFHASNANRRKLEQALAFTLILARVPAIYY
GTEQYMSGGTDPDNRARIPSFSTSTTAYQVIQKLAPLRKSNPAIAYGSTQERWINNDVLI
YERKFGSNVAVVAVNRNLNAPASISGLVTSLPQGSYNDVLGGLLNGNTLTVGSGGAASNF
TLAAGGTAVWQYTAATATPTIGHVGPMMAKPGVTITIDGRGFGSSKGTVYFGTTAVSGAN
ITSWEDTQIKVKIPAVAGGIYNIKVANAAGTASNVYDNFEVLSGDQVSVRFVVNNATTAL
GQNLYLTGNVSELGNWDPAKAIGPMYNQVVYQYPNWYYDVSVPAGKTIEFKFLKKQGSTV
TWEGGSNHTFTAPSSGTATINVNWQP
>CDGT_BACSS.1 [35,718]  P31747 Cyclomaltodextrin glucanotran
DPDIAVTNKQSFSTDVIYQVFTDRFLDGNPSNNPTGAAYDATCSNLKLYCGGDWQGLINK
INDNYFSDLGVTALWISQPVENIFATINYSGVTNTAYHGYWARDFKKTNPYFGTMADFQN
LITTAHAKGIKIIIDFAPNHTSPAMETDTSFAENGKLYDNGTLVGGYTNDTNGYFHHNGG
SDFSSLENGIYKNLYDLADFNHNNATIDKYFKDAIKLWLDMGVDGIRVDAVKHIALGWQK
SWMSSIYVHKPVFTFGEWFLGSAASDADNTDFANKSGMSLLDFRFNSAVRNVFRDNTSNM
YALDSMINSTATDYNQVNDQVTFIDNHDMDRFKTSAVNNRRLEQALAFTLTSRGVPAIYY
GTEQYLTGNGDPDNRAKMPSFSKSTTAFNVISKLAPLRKSNPAIAYGSTQQRWINNDVYV
YERKFGKSVAVVAVNRNLSTPANITGLSTSLPTGSYTDVLGGVLNGNNITSSNGSVNSFT
LAAGATAVWQYTAAETTPTIGHVGPVMGKPGNVVTIDGRGFGSTKGTVYFGTTAVTGAAI
TSWEDTQIKVTIPSVAAGNYAVKVAANGVNSNAYNHFTILTGDQVTVRFVINNASTTLGQ
NIYLTGNVAELGNWSTGSTAIGPAFNQVIHQYPTWYYDVSVPAGKELEFKFFKKNGSTIT
WEGGSNHKFTTPASGTATVTVNWQ
>CDGT_BACST.1 [32,711]  P31797 Cyclomaltodextrin glucanotran
AGNLNKVNFTSDVVYQIVVDRFVDGNTSNNPSGALFSSGCTNLRKYCGGDWQGIINKIND
GYLTDMGVTAIWISQPVENVFSVMNDASGSASYHGYWARDFKKPNPFFGTLSDFQRLVDA
AHAKGIKVIIDFAPNHTSPASETNPSYMENGRLYDNGTLLGGYTNDANMYFHHNGGTTFS
SLEDGIYRNLFDLADLNHQNPVIDRYLKDAVKMWIDMGIDGIRMDAVKHMPFGWQKSLMD
EIDNYRPVFTFGEWFLSENEVDANNHYFANESGMSLLDFRFGQKLRQVLRNNSDNWYGFN
QMIQDTASAYDEVLDQVTFIDNHDMDRFMIDGGDPRKVDMALAVLLTSRGVPNIYYGTEQ
YMTGNGDPNNRKMMSSFNKNTRAYQVIQKLSSLRRNNPALAYGDTEQRWINGDVYVYERQ
FGKDVVLVAVNRSSSSNYSITGLFTALPAGTYTDQLGGLLDGNTIQVGSNGSVNAFDLGP
GEVGVWAYSATESTPIIGHVGPMMGQVGHQVTIDGEGFGTNTGTVKFGTTAANVVSWSNN
QIVVAVPNVSPGKYNITVQSSSGQTSAAYDNFEVLTNDQVSVRFVVNNATTNLGQNIYIV
GNVYELGNWDTSKAIGPMFNQVVYSYPTWYIDVSVPEGKTIEFKFIKKDSQGNVTWESGS
NHVYTTPTNTTGKIIVDWQN
>CDGT_THETU.1 [28,710]  P26827 Cyclomaltodextrin glucanotran
ASDTAVSNVVNYSTDVIYQIVTDRFVDGNTSNNPTGDLYDPTHTSLKKYFGGDWQGIINK
INDGYLTGMGVTAIWISQPVENIYAVLPDSTFGGSTSYHGYWARDFKRTNPYFGSFTDFQ
NLINTAHAHNIKVIIDFAPNHTSPASETDPTYAENGRLYDNGTLLGGYTNDTNGYFHHYG
GTDFSSYEDGIYRNLFDLADLNQQNSTIDSYLKSAIKVWLDMGIDGIRLDAVKHMPFGWQ
KNFMDSILSYRPVFTFGEWFLGTNEIDVNNTYFANESGMSLLDFRFSQKVRQVFRDNTDT
MYGLDSMIQSTASDYNFINDMVTFIDNHDMDRFYNGGSTRPVEQALAFTLTSRGVPAIYY
GTEQYMTGNGDPYNRAMMTSFNTSTTAYNVIKKLAPLRKSNPAIAYGTTQQRWINNDVYI
YERKFGNNVALVAINRNLSTSYNITGLYTALPAGTYTDVLGGLLNGNSISVASDGSVTPF
TLSAGEVAVWQYVSSSNSPLIGHVGPTMTKAGQTITIDGRGFGTTSGQVLFGSTAGTIVS
WDDTEVKVKVPSVTPGKYNISLKTSSGATSNTYNNINILTGNQICVRFVVNNASTVYGEN
VYLTGNVAELGNWDTSKAIGPMFNQVVYQYPTWYYDVSVPAGTTIQFKFIKKNGNTITWE
GGSNHTYTVPSSSTGTVIVNWQQ
>CDGU_BACCI.1 [28,713]  P43379 Cyclomaltodextrin glucanotran
APDTSVSNKQNFSTDVIYQIFTDRFSDGNPANNPTGAAFDGTCTNLRLYCGGDWQGIINK
INDGYLTGMGVTAIWISQPVENIYSIINYSGVNNTAYHGYWARDFKKTNPAYGTIADFQN
LIAAAHAKNIKVIIDFAPNHTSPASSDQPSFAENGRLYDNGTLLGGYTNDTQNLFHHNGG
TDFSTTENGIYKNLYDLADLNHNNSTVDVYLKDAIKMWLDLGIDGIRMDAVKHMPFGWQK
SFMAAVNNYKPVFTFGEWFLGVNEVSPENHKFANESGMSLLDFRFAQKVRQVFRDNTDNM
YGLKAMLEGSAADYAQVDDQVTFIDNHDMERFHASNANRRKLEQALAFTLTSRGVPAIYY
GTEQYMSGGTDPDNRARIPSFSTSTTAYQVIQKLAPLRKCNPAIAYGSTQERWINNDVLI
YERKFGSNVAVVAVNRNLNAPASISGLVTSLPQGSYNDVLGGLLNGNTLSVGSGGAASNF
TLAAGGTAVWQYTAATATPTIGHVGPMMAKPGVTITIDGRGFGSSKGTVYFGTTAVSGAD
ITSWEDTQIKVKIPAVAGGNYNIKVANAAGTASNVYDNFEVLSGDQVSVRFVVNNATTAL
GQNVYLTGSVSELGNWDPAKAIGPMYNQVVYQYPNWYYDVSVPAGKTIEFKFLKKQGSTV
TWEGGSNHTFTAPSSGTATINVNWQP
>CHI1_BACCI.1 [42,699]  P20533 Chitinase A1 precursor (EC 3.
DSYKIVGYYPSWAAYGRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTC
QNEKSQTINVPNGTIVLGDPWIDTGKTFAGDTWDQPIAGNINQLNKLKQTNPNLKTIISV
GGWTWSNRFSDVAATAATREVFANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDK
QNYTLLLSKIREKLDAAGAVDGKKYLLTIASGASATYAANTELAKIAAIVDWINIMTYDF
NGAWQKISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVPFYGRG
WDGCAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLEANYINKNGYTRYWNDTAKVPYLYNA
SNKRFISYDDAESVGYKTAYIKSKGLGGAMFWELSGDRNKTLQNKLKADLPTGGTVPPVD
TTAPSVPGNARSTGVTANSVTLAWNASTDNVGVTGYNVYNGANLATSVTGTTATISGLTA
GTSYTFTIKAKDAAGNLSAASNAVTVSTTAQPGGDTQAPTAPTNLASTAQTTSSITLSWT
ASTDNVGVTGYDVYNGTALATTVTGTTATISGLAADTSYTFTVKAKDAAGNVSAASNAVS
VKTAAETTNPGVSAWQVNTAYTAGQLVTYNGKTYKCLQPHTSLAGWEPSNVPALWQLQ
>CHID_BACCI.1 [31,524]  P27050 Chitinase D precursor (EC 3.2
AAQWQAGTAYKQGDLVTYLNKDYECIQPHTALTGWEPSNVPALWKYVGEGTGGGTPTPDT
TPPTVPAGLTSSLVTDTSVNLTWNASTDNVGVTGYEVYRNGTLVANTSTTTAVVTGLTAG
TTYVFTVKAKDAAGNLSAASTSLSVTTSTGSSNPGPSGSKWLIGYWHNFDNGSTNIKLRN
VSTAYDVINVSFAEPISPGSGTLAFTPYNATVEEFKSDIAYLQSQGKKVLISMGGANGRI
ELTDATKKRQQFEDSLKSIISTYGFNGLDIDLEGSSLSLNAGDTDFRSPTTPKIVNLING
VKALKSHFGANFVLTAAPETAYVQGGYLNYGGPWGAYLPVIHALRNDLTLLHVQHYNTGS
MVGLDGRSYAQGTADFHVAMAQMLLQGFNVGGSSGPFFSPLRPDQIAIGVPASQQAAGGG
YTAPAELQKALNYLIKGVSYGGSYTLRQPAGYVGLKGIMTWSINWDAYTNNQFSNAHRPF
LNGLSTQKTEEVVY
>CHIS_BACCI.1 [43,301]  P33673 Chitosanase precursor (EC 3.2
ASPDDNFSPETLQFLRNNTGLDGEQWNNIMKLINKPEQDDLNWIKYYGYCEDIEDERGYT
IGLFGATTGGSRDTHPDGPDLFKAYDAAKGASNPSADGALKRLGINGKMKGSILEIKDSE
KVFCGKIKKLQNDAAWRKAMWETFYNVYIRYSVEQARQRGFTSAVTIGSFVDTALNQGAT
GGSDTLQGLLARSGSSSNEKTFMKNFHAKRTLVVDTNKYNKPPNGKNRVKQWDTLVDMGK
MNLKNVDSEIAQVTDWEMK
>CHIS_BACSU.1 [36,277]  O07921 Chitosanase precursor (EC 3.2
AGLNKDQKRRAEQLTSIFENGTTEIQYGYVERLDDGRGYTCGRAGFTTATGDALEVVEVY
TKAVPNNKLKKYLPELRRLAKEESDDTSNLKGFASAWKSLANDKEFRAAQDKVNDHLYYQ
PAMKRSDNAGLKTALARAVMYDTVIQHGDGDDPDSFYALIKRTNKKAGGSPKDGIDEKKW
LNKFLDVRYDDLMNPANHDTRDEWRESVARVDVLRSIAKENNYNLNGPIHVRSNEYGNFV
IK
>CIPA_CLOTM.1 [29,1853]  Q06851 Cellulosomal scaffolding pro
ATMTVEIGKVTAAVGSKVEIPITLKGVPSKGMANCDFVLGYDPNVLEVTEVKPGSIIKDP
DPSKSFDSAIYPDRKMIVFLFAEDSGRGTYAITQDGVFATIVATVKSAAAAPITLLEVGA
FADNDLVEISTTFVAGGVNLGSSVPTTQPNVPSDGVVVEIGKVTGSVGTTVEIPVYFRGV
PSKGIANCDFVFRYDPNVLEIIGIDPGDIIVDPNPTKSFDTAIYPDRKIIVFLFAEDSGT
GAYAITKDGVFAKIRATVKSSAPGYITFDEVGGFADNDLVEQKVSFIDGGVNVGNATPTK
GATPTNTATPTKSATATPTRPSVPTNTPTNTPANTPVSGNLKVEFYNSNPSDTTNSINPQ
FKVTNTGSSAIDLSKLTLRYYYTVDGQKDQTFWCDHAAIIGSNGSYNGITSNVKGTFVKM
SSSTNNADTYLEISFTGGTLEPGAHVQIQGRFAKNDWSNYTQSNDYSFKSASQFVEWDQV
TAYLNGVLVWGKEPGGSVVPSTQPVTTPPATTKPPATTKPPATTIPPSDDPNAIKIKVDT
VNAKPGDTVNIPVRFSGIPSKGIANCDFVYSYDPNVLEIIEIKPGELIVDPNPDKSFDTA
VYPDRKIIVFLFAEDSGTGAYAITKDGVFATIVAKVKSGAPNGLSVIKFVEVGGFANNDL
VEQRTQFFDGGVNVGDTTVPTTPTTPVTTPTDDSNAVRIKVDTVNAKPGDTVRIPVRFSG
IPSKGIANCDFVYSYDPNVLEIIEIEPGDIIVDPNPDKSFDTAVYPDRKIIVFLFAEDSG
TGAYAITKDGVFATIVAKVKSGAPNGLSVIKFVEVGGFANNDLVEQKTQFFDGGVNVGDT
TEPATPTTPVTTPTTTDDLDAVRIKVDTVNAKPGDTVRIPVRFSGIPSKGIANCDFVYSY
DPNVLEIIEIEPGDIIVDPNPDKSFDTAVYPDRKIIVFLFAEDSGTGAYAITKDGVFATI
VAKVKSGAPNGLSVIKFVEVGGFANNDLVEQKTQFFDGGVNVGDTTEPATPTTPVTTPTT
TDDLDAVRIKVDTVNAKPGDTVRIPVRFSGIPSKGIANCDFVYSYDPNVLEIIEIEPGDI
IVDPNPDKSFDTAVYPDRKIIVFLFAEDSGTGAYAITKDGVFATIVAKVKEGAPNGLSVI
KFVEVGGFANNDLVEQKTQFFDGGVNVGDTTEPATPTTPVTTPTTTDDLDAVRIKVDTVN
AKPGDTVRIPVRFSGIPSKGIANCDFVYSYDPNVLEIIEIEPGELIVDPNPTKSFDTAVY
PDRKMIVFLFAEDSGTGAYAITEDGVFATIVAKVKSGAPNGLSVIKFVEVGGFANNDLVE
QKTQFFDGGVNVGDTTEPATPTTPVTTPTTTDDLDAVRIKVDTVNAKPGDTVRIPVRFSG
IPSKGIANCDFVYSYDPNVLEIIEIEPGDIIVDPNPDKSFDTAVYPDRKIIVFLFAEDSG
TGAYAITKDGVFATIVAKVKEGAPNGLSVIKFVEVGGFANNDLVEQKTQFFDGGVNVGDT
TVPTTSPTTTPPEPTITPNKLTLKIGRAEGRPGDTVEIPVNLYGVPQKGIASGDFVVSYD
PNVLEIIEIEPGELIVDPNPTKSFDTAVYPDRKMIVFLFAEDSGTGAYAITEDGVFATIV
AKVKEGAPEGFSAIEISEFGAFADNDLVEVETDLINGGVLVTNKPVIEGYKVSGYILPDF
SFDATVAPLVKAGFKVEIVGTELYAVTDANGYFEITGVPANASGYTLKISRATYLDRVIA
NVVVTGDTSVSTSQAPIMMWVGDIVKDNSINLLDVAEVIRCFNATKGSANYVEELDINRN
GAINMQDIMIVHKHFGATSSDYDAQ
>CLOS_CLOHI.1 [28,526]  P09870 Alpha-clostripain precursor (
NPVTKSKDNNLKEVQQVTSKSNKNKNQKVTIMYYCDADNNLEGSLLNDIEEMKTGYKDSP
NLNLIALVDRSPRYSSDEKVLGEDFSDTRLYKIEHNKANRLDGKNEFPEISTTSKYEANM
GDPEVLKKFIDYCKSNYEADKYVLIMANHGGGAREKSNPRLNRAICWDDSNLDKNGEADC
LYMGEISDHLTEKQSVDLLAFDACLMGTAEVAYQYRPGNGGFSADTLVASSPVVWGPGFK
YDKIFDRIKAGGGTNNEDDLTLGGKEQNFDPATITNEQLGALFVEEQRDSTHANGRYDQH
LSFYDLKKAESVKRAIDNLAVNLSNENKKSEIEKLRGSGIHTDLMHYFDEYSEGEWVEYP
YFDVYDLCEKINKSENFSSKTKDLASNAMNKLNEMIVYSFGDPSNNFKEGKNGLSIFLPN
GDKKYSTYYTSTKIPHWTMQSWYNSIDTVKYGLNPYGKLSWCKDGQDPEINKVGNWFELL
DSWFDKTNDVTGGVNHYQW
>CMGG_BACSU.1 [29,124]  P25959 ComG operon protein 7 precurs
QYISRCMFEKETKELYIGENLLQNGVLLSIRHVLEERKGQEGTQQFLYGRVSYYIHDTSI
KEQKEINLRVSTDSGTERTAQIVFDQKQKKLLRWTE
>CNA_STAAU.1 [30,1183]   Q53654 Collagen adhesin precursor. 
ARDISSTNVTDLTVSPSKIEDGGKTTVKMTFDDKNGKIQNGDMIKVAWPTSGTVKIEGYS
KTVPLTVKGEQVGQAVITPDGATITFNDKVEKLSDVSGFAEFEVQGRNLTQTNTSDDKVA
TITSGNKSTNVTVHKSEAGTSSVFYYKTGDMLPEDTTHVRWFLNINNEKSYVSKDITIKD
QIQGGQQLDLSTLNINVTGTHSNYYSGQSAITDFEKAFPGSKITVDNTKNTIDVTIPQGY
GSYNSFSINYKTKITNEQQKEFVNNSQAWYQEHGKEEVNGKSFNHTVHNINANAGIEGTV
KGELKVLKQDKDTKAPIANVKFKLSKKDGSVVKDNQKEIEIITDANGIANIKALPSGDYI
LKEIEAPRPYTFDKDKEYPFTMKDTDNQGYFTTIENAKAIEKTKDVSAQKVWEGTQKVKP
TIYFKLYKQDDNQNTTPVDKAEIKKLEDGTTKVTWSNLPENDKNGKAIKYLVKEVNAQGE
DTTPEGYTKKENGLVVTNTEKPIETTSISGEKVWDDKDNQDGKRPEKVSVNLLANGEKVK
TLDVTSETNWKYEFKDLPKYDEGKKIEYTVTEDHVKDYTTDINGTTITNKYTPGETSATV
TKNWDDNNNQDGKRPTEIKVELYQDGKATGKTAILNESNNWTHTWTGLDEKAKGQQVKYT
VEELTKVKGYTTHVDNNDMGNLIVTNKYTPETTSISGEKVWDDKDNQDGKRPEKVSVNLL
ADGEKVKTLDVTSETNWKYEFKDLPKYDEGKKIEYTVTEDHVKDYTTDINGTTITNKYTP
GETSATVTKNWDDNNNQDGKRPTEIKVELYQDGKATGKTAILNESNNWTHTWTGLDEKAK
GQQVKYTVEELTKVKGYTTHVDNNDMGNLIVTNKYTPETTSISGEKVWDDKDNQDGKRPE
KVSVNLLANGEKVKTLDVTSETNWKYEFKDLPKYDEGKKIEYTVTEDHVKDYTTDINGTT
ITNKYTPGETSATVTKNWDDNNNQDGKRPTEIKVELYQDGKATGKTAILNESNNWTHTWT
GLDEKAKGQQVKYTVDELTKVNGYTTHVDNNDMGNLIVTNKYTPKKPNKPIYPEKPKDKT
PPTKPDHSNKVKPTPPDKPSKVDKDDQPKDNKTKPENPLKELPKTGMKIITSWITWVFIG
ILGLYLILRKRFNS
>COLA_CLOPE.1 [40,1104]  P43153 Microbial collagenase precur
ADKKVENSNNGQITREINADQISKTELNNEVATDNNRPLGPSIAPSRARNNKIYTFDELN
RMNYSDLVELIKTISYENVPDLFNFNDGSYTFFSNRDRVQAIIYGLEDSGRTYTADDDKG
IPTLVEFLRAGYYLGFYNKQLSYLNTPQLKNECLPAMKAIQYNSNFRLGTKAQDGVVEAL
GRLIGNASADPEVINNCIYVLSDFKDNIDKYGSNYSKGNAVFNLMKGIDYYTNSVIYNTK
GYDAKNTEFYNRIDPYMERLESLCTIGDKLNNDNAWLVNNALYYTGRMGKFREDPSISQR
ALERAMKEYPYLSYQYIEAANDLDLNFGGKNSSGNDIDFNKIKADAREKYLPKTYTFDDG
KFVVKAGDKVTEEKIKRLYWASKEVKAQFMRVVQNDKALEEGNPDDILTVVIYNSPEEYK
LNRIINGFSTDNGGIYIENIGTFFTYERTPEESIYTLEELFRHEFTHYLQGRYVVPGMWG
QGEFYQEGVLTWYEEGTAEFFAGSTRTDGIKPRKSVTQGLAYDRNNRMSLYGVLHAKYGS
WDFYNYGFALSNYMYNNNMGMFNKMTNYIKNNDVSGYKDYIASMSSDYGLNDKYQDYMDS
LLNNIDNLDVPLVSDEYVNGHEAKDINEITNDIKEVSNIKDLSSNVEKSQFFTTYDMRGT
YVGGRSQGEENDWKDMNSKLNDILKELSKKSWNGYKTVTAYFVNHKVDGNGNYVYDVVFH
GMNTDTNTDVHVNKEPKAVIKSDSSVIVEEEINFDGTESKDEDGEIKAYEWDFGDGEKSN
EAKATHKYNKTGEYEVKLTVTDNNGGINTESKKIKVVEDKPVEVINESEPNNDFEKANQI
AKSNMLVKGTLSEEDYSDKYYFDVAKKGNVKITLNNLNSVGITWTLYKEGDLNNYVLYAT
GNDGTVLKGEKTLEPGRYYLSVYTYDNQSGTYTVNVKGNLKNEVKETAKDAIKEVENNND
FDKAMKVDSNSKIVGTLSNDDLKDIYSIDIQNPSDLNIVVENLDNIKMNWLLYSADDLSN
YVDYANADGNKLSNTCKLNPGKYYLCVYQFENSGTGNYIVNLQNK
>COX2_BACPF.1 [23,342]  Q04441 Cytochrome c oxidase polypept
CLGEENLTALDPKGPQAQWIYDNMILSIIVMALVSIVVFAIFFIILAKYRRKPGDDEIPK
QVHGNTALEITWTVIPIILLVILAVPTITGTFMFADKDPDPEVGDNTVYIKVTGHQFWWQ
FDYENEGFTAGQDVYIPVGEKVIFELHAQDVLHSFWVPALGGKIDTVPGITNHMWLEADE
PGVFKGKCAELCGPSHALMDFKLIALERDEYDAWVEGMSAEVEEPTETLANQGRQVFEEN
SCIGCHAVGGTGTAAGPAFTNFGEREVIAGYLENNDENLEAWIRDPQSLKQGNVMPAYPD
MSEEDMEALIAYLRSLKVME
>COX2_BACSU.1 [21,356]  P24011 Cytochrome c oxidase polypept
CGKPFLSTLKPAGEVADKQYDLTVLSTLIMVVVVAVVSVIFFYVIVRFRRSRVGENTIPK
QVEGNKFLEITWTVIPILLLIILVIPVVLYTLELADTSPMDKKGRKAEDALVVNVRANLY
WWEFEYPDYGIITSQELIVPTDQRVYFNLKASDVKHSFWIPSVGGKLDTNTDNENKFFLT
FDSKRSKEAGDMFFGKCAELCGPSHALMDFKVKTMSAKEFQGWTKEMKNYKSTAESDLAK
QGEELFKEKNCLSCHAVEPNDKRAEAARTAPNLATFGERTKVAGVKEANKENVKAWLKDP
DSIKPGNKMTGTYPKLSDSETNALYEYLKGLKAESK
>CPLR_DESFA.1 [25,327]  Q8GFE2 Chlorophenol reductase precur
AVDTTTSATVEAATPAAPATPAATAPAAAPSVDTSKIAAGTYYTVVSGDFFWQIAAKHGL
TIDALAKLNPQIKNVNLIFPGQKILVKAEEAAAASTSTSTAAVAPAAKKLYQGIGMAANY
RDNTARQKDHDNLNITTVAALFDDAGKIVKLQFDVVEILPDMFPGWMDPEAADKSFYKDA
QANGFNWETKKEEGDAYGMKASAVSGKEWWEQMNFYEEYFKGKTVAEVQDWFAKYCDANG
RPYKMAYPEKLTDADKAKVATFTEAEKKMLVDVTTGATMSLQDPHSRFIDALVKAYEVRK
EVK
>CTA1_BACCI.1 [39,972]  P94286 Cycloisomaltooligosaccharide 
SGSGGIERVFTDKARYNPGDAVSIRVQAKNGTGSSWSGAARLEIFHLENSVYTSSQSLSL
TNGQSTTLTFTWTAPSTDFRGYFVRIDAGTLGQGATAIDVSSDFTKYPRYGYISEFESGE
TALESKAKVDQLAQDYHINAWQFYDWMWRHDKMIKRTGGSIDSTWLDLFNREISWSTLQN
QIDAVHDVNGKAMAYAMIYASRENYSPLGISPTWGIYEDSSHTNQFDVDFGDGSTYLYMS
DPQNPNWQNYIHAEYIDSINTAGFDGIHVDQMGQRSNVYDYNGNSIDLSTRFSPFLDQAK
SVLSANNPARDNLTYNIVDGTVNGWAVNDVSKNADLDFLYSEIWYLSDSYNQLKNYIEQL
RANGGNKAVVLAAYMNYADNAGTRYEAESASMTNVSTNTNHAGYTGSGFVDQFASTGDKV
SFAINAPEAGDYSLVFRYGNNTGANSTLNLYVDGNFVQKLYFFNQSSWGTWKHDAWYQVP
LTQGAHTVELRYESGNVGAVNLDSLTLGTFDEHSVRLADAMMSASGATHIELGDDNQMLP
HEYYPNRSKTMRSSLKNAMKDHYNFITAYENLLFDSDVVPNDTGSQFVNLTGVSASGDGS
ANTVWYINKRTSDYNIVHLINLLGNDNQWRNTASQPSFQTNLPAKIYIGADETISDVYLA
SPDLSGGETQELAFTSGTDAGGKYVSFTVPELKYWNMIYMKRTFSVPANDIYEAETAIKS
NVSTNTNHAGYTGSGFVDGFSSTNDGVSFVVKSTASDDYALRFRYANGGSDATRDVYVDG
KLAGTVSFKSTGSWSTWSYGEITARLEPGHHTIVLWQTSGNTGAINLDHLDLDKTYIWQF
DRQIVSVPAGYRITFRTGLPGWVHWGVNGWTGVTDTPLRSNGSLDGNLDHETSIGPFATG
TAVDVTFLWDDNNNGILEPSTDRWEGTDFGINVS
>CTA2_BACCI.1 [31,964]  P70873 Cycloisomaltooligosaccharide 
STPGFIERVYTDKARYEPGELVTVTAQINNSGGTNWSGDVTMTIFHLENAVYSSVQHASI
ASGQTTDVTFSWTSDTTDFKGYFVSVDAGSLGQGYSSIDVSSDFAKYPRYGYISEFSSNE
TAAESAAKVNELAQDYKINAWQFYDWMWRHETMIKRTGGTIDPTWIDLFNRQISWPTINN
QIAAIHNQNGAAMAYAMIYAARENYSGFGVNPEWGMYMDPAHTKQLDVDFGNNSTYMYLF
DPANAGWQQFIHEQYLDAIQTANFDGIHIDQMGQRNNIYDYSGNSIDLATRFTPFIKAAK
TKLTAANSNQDFMTFNIVDGTVNGWAANDVSKNANVDFLYSEIWHLSNSYMQLKDYIDSL
RANSGNKAVVLAAYMNYGENIGDRYEAEDAALQHTAVNTDHAGYTGSGFVDQFADVNDSV
TFTITAPEEGYYSLVFRFANHSGYTATRNLYVDSNFEIELPFQNQPNWDTWSHETWHQVY
LTPGTHTIKLSYDSSNTGAINLDSLTLGTFDEHSIRLADAMMAASGATHIELGEDSQMLA
HEYYPNRSKSMRSTLKSAMKDHYNFITAYENLLFDADVIDNDAGKQFINIAGVNTSPDGA
ANTVWHMSKRTPEYNILHLINLVNNDQNWRNSGNQPTAQTNLATKVYIGAEETITGVYAA
SPDHNQGATQSLPFTTGTDSSGSYISFTVPSLEYWSMIYMKRSTAAPVDNMYEAETAIKS
NVSVNTNHAGYTGSGFVDQFATVNDGVSFIVHASSKDDYVLRFRYSNGGSDANRDVFLNG
KYAGTVQLKHTGGWNQWAYGELTVPLAQGSHSVVLWYNSSNSGAVNLDHLKLDKTYIWQF
DRQIASVPAGYRITFKAGLPGWVHFGTDNWKNVMDIPLASNGSSDSSLNYEASIGPFPSA
TTVDVTFLWDDNNNGILEDMIDRWEGTDFQIAIP
>CWBA_BACSU.1 [26,705]  Q02113 Amidase enhancer precursor (M
ADSNISVKLLNYIGNKSSISLSPTGFYKVTGDNVAVTDRFAGASRYETATLASNSQWKNP
NTVILVNRDIFIDALPVIPLAKKLNAPVLFTQPDTLTKTTERQIAKFNPDNILIIGGARS
ISKDVENKLKSYGAVKRISGKNRYVLSENIAKQMGSYDKAIVVTGRVFQDALAIAPYAAA
HGYPILLTEKDKLPDYDLPKQVIIIGSSFSVSDSVENQIKKTSTVQRIPGSTRYELTANI
IKQLKLKADKVVMTNGTKYADVLIGASLASKKNSQILFVKQDSVPAAAKSITKDKATYAY
DFIGSTSSISAEVENSLADEFYLADGGTYNLKINSGKLNLENIKTYGNSLRIKPENYSTS
NRISLDGKQYLGTVNFSIESTKYIRPVNENIPFEDYLKGVIPNEMPASWSLEALKAQTVA
ARTYSITKTGTTVPDTTAFQVYGGYSWNSNTNKAVEQTKGKVLKYNGSLITAAYSSSNGG
YTEASNEVWSSSVPYLIAKKDTKDPQIGWTLTLSKQQLDTKSLDLTKPSSWWSSATETDS
ARLSGVKNWILKNKETSADSVKIASIDDLSFSGTTQGQRAKTASMKVKYFVKSSTGSYNL
SKITTISVPTSELRTMIGATVFKSTYVTVKKDTSKYTISGKGYGHGIGMSQYGAKARAEA
GDSYSSILKFYYPGTTLTSY
>CWLA_BACSU.1 [40,272]  P24808 N-acetylmuramoyl-L-alanine am
ANEISYMKNNSSSTSFHFAVDDKQVIQGIPTNRNAWHTGDGTNGTGNRKSIGVEICYSKS
GGVRYKAAEKLAIKFVAQLLKERGWGIDRVRKHQDWNGKYCPHRILSEGRWIQVKTAIEA
ELKKLGGKTNSSKASVAKKKTTNTSSKKTSYALPSGIFKVKSPMMRGEKVTQIQKALAAL
YFYPDKGAKNNGIDGVYGPKTADAIRRFQSMYGLTQDGIYGPKTKAKLEALLK
>CWLB_BACSU.1 [25,496]  Q02114 N-acetylmuramoyl-L-alanine am
DNSVKRVGGSNRYGTAVQISKQMYSTASTAVIVGGSSYADAISAAPLAYQKNAPLLYTNS
DKLSYETKTRLKEMQTKNVIIVGGTPAVSSNTANQIKSLGISIKRIAGSNRYDTAARVAK
AMGATSKAVILNGFLYADAPAVIPYAAKNGYPILFTNKTSINSATTSVIKDKGISSTVVV
GGTGSISNTVYNKLPSPTRISGSNRYELAANIVQKLNLSTSTVYVSNGFSYPDSIAGATL
AAKKKQSLILTNGENLSTGARKIIGSKNMSNFMIIGNTPAVSTKVANQLKNPVVGETIFI
DPGHGDQDSGAIGNGLLEKEVNLDIAKRVNTKLNASGALPVLSRSNDTFYSLQERVNKAA
SAQADLFLSIHANANDSSSPNGSETYYDTTYQAANSKRLAEQIQPKLAANLGTRDRGVKT
AAFYVIKYSKMPSVLVETAFITNASDASKLKQAVYKDKAAQAIHDGTVSYYR
>CYAA_BACAN.1 [34,800]  P40136 Calmodulin-sensitive adenylat
MNEHYTESDIKRNHKTEKNKTEKEKFKDSINNLVKTEFTNETLDKIQQTQDLLKKIPKDV
LEIYSELGGEIYFTDIDLVEHKELQDLSEEEKNSMNSRGEKVPFASRFVFEKKRETPKLI
INIKDYAINSEQSKEVYYEIGKGISLDIISKDKSLDPEFLNLIKSLSDDSDSSDLLFSQK
FKEKLELNNKSIDINFIKENLTEFQHAFSLAFSYYFAPDHRTVLELYAPDMFEYMNKLEK
GGFEKISESLKKEGVEKDRIDVLKGEKALKASGLVPEHADAFKKIARELNTYILFRPVNK
LATNLIKSGVATKGLNVHGKSSDWGPVAGYIPFDQDLSKKHGQQLAVEKGNLENKKSITE
HEGEIGKIPLKLDHLRIEELKENGIILKGKKEIDNGKKYYLLESNNQVYEFRISDENNEV
QYKTKEGKITVLGEKFNWRNIEVMAKNVEGVLKPLTADYDLFALAPSLTEIKKQIPQKEW
DKVVNTPNSLEKQKGVTNLLIKYGIERKPDSTKGTLSNWQKQMLDRLNEAVKYTGYTGGD
VVNHGTEQDNEEFPEKDNEIFIINPEGEFILTKNWEMTGRFIEKNITGKDYLYYFNRSYN
KIAPGNKAYIEWTDPITKAKINTIPTSAEFIKNLSSIRRSSNVGVYKDSGDKDEFAKKES
VKKIAGYLSDYYNSANHIFSQEKKRKISIFRGIQAYNEIENVLKSKQIAPEYKNYFQYLK
ERITNQVQLLLTHQKSNIEFKLLYKQLNFTENETDNFEVFQKIIDEK
>DACA_BACST.1 [31,452]  Q05523 D-alanyl-D-alanine carboxypep
ESAPLDIRADAAILVDAQTGRILYEKNIDTVLGIASMTKMMTEYLLLDAIKAKRVKWDQM
YTPSDYVYRLSQDRALSNVPLRKDGKYTVRELYEAMAIYSANGATVAIAEIIAGSEKNFV
KMMNDKAKELGLKDYKFVNATGLSNKDLKGFHPEGTSTNEENVMSARAMAMLAYRLLKDH
PEVLKTASIPHKVFREGTKDEIKMDNWNWMLPGLVYGYEGVDGLKTGYTEFAGNCFTGTA
KRNGVRLISVVMNAKDASGKTTKEARFKETEKLFNYGFNQYSLETLYPKGYQLKGKETLP
VVKGKEKEVRVATGKNLDLLVKNGEEKQYKPVYVLDKKKMTKEGKLVAPLKKGETVGYMT
LEYKGDDSLAFLSPDMQKNIRVPLVTTAEVEKANWFVLSMRAVGGLFVDLWTSVAKTVKG
WL
>DACA_BACSU.1 [32,443]  P08750 D-alanyl-D-alanine carboxypep
ASDPIDINASAAIMIEASSGKILYSKNADKRLPIASMTKMMTEYLLLEAIDQGKVKWDQT
YTPDDYVYEISQDNSLSNVPLRKDGKYTVKELYQATAIYSANAAAIAIAEIVAGSETKFV
EKMNAKAKELGLTDYKFVNATGLENKDLHGHQPEGTSVNEESEVSAKDMAVLADHLITDY
PEILETSSIAKTKFREGTDDEMDMPNWNFMLKGLVSEYKKATVDGLKTGSTDSAGSCFTG
TAERNGMRVITVVLNAKGNLHTGRFDETKKMFDYAFDNFSMKEIYAEGDQVKGHKTISVD
KGKEKEVGIVTNKAFSLPVKNGEEKNYKAKVTLNKDNLTAPVKKGTKVGKLTAEYTGDEK
DYGFLNSDLAGVDLVTKENVEKANWFVLTMRSIGGFFAGIWGSIVDTVTGWF
>DACB_BACSU.1 [28,382]  P35150 Penicillin-binding protein 5*
AIDVSAKSAIIIDGASGRVLYAKDEHQKRRIASITKIMTAVLAIESGKMDQTVTVSANAV
RTEGSAIYLTEGQKVKLKDLVYGLMLRSGNDAAVAIAEHVGGSLDGFVYMMNQKAEQLGM
KNTRFQNPHGLDDHENHYSTAYDMAILTKYAMKLKDYQKISGTKIYKAETMESVWKNKNK
LLTMLYPYSTGGKTGYTKLAKRTLVSTASKDGIDLIAVTINDPNDWDDHMKMFNYVFEHY
QTYLIAKKGDIPKLKGTFYESKAFIKRDITYLLTEEEKENVKINTTLLKPKKAWEKDASK
IPDIVGHMEIMFNDATIAKVPIYYENERHQKPKKQFFETFKSIFLNAAGGAKWSI
>DACF_BACSU.1 [24,389]  P38422 Penicillin-binding protein da
KQDGKRTSELAHEAKSAVLIERDTGKVLYNKNSNERLAPASMTKIMTMLLIMEALDKGKI
KMSDKVRTSEHAASMGGSQIFLEPGEEMTVKEMLKGIAIASGNDASVAMAEFISGSEEEF
VKKMNKKAKELGLKNTSFKNPTGLTEEGHYSSAYDMAIMAKELLKYESITKFTGTYEDYL
RENTDKKFWLVNTNRLIKFYPGVDGVKTGYTGEAKYCLTASAKKGNMRAIAVVFGASTPK
ERNAQVTKMLDFAFSQYETHPLYKRNQTVAKVKVKKGKQKFIELTTSEPISILTKKGEDM
NDVKKEIKMKDNISAPIQKGQELGTLVLKKDGEVLAESPVAAKEDMKKAGFITFLKRTMG
DWTKFK
>DEXT_STRDO.1 [31,1337]  P39653 Dextranase precursor (EC 3.2
DELANQTAKVADEASIVVSTSQAAVEQTQSQEKEISPAMEEDTSNLSLKPNAQQESQSPD
SSTELQDPAEQTPPETSDASAPATTSADSVEKYAQDATQNQSSTSNGPGVIRATSAQVTA
TRSVVSSQSGDAIVDLSADKASYRQGEDVNLSVDFKNTTDKEQDVTVYADVYYIDNKLGT
YKFSKHLKAGEGYKMQSGDLKIPASQFENNHGYLLKVRVRDADNNTLSEVNKAIAVESDW
TKFPRYGIVGGSQDTNNSLLSKDADRYRAEIEKMKNMNINSYFFYDVYKTATNPFPSDEA
TFKQDWNTWSGSEIDTQAVKDIVNQVHDGGAVAMLYNMILAENTNTGEAPVLPETEYAYN
SDDRGYGAQGQPMSYTVKIPKDGQEEDVEIQRYYNPTSKLWQDYIADKMGQAMKNGGFDG
WQGDTIGDNEVYSYADKDSNDPSKKFWLTEGYAEFLRAIKEKLPNYYLTVNDVNGEQIYR
LKDGNQDVIYNEIWPFGPALPSEMAAVKPNTVTSRPVLTKVRQGDWKISIVGAYMEGSEN
GGSKADAEAGKSLQTDAVLLTSASIAAAGGYHMSLAALANQQDETDGGQGIGVLQTAYYP
TQSLKTSSELTRKNNDYQQFITAYENVLRDGVENDDAQVNTFDSNGQKLSTDAKGITGNQ
VWTYGKKGDNFRTVQLLNLMGINSDWKNEDGSAANKTPDEQTNLTVKYALGDVSMEDAQR
MANQTYVTSPDDWSKSNLQKVSASVKTDENGKPVLVINVPKLTLWDVVYISNANQESAPE
ADQAQTPAAQSSDDKVAENETSQPAAEDAKEQTSEPAQDQAAPAEQGQAINQAESPATEP
EAEVTPATAEPAKVDAPEANQAADQAVSPEPASQEQAASQSQPEANQTPASNETPATQGN
SEQPELNEPTAQTQPSSQVSPANTSVTPVAEQPTNQGQAADKADQAPTNSTSTPESTSPV
EPAATDQSSDTPIVTAGNLSVQPAETETPTVPDKQGDSKANQSSTETPVADQVPAVAEQP
QATEPNQAKPSVDKAAAPEALSLIQLKQQTPAIQAKEADDPEVDETKSEVTPDSGTDKAP
EAGQVDSDKAPTVKPSTPENNDNQPNNANDADKNKTNEADSNKANQDSTKGSSADQSGKS
TTPEDGPDNSSPEDPETKPSDPNTDTSDQEQVKPSLPVVPNQTVDDPKTDDTDTPANTDS
AKSKKVADADKNKVATDSEGRQKSSEFPKEATDLEKVGQPASPQVAGVKSSVATSPEKKS
EPVSKTSTTSSSDKLPKTGDHKTVVLIIVLGLVFVGMTGLLARHEKK
>DLTD_BACSU.1 [20,392]  P39578 Protein dltD precursor. - Bac
IAIPSSWLTGFITDKRVKESATALNPSMFQGLYLQDQMLKDPTYLPIYGSSELSRLDEFH
PSNYFQVNNEGFTPYLVGKGGSQSLIHSLNFAAHMDQLKGKKIVFIVSPQWFIKRGSDEQ
HFAPNYSALQGLDLAFNDQIDPEIKKKMMKRMLRFKAVQNDAILSELYKAMVNGQTWKVN
ALKPAAKVYYSMLEKKDLYYSTTESSGPKRYISQSVKDKSWSELNKLADQSGKRHSGSND
FHIDNPVYKKLKPKVPKLKGKNKGRSYAVSPEYGDFEMMLDILKDAGAEPMFVTIPVNGK
WYDYTGFPKKGRTDYYKKVNKQIRAKGFQVADFSGHEYDPYFMKDTIHIGWKGWVYVDKA
IDEFYKTGKVTSS
>DLTD_LACRH.1 [50,161]  P55154 Protein dltD precursor (Fragm
ANVLKGETIKNEAMADNYVPFIGSSELSRMDAFHPSVLAQKYHRDYRPFLMGMAGSQSLT
HFLSINALTHVEGKKAVMVLSPQWFVPGGLRKAQFDYFYSPAQMTTFLLHAN
>DPPE_BACSU.1 [23,543]  P26906 Dipeptide-binding protein dpp
CTANEQAGKEGSHDKAKTSGEKVLYVNNENEPTSFDPPIGFNNVSWQPLNNIMEGLTRLG
KDHEPEPAMAEKWSVSKDNKTYTFTIRENAKWTNGDPVTAGDFEYAWKRMLDPKKGASSA
FLGYFIEGGEAYNSGKGKKDDVKVTAKDDRTLEVTLEAPQKYFLSVVSNPAYFPVNEKVD
KDNPKWFAESDTFVGNGPFKLTEWKHDDSITMEKSDTYWDKDTVKLDKVKWAMVSDRNTD
YQMFQSGELDTAYVPAELSDQLLDQDNVNIVDQAGLYFYRFNVNMEPFQNENIRKAFAMA
VDQEEIVKYVTKNNEKTAHAFVSPGFTQPDGKDFREAGGDLIKPNESKAKQLLEKGMKEE
NYNKLPAITLTYSTKPEHKKIAEAIQQKLKNSLGVDVKLANMEWNVFLEDQKALKFQFSQ
SSFLPDYADPISFLEAFQTGNSMNRTGWANKEYDQLIKQAKNEADEKTRFSLMHQAEELL
INEAPIIPVYFYNQVHLQNEQVKGIVRHPVGYIDLKWADKN
>DRN1_STREQ.1 [25,327]  P26295 Deoxyribonuclease precursor (
IPPYHHNTVLAKTVSVNQTYGEYKDYYTVIGESNIDQSAFPKIYKTTERVYKGQGTSEKR
VTVSDVVYNPLDGYKRSTGAYGVVTKDMIDMSKGYREKWETNPEPSGWFRFYNRADNEEI
SEKEYDSRRTKSYKVTNNVPVVLTTLKGKKYNSHLFVASHLFADSLGGKSIRKNAITGTQ
MQNVGTRKGGMQYIEKKVLSHITKNPDVYVFYSAIPEYQGAELLARSVLVSALSSDGVIN
ETVRVFNTADGFNINYEKGGLLTESPVSEIDNIEDSTTDEIENSVDDSEEIVYNDTTTEE
EEN
>E13B_BACCI.1 [39,682]  P23903 Glucan endo-1,3-beta-glucosid
AGTTVTSMEYFSPADGPVISKSGVGKASYGFVMPKFNGGSATWNDVYSDVGVNVKVGNNW
VDIDQAGGYIYNQNWGHWSDGGFNGYWFTLSATTEIQLYSKANGVKLEYQLVFQNINKTT
ITAMNPTQGPQITASFTGGAGFTYPTFNNDSAVTYEAVADDLKVYVKPVNSSSWIDIDNN
AASGWIYDHNFGQFTDGGGGYWFNVTESINVKLESKTSSANLVYTITFNEPTRNSYVITP
YEGTTFTADANGSIGIPLPKIDGGAPIAKELGNFVYQININGQWVDLSNSSQSKFAYSAN
GYNNMSDANQWGYWADYIYGLWFQPIQENMQIRIGYPLNGQAGGNIGNNFVNYTFIGNPN
APRPDVSDQEDISIGTPTDPAIAGMNLIWQDEFNGTTLDTSKWNYETGYYLNNDPATWGW
GNAELQHYTNSTQNVYVQDGKLNIKAMNDSKSFPQDPNRYAQYSSGKINTKDKLSLKYGR
VDFRAKLPTGDGVWPALWMLPKDSVYGTWAASGEIDVMEARGRLPGSVSGTIHFGGQWPV
NQSSGGDYHFPEGQTFANDYHVYSVVWEEDNIKWYVDGKFFYKVTNQQWYSTAAPNNPNA
PFDEPFYLIMNLAVGGNFDGGRTPNASDIPATMQVDYVRVYKEQ
>EDIN_STAAU.1 [36,247]  P24121 Epidermal cell differentiatio
ADVKNFTDLDEATKWGNKLIKQAKYSSDDKIALYEYTKDSSKINGPLRLAGGDINKLDST
TQDKVRRLDSSISKSTTPESVYVYRLLNLDYLTSIVGFTNEDLYKLQQTNNGQYDENLVR
KLNNVMNSRIYREDGYSSTQLVSGAAVGGRPIELRLELPKGTKAAYLNSKDLTAYYGQQE
VLLPRGTEYAVGSVELSNDKKKIIITAIVFKK
>ELYA_BACAO.1 [28,380]  P27693 Alkaline protease precursor (
AEEAKEKYLIGFNEQEAVSEFVEQVEANDEVAILSEEEEVEIELLHEFETIPVLSVELSP
EDVDALELDPAISYIEEDAEVTTMAQSVPWGISRVQAPAAHNRGLTGSGVKVAVLDTGIS
THPDLNIRGGASFVPGEPSTQDGNGHGTHVAGTIAALNNSIGVLGVAPNAELYAVKVLGA
SGSGSVSSIAQGLEWAGNNGMHVANLSLGSPSPSATLEQAVNSATSRGVLVVAASGNSGA
GSISYPARYANAMAVGATDQNNNRASFSQYGAGLDIVAPGVNVQSTYPGSTYASLNGTSM
ATPHVAGAAALVKQKNPSWSNVQIRNHLKNTATSLGSTNLYGSGLVNAEAATR
>ELYA_BACCS.1 [28,380]  P41362 Alkaline protease precursor (
AEEAKEKYLIGFNEQEAVSEFVEQVEANDEVAILSEEEEVEIELLHEFETIPVLSVELSP
EDVDALELDPAISYIEEDAEVTTMAQSVPWGISRVQAPAAHNRGLTGSGVKVAVLDTGIS
THPDLNIRGGASFVPGEPSTQDGNGHGTHVAGTIAALNNSIGVLGVAPSAELYAVKVLGA
SGSGSVSSIAQGLEWAGNNGMHVANLSLGSPSPSATLEQAVNSATSRGVLVVAASGNSGA
GSISYPARYANAMAVGATDQNNNRASFSQYGAGLDIVAPGVNVQSTYPGSTYASLNGTSM
ATPHVAGAAALVKQKNPSWSNVQIRNHLKNTATSLGSTNLYGSGLVNAEAATR
>ELYA_BACHD.1 [25,361]  P41363 Thermostable alkaline proteas
SEEKKEYLIVVEPEEVSAQSVEESYDVDVIHEFEEIPVIHAELTKKELKKLKKDPNVKAI
EKNAEVTISQTVPWGISFINTQQAHNRGIFGNGARVAVLDTGIASHPDLRIAGGASFISS
EPSYHDNNGHGTHVAGTIAALNNSIGVLGVAPSADLYAVKVLDRNGSGSLASVAQGIEWA
INNNMHIINMSLGSTSGSSTLELAVNRANNAGILLVGAAGNTGRQGVNYPARYSGVMAVA
AVDQNGQRASFSTYGPEIEISAPGVNVNSTYTGNRYVSLSGTSMATPHVAGVAALVKSRY
PSYTNNQIRQRINQTATYLGSPSLYGNGLVHAGRATQ
>ELYA_BACYA.1 [28,378]  P20724 Alkaline elastase YaB precurs
AEEAKEKYLIGFKEQEVMSQFVDQIDGDEYSISSQAEDVEIDLLHEFDFIPVLSVELDPE
DVDALELDPAIAYIEEDAEVTTMQTVPWGINRVQAPIAQSRGFTGTGVRVAVLDTGISNH
ADLRIRGGASFVPGEPNISDGNGHGTQVAGTIAALNNSIGVLGVAPNVDLYGVKVLGASG
SGSISGIAQGLQWAANNGMHIANMSLGSSAGSATMEQAVNQATASGVLVVAASGNSGAGN
VGFPARYANAMAVGATDQNNNRATFSQYGAGLDIVAPGVGVQSTVPGNGYASFNGTSMAT
PHVAGVAALVKQKNPSWSNVQIRNHLKNTATNLGNTTQFGSGLVNAEAATR
>EPIP_STAEP.1 [24,461]  P30199 Epidermin leader peptide proc
FGSSLNEELSYYSVEYDNAKTFKESIKQKNIELTYKIPELHTAQIKTSKSKLNSLIKSNK
NVKFVNPTCSTCVVEKSVKTGKNLNNKKNGSHDLFDRQWDMRKITNEGKSYKLSPDRKKA
KVALVDSGVNSSHTDLKSINKIVNEVPKNGFRGSENDESGNKNFEEDKLNHGTLVAGQIG
ANGNLKGVNPGVEMNVYRVFGSKKSEMLWVSKGIIDAANDDNDVINVSLGNYLIKDNQNK
KKLRDDEKVDYDALQKAINYAQKKGSIVVAAVGNDGINVKKVKEINKKRNLNSKTSKKVY
DSPANLNNVMTVGSIDDNDYISEFSNYGNNFIDLMTIGGSYKLLDKYGKDAWLEKGYMQK
QSVLSTSSNGRYIYQSGTSLAAPKVSGALALEIDKYQLKDQPETAIELFKKKGIEKEKYM
DKKHYGNGKLDVYKLLKE
>ETA_STAAU.1 [39,280]   P09331 Exfoliative toxin A precursor
EVSAEEIKKHEEKWNKYYGVNAFNLPKELFSKVDEKDRQKYPYNTIGNVFVKGQTSATGV
LIGKNTVLTNRHIAKFANGDPSKVSFRPSINTDDNGNTETPYGEYEVKEILQEPFGAGVD
LALIRLKPDQNGVSLGDKISPAKIGTSNDLKDGDKLELIGYPFDHKVNQMHRSEIELTTL
SRGLRYYGFTVPGNSGSGIFNSNGELVGIHSSKVSHLDREHQINYGVGIGNYVKRIINEK
NE
>ETB_STAAU.1 [32,277]   P09332 Exfoliative toxin B precursor
KEYSAEEIRKLKQKFEVPPTDKELYTHITDNARSPYNSVGTVFVKGSTLATGVLIGKNTI
VTNYHVAREAAKNPSNIIFTPAQNRDAEKNEFPTPYGKFEAEEIKESPYGQGLDLAIIKL
KPNEKGESAGDLIQPANIPDHIDIQKGDKYSLLGYPYNYSAYSLYQSQIEMFNDSQYFGY
TEVGNSGSGIFNLKGELIGIHSGKGGQHNLPIGVFFNRKISSLYSVDNTFGDTLGNDLKK
RAKLDK
>ETC1_STAAU.1 [28,266]  P01553 Enterotoxin type C-1 precurso
ESQPDPTPDELHKASKFTGLMENMKVLYDDHYVSATKVKSVDKFLAHDLIYNISDKKLKN
YDKVKTELLNEGLAKKYKDEVVDVYGSNYYVNCYFSSKDNVGKVTGGKTCMYGGITKHEG
NHFDNGNLQNVLIRVYENKRNTISFEVQTDKKSVTAQELDIKARNFLINKKNLYEFNSSP
YETGYIKFIENNGNTFWYDMMPAPGDKFDQSKYLMMYNDNKTVDSKSVKIEVHLTTKNG
>ETC2_STAAU.1 [28,266]  P34071 Enterotoxin type C-2 precurso
ESQPDPTPDELHKSSEFTGTMGNMKYLYDDHYVSATKVMSVDKFLAHDLIYNISDKKLKN
YDKVKTELLNEDLAKKYKDEVVDVYGSNYYVNCYFSSKDNVGKVTGGKTCMYGGITKHEG
NHFDNGNLQNVLIRVYENKRNTISFEVQTDKKSVTAQELDIKARNFLINKKNLYEFNSSP
YETGYIKFIENNGNTFWYDMMPAPGDKFDQSKYLMMYNDNKTVDSKSVKIEVHLTTKNG
>ETC3_STAAM.1 [28,266]  P23313 Enterotoxin type C-3 precurso
ESQPDPMPDDLHKSSEFTGTMGNMKYLYDDHYVSATKVKSVDKFLAHDLIYNISDKKLKN
YDKVKTELLNEDLAKKYKDEVVDVYGSNYYVNCYFSSKDNVGKVTGGKTCMYGGITKHEG
NHFDNGNLQNVLVRVYENKRNTISFEVQTDKKSVTAQELDIKARNFLINKKNLYEFNSSP
YETGYIKFIENNGNTFWYDMMPAPGDKFDQSKYLMMYNDNKTVDSKSVKIEVHLTTKNG
>ETXA_STAAW.1 [25,257]  P13163 Enterotoxin type A precursor 
SEKSEEINEKDLRKKSELQGTALGNLKQIYYYNEKAKTENKESHDQFLQHTILFKGFFTD
HSWYNDLLVDFDSKDIVDKYKGKKVDLYGAYYGYQCAGGTPNKTACMYGGVTLHDNNRLT
EEKKVPINLWLDGKQNTVPLETVKTNKKNVTVQELDLQARRYLQEKYNLYNSDVFDGKVQ
RGLIVFHTSTEPSVNYDLFGAQGQYSNTLLRIYRDNKTINSENMHIDIYLYTS
>ETXB_CLOPE.1 [33,328]  Q02307 Epsilon-toxin, type B precurs
KEISNTVSNEMSKKASYDNVDTLIEKGRYNTKYNYLKRMEKYYPNAMAYFDKVTINPQGN
DFYINNPKVELDGEPSMNYLEDVYVGKALLTNDTQQEQKLKSQSFTCKNTDTVTATTTHT
VGTSIQATAKFTVPFNETGVSLTTSYSFANTNTNTNSKEITHNVPSQDILVPANTTVEVI
AYLKKVNVKGNVKLVGQVSGSEWGEIPSYLAFPRDGYKFSLSDTVNKSDLNEDGTINING
KGNYSAVMGDELIVKVRNLNTNNVQEYVIPVDKKEKSNDSNIVKYRSLYIKAPGIK
>ETXB_STAAU.1 [28,266]  P01552 Enterotoxin type B precursor 
ESQPDPKPDELHKSSKFTGLMENMKVLYDDNHVSAINVKSIDQFLYFDLIYSIKDTKLGN
YDNVRVEFKNKDLADKYKDKYVDVFGANYYYQCYFSKKTNDINSHQTDKRKTCMYGGVTE
HNGNQLDKYRSITVRVFEDGKNLLSFDVQTNKKKVTAQELDYLTRHYLVKNKKLYEFNNS
PYETGYIKFIENENSFWYDMMPAPGDKFDQSKYLMMYNDNKMVDSKDVKIEVYLTTKKK
>ETXD_STAAU.1 [26,258]  P20723 Enterotoxin type D precursor 
NENIDSVKEKELHKKSELSSTALNNMKHSYADKNPIIGENKSTGDQFLENTLLYKKFFTD
LINFEDLLINFNSKEMAQHFKSKNVDVYPIRYSINCYGGEIDRTACTYGGVTPHEGNKLK
ERKKIPINLWINGVQKEVSLDKVQTDKKNVTVQELDAQARRYLQKDLKLYNNDTLGGKIQ
RGKIEFDSSDGSKVSYDLFDVKGDFPEKQLRIYSDNKTLSTEHLHIDIYLYEK
>ETXE_STAAU.1 [28,257]  P12993 Enterotoxin type E precursor 
SEEINEKDLRKKSELQRNALSNLRQIYYYNEKAITENKESDDQFLENTLLFKGFFTGHPW
YNDLLVDLGSKDATNKYKGKKVDLYGAYYGYQCAGGTPNKTACMYGGVTLHDNNRLTEEK
KVPINLWIDGKQTTVPIDKVKTSKKEVTVQELDLQARHYLHGKFGLYNSDSFGGKVQRGL
IVFHSSEGSTVSYDLFDAQGQYPDTLLRIYRDNKTINSENLHIDLYLYTT
>ETXG_STAAM.1 [26,258]  O85382 Enterotoxin type G precursor 
QPDPKLDELNKVSDYKNNKGTMGNVMNLYTSPPVEGRGVINSRQFLSHDLIFPIEYKSYN
EVKTELENTELANNYKDKKVDIFGVPYFYTCIIPKSEPDINQNFGGCCMYGGLTFNSSEN
ERDKLITVQVTIDNRQSLGFTITTNKNMVTIQELDYKARHWLTKEKKLYEFDGSAFESGY
IKFTEKNNTSFWFDLFPKKELVPFVPYKFLNIYGDNKVVDSKSIKMEVFLNTH
>ETXH_STAAW.1 [25,241]  Q53585 Enterotoxin type H precursor 
EDLHDKSELTDLALANAYGQYNHPFIKENIKSDEISGEKDLIFRNQGDSGNDLRVKFATA
DLAQKFKNKNVDIYGASFYYKCEKISENISECLYGGTTLNSEKLAQERVIGANVWVDGIQ
KETELIRTNKKNVTLQELDIKIRKILSDKYKIYYKDSEISKGLIEFDMKTPRDYSFDIYD
LKGENDYEIDKIYEDNKTLKSDDISHIDVNLYTKKKV
>FEUA_BACSU.1 [20,317]  P40409 Iron-uptake system binding pr
CGSKNESTASKASGTASEKKKIEYLDKTYEVTVPTDKIAITGSVESMEDAKLLDVHPQGA
ISFSGKFPDMFKDITDKAEPTGEKMEPNIEKILEMKPDVILASTKFPEKTLQKISTAGTT
IPVSHISSNWKENMMLLAQLTGKEKKAKKIIADYEQDLKEIKTKINDKAKDSKALVIRIR
QGNIYIYPEQVYFNSTLYGDLGLKAPNEVKAAKAQELSSLEKLSEMNPDHIFVQFSDDEN
ADKPDALKDLEKNPIWKSLKAVKEDHVYVNSVDPLAQGGTAWSKVRFLKAAAEKLTQN
>FHUD_BACSU.1 [24,315]  P37580 Ferrichrome-binding protein p
CGNNSESKGSASDSKGAETFTYKAENGNVKIPKHPKRVVVMADGYYGYFKTLGINVVGAP
ENVFKNPYYKGKTNGVENIGDGTSVEKVIDLNPDLIIVWTTQGADIKKLEKIAPTVAVKY
DKLDNIEQLKEFAKMTGTEDKAEKWLAKWDKKVAAAKTKIKKAVGDKTISIMQTNGKDIY
VFGKDFGRGGSIIYKDLGLQATKLTKEKAIDQGPGYTSISLEKLPDFAGDYIFAGPWQSG
GDDGGVFESSIWKNLNAVKNGHVYKMDPIGFYFTDPISLEGQLEFITESLTK
>FIB_STAAM.1 [30,165]   Q08691 Fibrinogen-binding protein pr
SEGYGPREKKPVSINHNIVEYNDGTFKYQSRPKFNSTPKYIKFKHDYNILEFNDGTFEYG
ARPQFNKPAAKTDATIKKEQKLIQAQNLVREFEKTHTVSAHRKAQKAVNLVSFEYKVKKM
VLQERIDNVLKQGLVR
>FLIZ_BACSU.1 [27,219]  P35536 Flagellar biosynthetic protei
ADSDNSTVNEWFQKKDEKTADQSEQKKEKTTKTADETEGAAAPSVSAFDFVKMIFALLFV
IVLIYGLVKLMNKRNRLLKPFQYVENIGGTSVGQNRSIQLIKVGKSVLVVGVGETIQLLK
EIEDEKEIEVILSQHEEAMSSKIEWQKFVKPLKSSEHQPQQKLPSFSKALKEQLEELKQN
RSEGKKKGPRHHE
>FNBA_STAAU.1 [37,1018]  P14738 Fibronectin-binding protein 
ASEQKTTTVEENGNSATDNKTSETQTTATNVNHIEETQSYNATVTEQPSNATQVTTEEAP
KAVQAPQTAQPANIETVKEEVVKEEAKPQVKETTQSQDNSGDQRQVDLTPKKATQNQVAE
TQVEVAQPRTASESKPRVTRSADVAEAKEASNAKVETGTDVTSKVTVEIGSIEGHNNTNK
VEPHAGQRAVLKYKLKFENGLHQGDYFDFTLSNNVNTHGVSTARKVPEIKNGSVVMATGE
VLEGGKIRYTFTNDIEDKVDVTAELEINLFIDPKTVQTNGNQTITSTLNEEQTSKELDVK
YKDGIGNYYANLNGSIETFNKANNRFSHVAFIKPNNGKTTSVTVTGTLMKGSNQNGNQPK
VRIFEYLGNNEDIAKSVYANTTDTSKFKEVTSNMSGNLNLQNNGSYSLNIENLDKTYVVH
YDGEYLNGTDEVDFRTQMVGHPEQLYKYYYDRGYTLTWDNGLVLYSNKANGNEKNGPIIQ
NNKFEYKEDTIKETLTGQYDKNLVTTVEEEYDSSTLDIDYHTAIDGGGGYVDGYIETIEE
TDSSAIDIDYHTAVDSEAGHVGGYTESSEESNPIDFEESTHENSKHHADVVEYEEDTNPG
GGQVTTESNLVEFDEESTKGIVTGAVSDHTTVEDTKEYTTESNLIELVDELPEEHGQAQG
PVEEITKNNHHISHSGLGTENGHGNYDVIEEIEENSHVDIKSELGYEGGQNSGNQSFEED
TEEDKPKYEQGGNIVDIDFDSVPQIHGQNKGNQSFEEDTEKDKPKYEHGGNIIDIDFDSV
PHIHGFNKHTEIIEEDTNKDKPSYQFGGHNSVDFEEDTLPKVSGQNEGQQTIEEDTTPPI
VPPTPPTPEVPSEPETPTPPTPEVPSEPETPTPPTPEVPSEPETPTPPTPEVPAEPGKPV
PPAKEEPKKPSKPVEQGKVVTPVIEINEKVKAVAPTKKPQSKKSELPETGGEESTNKGML
FGGLFSILGLALLRRNKKNHKA
>FRUA_STRMU.1 [40,1423]  Q03174 Fructan beta-fructosidase pr
EEISQTTAADTAVTEVRTEDSSQTSSQETAVTETTQSEGTASKQLTTPAVADQTTEPTDN
EPISSSDGASSPYQVTDTTEPQQTLTPADSEPQAKADVQQAAAPKKEEINPVTNLEDMSH
DTNGTWEVREDGIHSNAIGKGDSFLYSQSSGKNFVYATDVTFKQNSGAAALVFRSNNDSN
NKNMYAVNVDIGGHKAKFWRWVDNKDIQLIDERDVVPTADNRYTLKVVAVNNWISYYVND
ILMASTGDYVLQKADKGQNTVIPEGHFGLLNWNGDMVFQNTKFALLDDTTAPLIDNITVR
SDRGNVEKQGQFFSEEPLHIQYVSNDASQVSLDIAKHNPAATVTVEDKTGRVYTDPSHLP
VNVGANYFTVKSTVIDSFGRTVTLTYRINVHRRQNDEVYYNELYRDQYHYSVKDGWANDP
NGLVYYNGVYHLFHQFYDDTKWGPMHWAHATSTDLIHWKEEPIAFYPDSNGYMFSGCVVV
DEHNSSGLFKTAKGGLVAIITANGNGQRMELAYSEDEGKTWQKYDRIVADWSNDPLQNQD
FRDPKVFHWNNQWFMVLAGGPLRIYSSNNLKDWKVESTYPDLHTECPDMYPIVANDGVLK
WVLSRGGRFYKVGDFKQVDGKWTFIADDAYKDKDQVMNFGKDSYAAMTYYVHDFGTETRP
TIPKLTEVNWMNTWEDYCNLVADTVGQDFNGTFNLNLDLGLINENGQYILTQTPVKAYDS
LRDVNTALHFKDVTVDANNTLLKDFKGDSYEIVSHFRPDEKTTKVGFNLRVGNGQATKVI
YDLQTETLSIDRSQSGTILSAAFAKVNSQHVTKNADGSIDLHIYVDRASVEVFSKNNTVA
GANQIFPNPEAVGASIIVEGGKAQADISVYQMKTIWTDKKDTAKPVAMNTTTAKELALQV
GQSQDLQVYLAPASVRQDVEWTISDPSLVRTSQKGNVLHLTAVKKGKLTITAISKENPSL
SKTFTISITLNNFKTNLKGLQSVTGKWYVDDETLYDSNTSSNDYYMASQKPGFKEYDYDI
DLKYQRGLINLFVASGNIDPSQAYSVQFGDSETVRLYRFAGDTIAEANMGKRINDDQYHH
IKVTKTKNSIIISVDGQEVMSHNFDQVDSYFNDAYVGLGLWDGAVEFQNFFVTDHATTPK
PDSDPTPQPDAPEALAQERELIDPATGVRVILQKGELASIVRVKVSHIETNDAHTPAVLN
AKDYDLFNITPIDKNEKVVAITKPATVLLPIDAGKVVDKVVYLPNTDKEENLPFTIVSLT
DSNGKKQSYVRFTAEHFSEYGLVYQAENQTNLKSKEKQDNVAISYPLNLEQEVKVSSISR
KYAANKTADVNSVQQTEPSVMSSSPKATLPDTGDHKTDLSQLGVLAMIGSFLVEIAGYFK
KRKD
>GERD_BACSU.1 [20,185]  P16450 Spore germination protein ger
CAPKDQAADMDYDQTKKMVVDILKTDDGKKAIKELLNDDAMNEALVIDQDAIKGTIEKTL
TSKKGEEFWKNIFEDTDFAEGFAKTLQTEHEKVIKKLMKDPDYQKMLMSVMQDPGMDKKY
SQLAKSQEFRSYLEEVINETLSSPLYKKQFEDELKKAAKDTAKESE
>GGT_BACSU.1 [29,587]   P54422 Gamma-glutamyltranspeptidase 
KKPPKSYDEYKQVDVGKDGMVATAHPLASEIGADVLKKGGNAIDAAVAIQFALNVTEPMM
SGIGGGGFMMVYDGKTKDTTIIDSRERAPAGATPDMFLDENGKAIPFSERVTKGTAVGVP
GTLKGLEEALDKWGTRSMKQLITPSIKLAEKGFPIDSVLAEAISDYQEKLSRTAAKDVFL
PNGEPLKEGDTLIQKDLAKTFKLIRSKGTDAFYKGKFAKTLSDTVQDFGGSMTEKDLENY
DITIDEPIWGDYQGYQIATTPPPSSGGIFLLQMLKILDHFNLSQYDVRSWEKYQLLAETM
HLSYADRASYAGDPEFVNVPLKGLLHPDYIKERQQLINLDQVNKKPKAGDPWKYQEGSAN
YKQVEQPKDKVEGQTTHFTVADRWGNVVSYTTTIEQLFGTGIMVPDYGVILNNELTDFDA
IPGGANEVQPNKRPLSSMTPTILFKDDKPVLTVGSPGGATIISSVLQTILYHIEYGMELK
AAVEEPRIYTNSMSSYRYEDGVPKDVLSKLNGMGHKFGTSPVDIGNVQSISIDHENGTFK
GVADSSRNGAAIGINLKRK
>GLNH_BACST.1 [27,262]  P27676 Glutamine-binding protein pre
CSSESSTTNKEDGAKSTETSAGTNTLEKIKKRGKLIVGVKYDLNLFGLKNPETGKVEGFD
IDIAKGLAKKILGDENKIELKEVTSKTRIPMLNNGEIDAIIGTMTITEERKKEVDFSDVY
FMAGQSLLVKKDSKINSVKDLKKGMTVLTAKGSTSAQNIRKVAPEVNVLEFENYAEAFTA
LKAGQGDALTTDNALLWGMAKQDPNYRVLDETFSKEPYGIGSAKETKNYCKSLTNT
>GRAC_BACSU.1 [18,373]  P07870 Spore germination protein A3 
CWDSENIEELSLVIGIGLDKPDDENLELTQQILVPKIISAKEGSSSDPTQLSITKGKTVH
QMMRTSALKHKPTFSQHLRLILLSKSVIADQIGMDAIINQFVRDNGTRRSSYVFITNGRT
KDIFNMNDEGEPASNVIYDLTENNKVTIRTMEPVTLGEISEHLTSDDSFLIPHVGKENGK
LAINGASIIKNKLWHRDLTPIEVQNISLFSGTVEGGVIDLKRDGHLFSYEVYSSNRKIKT
AYKDGKFKFTVTRNIEGRLSEDWNPNEDSFKDSYIKSIEKTVEKRVHETVTSFITEKLQK
EIKADVTGLGNEVRIHYPQKWKKISRKWDDDYFSNAEIDYRVNVIVRDFGTKGANK
>GRBC_BACSU.1 [20,374]  P39571 Spore germination protein B3 
CWDVKDIEQLSFARGLAIDETNDHQYKLTYQNLLPQSEDSQASGKPEFVNVTSHGKTILE
AVSDVSIKDPPVYSDHLKVILLGEKLMRNQNVDQVLNHFIRDDELRRSSYLMAARGNAAD
VFTKGNPNQQQPMPSEKLIDLTTHSGYNGKIMIPLRIGRASVYSQNGYSYLIQAVKNEKG
KAKYDGAGIIKRGSNKLVGFLSADETQTLSWVMGTIQGGVMPTTDKGHPITFEIKKSKTK
IKPVIENGKPVFHISVKTKGILTEDQNPNENSFSKSYLHRLENIFEKKLERDVKQVMDKL
QHEYKTDPVFLSDHIRIQHPDYWNKVKGHWDEIFSETDFKYDISFKIINFGTVGK
>GRKC_BACSU.1 [21,407]  P49941 Spore germination protein KC 
CWDKRELTDLAIISAIGIDRTNDSNYVLHLQIINPGNVAGGLQGGGAGDRPPVSVYSIEG
NNITEALRKASMKVSRRLYFAHTNLVVINEKLAKEEGLDFVLDNLDRDTEFRTTATFVVA
HKTKAENIVKILTPIDKIPSNKVNKTLDFTEAQYGRVVKINIQDVLKTLAANTMAPVIPG
YMMIGDDKKGVSMENTQATDPKAILQADGLAVFDKAGYLKYWLEDDESVGAVWLMNKIQH
TFINADWGKTKDAVSLQVTHQDTKLVPKMRNGRPYIHVKVSVEGIIDAVKYPFQLSDPKV
LAAIEKALNKELEKEISHTVKKIKKNKIDFIGFGDTIYRKYPEQWEKMKDTWDKEYLPEL
PIDVKAETYIRRTGLRNNPIKHQFKDD
>GRXC_BACAN.1 [21,317]  Q9ZFB3 Spore germination protein XC 
CWDRRELEHVLFINTLGIDFKDNHYIIYPQFINFTNMAKQEGPANRNYSPAYIGKGEGKL
LYDAAFDFYKSSQQKVSWEHIKSIVVTERFLKNGNLNQLNDFLSRFFQFRNTMWVFGTKE
PLENILATNNIFNISSLYTIMNLPQETIRQSASVDPLRLYTFRSNYYEPGMTTRIPFLAT
TTEHWKQGHKAFWMLEFNEYGCIAAKSYVNHLNDSDIAGVRWTNKNTNRAPLLLKVKNRA
IGELILKKPKIDTKVSIEKGKPHIVMNISLEGDIYQLMKPMPVHKVKKTLRISLKKK
>GSEP_BACLI.1 [31,316]  P80057 Glutamyl endopeptidase precur
APSPHTPVSSDPSYKAETSVTYDPNIKSDQYGLYSKAFTGTGKVNETKEKAEKKSPAKAP
YSIKSVIGSDDRTRVTNTTAYPYRAIVHISSSIGSCTGWMIGPKTVATAGHCIYDTSSGS
FAGTATVSPGRNGTSYPYGSVKSTRYFIPSGWRSGNTNYDYGAIELSEPIGNTVGYFGYS
YTTSSLVGTTVTISGYPGDKTAGTQWQHSGPIAISETYKLQYAMDTYGGQSGSPVFEQSS
SRTNCSGPCSLAVHTNGVYGGSSYNRGTRITKEVFDNLTNWKNSAQ
>GTF1_STRDO.1 [39,1597]  P11001 Glucosyltransferase-I precur
DTETVSEDSNQAVLTADQTTTNQDTEQTSVAATATSEQSASTDAATDQASATDQASAAEQ
TQGTTASTDTAAQTTTNANEAKWVPTENENQVFTDEMLAEAKNVATAESNSIPSDLAKMS
NVKQVDGKYYYYDQDGNVKKNFAVSVGEKIYYFDETGAYKDTSKVEADKSGSDISKEETT
FAANNRAYSTSAENFEAIDNYLTADSWYRPKSILKDGKTWTESSKDDFRPLLMAWWPDTE
TKRNYVNYMNKVVGIDKTYTAETSQADLTAAAELVQARIEQKITTEQNTKWLREAISAFV
KTQPQWNGESEKPYDDHLQNGALKFDNQSDLTPDTQSNYRLLNRTPTNQTGSLDSRFTYN
ANDPLGGYELLLANDVDNSNPIVQAEQLNWLHYLLNFGTIYAKDADANFDSIRVDAVDNV
DADLLQISSDYLKAAYGIDKNNKNANNHVSIVEAWSDNDTPYLHDDGDNLMNMDNKFRLS
MLWSLAKPLDKRSGLNPLIHNSLVDREVDDREVETVPSYSFARAHDSEVQDLIRDIIKAE
INPNAFGYSFTQDEIDQAFKIYNEDLKKTDKKYTHYNVPLSYTLLLTNKGSIPRVYYGDM
FTDDGQYMANKTVNYDAIESLLKARMKYVAGGQAMQNYQIGNGEILTSVRYGKGALKQSD
KGDATTRTSGVGVVMGNQPNFSLDGKVVALNMGAAHANQEYRALMVSTKDGVATYATDAD
ASKAGLVKRTDENGYLYFLNDDLKGVANPQVSGFLQVWVPVGAADDQDIRVAASDTASTD
GKSLHQDAAMDSRVMFEGFSNFQSFATKEEEYTNVVIANNVDKFVSWGITDFEMAPQYVS
STDGQFLDSVIQNGYAFTDRYDLGMSKANKYGTADQLVKAIKALHAKGLKVMADWVPDQM
YTFPKQEVVTVTRTDKFGKPIAGSQINHSLYVTDTKSSGDDYQAKYGGAFLDELKEKYPE
LFTKKQISTGQAIDPSVKIKQWSAKYFNGSNILGRGADYVLSDQASNKYLNVSDDKLFLP
KTLLGQVVESGIRFDGTGYVYNSSTTGEKVTDSFITEAGNLYYFGQDGYMVTGAQNIKGS
NYYFLANGAALRNTVYTDAQGQNHYYGNDGKRYENGYQQFGNDSWRYFKNGVMALGLTTV
DGHVQYFDKDGVQAKDKIIVTRDGKVRYFDQHNGNAVTNTFVADKTGHWYYLGKDGVAVT
GAQTVGKQHLYFEANGQQVKGDFVTAKDGKLYFYDVDSGDMWTNTFIEDKAGNWFYLGKD
GAAVTGAQTIKGQKLYFKANGQQVKGDIVKDADGKIRYYDAQTGEQVFNKSVSVNGKTYY
FGSDGTAQTQANPKGQTFKDGSGVLRFYNLEGQYVSGSGWYETAEHEWVYVKSGKVLTGA
QTIGNQRVYFKDNGHQVKGQLVTGNDGKLRYYDANSGDQAFNKSVTVNGKTYYFGSDGTA
QTQANPKGQTFKDGSGVLRFYNLEGQYVSGSGWYKNAQGQWLYVKDGKVLTGLQTVGNQK
VYFDKNGIQAKGKAVRTSDGKVRYFDENSGSMITNQWKFVYGQYYYFGSDGAAVYRGWN
>GTF2_STRDO.1 [39,1592]  P27470 Glucosyltransferase-I precur
DTDTASDDSNQTVVTGDQTTNNQATDQTSIAATATSEQSASTDAATDQASAAEQTQGTTA
STDTAAQTTTNANEAKWVPTENENQGFTDEMLAEAKNVATAESDSIPSDLAKMSNVKQVD
GKYYYYDQDGNVKKNFAVSVGDKIYYFDETGAYKDTSKVDADKSSSAVSQNATIFAANNR
AYSTSAKNFEAVDNYLTADSWYRPKSILKDGKTWTESGKDDFRPLLMAWWPDTETKRNYV
NYMNKVVGIDKTYTAETSQADLTAAAELVQARIEQKITSENNTKWLREAISAFVKTQPQW
NGESEKPYDDHLQNGALLFDNQTDLTPDTQSNYRLLNRTPTNQTGSLDSRFTYNPNDPLG
GYDFLLANDVDNSNPVVQAEQLNWLHYLLNFGSIYANDADANFDSIRVDAEDNVDADQLQ
ISSDYLKAAYGIDKNNKNANNHVSIVEAWSDNDTPYLHDDGDNLMNMDNKFRLSMLWSLA
KPTDVRSGLNPLIHNSLVDREVDDREVETVPSYSFARAHDSEVQDIIRDIIKAEINPNSF
GYSFTQEEIDQAFKIYNEDLKKSDKKYTHYNVPLSYTLLLTNKGSIPRVYYGDMFTDDGQ
YMANKTVNYDAIESLLKARMKYVAGGQAMQNYQIGNGEILTSVRYGKGALKQSDKGDATT
RTSGVGVVMGNQPNFSLDGKVVALNMGAAHANQEYRALMVSTKDGVATYATDADASKAGL
VKRTDENGYLYFLNDDLKGVANPQVSGFLQVWVPVGAADDQDIRVAASDTASTDGKSLHQ
DAAMDSRVMFEGFSNFQSFATKEEEYTNVVIANNVDKFVSWGITDFEMAPQYVSSTDGQF
QDSVIQNGYAFTDRYDLGMSKANKYGTADQLVKAIKALHAKGLKVMADWVPDQMYTFPKQ
EVVTVTRTDKFGKPIAGSQINHSLYVTDTKSSGDDYQAKYGGAFLDELKEKYPELFTKKQ
MSTGQAIDPSVKIKQWSAKYFNGSNILGRGADYVLSDQVSNKYFNVASDTLFLPSSLLGK
VVESGIRYDGKGYIYNSSATGDQVKASFITEAGNLYYFGKDGYMVTGAQTINGANYFFLE
NGTALRNTIYTDAQGNSHYYANDGKRYENENGYQQFGNDWRYFKDGNMAVGLTTVDGNVQ
YFDKDGVQAKDKIIVTRDGKVRYFDQHNGNAVTNTFIADKTGHWYYLGKDGVAVTGAQTV
GKQKLYFEANGQQVKGDFVTSDEGKLYFYDVDSGDMWTDTFIEDKAGNWFYLGKDGAAVT
GAQTIRGQKLYFKANGQQVKGDIVKGTDGKIRYYDAKSGEQVFNKTVKAADGKTYVIGND
GVAVDPSVVKGQTFKDASGALRFYNLKGQLVTGSGWYETANHDWVYIQSGKALTGEQTIN
GQHLYFKKDGHQVKGQLVTGTDGKVRYYDANSGDQAFNKSVTVNGKTYYFGNDGTAQTAG
NPKGQTFKDGSDIRFYSMEGQLVTGSGWYSNAQGQWLYVKNGKVLTGLQTVGSQRVYFDE
NGIQAKGKAVRTSDGKIRYFDENSGSMITNQWKEVNGRYYYFGNDGARIYRGWN
>GTFB_STRMU.1 [35,1476]  P08987 Glucosyltransferase-I precur
LVKADSNESKSQISNDSNTSVVTANEESNVTTEVTSKQEAASSQTNHTVTTISSSTSVVN
PKEVVSNPYTVGETASNGEKLQNQTTTVDKTSEAAANNISKQTTEADTDVIDDSNAANLQ
ILEKLPNVKEIDGKYYYYDNNGKVRTNFTLIADGKILHFDETGAYTDTSIDTVNKDIVTT
RSNLYKKYNQVYDRSAQSFEHVDHYLTAESWYRPKYILKDGKTWTQSTEKDFRPLLMTWW
PSQETQRQYVNYMNAQLGINKTYDDTSNQLQLNIAAATIQAKIEAKITTLKNTDWLRQTI
SAFVKTQSAWNSDSEKPFDDHLQNGAVLYDNEGKLTPYANSNYRILNRTPTNQTGKKDPR
YTADNTIGGYEFLLANDVDNSNPVVQAEQLNWLHFLMNFGNIYANDPDANFDSIRVDAVD
NVDADLLQIAGDYLKAAKGIHKNDKAANDHLSILEAWSDNDTPYLHDDGDNMINMDNKLR
LSLLFSLAKPLNQRSGMNPLITNSLVNRTDDNAETAAVPSYSFIRAHDSEVQDLIRDIIK
AEINPNVVGYSFTMEEIKKAFEIYNKDLLATEKKYTHYNTALSYALLLTNKSSVPRVYYG
DMFTDDGQYMAHKTINYEAIETLLKARIKYVSGGQAMRNQQVGNSEIITSVRYGKGALKA
TDTGDRTTRTSGVAVIEGNNPSLRLKASDRVVVNMGAAHKNQAYRPLLLTTDNGIKAYHS
DQEAAGLVRYTNDRGELIFTAADIKGYANPQVSGYLGVWVPVGAAADQDVRVAASTAPST
DGKSVHQNAALDSRVMFEGFSNFQAFATKKEEYTNVVIAKNVDKFAEWGVTDFEMAPQYV
SSTDGSFLDSVIQNGYAFTDRYDLGISKPNKYGTADDLVKAIKALHSKGIKVMADWVPDQ
MYAFPEKEVVTATRVDKFGKPVEGSQIKSVLYVADSKSSGKDQQAKYGGAFLEELQAKYP
ELFARKQISTGVPMDPSVKIKQWSAKYFNGTNILGRGAGYVLKDQATNTYFNISDNKEIN
FLPKTLLNQDSQVGFSYDGKGYVYYSTSGYQAKNTFISEGDKWYYFDNNGYMVTGAQSIN
GVNYYFLSNGLQLRDAILKNEDGTYAYYGNDGRRYENGYYQFMSGVWRHFNNGEMSVGLT
VIDGQVQYFDEMGYQAKGKFVTTADGKIRYFDKQSGNMYRNRFIENEEGKWLYLGEDGAA
VTGSQTINGQHLYFRANGVQVKGEFVTDRYGRISYYDSNSGDQIRNRFVRNAQGQWFYFD
NNGYAVTGARTINGQHLYFRANGVQVKGEFVTDRHGRISYYDGNSGDQIRNRFVRNAQGQ
WFYFDNNGYAVTGARTINGQHLYFRANGVQVKGEFVTDRYGRISYYDSNSGDQIRNRFVR
NAQGQWFYFDNNGYAVTGARTINGQHLYFRANGVQVKGEFVTDRYGRISYYDANSGERVR
IN
>GTFC_STRMU.1 [35,1455]  P13470 Glucosyltransferase-SI precu
LVKADSTDDRQQAVTESQASLVTTSEAAKETLTATDTSTATSATSQPTATVTDNVSTTNQ
STNTTANTANFDVKPTTTSEQSKTDNSDKIIATSKAVNRLTATGKFVPANNNTAHSRTVT
DKIVPIKPKIGKLKQPSSLSQDDIAALGNVKNIRKVNGKYYYYKEDGTLQKNYALNINGK
TFFFDETGALSNNTLPSKKGNITNNDNTNSFAQYNQVYSTDAANFEHVDHYLTAESWYRP
KYILKDGKTWTQSTEKDFRPLLMTWWPDQETQRQYVNYMNAQLGIHQTYNTATSPLQLNL
AAQTIQTKIEEKITAEKNTNWLRQTISAFVKTQSAWNSDSEKPFDDHLQKGALLYSNNSK
LTSQANSNYRILNRTPTNQTGKKDPRYTADRTIGGYEFLLANDVDNSNPVVQAEQLNWLH
FLMNFGNIYANDPDANFDSIRVDAVDNVDADLLQIAGDYLKAAKGIHKNDKAANDHLSIL
EAWSYNDTPYLHDDGDNMINMDNRLRLSLLYSLAKPLNQRSGMNPLITNSLVNRTDDNAE
TAAVPSYSFIRAHDSEVQDLIRNIIRAEINPNVVGYSFTMEEIKKAFEIYNKDLLATEKK
YTHYNTALSYALLLTNKSSVPRVYYGDMFTDDGQYMAHKTINYEAIETLLKARIKYVSGG
QAMRNQQVGNSEIITSVRYGKGALKATDTGDRTTRTSGVAVIEGNNPSLRLKASDRVVVN
MGAAHKNQAYRPLLLTTDNGIKAYHSDQEAAGLVRYTNDRGELIFTAADIKGYANPQVSG
YLGVWVPVGAAADQDVRVAASTAPSTDGKSVHQNAALDSRVMFEGFSNFQAFATKKEEYT
NVVIAKNVDKFAEWGVTDFEMAPQYVSSTDGSFLDSVIQNGYAFTDRYDLGISKPNKYGT
ADDLVKAIKALHSKGIKVMADWVPDQMYALPEKEVVTATRVDKYGTPVAGSQIKNTLYVV
DGKSSGKDQQAKYGGAFLEELQAKYPELFARKQISTGVPMDPSVKIKQWSAKYFNGTNIL
GRGAGYVLKDQATNTYFSLVSDNTFLPKSLVNPNHGTSSSVTGLVFDGKGYVYYSTSGNQ
AKNAFISLGNNWYYFDNNGYMVTGAQSINGANYYFLSNGIQLRNAIYDNGNKVLSYYGND
GRRYENGYYLFGQQWRYFQNGIMAVGLTRIHGAVQYFDASGFQAKGQFITTADGKLRYFD
RDSGNQISNRFVRNSKGEWFLFDHNGVAVTGTVTFNGQRLYFKPNGVQAKGEFIRDADGH
LRYYDPNSGNEVRNRFVRNSKGEWFLFDHNGIAVTGTRVVNGQRLYFKSNGVQAKGELIT
ERKGRIKYYDPNSGNEVRNRYVRTSSGNWYYFGNDGYALIGWHVVEGRRVYFDENGVYRY
ASHDQRNHWDYDYRRDFGRGSSSAVRFRHSRNGFFDNFFRF
>GTFD_STRMU.1 [1,1462]  P49331 Glucosyltransferase-S precurs
METKRRYKMYKVKKHWVTIAVASGLITLGTTTLGSSVSAETEQQTSDKVVTQKSEDDKAA
SESSQTDAPKTKQAQTEQTQAQSQANVADTSTSITKETPSQNITTQANSDDKTVTNTKSE
EAQTSEERTKQAEEAQATASSQALTQAKAELTKQRQTAAQENKNPVDLAAIPNVKQIDGK
YYYIGSDGQPKKNFALTVNNKVLYFDKNTGALTDTSQYQFKQGLTKLNNDYTPHNQIVNF
ENTSLETIDNYVTADSWYRPKDILKNGKTWTASSESDLRPLLMSWWPDKQTQIAYLNYMN
QQGLGTGENYTADSSQESLNLAAQTVQVKIETKISQTQQTQWLRDIINSFVKTQPNWNSQ
TESDTSAGEKDHLQGGALLYSNSDKTAYANSDYRLLNRTPTSQTGKPKYFEDNSSGGYDF
LLANDIDNSNPVVQAEQLNWLHYLMNYGSIVANDPEANFDGVRVDAVDNVNADLLQIASD
YLKAHYGVDKSEKNAINHLSILEAWSDNDPQYNKDTKGAQLPIDNKLRLSLLYALTRPLE
KDASNKNEIRSGLEPVITNSLNNRSAEGKNSERMANYIFIRAHDSEVQTVIAKIIKAQIN
PKTDGLTFTLDELKQAFKIYNEDMRQAKKKYTQSNIPTAYALMLSNKDSITRLYYGDMYS
DDGQYMATKSPYYDAIDTLLKARIKYAAGGQDMKITYVEGDKSHMDWDYTGVLTSVRYGT
GANEATDQGSEATKTQGMAVITSNNPSLKLNQNDKVIVNMGTAHKNQEYRPLLLTTKDGL
TSYTSDAAAKSLYRKTNDKGELVFDASDIQGYLNPQVSGYLAVWVPVGASDNQDVRVAAS
NKANATGQVYESSSALDSQLIYEGFSNFQDFVTKDSDYTNKKIAQNVQLFKSWGVTSFEM
APQYVSSEDGSFLDSIIQNGYAFEDRYDLAMSKNNKYGSQQDMINAVKALHKSGIQVIAD
WVPDQIYNLPGKEVVTATRVNDYGEYRKDSEIKNTLYAANTKSNGKDYQAKYGGAFLSEL
AAKYPSIFNRTQISNGKKIDPSEKITAWKAKYFNGTNILGRGVGYVLKDNASDKYFELKG
NQTYLPKQMTNKEASTGFVNDGNGMTFYSTSGYQAKNSFVQDAKGNWYYFDNNGHMVYGL
QHLNGEVQYFLSNGVQLRESFLENADGSKNYFGHLGNRYSNGYYSFDNDSKWRYFDASGV
MAVGLKTINGNTQYFDQDGYQVKGAWITGSDGKKRYFDDGSGNMAVNRFANDKNGDWYYL
NSDGIALVGVQTINGKTYYFGQDGKQIKGKIITDNGKLKYFLANSGELARNIFATDSQNN
WYYFGSDGVAVTGSQTIAGKKLYFASDGKQVKGSFVTYNGKVHYYHADSGELQVNRFEAD
KDGNWYYLDSNGEALTGSQRINGQRVFFTREGKQVKGDVAYDERGLLRYYDKNSGNMVYN
KVVTLANGRRIGIDRWGIARYY
>GTFS_STRDO.1 [37,1365]  P29336 Glucosyltransferase-S precur
ADTNNNDGTSVQVNKMVPSDPKFDAQAQNGQLAQAMFKAANQADQTATSQVSPATDGRVD
NQVTPAANQPAANVANQDVANPATDAGALNRQSAADTSTDGKAVPQTSDQPGHLETVDGK
TYYVDANGQRLKNYSMVIDGKTYYFDGQTGEAQTDLPKTGQANQDNVPDSYQANNQAYSN
EASSFETVDNYLTADSWYRPRKILKNGQSWQASSEGDLRPILMTWWPDAATKAAYANFWA
KEGLISGSYRQNSANLDAATQNIQSAIEKKIASEGNTNWLRDKMSQFVKSQNQWSIASEN
ETVYPNQDHMQGGALLFSNSKDTEHANSDWRLLNRNPTFQTGKQKYFTTNYAGYELLLAN
DVDNSNPVVQAEQLNHLHYLMNWGDIVMGDKDANFDGVRVDAVDNVNADLLQIQRDYYKA
KYGTDQNEKNAIDHLSILEAWSGNDNDYVKDQNNFSLSIDNDQRSGMLKAFGYASAYRGN
LSNLATAGLKNRSANPDSDPVPNYVFIRAHDSEVQTRIAKIIREKLGKTNADGLTNLTLD
DLNKAFDIYNQDMNATDKVYYPNNLPMAYAWMLQNKDTVTRVYYGDMYTDNGQYMATKTP
FYNAIETLLKGRIKYVAGGQAVSYKQDWSSGILTSVRYGKGANSASDAGNTETRNSGMAL
LINNRPNFRAYRNLTLNMGAAHKSQAYRPLLLSTKDGIATYLNDSDVDSRQYKYTDSQGN
LSFSASELQSVANAQVSGMIQVWVPVGAADNQDVRTSPSTQATKDGNIYHQSDALDSQVI
YEGFSNFQAFAQSPDQYTNAVIAKNGDLFKSWGITQFEMAPQYVSSEDGTFLDSVILNGY
AFSDRYDLAMSKNNKYGSKQDLANAIKGLQSAGIKVLSDLVPNQLYNLPGKEVVTATRVN
QYGQAKSGATINKTPYVANTRSYGDYQEQYGGKFLDDLQKLYPRLFSTKQISTGKPIDPS
VKITNWSAKYFNGSNILGRGAKYVLSEGNKYLNLADGKLFLPTVLNNTYGQPQVSANGFI
SKNGGIHYLDKNGQEVKNRFKEISGSWYYFDSDGKMATGKTKIGNDTYLFMPNGKQLKEG
VWYDGKKAYYYDDNGRTWTNKGFVEFRVDGQDKWRYFNGDGTIAIGLVSLDNRTLYFDAY
GYQVKGQTVTINGKSYTFDADQGDLVQTDNANPAPQGQAGWKLLGDNQWGYRKDGQLLTG
EQTIDGQKVFFQDNGVQVKGGTATDASGVLRFYDRDQGHQVGKGWYSTSDDNWVYVNESG
QVLTGLQTIDGQTVYFDDKGIQAKGKAVWDENGNLRYFDADSGNMLRDRWKNVDGNWYYF
NRNGLATRW
>GUB_BACAM.1 [26,239]   P07980 Beta-glucanase precursor (EC 
QTGGSFFEPFNSYNSGLWQKADGYSNGDMFNCTWRANNVSMTSLGEMRLALTSPSYNKFD
CGENRSVQTYGYGLYEVRMKPAKNTGIVSSFFTYTGPTEGTPWDEIDIEFLGKDTTKVQF
NYYTNGAGNHEKFADLGFDAANAYHTYAFDWQPNSIKWYVDGQLKHTATTQIPAAPGKIM
MNLWNGTGVDDWLGSYNGVNPIYAHYDWMRYRKK
>GUB_BACBR.1 [32,259]   P37073 Beta-glucanase precursor (EC 
EEERPMGTAFYESFDAFDDERWSKAGVWTNGQMFNATWYPEQVTADGLMRLTIAKKTTSA
RNYKAGELRTNDFYHYGLFEVSMKPAKVEGTVSSFFTYTGEWDWDGDPWDEIDIEFLGKD
TTRIQFNYFTNGVGGNEFYYDLGFDASESFNTYAFEWREDSITWYVNGEAVHTATENIPQ
TPQKIMMNLWPGVGVDGWTGVFDGDNTPVYSYYDWVRYTPLQNYQIHQ
>GUB_BACCI.1 [32,409]   P19254 Beta-glucanase precursor (EC 
APNKPFPQHTTYTSGSIKPNHVTQSAMDSSVKAKWDSWKSAYLKTAGTGKYYVKYQSNGD
TVSEAHGYGMLATVIMAGYDGNAQTYFDGLYQYYKAHPSANNSKLMAWKQNSSFQNIEGA
DSATDGDMDIAYSLLLADKQWGSSGSINYLQAGKDIINAIMQSDVNQSQWTLRLGDWATD
NTFKNATRPSDFMLNHLKAFQAATGDARWANVIDKTYTIINSLYSGYSSSTGLLPDFVVL
SGSTYKPASADFLEGANDGSYDYNSCRTPWRIATDYLMTGDSRALNQLNQMNSWISAKVS
GNPSNVKDGYKLNGTVTGSGGSGAFYAPFGVSAMTSSVNQNWLNSVWTKTAGSSNEGYYE
DSIKLFSMIVMSGNWWTY
>GUB_BACLI.1 [28,243]   P27051 Beta-glucanase precursor (EC 
SAQTGGSFYEPFNNYNTGLWQKADGYSNGNMFNCTWRANNVSMTSLGEMRLSLTSPSYNK
FDCGENRSVQTYGYGLYEVNMKPAKNVGIVSSFFTYTGPTDGTPWDEIDIEFLGKDTTKV
QFNYYTNGVGNHEKIVNLGFDAANSYHTYAFDWQPNSIKWYVDGQLKHTATTQIPQTPGK
IMMNLWNGAGVDEWLGSYNGVTPLSRSLHWVRYTKR
>GUB_BACSU.1 [29,242]   P04957 Beta-glucanase precursor (EC 
QTGGSFFDPFNGYNSGFWQKADGYSNGNMFNCTWRANNVSMTSLGEMRLALTSPAYNKFD
CGENRSVQTYGYGLYEVRMKPAKNTGIVSSFFTYTGPTDGTPWDEIDIEFLGKDTTKVQF
NYYTNGAGNHEKIVDLGFDAANAYHTYAFDWQPNSIKWYVDGQLKHTATNQIPTTPGKIM
MNLWNGTGVDEWLGSYNGVNPLYAHYDWVRYTKK
>GUB_CLOTM.1 [28,334]   P29716 Beta-glucanase precursor (EC 
EAATVVNTPFVAVFSNFDSSQWEKADWANGSVFNCVWKPSQVTFSNGKMILTLDREYGGS
YPYKSGEYRTKSFFGYGYYEVRMKAAKNVGIVSSFFTYTGPSDNNPWDEIDIEFLGKDTT
KVQFNWYKNGVGGNEYLHNLGFDASQDFHTYGFEWRPDYIDFYVDGKKVYRGTRNIPVTP
GKIMMNLWPGIGVDEWLGRYDGRTPLQAEYEYVKYYPNGVPQDNPTPTPTIAPSTPTNPN
LPLKGDVNGDGHVNSSDYSLFKRYLLRVIDRFPVGDQSVADVNRDGRIDSTDLTMLKRYL
IRAIPSL
>GUB_PAEMA.1 [24,237]   P23904 Beta-glucanase precursor (EC 
LAGSVFWEPLSYFNRSTWEKADGYSNGGVFNCTWRANNVNFTNDGKLKLGLTSSAYNKFD
CAEYRSTNIYGYGLYEVSMKPAKNTGIVSSFFTYTGPAHGTQWDEIDIEFLGKDTTKVQF
NYYTNGVGGHEKVISLGFDASKGFHTYAFDWQPGYIKWYVDGVLKHTATANIPSTPGKIM
MNLWNGTGVDDWLGSYNGANPLYAEYDWVKYTSN
>GUB_PAEPO.1 [27,238]   P45797 Beta-glucanase precursor (EC 
GNVFWEPLSYFNSSTWQKADGYSNGQMFNCTWRANNVNFTNDGKLKLSLTSPANNKFDCG
EYRSTNNYGYGLYEVSMKPAKNTGIVSSFFTYTGPSHGTQWDEIDIEFLGKDTTKVQFNY
YTNGVGGHEKIINLGFDASTSFHTYAFDWQPGYIKWYVDGVLKHTATTNIPSTPGKIMMN
LWNGTGVDSWLGSYNGANPLYAEYDWVKYTSN
>GUN1_BACSU.1 [30,499]  P07983 Endoglucanase precursor (EC 3
AGTKTPVAKNGQLSIKGTQLVNRDGKAVQLKGISSHGLQWYGDFVNKDSLKWLRDDWGIT
VFRAAMYTADGGYIDNPSVKNKVKEAVEAAKELGIYVIIDWHILNDGNPNQNKEKAKEFF
KEMSSLYGNTPNVIYEIANEPNGDVNWKRDIKPYAEEVISVIRKNDPDNIIIVGTGTWSQ
DVNDAADDQLKDANVMYALHFYAGTHGQSLRDKANYALSKGAPIFVTEWGTSDASGNGGV
FLDQSREWLNYLDSKNISWVNWNLSDKQESSSALKPGASKTGGWPLTDLTASGTFVRENI
RGTKDSTKDVPETPAQDNPTQEKGVSVQYKAGDGRVNSNQIRPQLHIKNNGNATVDLKDV
TARYWYNVKNKGQNFDCDYAQMGCGNLTHKFVTLHKPKQGADTYLELGFKTGTLSPGAST
GNIQLRLHNDDWSNYAQSGDYSFFQSNTFKTTKKITLYHQGKLIWGTEPN
>GUN1_RUMAL.1 [44,406]  P16216 Endoglucanase I precursor (EC
AADESETENVPVSQTHTNDTMTVTSAKDLVAKMTNGWNLGNTMDATAQGLGSEVSWLPLK
VTTNKYMIDMLPEAGFNVLRIPVSWGNHIIDDKYTSDPAWMDRVQEIVNYGIDNGLYVIL
NTHHEEWYMPKPSEKDGDIEEIKAVWAQIADRFKGYDEHLIFEGLNEPRLRGEGAEWTGT
SEAREIINEYEKAFVETVRASGGNNGDRCLMITGYAASSAYNNLSAIELPEDSDKLIISV
HAYLPYSFALDTKGTDKYDPEDTAIPELFEHLNELFISKGIPVIVGEFGTMNKENTEDRV
KCLEDYLAAAAKYDIPCVWWDNYARIGNGENFGLMNRADLEWYFPDLIETFKTYAEKDPA
SAE
>GUN2_BACSU.1 [30,499]  P10475 Endoglucanase precursor (EC 3
AGTKTPVAKNGQLSIKGTQLVNRDGKAVQLKGISSHGLQWYGEYVNKDSLKWLRDDWGIT
VFRAAMYTADGGYIDNPSVKNKVKEAVEAAKELGIYVIIDWHILNDGNPNQNKEKAKEFF
KEMSSLYGNTPNVIYEIANEPNGDVNWKRDIKPYAEEVISVIRKNDPDNIIIVGTGTWSQ
DVNDAADDQLKDANVMYALHFYAGTHGQFLRDKANYALSKGAPIFVTEWGTSDASGNGGV
FLDQSREWLKYLDSKTISWVNWNLSDKQESSSALKPGASKTGGWRLSDLSASGTFVRENI
LGTKDSTKDIPETPSKDKPTQENGISVQYRAGDGSMNSNQIRPQLQIKNNGNTTVDLKDV
TARYWYKAKNKGQNFDCDYAQIGCGNVTHKFVTLHKPKQGADTYLELGFKNGTLAPGAST
GNIQLRLHNDDWSNYAQSGDYSFFKSNTFKTTKKITLYDQGKLIWGTEPN
>GUN2_CLOJO.1 [33,460]  P37701 Endoglucanase 2 precursor (EC
ADQIPFPYNATYPYGAYSCLADSQSSANNLLKSEWEQWKSAHITSNGARGYKRVQRDAST
NYDTVSEGLGYGMLLAVYFGEQQLFDDLYRYVKVFLNSNGLMSWRIDANGNIMGQNAIGA
ATDADEDIAVSLVFAHKKWGTSGGFNYQTEAKNYINNIYNKMVEPGTYVLKPGDMWGGSD
VTNPSYFAPAWYRIFADFTGNSGWINVANKCYEIADKARNSNTGLVPDWCTANGTPASGQ
GYDFYYDAIRYQWRTAIDYSWYGTAKAKTHCDAISNFFKNIGYPNIKDGYTLSGSQISAN
HTATFVSCAAAAAMTGTDATYAKNIYNECVKVKDTGNYTYFGNTLRMMILLYTTGNFPNL
YSYSSQPQQGLKGDVNNDGAIDALDIAALKKAILTQSTSNINLTNADMNNDGNIDAIDFA
QLKVKLLN
>GUN3_BACS4.1 [29,825]  P19570 Endoglucanase C precursor (EC
EEGDNGDDDDLVTPIEIEERPHESNYEKYPALLDGGLDERRPSEAGALQLVEVDGQVTLA
DQDGVPIQLRGMSTHGLQWFGEIVNENAFAALANDWGSNVIRLALYIGENAYRYNPDLIE
KVYAGIELAKENDMYVIIDWHVHAPGDPNADIYQGGVNEDGEEYLGAKDFFLHIAEKYPN
DPHLIYELANEPSSNSSGGPGITNDEDGWEAVREYAQPIVDALRDSGNAEDNIIIVGSPN
WSQRMDLAAADNPIDDHHTMYTLHFYTGTHEGTNESYPEGISSEDRSNVMANAKYALDKG
KAIFATEWGVSEADGNNGPYLNEADVWLNFLNENNISWTNWSLTNKNETSGAFTPFILNE
SDATDLDPGEDQVWSMEELSVSGEYVRSRILGEEYQPIDRTPREEFSEVIWDFNDGTTQG
FVQNSDSPLDVTIENVNDALQITGLDESNAIAGEEEDYWSNVRISADEWEETFDILGAEE
LSMDVVVDDPTTVAIAAIPQSSAHEWANASNSVLITEDDFEEQEDGTYKALLTITGEDAP
NLTNIAEDPEGSELNNIILFVGTENADVISLDNITVTGDRESVPEPVEHDTKGDSALPSD
FEDGTRQGWEWDSESAVRTALTIEEANGSNALSWEYAYPEVKPSDDWATAPRLTLYKDDL
VRGDYEFVAFDFYIDPIEDRATEGAIDINLIFQPPAAGYWAQASETFEIDLEELDSATVT
DDGLYHYEVEINIEDIENDIELRNLMLIFADDESDFAGRVFLDNVRMDMSLETKVEVLER
NINELQEQLVEVEALMR
>GUN3_BACSU.1 [30,499]  P23549 Endoglucanase precursor (EC 3
AGTKTPVAKNGQLSIKGTQLVNRDGKAVQLKGISSHGLQWYGEYVNKDSLKWLRDDWGIT
VFRAAMYTADGGIIDNPSVKNKMKEAVEAAKELGIYVIIDWHILNDGNPNQNKEKAKEFF
KEMSSLYGNTPNVIYEIANEPNGDVNWKRDIKPYAEEVISVIRKNDPDNIIIVGTGTWSQ
DVNDAADDQLKDANVMDALHFYAGTHGQFLRDKANYALSKGAPIFVTEWGTSDASGNGGV
FLDQSREWLKYLDSKTISWVNWNLSDKQESSSALKPGASKTGGWRLSDLSASGTFVRENI
LGTKDSTKDIPETPAKDKPTQENGISVQYRAGDGSMNSNQIRPQLQIKNNGNTTVDLKDV
TARYWYNAKNKGQNVDCDYAQLGCGNVTYKFVTLHKPKQGADTYLELGFKNGTLAPGAST
GNIQLRLHNDDWSNYAQSGDYSFFKSNTFKTTKKITLYDQGKLIWGTEPN
>GUNA_BUTFI.1 [35,429]  P22541 Endoglucanase A precursor (EC
VTFPWQLQNSEAKTEQVKEPAKEEPKLVIKEKKQDESAKKEQELKKAKEEAEAAVEKETE
KTEEEPVDNLLNDMKLKYYGKLAVEGSHLVDADGHEVLLMGVSTHGINWYPEYASAETIK
SLRDTWGINVIRLAMYTSDYNGYCVAGKENQEKLKDIIDDAVEAATDNDMYVIIDWHTLN
DADPNEYKADAIQFFGEMVRKYKDNENVIYEICNEPNGDTTWNDVRRYANEVIPVIRNVD
AIILVGTPKWATDLDSVLDKPLDFDNIMYTYHFYAGTHHKAERNALRDALDEGLPVFISE
YGLVDADGDGNLNEKEADYWYDMIRKEYGVSSCMWNLSNKDEGSAMINADCDKLSDFTEE
DLSESAMWLIDQISQLKHSDLEQGVDWITPENNNR
>GUNA_CLOCE.1 [27,475]  P17901 Endoglucanase A precursor (EC
YDASLIPNLQIPQKNIPNNDGMNFVKGLRLGWNLGNTFDAFNGTNITNELDYETSWSGIK
TTKQMIDAIKQKGFNTVRIPVSWHPHVSGSDYKISDVWMNRVQEVVNYCIDNKMYVILNT
HHDVDKVKGYFPSSQYMASSKKYITSVWAQIAARFANYDEHLIFEGMNEPRLVGHANEWW
PELTNSDVVDSINCINQLNQDFVNTVRATGGKNASRYLMCPGYVASPDGATNDYFRMPND
ISGNNNKIIVSVHAYCPWNFAGLAMADGGTNAWNINDSKDQSEVTWFMDNIYNKYTSRGI
PVIIGECGAVDKNNLKTRVEYMSYYVAQAKARGILCILWDNNNFSGTGELFGFFDRRSCQ
FKFPEIIDGMVKYAFEAKTDPDPVIVYGDYNNDGNVDALDFAGLKKYIMAADHAYVKNLD
VNLDNEVNAFDLAILKKYLLGMVSKLPSN
>GUNA_CLOLO.1 [26,517]  P54937 Endoglucanase A precursor (EC
RNPLEVQAASMRSASEIVQEMGVGWNLGNTLDAKITNLSYNTSPISFETGWGNPVTTKAM
IDKIKNAGFKTIRIPTTWGEHLDGNNKLNEEWVKRVKEVVDYCIADDLYVILNTHHEGNW
VIPTYAKESSVTPKLKTLWTQISEAFKDYDDHLIFETLNEPRLEGTPYEWTGGTSESRDV
VNKYNAAALESIRKTGGNNLSRAVMMPTYAASGSSTTMNDFKVPDDKNVIASVHAYSPYF
FAMDTSSNSVNTWGSSYDKYSLDVELDSYLNTFKSKGVPVVIGEFGSINKNNTSSRAELA
EYYVTAAQKRGIPCVWWDNNYAETNKGETFGLLNRSTLNWYFSDIKDALIRGYKNVHPEA
TEDDKPSTDVTNPDSGNTKPDSGNTNPGTETTTPTDNEKISITSKINDWGGAYQADFTLK
NNTSSDINNWSFKIKKNDIVFTNYWDVKITEENGYYVVTPQAWKTTILANSSIVISIQGT
GKVISNFEYKFD
>GUNA_CLOTM.1 [33,477]  P04955 Endoglucanase A precursor (EC
AGVPFNTKYPYGPTSIADNQSEVTAMLKAEWEDWKSKRITSNGAGGYKRVQRDASTNYDT
VSEGMGYGLLLAVCFNEQALFDDLYRYVKSHFNGNGLMHWHIDANNNVTSHDGGDGAATD
ADEDIALALIFADKLWGSSGAINYGQEARTLINNLYNHCVEHGSYVLKPGDRWGGSSVTN
PSYFAPAWYKVYAQYTGDTRWNQVADKCYQIVEEVKKYNNGTGLVPDWCTASGTPASGQS
YDYKYDATRYGWRTAVDYSWFGDQRAKANCDMLTKFFARDGAKGIVDGYTIQGSKISNNH
NASFIGPVAAASMTGYDLNFAKELYRETVAVKDSEYYGYYGNSLRLLTLLYITGNFPNPL
SDLSGQPTPPSNPTPSLPPQVVYGDVNGDGNVNSTDLTMLKRYLLKSVTNINREAADVNR
DGAINSSDMTILKRYLIKSIPHLPY
>GUNA_PAELA.1 [34,700]  P29719 Endoglucanase A precursor (EC
SDVTFTINTQSERAAISPNIYGTNQDLSGTENWSSRRLGGNRLTGYNWENNASSAGRDWL
HYSDDFLCGNGGVPDTDCDKPGAVVTAFHDKSLENGAYSIVTLQMAGYVSRDKNGPVDES
ETAPSPRWDKVEFAKNAPFSLQPHLNDGQVYMDEEVNFLVNRYGNASTSTGIKAYSLDNE
PALWSETHPRIHPEQLQAAELVAKSIDLSKAVKNVDPHAEIFGPALYGFGAYLSLQDAPG
WPSLQGNYSWFIDYYLDQMKNAHTQNGKRLLDVLDVHWYPEAQGGGQRIVFGGAGNIDTQ
KARVQAPRSLWDPAYQEDSWIGTWFSSYLPLIPKLQSSIQTYYPGTKLAITESSYGGDNH
ISGGIATADALGIFGKYGVYAANYWQTEDNTDYTSAAYKLYRNYDGNKSGFGSIKVDAAT
SDTENSSVYASVTDEENSELHLIVLNKNFDDPINATFQLSGDKTYTSGRVWGFDQTGSDI
TEQAAITNINNNQFTYTLPPLSAYHIVLKADSTEPVNSDLVVQYKDGDRNNATDNQIKPH
FNIQNKGTSPVDLSSLTLRYYFTKDSSAAMNGWIDWAKLGGSNIQISFGNHNGADSDTYA
ELGFSSGAGSIAEGGQSGEIQLRMSKADWSNFNEANDYSFDGAKTAYIDWDRVTLYQDGQ
LVWGIEP
>GUNB_CALSA.1 [29,1039]  P10474 Endoglucanase/exoglucanase B
YFPVETQAAPDWSIPSLCESYKDDFMIGVAIPARCLSNDTDKRMVLKHFNSITAENEMKP
ESLLAGQTSTGLSYRFSTADAFVDFASTNKIGIRGHTLVWHNQTPDWFFKDSNGQRLSKD
ALLARLKQYIYDVVGRYKGKVYAWDVVNEAIDENQPDSYRRSTWYEICGPEYIEKAFIWA
HEADPNAKLFYNDYNTEISKKRDFIYNMVKNLKSKGIPIHGIGMQCHINVNWPSVSEIEN
SIKLFSSIPGIEIHITELDMSLYNYGSSENYSTPPQDLLQKQSQKYKEIFTMLKKYKNVV
KSVTFWGLKDDYSWLRSFYGKNDWPLLFFEDYSAKPAYWAVIEASGVTTSSPTPTPTPTV
TVTPTPTPTPTPTVTATPTPTPTPVSTPATGGQIKVLYANKETNSTTNTIRPWLKVVNSG
SSSIDLSRVTIRYWYTVDGERAQSAVSDWAQIGASNVTFKFVKLSSSVSGADYYLEIGFK
SGAGQLQPGKDTGEIQIRFNKSDWSNYNQGNDWSWLQSMTSYGENEKVTAYIDGVLVWGQ
EPSGATPAPTMTVAPTATPTPTLSPTVTPTPAPTQTAIPTPTLTPNPTPTSSIPDDTNDD
WLYVSGNKIVDKDGRPVWLTGINWFGYNTGTNVFDGVWSCNLKDTLAEIANRGFNLLRVP
ISAELILNWSQGIYPKPNINYYVNPELEGKNSLEVFDIVVQTCKEVGLKIMLDIHSIKTD
AMGHIYPVWYDEKFTPEDFYKACEWITNRYKNDDTIIAFDLKNEPHGKPWQDTTFAKWDN
STDINNWKYAAETCAKRILNINPNLLIVIEGIEAYPKDDVTWTSKSSSDYYSTWWGGNLR
GVRKYPINLGKYQNKVVYSPHDYGPSVYQQPWFYPGFTKESLLQDCWRPNWAYIMEENIA
PLLIGEWGGHLDGADNEKWMKYLRDYIIENHIHHTFWCFNANSGDTGGLVGYDFTTWDEK
KYSFLKPALWQDSQGRFVGLDHKRPLGTNGKNINITTYYNNNEPEPVPASK
>GUNB_CLOCL.1 [34,440]  P28621 Endoglucanase B precursor (EC
KTGIRDITSQQVVKEMKVGWNLGNTMDATGGETNWGNPLTTHAMIDKVKAAGFNTLRLPI
TWDGHIGAAPDYAIDATWMNRVEEIANYAFDNNMYVIINLHHEDGWLKPYYANEAEVKAK
ITKVWTQIANRFKDYGDYLIFETMNEPRPVGAADEWSGGSYENRDMVNRYNLTAVNTIRA
TGGNNALRHIMVPTLAAAALSTTMNDYIVPNNDSRVIVSLHMYSPYFFSADLTSQWTTAT
WGSDADKAALSADFDAVYNKFVKNGRAVVIGEMGTINKNNLDSRVKHAEYYAKEATVRGI
TPIWWDNGYCVAGKEQTFGIFNRKNLTWCCPEVMQAFIRGAGATQTQTSYSLGDVNKDGK
VNAIDYAVLKSILLGTNTNVDLSVSDMNKDGKVNALDLAVLKKMLLS
>GUNB_CLOTM.1 [28,563]  P04956 Endoglucanase B precursor (EC
EGSYADLAEPDDDWLHVEGTNIVDKYGNKVWITGANWFGFNCRERMLLDSYHSDIIADIE
LVADKGINVVRMPIATDLLYAWSQGIYPPSTDTSYNNPALAGLNSYELFNFMLENFKRVG
IKVILDVHSPETDNQGHNYPLWYNTTITEEIFKKAWVWVAERYKNDDTIIGFDLKNEPHT
NTGTMKIKAQSAIWDDSNHPNNWKRVAEETALAILEVHPNVLIFVEGVEMYPKDGIWDDE
TFDTSPWTGNNDYYGNWWGGNLRGVKDYPINLGKYQSQLVYSPHDYGPIVYEQDWFKGDF
ITANDEQAKRILYEQCWRDNWAYIMEEGISPLLLGEWGGMTEGGHPLLDLNLKYLRCMRD
FILENKYKLHHTFWCINIDSADTGGLFTRDEGTPFPGGRDLKWNDNKYDNYLYPVLWKTE
DGKFIGLDHKIPLGRNGISISQLSNYTPSVTPSPSATPSPTTITAPPTDTVTYGDVNGDG
RVNSSDVALLKRYLLGLVENINKEAADVNVSGTVNSTDLAIMKRYVLRSISELPYK
>GUNB_PAELA.1 [31,566]  P23550 Endoglucanase B precursor (EC
AAPPSAMQSYVEAMQPGWNLGNSLDAVGADETLARGNPRITKELIQNIAAQGYKSIRIPV
TWDSHIGAAPNYQIEAAYLNRVQEVVQWALDANLYVMINVHHDSWLWISKMESQHDQVLA
RYNAIWTQIANKFKNSPSKLMFESVNEPRFTDGGTTDEAKQQKMLDELNVSFFNIVRNSG
GQNATRPLVLSTLEASPTQERMTALYNTMTKLNDKNLIATVHFYGFWPFSVNIAGYTKFD
AETQNDIITTFDNVYNTFVAKGIPVVVGEYGLLGFDKNTGVIEQGEKLKFFEFFAQYVKQ
KSISTMLWDNGQHFNRTSFKWSDPDLFNMIKASWTGRSSTASSDLIHVKQGTAVKDTSVQ
LNLNGNTLTSLSVNGTTLKSGTDYTLNSSRLTFKASQLTKLTSLGKLGVNATIVTKFNRG
ADWKFNVVLYNTPKLSSTTGTTSSFAIPTAFNGDQLATMEAVYVNGGNAGPHNWTSFKEF
ETTFSPAYSEGKIKLQQAFFNEVNDTTVTLKFQFWSGEIVNYTIKKSGSTVTGTAS
>GUNB_RUMAL.1 [22,409]  P23661 Endoglucanase B precursor (EC
SCGGSKSDDKSKADTKSAAETSGAEGDSSESEEIPVSQTHTNDPMTVTSAKDLVAKMSNG
WNLGNTMDATGEGLESEISWLPTKVYTNKFMIDMLPEAGFNVLRIPVSWGNHLIDNNYTI
DPAWMDRVQEIVNYGIDDGMYVILNTHHEEWYMPKPSEKDGDIEELKAIWSQIADRFKGY
DEHLIFEGLNEPRLRGEGAEWTGTSEAREIINEYEKAFVETVRASGGNNGDRCLMITGYA
ASSGYNNLSAIELPEDSDKLIISVHAYLPYSFALDTKGTDKYDPEDTAIPTLFESLNELF
ISRDIPVIVGEFGSMNKDNIDDRVKCLDDYLGNAAKYDIPCVWWDNYARIGNGENFGLLN
RQEYDWYFPKLMDVFKKYAESDPSAAAA
>GUNC_CLOCE.1 [33,460]  P37699 Endoglucanase C precursor (EC
ADQIPFPYDAKYPNGAYSCLADSQSIGNNLVRSEWEQWKSAHITSNGARGYKRVQRDATT
NYDTVSEGLGYGLLLSVYFGEQQLFDDLYRYVKVFLNSNGLMSWRIDSSGNIMGKDSIGA
ATDADEDIAVSLVFAHKKWGTSGGFNYQTEAKNYINNIYNKMVEPGTYVIKAGDTWGGSN
VTNPSYFAPAWYRIFADFTGNSGWINVANKCYEIADKARNSNTGLVPDWCTANGTPASGQ
GFDFYYDAIRYQWRAAIDYSWYGTAKAKTHCDAISNFFKNIGYANIKDGYTISGSQISSN
HTATFVSCAAAAAMTGTDTTYAKNIYNECVKVKDSGNYTYFGNTLRMMVLLYTTGNFPNL
YTYNSQPKPDLKGDVNNDGAIDALDIAALKKAILTQTTSNISLTNADMNNDGNIDAIDFA
QLKVKLLN
>GUND_CLOCE.1 [25,584]  P25472 Endoglucanase D precursor (EC
AINSQDMVKKMGIGMNLGNTFDAPTEGSWSKAAQEYYFDDFKQAGFKHVRIPIRWDQHTL
ANSPYTVDSNFLNRIETVIDWSLSRGFVTVINSHHDTWLMDNYSQNIGRFEKIWEQIAQR
FKGKSENLVFEILNEPHGNITDSQINDMNKRILNIIRKTNPTRNVIIGAGYWNSYNSLSQ
LEIPNDPNLIATFHYYDPYSFTHQWQGTWGTKNDMDAIAMVFNHVKKWSDKNNIPVYLGE
YGVMGHSDRTSAVKWFDFVSDQAISHGFSCGAWDNGVFGSVDNDMAFYNRDTRQFDKEIL
NAILTTGTTYDWTPPTETNPDPPRTPATPAYGEQLIEDFEGAMQWAAYSGVDATASCKIS
SGKSNNGLEITYAGSSNGYWGVVDNEHRNQDWEKWQKISFDIKSSNTNEVRLLIAEQSKI
EGEDGEHWTYVIKPSTSWTTIEIPFSSFTKRMDYQPPAQDGSETFDLYKVGSLHFMYSNS
NSGTLNIDNIKLIGLPEEQIGGKIGDVNEDGNIDAIDFALLKKYLLDSSISINKVNADIN
LDGDINAIDFAKLKMMLLGD
>GUND_CLOCL.1 [32,515]  P28623 Endoglucanase D precursor (EC
STAFTGVRDVPAQQIVNEMKVGWNLGNTMDAIGGETNWGNPMTTHAMINKIKEAGFNTLR
LPVTWDGHMGAAPEYTIDQTWMKRVEEIANYAFDNDMYVIINLHHENEWLKPFYANEAQV
KAQLTKVWTQIANNFKKYGDHLIFETMNEPRPVGASLQWTGGSYENREVVNRYNLTAVNA
IRATGGNNATRYIMVPTLAASAMSTTINDLVIPNNDSKVIVSLHMYSPYFFAMDINGTSS
WGSDYDKSSLDSEFDAVYNKFVKNGRAVVIGEMGSINKNNTAARVTHAEYYAKSAKARGL
TPIWWDNGYSVAGKAETFGIFNRSNLTWDAPEVMKAFIKGIGGSSTTTPTTPTTPTTPTT
PTTPTTPTTPTTPTTPQSAVEVTYAITNSWGSGASVNVTIKNNGTTPINGWTLKWTMPIN
QTITNMWSASFVASGTTLSVTNAGYNGTIAANGGTQSFGFNINYSGVLSKPTGFTVNGTE
CTVK
>GUND_CLOTM.1 [42,649]  P04954 Endoglucanase D precursor (EC
AKITENYQFDSRIRLNSIGFIPNHSKKATIAANCSTFYVVKEDGTIVYTGTATSMFDNDT
KETVYIADFSSVNEEGTYYLAVPGVGKSVNFKIAMNVYEDAFKTAMLGMYLLRCGTSVSA
TYNGIHYSHGPCHTNDAYLDYINGQHTKKDSTKGWHDAGDYNKYVVNAGITVGSMFLAWE
HFKDQLEPVALEIPEKNNSIPDFLDELKYEIDWILTMQYPDGSGRVAHKVSTRNFGGFIM
PENEHDERFFVPWSSAATADFVAMTAMAARIFRPYDPQYAEKCINAAKVSYEFLKNNPAN
VFANQSGFSTGEYATVSDADDRLWAAAEMWETLGDEEYLRDFENRAAQFSKKIEADFDWD
NVANLGMFTYLLSERPGKNPALVQSIKDSLLSTADSIVRTSQNHGYGRTLGTTYYWGCNG
TVVRQTMILQVANKISPNNDYVNAALDAISHVFGRNYYNRSYVTGLGINPPMNPHDRRSG
ADGIWEPWPGYLVGGGWPGPKDWVDIQDSYQTNEIAINWNAALIYALAGFVNYNSPQNEV
LYGDVNDDGKVNSTDLTLLKRYVLKAVSTLPSSKAEKNADVNRDGRVNSSDVTILSRYLI
RVIEKLPI
>GUNE_CLOTM.1 [35,814]  P10477 Endoglucanase E precursor (EC
SGTKLLDASGNELVMRGMRDISAIDLVKEIKIGWNLGNTLDAPTETAWGNPRTTKAMIEK
VREMGFNAVRVPVTWDTHIGPAPDYKIDEAWLNRVEEVVNYVLDCGMYAIINLHHDNTWI
IPTYANEQRSKEKLVKVWEQIATRFKDYDDHLLFETMNEPREVGSPMEWMGGTYENRDVI
NRFNLAVVNTIRASGGNNDKRFILVPTNAATGLDVALNDLVIPNNDSRVIVSIHAYSPYF
FAMDVNGTSYWGSDYDKASLTSELDAIYNRFVKNGRAVIIGEFGTIDKNNLSSRVAHAEH
YAREAVSRGIAVFWWDNGYYNPGDAETYALLNRKTLSWYYPEIVQALMRGAGVEPLVSPT
PTPTLMPTPSPTVTANILYGDVNGDGKINSTDCTMLKRYILRGIEEFPSPSGIIAADVNA
DLKINSTDLVLMKKYLLRSIDKFPAEDSQTPDEDNPGILYNGRFDFSDPNGPKCAWSGSN
VELNFYGTEASVTIKSGGENWFQAIVDGNPLPPFSVNATTSTVKLVSGLAEGAHHLVLWK
RTEASLGEVQFLGFDFGSGKLLAAPKPLERKIEFIGDSITCAYGNEGTSKEQSFTPKNEN
SYMSYAAITARNLNASANMIAWSGIGLTMNYGGAPGPLIMDRYPYTLPYSGVRWDFSKYV
PQVVVINLGTNDFSTSFADKTKFVTAYKNLISEVRRNYPDAHIFCCVGPMLWGTGLDLCR
SYVTEVVNDCNRSGDLKVYFVEFPQQDGSTGYGEDWHPSIATHQLMAERLTAEIKNKLGW
>GUNE_RUMFL.1 [30,320]  Q05622 Endoglucanase E precursor (EC
SAKEAFEDISKRSECTKVFDNDNGTYTAYSNTAPIHYLNNDEWKEIDNTLIEDSDDYYRN
KDNSFNIYIPKEYSLGKNIKNPVIMNYDTFSLSTSITDIKMPDRPEEETFSEGVYADINN
EVYTTIDNSAIAEGMKAALKKSASMATYHSIVEDIDLDIAVHNASVSESIIINKLESLPE
TITYSISVEDAIIKKTEDNRLQLIKDNEAVLILSPFTISDSSENVNVMQVEYDLTESEEG
YEVTLYPAETVNRMSSPVMPLSLGSEYSYDRPFSTVYNSQASLHPSIIIIT
>GUNF_CLOCE.1 [30,722]  P37698 Endoglucanase F precursor (EC
ASSPANKVYQDRFESMYSKIKDPANGYFSEQGIPYHSIETLMVEAPDYGHVTTSEAMSYY
MWLEAMHGRFSGDFTGFDKSWSVTEQYLIPTEKDQPNTSMSRYDANKPATYAPEFQDPSK
YPSPLDTSQPVGRDPINSQLTSAYGTSMLYGMHWILDVDNWYGFGARADGTSKPSYINTF
QRGEQESTWETIPQPCWDEHKFGGQYGFLDLFTKDTGTPAKQFKYTNAPDADARAVQATY
WADQWAKEQGKSVSTSVGKATKMGDYLRYSFFDKYFRKIGQPSQAGTGYDAAHYLLSWYY
AWGGGIDSTWSWIIGSSHNHFGYQNPFAAWVLSTDANFKPKSSNGASDWAKSLDRQLEFY
QWLQSAEGAIAGGATNSWNGRYEAVPSGTSTFYGMGYVENPVYADPGSNTWFGMQVWSMQ
RVAELYYKTGDARAKKLLDKWAKWINGEIKFNADGTFQIPSTIDWEGQPDTWNPTQGYTG
NANLHVKVVNYGTDLGCASSLANTLTYYAAKSGDETSRQNAQKLLDAMWNNYSDSKGIST
VEQRGDYHRFLDQEVFVPAGWTGKMPNGDVIKSGVKFIDIRSKYKQDPEWQTMVAALQAG
QVPTQRLHRFWAQSEFAVANGVYAILFPDQGPEKLLGDVNGDETVDAIDLAILKKYLLNS
STTINTANADMNSDNAIDAIDYALLKKALLSIQ
>GUNF_CLOTM.1 [28,739]  P26224 Endoglucanase F precursor (EC
ADFNYGEALQKAIMFYEFQRSGKLPENKRNNWRGDSALNDGADNGLDLTGGWYDAGDHVK
FNLPMAYAVTMLAWSVYESRDAYVQSGQLPYILDNIKWATDYFIKCHPSPNVYYYQVGDG
ALDHSWWGPAEVMQMPRPSFKVDLTNPGSTVVAETAAAMAASSIVFKPTDPEYAATLLRH
AKELFTFADTTRSDAGYRAAEGYYSSHSGFYDELTWASIWLYLATGDQSYLDKAESYEPH
WERERGTTLISYSWAHCWDNKLYGSLLLLAKITGKSYYKQCIENHLDYWTVGFNGSRVQY
TPKGLAYLDRWGSLRYATTQAFLASVYADWSGCDPAKAAVYKEFAKKQVDYALGSTGRSF
VVGFGKNPPRNPHHRTAHSSWSALMTEPAECRHILVGALVGGPDGSDSYVDRLDDYQCNE
VANDYNAGFVGALAKMYEKYGGEPIPNFVAFETPGEEFYVEAAVNAAGPGFVNIKASIIN
KSGWPARGSDKLSAKYFVDISEAVAKGITLDQITVQSTTNGGAKVSQLLPWDPDNHIYYV
NIDFTGINIFPGGINEYKRDVYFTITAPYGEGNWDNTNDFSFQGLEQGFTSKKTEYIPLY
DGNVRVWGKVPDGGSEPDPTPTITVGPTPSVTPTSVPGIMLGDVNFDGRINSTDYSRLKR
YVIKSLEFTDPEEHQKFIAAADVDGNGRINSTDLYVLNRYILKLIEKFPAEQ
>GUNG_CLOCE.1 [36,725]  P37700 Endoglucanase G precursor (EC
AGTYNYGEALQKSIMFYEFQRSGDLPADKRDNWRDDSGMKDGSDVGVDLTGGWYDAGDHV
KFNLPMSYTSAMLAWSLYEDKDAYDKSGQTKYIMDGIKWANDYFIKCNPTPGVYYYQVGD
GGKDHSWWGPAEVMQMERPSFKVDASKPGSAVCASTAASLASAAVVFKSSDPTYAEKCIS
HAKNLFDMADKAKSDAGYTAASGYYSSSSFYDDLSWAAVWLYLATNDSTYLDKAESYVPN
WGKEQQTDIIAYKWGQCWDDVHYGAELLLAKLTNKQLYKDSIEMNLDFWTTGVNGTRVSY
TPKGLAWLFQWGSLRHATTQAFLAGVYAEWEGCTPSKVSVYKDFLKSQIDYALGSTGRSF
VVGYGVNPPQHPHHRTAHGSWTDQMTSPTYHRHTIYGALVGGPDNADGYTDEINNYVNNE
IACDYNAGFTGALAKMYKHSGGDPIPNFKAIEKITNDEVIIKAGLNSTGPNYTEIKAVVY
NQTGWPARVTDKISFKYFMDLSEIVAAGIDPLSLVTSSNYSEGKNTKVSGVLPWDVSNNV
YYVNVDLTGENIYPGGQSACRREVQFRIAAPQGRRYWNPKNDFSYDGLPTTSTVNTVTNI
PVYDNGVKVFGNEPAGGSENPDPEILYGDVNSDKNVDALDFAALKKYLLGGTSSIDVKAA
DTYKDGNIDAIDMATLKKYLLGTITQLPQG
>GUNG_CLOTM.1 [31,566]  Q05332 Endoglucanase G precursor (EC
TTAAAAVDSNNDDWLHCKGNKIYDMYGNEVWLTGANWFGFNCSENCFHGAWYDVKTILTS
IADRGINLLRIPISTELLYSWMIGKPNPVSSVTASNNPPYHVVNPDFYDPETDDVKNSME
IFDIIMGYCKELGIKVMIDIHSPDANNSGHNYELWYGKETSTCGVVTTKMWIDTLVWLAD
KYKNDDTIIAFDLKNEPHGKRGYTAEVPKLLAKWDNSTDENNWKYAAETCAKAILEVNPK
VLIVIEGVEQYPKTEKGYTYDTPDIWGATGDASPWYSAWWGGNLRGVKDYPIDLGPLNSQ
IVYSPHDYGPSVYAQPWFEKDFTMQTLLDDYWYDTWAYIHDQGIAPILIGEWGGHMDGGK
NQKWMTLLRDYIVQNRIHHTFWCINPNSGDTGGLLGNDWSTWDEAKYALLKPALWQTKDG
KFIGLDHKIPLGSKGISLGEYYGTPQASDPPATPTATPTKPAASSTPSFIYGDINSDGNV
NSTDLGILKRIIVKNPPASANMDAADVNADGKVNSTDYTVLKRYLLRSIDKLPHTT
>GUNH_CLOTM.1 [45,900]  P16218 Endoglucanase H precursor (EC
AIKSFQELQGRKLDIVHQFINWSTDFSWVRPYADAVYNNGSILMITWEPWEYNTVDIKNG
KADAYITRMAQDMKAYGKEIWLRPLHEANGDWYPWAIGYSSRVNTNETYIAAFRHIVDIF
RANGATNVKWVFNVNCDNVGNGTSYLGHYPGDNYVDYTSIDGYNWGTTQSWGSQWQSFDQ
VFSRAYQALASINKPIIIAEFASAEIGGNKARWITEAYNSIRTSYNKVIAAVWFHENKET
DWRINSSPEALAAYREAIGAGSSNPTPTPTWTSTPPSSSPKAVDPFEMVRKMGMGTNLGN
TLEAPYEGSWSKSAMEYYFDDFKAAGYKNVRIPVRWDNHTMRTYPYTIDKAFLDRVEQVV
DWSLSRGFVTIINSHHDDWIKEDYNGNIERFEKIWEQIAERFKNKSENLLFEIMNEPFGN
ITDEQIDDMNSRILKIIRKTNPTRIVIIGGGYWNSYNTLVNIKIPDDPYLIGTFHYYDPY
EFTHKWRGTWGTQEDMDTVVRVFDFVKSWSDRNNIPVYFGEFAVMAYADRTSRVKWYDFI
SDAALERGFACSVWDNGVFGSLDNDMAIYNRDTRTFDTEILNALFNPGTYPSYSPKPSPT
PRPTKPPVTPAVGEKMLDDFEGVLNWGSYSGEGAKVSTKIVSGKTGNGMEVSYTGTTDGY
WGTVYSLPDGDWSKWLKISFDIKSVDGSANEIRFMIAEKSINGVGDGEHWVYSITPDSSW
KTIEIPFSSFRRRLDYQPPGQDMSGTLDLDNIDSIHFMYANNKSGKFVVDNIKLIGATSD
PTPSIKHGDLNFDNAVNSTDLLMLKRYILKSLELGTSEQEEKFKKAADLNRDNKVDSTDL
TILKRYLLKAISEIPI
>GUNI_CLOTM.1 [56,879]  Q02934 Endoglucanase I precursor (EC
KNGGYLPEEEIPDQPPATGAFNYGEALQKAIFFYECQRSGKLDPSTLRLNWRGDSGLDDG
KDAGIDLTGGWYDAGDHVKFNLPMSYSAAMLGWAVYEYEDAFKQSGQYNHILNNIKWACD
YFIKCHPEKDVYYYQVGDGHADHAWWGPAEVMPMERPSYKVDRSSPGSTVVAETSAALAI
ASIIFKKVDGEYSKECLKHAKELFEFADTTKSDDGYTAANGFYNSWSGFYDELSWAAVWL
YLATNDSSYLDKAESYSDKWGYEPQTNIPKYKWAQCWDDVTYGTYLLLARIKNDNGKYKE
AIERHLDWWTTGYNGERITYTPKGLAWLDQWGSLRYATTTAFLACVYSDWENGDKEKAKT
YLEFARSQADYALGSTGRSFVVGFGENPPKRPHHRTAHGSWADSQMEPPEHRHVLYGALV
GGPDSTDNYTDDISNYTCNEVACDYNAGFVGLLAKMYKLYGGSPDPKFNGIEEVPEDEIF
VEAGVNASGNNFIEIKAIVNNKSGWPARVCENLSFRYFINIEEIVNAGKSASDLQVSSSY
NQGAKLSDVKHYKDNIYYVEVDLSGTKIYPGGQSAYKKEVQFRISAPEGTVFNPENDYSY
QGLSAGTVVKSEYIPVYDAGVLVFGREPGSASKSTSKDNGLSKATPTVKTESQPTAKHTQ
NPASDFKTPANQNSVKKDQGIKGEVVLQYANGNAGATSNSINPRFKIINNGTKAINLSDV
KIRYYYTKEGGASQNFWCDWSSAGNSNVTGNFFNLSSPKEGADTCLEVGFGSGAGTLDPG
GSVEVQIRFSKEDWSNYNQSNDYSFKQACLRQRTLIYLYATWLR
>GUNS_CLOTM.1 [28,741]  P38686 Endoglucanase SS precursor (E
GPTKAPTKDGTSYKDLFLELYGKIKDPKNGYFSPDEGIPYHSIETLIVEAPDYGHVTTSE
AFSYYVWLEAMYGNLTGNWSGVETAWKVMEDWIIPDSTEQPGMSSYNPNSPATYADEYED
PSYYPSELKFDTVRVGSDPVHNDLVSAYGPNMYLMHWLMDVDNWYGFGTGTRATFINTFQ
RGEQESTWETIPHPSIEEFKYGGPNGFLDLFTKDRSYAKQWRYTNAPDAEGRAIQAVYWA
NKWAKEQGKGSAVASVVSKAAKMGDFLRNDMFDKYFMKIGAQDKTPATGYDSAHYLMAWY
TAWGGGIGASWAWKIGCSHAHFGYQNPFQGWVSATQSDFAPKSSNGKRDWTTSYKRQLEF
YQWLQSAEGGIAGGATNSWNGRYEKYPAGTSTFYGMAYVPHPVYADPGSNQWFGFQAWSM
QRVMEYYLETGDSSVKNLIKKWVDWVMSEIKLYDDGTFAIPSDLEWSGQPDTWTGTYTGN
PNLHVRVTSYGTDLGVAGSLANALATYAAATERWEGKLDTKARDMAAELVNRAWYNFYCS
EGKGVVTEEARADYKRFFEQEVYVPAGWSGTMPNGDKIQPGIKFIDIRTKYRQDPYYDIV
YQAYLRGEAPVLNYHRFWHEVDLAVAMGVLATYFPDMTYKVPGTPSTKLYGDVNDDGKVN
STDAVALKRYVLRSGISINTDNADLNEDGRVNSTDLGILKRYILKEIDTLPYKN
>GUNZ_CLOSR.1 [26,986]  P23659 Endoglucanase Z precursor (EC
EAAGYNYGEALQKAIMFYEFQRSGKLPENKRDNWRGDSGLNDGADVGLDLTGGWYDAGDH
VKFNLPMAYSQTMLAWAAYEAEEALERSGQMGYLLDAIKWVSDYLIKCHPSPNVFYYQVG
DGHLDHSWWGPAEVMQMDRPAYKVDLANPGSTVVAEAAAALASAAVVFADRDPAYAATCI
QHAKELYNFAEITKSDSGYTAASGFYDSHSGFYDELSWAGVWLYLATGDETYLNKAEQYV
AYWGTEPQTNIISYKWAHCWDDVHYGACLLLAKITGKQIYKEAIERHLDYWSVGYNGERV
HYTPKGLAWLDSWGSLRYATTTAFLASVYADWEGCSREKAAIYNDFAKQQIDYALGSSGR
SYVVGFGVNPPKRPHHRTAHSSWADSMSVPDYHRHVLIGALVGGPGKDDSYTDDINNYIN
NEVACDYNAGFVGALAKMYEDYGGSPIPDLNAFEEITNDEFFVMAGINASGQNFIEIKAL
LHNQSGWPARVADKLSFRYFVDLTELIEAGYSASDVTITTNYNAGAKVTGLHPWNEAENI
YYVNVDFTGTKIYPGGQSAYRKEVQFRIAAPQNTNFWNNDNDYSFRDIKGVTSGNTVKTV
YIPVYDDGVLVFGVEPEGGSGENNSSISITNATFDKNPAKQENIQVVMNLNGNTLNGIKY
GNTYLREGTDYTVSGDTVTILKSFLNSFDTSTVQLIFDFSAGRDPVLTVNIIDTTTSASI
VPTTADFDKNPDASRDVKVKLVPNGNTLLAVKKDGEALVLGRDYSIDGDEVTIFREYLAD
QPVGRVTLTFDFDRGTDPVLTINITDSRQVETGVIQIQMFNGNTSDKTNGIMPRYRLTNT
GTTPIRLSDVKIRYYYTIDGEKDQNFWCDWSSVGSNNITGTFVKMAEPKEGADYYLETGF
TDGAGYLQPNQSIEVQNRFSKADWTDYIQTNDYSFSTNTSYGSNDRITVYISGVLVSGIE
P
>GUN_BACS1.1 [31,800]   P06564 Endoglucanase precursor (EC 3
EGNTREDNFKHLLGNDNVKRPSEAGALQLQEVDGQMTLVDQHGEKIQLRGMSTHGLQWFP
EILNDNAYKALANDWESNMIRLAMYVGENGYASNPELIKSRVIKGIDLAIENDMYVIVDW
HVHAPGDPRDPVYAGAEDFFRDIAALYPNNPHIIYELANEPSSNNNGGAGIPNNEEGWNA
VKEYADPIVEMLRDSGNADDNIIIVGSPNWSQRPDLAADNPIDDHHTMYTVHFYTGSHAA
STESYPPETPNSERGNVMSNTRYALENGVAVFATEWGTSQANGDGGPYFDEADVWIEFLN
ENNISWANWSLTNKNEVSGAFTPFELGKSNATSLDPGPDQVWVPEELSLSGEYVRARIKG
VNYEPIDRTKYTKVLWDFNDGTKQGFGVNGDSPVEDVVIENEAGALKLSGLDASNDVSEG
NYWANARLSADGWGKSVDILGAEKLTMDVIVDEPTTVSIAAIPQGPSANWVNPNRAIKVE
PTNFVPLEDKFKAELTITSADSPSLEAIAMHAENNNINNIILFVGTEGADVIYLDNIKVI
GTEVEIPVVHDPKGEAVLPSVFEDGTRQGWDWAGESGVKTALTIEEANGSNALSWEFGYP
EVKPSDNWATAPRLDFWKSDLVRGENDYVTFDFYLDPVRATEGAMNINLVFQPPTNGYWV
QAPKTYTINFDELEEPNQVNGLYHYEVKINVRDITNIQDDTLLRNMMIIFADVESDFAGR
VFVDNVRFEGAATTEPVEPEPVDPGEETPPVDEKEAKTEQKEAEKEEKEE
>GUN_BACS6.1 [30,941]   P19424 Endoglucanase precursor (EC 3
NTNESKSNAFPFSDVKKTSWSFPYIKDLYEQEVITGTSATTFSPTDSVTRAQFTVMLTRG
LGLEASSKDYPFKDRKNWAYKEIQAAYEAGIVTGKTNGEFAPNENITREQMAAMAVRAYE
YLENELSLPEEQREYNDSSSISTFAQDAVQKAYVLELMEGNTDGYFQPKRNSTREQSAKV
ISTLLWKVASHDYLYHTEAVKSPSEAGALQLVELNGQLTLAGEDGTPVQLRGMSTHGLQW
FGEIVNENAFVALSNDWGSNMIRLAMYIGENGYATNPEVKDLVYEGIELAFEHDMYVIVD
WHVHAPGDPRADVYSGAYDFFEEIADHYKDHPKNHYIIWELANEPSPNNNGGPGLTNDEK
GWEAVKEYAEPIVEMLREKGDNMILVGNPNWSQRPDLSADNPIDAENIMYSVHFYTGSHG
ASHIGYPEGTPSSERSNVMANVRYALDNGVAVFATEWGTSQANGDGGPYFDEADVWLNFL
NKHNISWANWSLTNKNEISGAFTPFELGRTDATDLDPGANQVWAPEELSLSGEYVRARIK
GIEYTPIDRTKFTKLVWDFNDGTTQGFQVNGDSPNKESITLSNNNDALQIEGLNVSNDIS
EGNYWDNVRLSADGWSENVDILGATELTIDVIVEEPTTVSIAAIPQGPAAGWANPTRAIK
VTEDDFESFGDGYKALVTITSEDSPSLETIATSPEDNTMSNIILFVGTEDADVISLDNIT
VSGTEIEIEVIHDEKGTATLPSTFEDGTRQGWDWHTESGVKTALTIEEANGSNALSWEYA
YPEVKPSDGWATAPRLDFWKDELVRGTSDYISFDFYIDAVRASEGAISINAVFQPPANGY
WQEVPTTFEIDLTELDSATVTSDELYHYEVKINIRDIEAITDDTELRNLLLIFADEDSDF
AGRVFVDNVRFE
>GUN_BACSZ.1 [28,463]   P29019 Endoglucanase precursor (EC 3
AAIDNDTLINNGHKINSSIITNSSQVSAVAKEMKPFPQQVNYSGILKPNHVSQESLNNAV
KNYYNDWKKKYLKNDLSSLPGGYYVKGEITGNPDGFRPLGTSEGQGYGMIITVLMAGHDS
NAQTIYDGLFKTARAFKSSINPNLMGWVVADDKKAQGHFDSATDGDLDIAYSLLLAHKQW
GSSGKINYLKEAQNMITKGIKASNVTKNNGLNLGDWGDKSTFDTRPSDWMMSHLRAFYEF
TGDKTWLNVIDNLYNTYTNFTNKYSPKTGLISDFVVKNPPQPAPKDFLDESKYTDSYYYN
ASRVPLRIVMDYAMYGEKRGKVISDKVATWIKSKTKGNPSKIVDGYKLDGTNIGDYPTAV
YVSPFIAAGTTNSKNQEWVNSGWDWMKNKKESYFSDSYNLLTMLFLTGNWWKPIPDEKKI
QSPINLEVQSELKEQD
>GUN_CLOSA.1 [35,448]   P15704 Endoglucanase precursor (EC 3
KAEAATTSFGGQLKVVGSQLCDSNGKPIQLKGMSSHGLQWYVNFVNYDSMKFLRDKWGVN
VIRAAMYTNEGGYISNPSSQKEKIKKIVQDAIDLNMYVIIDWHILSDNNPNTYKEQAKSF
FQEMAEEYGKYSNVIYEICNEPNGGTNWANDIKPYANYIIPAIRAIDPNNIIIVGTSTWS
QDVDIAADNPLRYSNIMYTCHFYAGTHTQSLRDKINYAMSKGIAIFVTEWGTSDASGNGG
PYLDESQKWVDFMASKNISWTNWALCDKSEASAALKSGSSTTGGWTDSDLTTSGLFVKKS
IGGSNTTSQTSAPTFSLQSGTYDSAQTVTLTSSDNDSVIHYTTDGTTPTSSSPVYTSPIT
ISKTTTVKAFTTKTGMTDSNITSAVYTISNTDPVKQVSAPTFSYNQEHTIQLKL
>GUX2_CLOSR.1 [34,914]  P50900 Exoglucanase II precursor (EC
ASSDDPYKQRFLELWEELHDPSNGYFSSHGIPYHAVETLIVEAPDYGHLTTSEAMSYYLW
LEALYGKFTGDFSYFMKAWETIEKYMIPTEQDQPNRSMAGYNPAKPATYAPEWEEPSMYP
SQLDFSAPVGIDPIYNELVSTYGTNTIYGMHWLLDVDNWYGFGRRADRISSPAYINTFQR
GSQESVWETIPQPCWDDLTIGGRNGFLDLFVGDSQYSAQFKYTNAPDADARAIQATYWAN
QWAKEHGVNLSQYVKKASRMGDYLRYAMFDKYFRKIGDSKQAGTGYDAAHYLLSWYYAWG
GGITADWAWIIGCSHVHAGYQNPMTAWILANDPEFKPESPNGANDWAKSLERQLEFYQWL
QSAEGAIAGGATNSYKGRYETLPAGISTFYGMAYEEHPVYLDPGSNTWFGFQAWTMQRVA
EYYYLTGDTRAEQLLDKWVDWIKSVVRLNSDGTFEIPGNLEWSGQPDTWTGTYTGNPNLH
VSVVSYRTDLGAAGSLANALLYYAKTSGDDEARNLAKELLDRMWNLYRDDKGLSAPETRE
DYVRFFEQEVYVPQGWSGTMPNGDRIEPGVTFLDIRSKYLNDPDYPKLQQAYNEGKAPVF
NYHRFWAQCDIAIANGLYSILFGSEQANDSFITPTSATFDKNNQEDISVTVTYNGNTLLG
IKSGSSYLIEGVDYIVNGDVIIIKKEFLAGQATGSISLLFDFSAGLDRTLTIDIIDTGGG
EEPVEPVEPVEGVLIIQSFNANTQEISNSIMPRFRIYNSGNTSIPLSEVKLRYYYTVDGD
KPQNFWCDWASIGSSNVTGTFVKMDGATTGADYYLEIGFTPQAGTLEPGASIEVQGRFSK
IDWTDYTQTNDYSFNPTASSYVDFNKITAYISGNLVYGIEP
>HBLA_BACCE.1 [32,375]  P80172 Hemolysin BL binding componen
SEIEQTNNGDTALSANEAKMKETLQKAGLFAKSMNAYSYMLIKNPDVNFEGITINGYVDL
PGRIVQDQKNARAHAVTWDTKVKKQLLDTLTGIVEYDTTFDNYYETMVEAINTGDGETLK
EGITDLRGEIQQNQKYAQQLIEELTKLRDSIGHDVRAFGSNKELLQSILKNQGADVDADQ
KRLEEVLGSVNYYKQLESDGFNVMKGAILGLPIIGGIIVGVARDNLGKLEPLLAELRQTV
DYKVTLNRVVGVAYSNINEIDKALDDAINALTYMSTQWHDLDSQYSGVLGHIENAAQKAD
QNKFKFLKPNLNAAKDSWKTLRTDAVTLKEGIKELKVETVTPQK
>HLA_STAAU.1 [27,319]   P09616 Alpha-hemolysin precursor (Al
ADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGT
IAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGF
NGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWG
PYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASK
QQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN
>HLGA_STAAM.1 [30,309]  P31714 Gamma-hemolysin component A p
ENKIEDIGQGAEIIKRTQDITSKRLAITQNIQFDFVKDKKYNKDALVVKMQGFISSRTTY
SDLKKYPYIKRMIWPFQYNISLKTKDSNVDLINYLPKNKIDSADVSQKLGYNIGGNFQSA
PSIGGSGSFNYSKTISYNQKNYVTEVESQNSKGVKWGVKANSFVTPNGQVSAYDQYLFAQ
DPTGPAARDYFVPDNQLPPLIQSGFNPSFITTLSHERGKGDKSEFEITYGRNMDATYAYV
TRHRLAVDRKHDAFKNRNVTVKYEVNWKTHEVKIKSITPK
>HLGB_STAAN.1 [26,325]  Q07226 Gamma-hemolysin component B p
AEGKITPVSVKKVDDKVTLYKTTATADSDKFKISQILTFNFIKDKSYDKDTLVLKATGNI
NSGFVKPNPNDYDFSKLYWGAKYNVSISSQSNDSVNVVDYAPKNQNEEFQVQNTLGYTFG
GDISISNGLSGGLNGNTAFSETINYKQESYRTTLSRNTNYKNVGWGVEAHKIMNNGWGPY
GRDSFHPTYGNELFLAGRQSSAYAGQNFIAQHQMPLLSRSNFNPEFLSVLSHRQDGAKKS
KITVTYQREMDLYQIRWNGFYWAGANYKNFKTRTFKSTYEIDWENHKVKLLDTKETENNK
>HLGC_STAAU.1 [30,315]  Q07227 Gamma-hemolysin component C p
ANDTEDIGKGSDIEIIKRTEDKTSNKWGVTQNIQFDFVKDKKYNKDALILKMQGFISSRT
TYYNYKKTNHVKAMRWPFQYNIGLKTNDKYVSLINYLPKNKIESTNVSQTLGYNIGGNFQ
SAPSLGGNGSFNYSKSISYTQQNYVSEVEQQNSKSVLWGVKANSFATESGQKSAFDSDLF
VGYKPHSKDPRDYFVPDSELPPLVQSGFNPSFIATVSHEKGSSDTSEFEITYGRNMDVTH
AIKRSTHYGNSYLDGHRVHNAFVNRNYTVKYEVNWKTHEIKVKGQN
>HYSA_STAAU.1 [41,807]  Q59801 Hyaluronate lyase precursor (
DTNVQTPDYEKLRNTWLDVNYGYDKYDENNPDMKKKFDATEKEATNLLKEMKTESGRKYL
WSGAETLETNSSHMTRTYRNIEKIAEAMRNPKTTLNTDENKKKVKDALEWLHKNAYGKEP
DKKVKELSENFTKTTGKNTNLNWWDYEIGTPKSLTNTLILLNDQFSNEEKKKFTAPIKTF
APDSDKILSSVGKAELAKGGNLVDISKVKLLECIIEEDKDMMKKSIDSFNKVFTYVQDSA
TGKERNGFYKDGSYIDHQDVPYTGAYGVVLLEGISQMMPMIKETPFNDKTQNDTTLKSWI
DDGFMPLIYKGEMMDLSRGRAISRENETSHSASATVMKSLLRLSDAMDDSTKAKYKKIVK
SSVESDSSYKQNDYLNSYSDIDKMKSLMTDNSISKNGLTQQLKIYNDMDRVTYHNKDLDF
AFGLSMTSKNVARYESINGENLKGWHTGAGMSYLYNSDVKHYHDNFWVTADMKRLSGTTT
LDNEILKDTDDKKSSKTFVGGTKVDDQHASIGMDFENQDKTLTAKKSYFILNDKIVFLGT
GIKSTDSSKNPVTTIENRKANGYTLYTDDKQTTNSDNQENNSVFLESTDTKKNIGYHFLN
KPKITVKKESHTGKWKEINKSQKDTQKTDEYYEVTQKHSNSDNKYGYVLYPGLSKDVFKT
KKDEVTVVKQEDDFHVVKDNESVWAGVNYSNSTQTFDINNTKVEVKAKGMFILKKKDDNT
YECSFYNPESTNSASDIESKISMTGYSITNKNTSTSNESGVHFELTK
>HYSA_STRPN.1 [31,1066]  Q54873 Hyaluronate lyase precursor 
EETTTNTIQQSQKEVQYQQRDTKNLVENGDFGQTEDGSSPWTGSKAQGWSAWVDQKNSAD
ASTRVIEAKDGAITISSHEKLRAALHRMVPIEAKKKYKLRFKIKTDNKIGIAKVRIIEES
GKDKRLWNSATTSGTKDWQTIEADYSPTLDVDKIKLELFYETGTGTVSFKDIELVEVADQ
LSEDSQTDKQLEEKIDLPIGKKHVFSLADYTYKVENPDVASVKNGILEPLKEGTTNVIVS
KDGKEVKKIPLKILASVKDAYTDRLDDWNGIIAGNQYYDSKNEQMAKLNQELEGKVADSL
SSISSQADRTYLWEKFSNYKTSANLTATYRKLEEMAKQVTNPSSRYYQDETVVRTVRDSM
EWMHKHVYNSEKSIVGNWWDYEIGTPRAINNTLSLMKEYFSDEEIKKYTDVIEKFVPDPE
HFRKTTDNPFKALGGNLVDMGRVKVIAGLLRKDDQEISSTIRSIEQVFKLVDQGEGFYQD
GSYIDHTNVAYTGAYGNVLIDGLSQLLPVIQKTKNPIDKDKMQTMYHWIDKSFAPLLVNG
ELMDMSRGRSISRANSEGHVAAVEVLRGIHRIADMSEGETKQCLQSLVKTIVQSDSYYDV
FKNLKTYKDISLMQSLLSDAGVASVPRPSYLSAFNKMDKTAMYNAEKGFGFGLSLFSSRT
LNYEHMNKENKRGWYTSDGMFYLYNGDLSHYSDGYWPTVNPYKMPGTTETDAKRADSDTG
KVLPSAFVGTSKLDDANATATMDFTNWNQTLTAHKSWFMLKDKIAFLGSNIQNTSTDTAA
TTIDQRKLESGNPYKVYVNDKEASLTEQEKDYPETQSVFLESFDSKKNIGYFFFKKSSIS
MSKALQKGAWKDINEGQSDKEVENEFLTISQAHKQNRDSYGYMLIPNVDRATFNQMIKEL
ESSLIENNETLQSVYDAKQGVWGIVKYDDSVSTISNQFQVLKRGVYTIRKEGDEYKIAYY
NPETQESAPDQEVFKKLEQAAQPQVQNSKEKEKSEEEKNHSDQKNLPQTGEGQSILASLG
FLLLGAFYLFRRGKNN
>INLA_LISMO.1 [36,800]  P25146 Internalin A precursor. - Lis
ATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVE
YLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT
DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS
SNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNL
TDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI
SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQI
SDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTE
PDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPLKAIFNVKFHVDGKETTKEVEA
GNLLTEPAKPVKEGHTFVGWFDAQTGGTKWNFSTDKMPTNDINLYAQFSINSYTATFDND
GVTTSQTVDYQGLLQEPTAPTKEGYTFKGWYDAKTGGDKWDFATSKMPAKNITLYAQYSA
NSYTATFDVDGKSTTQAVDYQGLLKEPKAPTKAGYTFKGWYDEKTDGKKWDFATDKMPAN
DITLYAQFTKNPVAPPTTGGNTPPTTNNGGNTTPPSANIPGSDTSNTSTGNSASTTSTMN
AYDPYNSKEASLPTTGDSDNALYLLLGLLAVGTAMALTKKARASK
>INLB_LISMO.1 [31,630]  P25147 Internalin B precursor. - Lis
AKVQAETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS
VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE
HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKL
QNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE
IISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD
GTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAVFKA
ETTEKAVNLTRYVKYIRGNAGIYKLPREDNSLKQGTLASHRCKALTVDREARNGGKLWYR
LKNIGWTKAENLSLDRYDKMEYDKGVTAYARVRNASGNSVWTKPYNTAGAKHVNKLSVYQ
GKNMRILREAKTPITTWYQFSIGGKVIGWVDTRALNTFYKQSMEKPTRLTRYVSANKAGE
SYYKVPVADNPVKRGTLAKYKNQKLIVDCQATIEGQLWYRIRTSSTFIGWTKAANLRAQK
>ISAA_STAAM.1 [30,233]  Q99R69 Immunodominant staphylococcal
AEVNVDQAHLVDLAHNHQDQLNAAPIKDGAYDIHFVKDGFQYNFTSNGTTWSWSYEAANG
QTAGFSNVAGADYTTSYNQGSDVQSVSYNAQSSNSNVEAVSAPTYHNYSTSTTSSSVRLS
NGNTAGATGSSAAQIMAQRTGVSASTWAAIIARESNGQVNAYNPSGASGLFQTMPGWGPT
NTVDQQINAAVKAYKAQGLGAWGF
>ISAA_STAAU.1 [30,233]  P60158 Immunodominant staphylococcal
AEVNVDQAHLVDLAHNHQDQLNAAPIKDGAYDIHFVKDGFQYNFTSNGTTWSWSYEAANG
QTAGFSNVAGADYTTSYNQGSNVQSVSYNAQSSNSNVEAVSAPTYHNYSTSTTSSSVRLS
NGNTAGATGSSAAQIMAQRTGVSASTWAAIIARESNGQVNAYNPSGASGLFQTMPGWGPT
NTVDQQINAAVKAYKAQGLGAWGF
>ISAA_STAAW.1 [30,233]  P60157 Immunodominant staphylococcal
AEVNVDQAHLVDLAHNHQDQLNAAPIKDGAYDIHFVKDGFQYNFTSNGTTWSWSYEAANG
QTAGFSNVAGADYTTSYNQGSNVQSVSYNAQSSNSNVEAVSAPTYHNYSTSTTSSSVRLS
NGNTAGATGSSAAQIMAQRTGVSASTWAAIIARESNGQVNAYNPSGASGLFQTMPGWGPT
NTVDQQINAAVKAYKAQGLGAWGF
>ISAA_STAEP.1 [29,235]  Q8CMZ9 Immunodominant staphylococcal
SETTNVDKAHLVDLAQHNPEELNAKPVQAGAYDIHFVDNGYQYNFTSNGSEWSWSYAVAG
SDADYTESSSNQEVSANTQSSNTNVQAVSAPTSSESRSYSTSTTSYSAPSHNYSSHSSSV
RLSNGNTAGSVGSYAAAQMAARTGVSASTWEHIIARESNGQLHARNASGAAGLFQTMPGW
GSTGSVNDQINAAYKAYKAQGLSAWGM
>LEF_BACAN.1 [34,809]   P15917 Lethal factor precursor (EC 3
AGGHGDVGMHVKEKEKNKDENKRKDEERNKTQEEHLKEIMKHIVKIEVKGEEAVKKEAAE
KLLEKVPSDVLEMYKAIGGKIYIVDGDITKHISLEALSEDKKKIKDIYGKDALLHEHYVY
AKEGYEPVLVIQSSEDYVENTEKALNVYYEIGKILSRDILSKINQPYQKFLDVLNTIKNA
SDSDGQDLLFTNQLKEHPTDFSVEFLEQNSNEVQEVFAKAFAYYIEPQHRDVLQLYAPEA
FNYMDKFNEQEINLSLEELKDQRMLARYEKWEKIKQHYQHWSDSLSEEGRGLLKKLQIPI
EPKKDDIIHSLSQEEKELLKRIQIDSSDFLSTEEKEFLKKLQIDIRDSLSEEEKELLNRI
QVDSSNPLSEKEKEFLKKLKLDIQPYDINQRLQDTGGLIDSPSINLDVRKQYKRDIQNID
ALLHQSIGSTLYNKIYLYENMNINNLTATLGADLVDSTDNTKINRGIFNEFKKNFKYSIS
SNYMIVDINERPALDNERLKWRIQLSPDTRAGYLENGKLILQRNIGLEIKDVQIIKQSEK
EYIRIDAKVVPKSKIDTKIQEAQLNINQEWNKALGLPKYTKLITFNVHNRYASNIVESAY
LILNEWKNNIQSDLIKKVTNYLVDGNGRFVFTDITLPNIAEQYTHQDEIYEQVHSKGLYV
PESRSILLHGPSKGVELRNDSEGFIHEFGHAVDDYAGYLLDKNQSDLVTNSKKFIDIFKE
EGSNLTSYGRTNEAEFFAEAFRLMHSTDHAERLKVQKNAPKTFQFINDQIKFIINS
>LIPA_MYCPU.1 [28,578]  Q50274 Lipoprotein A precursor. - My
CNHNVAKKEDKTQNDSSNLSNKTNKSDPNDHLKDKDKNVSQDNKDSTNKAVSNENSQTQS
QKTNESSQNTKDDSSKTSNLITNQNSSSNTKSKIQENKQSQKDQNTSAVNVSALEKQTKN
DENISLVNSKDTNVILKNDEKVALAKDDSKEKSKNSSNLNLKTPVENRQNKNEVKDDKKA
LQWWQKLNESASILESFSYDQTSLSLTFKEGMPLGLEVVLKLENLDSHEEKEISFKTTNG
KVQNVLLTSSNLTSGKWKIKSFSFDKTYSHSPTIETTFDFKTNEKLKQERIEKIQKAIDK
YQIKIKQNYKDKPLISKYALSNFDLNLNFKDLEIVNNSLKFDGSNLNQDLKSEKQMKITF
EKVSENQANKTRKAHFKITTLDNLVFEKTLEWSYKTNKEYLDEFKNGSALWDDLQASLTS
VFEKSLWHPYQLPKAKSKINTINLINDVSASFQGYDYLDDFNGSAKLKFKLQRGQEQRDI
TFTINGFLKVSLIDPLYKGNLRNSEFDVKASSNGYWLGQYYTAAEVFKHYSNGKSYWYAT
ANDGNPWLEFS
>LIPB_MYCPU.1 [28,236]  Q9L8P6 Lipoprotein B precursor. - My
CSYNLAKEKDKDQKESTNLSEPNKSNTSKTNTFQDKKDSTNKIDSQESSKTQSQNTSESN
QNTKVDSSKTNNLATNQNNPSKSNVNIQETNETKQEQNINPNNAVISEKQAENDKNASSL
NSKQINNTLKNQDKTKQENDQFKQESKDSSNFTSPKPITHDPINKVISSQSTTRLEMPKN
DQSNSESEDNKKSPESPKWWEKLNQGDAF
>LIPO_BACSU.1 [22,502]  P37966 Lipoprotein lplA precursor. -
CSHSETSNSASGSKDTIKIMAPLLSPESPSDKSPSLKALEKYTGKEIKVTWVPDSSYNDK
FNIVMASGEMPHAIVIKDKSAGFIKSVKAGAFWELSPYLKDYKNLSQADEKILKNSSVNG
EVYGIYRTRDLIRACMIIRTDWLKNVGLDMPETLDDFYEVLKAFKEKDPDGNGKDDTYGM
VVPKWMGLGNGSPWDVLQIWFGAPNRYGVENGKLIPDFTTKEYMDALTFFKKLYDEGLIN
KDFAVMDSAKWNDPVVKGKAGVIVDTGSRASQIQSAMEEADESNKDIIDIVGSLEGPNGK
RTFPTSGYSGMITIPKSSVKTEKELKEVLSFLDKMNDKEAQILTNNGVKGRNYELKDGVF
TSLEKNNKSLLYEHEGLAQFSMSIPKSEYYIEDQKTKLFQHRKDIITEGEKIAVFNPAES
LVSDVYTQKGAQLDNIILDARTQFIIGEIDEKGFDDAVELWKKSGGNELMKDLNKLYQSS
K
>LIP_BACSU.1 [25,212]   P37957 Lipase precursor (EC 3.1.1.3)
LQPSAKAAEHNPVVMVHGIGGASFNFAGIKSYLVSQGWSRDKLYAVDFWDKTGTNYNNGP
VLSRFVQKVLDETGAKKVDIVAHSMGGANTLYYIKNLDGGNKVANVVTLGGANRLTTGKA
LPGTDPNQKILYTSIYSSADMIVMNYLSRLDGARNVQIHGVGHIGLLYSSQVNSLIKEGL
NGGGQNTN
>LIP_STAAM.1 [36,681]   Q99QX0 Lipase precursor (EC 3.1.1.3)
AEKQVNMGNSQEDTVTAQSIGDQQTRENANYQRENGVDEQQHTENLTKNLHNDKTISEEN
HRKTDDLNKDQLKDDKNSSLNNKNIQRDTTKNNNANPSDVNQGLEQAINDGKQSKVASQQ
QSKEVDNSQDSNANNNLPSQSLTKEAPSLNKSDQTSQREIVNETEIEKVQPQQNNQANDK
ITNHNFNNEQEVKPQKDEKTLSVSDLKNNQKSPVEPTKDNDKKNGLNLLKSSAVATLPNK
GTKELTAKAKDDQTNKVAKQGQYKNQDPIVLVHGFNGFTDDINPSVLAHYWGGNKMNIRQ
DLEENGYKAYEASISAFGSNYDRAVELYYYIKGGRVDYGAAHAAKYGHERYGKTYEGIYK
DWKPGQKVHLVGHSMGGQTIRQLEELLRNGNREEIEYQKKHGGEISPLFKGNNDNMISSI
TTLGTPHNGTHASDLAGNEALVRQIVFDIGKMFGNKNSRVDFGLAQWGLKQKPNESYIDY
VKRVKQSNLWKSKDNGFYDLTREGATDLNRKTSLNPNIVYKTYTGEATHKALNSDRQKAD
LNMFFPFVITGNLIGKATEKEWRENDGLVSVISSQHPFNQAYTNATDKIQKGIWQVTPTK
HDWDHVDFVGQDSSDTVRTREELQDFWHHLADDLVKTEKVTDTKQA
>LIP_STAAU.1 [38,690]   P10335 Lipase precursor (EC 3.1.1.3)
SEKTSTNAAAQKETLNQPGEQGNAITSHQMQSGKQLDDMHKENGKSGTVTEGKDTLQSSK
HQSTQNSKTIRTQNDNQVKQDSERQGSKQSHQNNATNNTERQNDQVQNTHHAERNGSQST
TSQSNDVDKSQPSIPAQKVIPNHDKAAPTSTTPPSNDKTAPKSTKAQDATTDKHPNQQDT
HQPAHQIIDAKQDDTVRQSEQKPQVGDLSKHIDGQNSPEKPTDKNTDNKQLIKDALQAPK
TRSTTNAAADAKKVRPLKANQVQPLNKYPVVFVHGFLGLVGDNAPALYPNYWGGNKFKVI
EELRKQGYNVHQASVSAFGSNYDRAVELYYYIKGGRVDYGAAHAAKYGHERYGKTYKGIM
PNWEPGKKVHLVGHSMGGQTIRLMEEFLRNGNKEEIAYHKAHGGEISPLFTGGHNNMVAS
ITTLATPHNGSQAADKFGNTEAVRKIMFALNRFMGNKYSNIDLGLTQWGFKQLPNESYID
YIKRVSKSKIWTSDDNAAYDLTLDGSAKLNNMTSMNPNITYTTYTGVSSHTGPLGYENPD
LGTFFLMATTSRIIGHDAREEWRKNDGVVPVISSLHPSNQPFVNVTNDEPATRRGIWQVK
PIIQGWDHVDFIGVDFLDFKRKGAELANFYTGIINDLLRVEATESKGTQLKAS
>LIP_STAAW.1 [38,690]   Q8NYC2 Lipase precursor (EC 3.1.1.3)
SEKTPTNAAVQKETLNQPGEQGNAITSHQMQSGKQLDDMHKENGKSGTVTEGKDTLQLSK
YQSTQNSKTIRTQNDNQVKQDSERQGSKQSHQNNATNNTERQNDQVQNTHHAERNGSQST
TSQSNDVDKSQPSIPAQKVLPNHDKAAPTSTTPPSNDKTAPKSTKAQDATTDKHPNQQDT
HQPAHQIIDAKQDDTVRQSEQKPQVGDLSKHIDGQNSPEKPTDKNTDNKQLIKDALQAPK
TRSTTNAAADAKKVRPLKANQVQPLNKYPVVFVHGFLGLVGDNAPALYPNYWGGNKFKVI
EELRKQGYNVHQASVSAFGSNYDRAVELYYYIKGGRVDYGAAHAAKYGHERYGKTYKGIM
PNWEPGKKVHLVGHSMGGQTIRLMEEFLRNGNKEEIAYHKAHGGEISPLFTGGHNNMVAS
ITTLATPHNGSQAADKFGNTEAVRKIMFALNRFMGNKYSNIDLGLTQWGFKQLPNESYID
YIKRVSKSKIWTSDDNAAYDLTLDGSAKLNNMTSMNPNITYTTYTGVSSHTGPLGYENPD
LGTFFLMDTTSRIIGHDAREEWRKNDGVVPVISSLHPSNQPFVNVTNDEPATRRGIWQVK
PIIQGWDHVDFIGVDFLDFKRKGAELANFYTGIINDLLRVEATESKGTQLKAS
>LIP_STAEP.1 [36,688]   Q02510 Lipase precursor (EC 3.1.1.3)
AEQQQDKGTVENSTTQSIGDGNEKLSEQQSTQNKNVNEKSNVNSITENESLHNETPKNED
WIQQQKDSQNDNKSESVVEQNKENEAFVQNHSEEKPQQEQVELEKHASENNQTLHSKAAQ
SNEDVKTKPSQLDNTAAKQEDSQKENLSKQDTQSSKTTDLLRATAQNQSKDSQSTEEINK
EVNNDTQQVTAKNDDAKVESFNLNSKEEPLKVDKQANPTTDKDKSSKNDKGSQDGLANLE
SNAVATTNKQSKQQVSEKNEDQTNKSAKQKQYKNNDPIILVHGFNGFTDDINPSVLTHYW
GGDKMNIRQDLEENGYEAYEASISAFGSNYDRAVELYYYIKGGRVDYGAAHAAKYGHERY
GKTYEGVYKDWKPGQKIHLVGHSMGGQTIRQLEELLRHGNPEEVEYQKQHGGEISPLYQG
GHDNMVSSITTLGTPHNGTHASDLLGNEAIVRQLAYDVGKMYGNKDSRVDFGLEHWGLKQ
KPNESYIQYVKRVQNSKLWKSKDSGLHDLTRDGATDLNRKTSLNPNIVYKTYTGESTHKT
LAGKQKADLNMFLPFTITGNLIGKAKEKEWRENDGLVSVISSQHPFNQKYVEATDKNQKG
VWQVTPTKHDWDHVDFVGQDSTDTKRTRDELQQFWHGLAEDLVQSEQLTSTNK
>LIP_STAHY.1 [39,641]   P04635 Lipase precursor (EC 3.1.1.3)
NDSTTQTTTPLEVAQTSQQETHTHQTPVTSLHTATPEHVDDSKEATPLPEKAESPKTEVT
VQPSSHTQEVPALHKKTQQQPAYKDKTVPESTIASKSVESNKATENEMSPVEHHASNVEK
REDRLETNETTPPSVDREFSHKIINNTHVNPKTDGQTNVNVDTKTIDTVSPKDDRIDTAQ
PKQVDVPKENTTAQNKFTSQASDKKPTVKAAPEAVQNPENPKNKDPFVFVHGFTGFVGEV
AAKGENHWGGTKANLRNHLRKAGYETYEASVSALASNHERAVELYYYLKGGRVDYGAAHS
EKYGHERYGKTYEGVLKDWKPGHPVHFIGHSMGGQTIRLLEHYLRFGDKAEIAYQQQHGG
IISELFKGGQDNMVTSITTIATPHNGTHASDDIGNTPTIRNILYSFAQMSSHLGTIDFGM
DHWGFKRKDGESLTDYNKRIAESKIWDSEDTGLYDLTREGAEKINQKTELNPNIYYKTYT
GVATHETQLGKHIADLGMEFTKILTGNYIGSVDDILWRPNDGLVSEISSQHPSDEKNISV
DENSELHKGTWQVMPTMKGWDHSDFIGNDALDTKHSAIELTNFYHSISDYLMRIEKAEST
KNA
>LPP_MYCMS.1 [25,548]   P55802 Hypothetical lipoprotein lpp 
CSTRNSNAKQPDKKPEKPNEKGPIIPKNPDNKKPTNNNNNSNNNSNSNNNKPGSTVPNEN
KDPSKSEETPEKPERDPKKPDKQPQGDDPNNHQPHNNQHADQPNINKDEFADLDKLPKEI
SFERFDFYTSKDATTALSHLRTDGSVIKIIFSNTHRNIFGKYNINLELDGNEKEDVKKGL
IDKVKVKFTNKKDKKSKIIEFTFTGFKVIQKSPDKENKNSKKNYIKKKEKIDNKLTGLYP
SLVAYMIMYTQEPKNYKNLMQKDSINFEELENNNPNLFADPEINLNVVALKDLLLEYNRE
LGKLYKDKVIAVSYDDVNGKLGLKLLIENREENDTIASKYSETLEFDFVGFRKIDLKNPN
KNVLSLLFPQNNFKDMIKNNVFKKKIEVLKSGKQKEDMVLVKEEYAKQLIFKNLLVQIID
NENNLYRSTQTLSLQNNKKDNYTSILGLAGGGTLYPFHTIINNNSIKNIYLMINKEKNKK
YKVAINFEVDIPIFASTTSDLTFHATSGDTNILKLDITTNALID
>LSTP_STASI.1 [24,493]  P10547 Lysostaphin precursor (EC 3.4
SIVYGGIQNETHASEKSNMDVSKKVAEVETSKAPVENTAEVETSKAPVENTAEVETSKAP
VENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVE
TSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVEN
TAEVETSKAPVENTAEVETSKAPVENTAEVETSKALVQNRTALRAATHEHSAQWLNNYKK
GYGYGPYPLGINGGMHYGVDFFMNIGTPVKAISSGKIVEAGWSNYGGGNQIGLIENDGVH
RQWYMHLSKYNVKVGDYVKAGQIIGWSGSTGYSTAPHLHFQRMVNSFSNSTAQDPMPFLK
SAGYGKAGGTVTPTPNTGWKTNKYGTLYKSESASFTPNTDIITRTTGPFRSMPQSGVLKA
GQTIHYDEVMKQDGHVWVGYTGNSGQRIYLPVRTWNKSTNTLGVLWGTIK
>LSTP_STAST.1 [24,480]  P10548 Lysostaphin precursor (EC 3.4
SIVYGGIQNETHASEKSNMDVSKKVAEVETSKPPVENTAEVETSKAPVENTAEVETSKAP
VENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVE
TSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVENTAEVETSKAPVEN
TAEVETSKAPVENTAEVETSKALVQNRTALRAATHEHSAQWLNNYKKGYGYGPYPLGING
GIHYGVDFFMNIGTPVKAISSGKIVEAGWSNYGGGNQIGLIENDGVHRQWYMHLSKYNVK
VGDYVKAGQIIGWSGSTGYSTAPHLHFQRMVNSFSNSTAQDPMPFLKSAGYGKAGGTVTP
TPNTGWKTNKYGTLYKSESASFTPNTDIITRTTGPFRSMPQSGVLKAGQTIHYDEVMKQD
GHVWVGYTGNSGQRIYLPVRTWNKSTNTLGVLWGTIK
>LUKF_STAAU.1 [26,323]  P31715 Leukocidin F subunit precurso
AEGKITPVSVKKVDDKVTLYKTTATADSDKFKISQILTFNFIKDKSYDKDTLVLKATGNI
NSGFVKPNPNDYDFSKLYWGAKYNVSISSQSNDSVNAVDYAPKNQNEEFQVQNTLGYTFG
GDISISNGLSGGLNGNTAFSETINYKQESYRTLSRNTNYKNVGWGVEAHKIMNGWGPYGR
DSFHPTYGNELFLAGRQSSAYAGQNFIAQHQMPLLSRSNFNPEFLSVLSHRQDRAKKSKI
TVTYQREMDLYQIRWNGFYWAGANYKNFKTRTFKSTYEIDWENHKVKLLDTKETENNK
>LUKS_STAAU.1 [30,315]  P31716 Leukocidin S subunit precurso
ANDTEDIGKGSDIEIIKRTEDKTSNKWGVTQNIQFDFVKDTKYNKDALILKMQGFISSRT
TYYNYKKTNHVKAMRWPFQYNIGLKTNDKYVSLINYLPKNKIESTNVSQTLGYNIGGNFQ
SAPSLGGNGSFNYSKSISYTQQNYVSEVEQQNSKSVLWGVKANSFATESGQKSAFDSDLF
VGYKPHSKDPRDYFVPDSELPPLVQSGFNPSFIATVSHEKGSSDTSEFEITYGRNMDVTH
AIKRSTHYGNSYLDGHRVHNAFVNRNYTVKYEVNWKTHEIKVKGQN
>LYTA_BACSU.1 [17,102]  Q02112 Membrane-bound protein lytA p
CGVNSQKSQGEDVSPDSNIETKEGTYVGLADTHTIEVTVDNEPVSLDITEESTSDLDKFN
SGDKVTITYEKNDEGQLLLKDIERAN
>LYTB_STRPN.1 [24,658]  P59205 Putative endo-beta-N-acetylgl
SDGTWQGKQYLKEDGSQAANEWVFDTHYQSWFYIKADANYAENEWLKQGDDYFYLKSGGY
MAKSEWVEDKGAFYYLDQDGKMKRNAWVGTSYVGATGAKVIEDWVYDSQYDAWFYIKADG
QHAEKEWLQIKGKDYYFKSGGYLLTSQWINQAYVNASGAKVQQGWLFDKQYQSWFYIKEN
GNYADKEWIFENGHYYYLKSGGYMAANEWIWDKESWFYLKFDGKMAEKEWVYDSHSQAWY
YFKSGGYMTANEWIWDKESWFYLKSDGKIAEKEWVYDSHSQAWYYFKSGGYMTANEWIWD
KESWFYLKSDGKIAEKEWVYDSHSQAWYYFKSGGYMAKNETVDGYQLGSDGKWLGGKTTN
ENAAYYQVVPVTANVYDSDGEKLSYISQGSVVWLDKDRKSDDKRLAITISGLSGYMKTED
LQALDASKDFIPYYESDGHRFYHYVAQNASIPVASHLSDMEVGKKYYSADGLHFDGFKLE
NPFLFKDLTEATNYSAEELDKVFSLLNINNSLLENKGATFKEAEEHYHINALYLLAHSAL
ESNWGRSKIAKDKNNFFGITAYDTTPYLSAKTFDDVDKGILGATKWIKENYIDRGRTFLG
NKASGMNVEYASDPYWGEKIASVMMKINEKLGGKD
>LYTB_STRR6.1 [24,702]  P59206 Putative endo-beta-N-acetylgl
SDGTWQGKQYLKEDGSQAANEWVFDTHYQSWFYIKADANYAENEWLKQGDDYFYLKSGGY
MAKSEWVEDKGAFYYLDQDGKMKRNAWVGTSYVGATGAKVIEDWVYDSQYDAWFYIKADG
QHAEKEWLQIKGKDYYFKSGGYLLTSQWINQAYVNASGAKVQQGWLFDKQYQSWFYIKEN
GNYADKEWIFENGHYYYLKSGGYMAANEWIWDKESWFYLKFDGKIAEKEWVYDSHSQAWY
YFKSGGYMAANEWIWDKESWFYLKFDGKMAEKEWVYDSHSQAWYYFKSGGYMTANEWIWD
KESWFYLKSDGKIAEKEWVYDSHSQAWYYFKSGGYMTANEWIWDKESWFYLKSDGKMAEK
EWVYDSHSQAWYYFKSGGYMAKNETVDGYQLGSDGKWLGGKATNKNAAYYQVVPVTANVY
DSDGEKLSYISQGSVVWLDKDRKSDDKRLAITISGLSGYMKTEDLQALDASKDFIPYYES
DGHRFYHYVAQNASIPVASHLSDMEVGKKYYSADGLHFDGFKLENPFLFKDLTEATNYSA
EELDKVFSLLNINNSLLENKGATFKEAEEHYHINALYLLAHSALESNWGRSKIAKDKNNF
FGITAYDTTPYLSAKTFDDVDKGILGATKWIKENYIDRGRTFLGNKASGMNVEYASDPYW
GEKIASVMMKINEKLGGKD
>LYTD_BACSU.1 [28,880]  P39848 Beta-N-acetylglucosaminidase 
AAYTDYSLYKVEPSNTFSTESQASQAVAKLEKDTGWDASYQASGTTTTYQISASGIHSES
EAKAILSGLAKQTSITGTSSPVGSKQPYVTISSGAISGEKQANTILAKLKQETGVAGAVK
AYGAAQPYMNVMTSDIADETKVKALIQSLAKQTGIKSSYQPITHTVSVTTIQSGTIVGDS
RAAQIKNAFQKESGLQASLKETVKGQAYYTFTTAAISGEANAKTLLQQLKQSTGITGSYK
SINQKTTVESYNVQSAYFKGLSTVKDAISQIKKNTGVSGSYQQVGKSTSYTVNMKGITKQ
QLQKIDTFFKKKKWHYTSSSVKKTTTSAAYQITTAKILGEQQANKAAAFFAQKKVKAAKT
AAGSTAENQYQLISEETSDQAKVTKGLNILKKNQLSASAKSVKKQIADTFKITTESLLDQ
TKVNQALTFFKSNHISVASQKTGQTAASSYQITTEAIISQEEIDRVLTFFKQNHIAVTTS
KTGQTAYTQYKIVTTQLSSKTALNNGLTYLKSKSVTPSYTTKSNTLYKISVNEQFTGNDT
AAAASTKLKQLYGWTSSIVKIKNGPQIMKTNYNLSLRDMVQKQMTVSPQTDGAAYVSLTY
INTATSTVTADVLNIRSTPEVSPTNVIGQFKKGDKVKVIGQINGWAKINLGWRNASSDEV
VQYVDPNNFSRDSKYYFQFLKLSQTAGLSVTEVNQKVLAGKGILTGRAKAFIDAANQYSI
NELYLISHALLETGNGTSALANGLTYNGKTVYNMYGIGAYDSNPNYYGAKYAYEQGWFTP
EAAIIGGAKFIGSSYIHNTAYNQDTLYKMRWSATATHQYATDIGWAYKQVNRMYSLYSLL
DGYTLYFDVPEYR
>LYTE_BACSU.1 [26,334]  P54421 Probable endopeptidase lytE p
QSIKVKKGDTLWDLSRKYDTTISKIKSENHLRSDIIYVGQTLSINGKSTSSKSSSSSSSS
STYKVKSGDSLWKISKKYGMTINELKKLNGLKSDLLRVGQVLKLKGSTSSSSSSSSKVSS
SSTSTYKVKSGDSLSKIASKYGTTVSKLKSLNGLKSDVIYVNQVLKVKGTSTSSSKPASS
SSSSSSKTSSTSLNVSKLVSDAKALVGTPYKWGGTTTSGFDCSGFIWYVLNKQTSVGRTS
TAGYWSSMKSIASPSVGDFVFFTTYKSGPSHMGIYIGNNSFIHAGSDGVQISSLNNSYWK
PRYLGAKRF
>LYTF_BACSU.1 [27,488]  O07532 Endopeptidase lytF precursor 
ATIKVKSGDSLWKLAQTYNTSVAALTSANHLSTTVLSIGQTLTIPGSKSSTSSSTSSSTT
MKSGSSVYTVKSGDSLWLIANEFKMTVQELKKLNGLSSDLIRAGQKLKVSGTVSSSSSSS
KKSNSNKSSSSSSKSSSNKSSSSSSSTGTYKVQLGDSLWKIANKVNMSIAELKVLNNLKS
DTIYVNQVLKTKSSGSDTSSKDNSSKSNQTSATTKYTVKSGDSLWKIANNYNLTVQQIRN
INNLKSDVLYVGQVLKLTGKASSGSSSSSSSSSNASSGTTTTYTVKSGDSLWVIAQKFNV
TAQQIREKNNLKTDVLQVGQKLVISGKASSSSSSGSSNTTSSTSAKINTMISAAKAQLGV
PYRWGGTTPSGFDCSGFIYYVLNKVTSVSRLTAAGYWNTMKSVSQPAVGDFVFFSTYKAG
PSHVGIYLGNGEFINANDSGVVISNMNNSYWKQRYLGAKRYF
>M12_STRPY.1 [42,564]   P19401 M protein, serotype 12 precur
DHSDLVAEKQRLEDLGQKFERLKQRSELYLQQYYDNKSNGYKGDWYVQQLKMLNRDLEQA
YNELSGEAHKDALGKLGIDNADLKAKITELEKSVEEKNDVLSQIKKELEEAEKDIQFGRE
VHAADLLRHKQEIAEKENVISKLNGELQPLKQKVDETDRNLQQEKQKVLSLEQQLAVTKE
NAKKDFELAALGHQLADKEYNAKIAELESKLADAKKDFELAALGHQHAHNEYQAKLAEKD
GQIKQLEEQKQILDASRKGTARDLEAVRQAKKATEAELNNLKAELAKVTEQKQILDASRK
GTARDLEAVRKSKKQQVEAALKQLEEQNKISEASRKGLRRDLDTSREAKKQVEKDLANLT
AELDKVKEEKQISDASRQGLRRDLDASREAKKQVEKALEEANSKLAALEKLNKDLEESKK
LTEKEKAELQAKLEAEAKALKEQLAKQAEELAKLRAGKASDSQTPDAKPGNKAVPGKGQA
PQAGTKPNQNKAPMKETKRQLPSTGETANPFFTAAALTVMAAA
>M21_STRPY.1 [42,407]   P50468 M protein, serotype 2.1 precu
NSKNPVPVKKEAKLSEAELHDKIKNLEEEKAELFEKLDKVEEEHKKVEEEHKKDHEKLEK
KSEDVERHYLRQLDQEYKEQQERQKNLEELERQSQREVEKRYQEQLQKQQQLEKEKQISE
ASRKSLRRDLEASRAAKKDLEAEHQKLKEEKQISEASRKSLRRDLEASRAAKKDLEAEHQ
KLKEEKQISEASRQGLSRDLEASRAAKKDLEAEHQKLKEEKQISEASRQGLSRDLEASRE
AKKKVEADLAEANSKLQALEKLNKELEEGKKLSEKEKAELQAKLEAEAKALKEQLAKQAE
ELAKLKGNQTPNAKVAPQANRSRSAMTQQKRTLPSTGETANPFFTAAAATVMVSAGMLAL
KRKEEN
>M22_STRPY.1 [42,372]   P50469 M protein, serotype 2.2 precu
DEAKKMEVKESEKESQYKTLALRGENADLRNVNAKYLEKINAEEEKNKKLEAINKELNEN
YYKLQDGIDALEKEKEDLKTTLAKTTKENEISEASRKGLSRDLEASRTAKKELEAKHQKL
EAENKKLTEGNQVSEASRKGLSNDLEASRAAKKELEAKYQKLETDHQALEAKHQKLEADY
QVSETSRKGLSRDLEASREANKKVTSELTQAKAQLSALEESKKLSEKEKAELQAKLDAQG
KALKEQLAKQTEELAKLRAEKAAGSKTPATKPANKERSGRAAQTATRPSQNKGMRSQLPS
TGEAANPFFTAAAATVMVSAGMLALKRKEEN
>M24_STRPY.1 [43,539]   P12379 M protein, serotype 24 precur
VATRSQTDTLEKVQERADKFEIENNTLKLKNSDLSFNNKALKDHNDELTEELSNAKEKLR
KNDKSLSEKASKIQELEARKADLEKALEGAMNFSTADSAKIKTLEAEKAALAARKADLEK
ALEGAMNFSTADSAKIKTLEAEKAALEARQAELEKALEGAMNFSTADSAKIKTLEAEKAA
LAARKADLEKALEGAMNFSTADSAKIKTLEAEKAALEARQAELEKALEGAMNFSTADSAK
IKTLEAEKAALEAEKADLEHQSQVLNANRQSLRRDLDASREAKKQLEAEHQKLEEQNKIS
EASRQSLRRDLDASREAKKQLEAEHQKLEEQNKISEASRQSLRRDLDASREAKKQVEKAL
EEANSKLAALEKLNKELEESKKLTEKEKAELQAKLEAEAKALKEKLAKQAEELAKLRAGK
ASDSQTPDAKPGNKAVPGKGQAPQAGTKPNQNKAPMKETKRQLPSTGETANPFFTAAALT
VMATAGVAAVVKRKEEN
>M49_STRPY.1 [42,389]   P16947 M protein, serotype 49 precur
AEKKVEAKVEVAENNVSSVARREKELYDQIADLTDKNGEYLERIGELEERQKNLEKLEHQ
SQVAADKHYQEQAKKHQEYKQEQEERQKNQEQLERKYQREVEKRYQEQLQKQQQLETEKQ
ISEASRKSLSRDLEASREAKKKVEADLAALTAEHQKLKEEKQISDASRQGLSRDLEASRE
AKKKVEADLAALTAEHQKLKEEKQISDASRQGLSRDLEASREAKKKVEADLAEANSKLQA
LEKLNKELEEGKKLSEKEKAELQARLEAEAKALKEQLAKQAEELAKLKGNQTPNAKVAPQ
ANRSRSAMTQQKRTLPSTGETANPFFTAAAATVMVSAGMLALKRKEEN
>M5_STRP5.1 [43,492]    P02977 M protein, serotype 5 precurs
AVTRGTINDPQRAKEALDKYELENHDLKTKNEGLKTENEGLKTENEGLKTENEGLKTEKK
EHEAENDKLKQQRDTLSTQKETLEREVQNTQYNNETLKIKNGDLTKELNKTRQELANKQQ
ESKENEKALNELLEKTVKDKIAKEQENKETIGTLKKILDETVKDKIAKEQENKETIGTLK
KILDETVKDKLAKEQKSKQNIGALKQELAKKDEANKISDASRKGLRRDLDASREAKKQLE
AEHQKLEEQNKISEASRKGLRRDLDASREAKKQLEAEQQKLEEQNKISEASRKGLRRDLD
ASREAKKQVEKALEEANSKLAALEKLNKELEESKKLTEKEKAELQAKLEAEAKALKEQLA
KQAEELAKLRAGKASDSQTPDTKPGNKAVPGKGQAPQAGTKPNQNKAPMKETKRQLPSTG
ETANPFFTAAALTVMATAGVAAVVKRKEEN
>M6_STRPY.1 [43,483]    P08089 M protein, serotype 6 precurs
RVFPRGTVENPDKARELLNKYDVENSMLQANNDKLTTENNNLTDQNKNLTTENKNLTDQN
KNLTTENKNLTDQNKNLTTENKELKAEENRLTTENKGLTKKLSEAEEEAANKERENKEAI
GTLKKTLDETVKDKIAKEQESKETIGTLKKTLDETVKDKIAKEQESKETIGTLKKTLDET
VKDKIAKEQESKETIGTLKKILDETVKDKIAREQKSKQDIGALKQELAKKDEGNKVSEAS
RKGLRRDLDASREAKKQVEKDLANLTAELDKVKEEKQISDASRQGLRRDLDASREAKKQV
EKALEEANSKLAALEKLNKELEESKKLTEKEKAELQAKLEAEAKALKEQLAKQAEELAKL
RAGKASDSQTPDAKPGNKVVPGKGQAPQAGTKPNQNKAPMKETKRQLPSTGETANPFFTA
AALTVMATAGVAAVVKRKEEN
>MALX_STRPN.1 [25,423]  P59213 Maltose/maltodextrin-binding 
CGSKTADKPADSGSSEVKELTVYVDEGYKSYIEEVAKAYEKEAGVKVTLKTGDALGGLDK
LSLDNQSGNVPDVMMAPYDRVGSLGSDGQLSEVKLSDGAKTDDTTKSLVTAANGKVYGAP
AVIESLVMYYNKDLVKDAPKTFADLENLAKDSKYAFAGEDGKTTAFLADWTNFYYTYGLL
AGNGAYVFGQNGKDAKDIGLANDGSIVGINYAKSWYEKWPKGMQDTEGAGNLIQTQFQEG
KTAAIIDGPWKAQAFKDAKVNYGVATIPTLPNGKEYAAFGGGKAWVIPQAVKNLEASQKF
VDFLVATEQQKVLYDKTNEIPANTEARSYAEGKNDELTTAVIKQFKNTQPLPNISQMSAV
WDPAKNMLFDAVSGQKDAKTAANDAVTLIKETIKQKFGE
>MALX_STRR6.1 [25,423]  P59214 Maltose/maltodextrin-binding 
CGSKTADKPADSGSSEVKELTVYVDEGYKSYIEEVAKAYEKEAGVKVTLKTGDALGGLDK
LSLDNQSGNVPDVMMAPYDRVGSLGSDGQLSEVKLSDGAKTDDTTKSLVTAANGKVYGAP
AVIESLVMYYNKDLVKDAPKTFADLENLAKDSKYAFAGEDGKTTAFLADWTNFYYTYGLL
AGNGAYVFGQNGKDAKDIGLANDGSIAGINYAKSWYEKWPKGMQDTEGAGNLIQTQFQEG
KTAAIIDGPWKAQAFKDAKVNYGVATIPTLPNGKEYAAFGGGKAWVIPQAVKNLEASQKF
VDFLVATEQQKVLYDKTNEIPANTEARSYAEGKNDELTTAVIKQFKNTQPLPNISQMSAV
WDPAKNMLFDAVSGQKDAKTAANDAVTLIKETIKQKFGE
>MANB_BACSM.1 [27,513]  P16699 Mannan endo-1,4-beta-mannosid
SEANGAALSNPNANQTTKNVYSWLANLPNKSNKRVVSGHFGGYSDSTLAWIKQCARELTG
KMPGILSCDYKNWQTRLYVADQISYGCNQELINFWNQGGLVTISVHMPNPGFHSGENYKT
ILPTSQFQNLTNHRTTEGRRWKDMLDKMADGLDELQNNGVTVLFRPLHEMNGEWFWWGAE
GYNQFDQTRANAYISAWRDMYQYFTHERKLNNLIWVYSPDVYRDHVTSYYPGANYVDIVA
LDSYHPDPHSLTDQYNRMIALDKPFAFAEIGPPESMAGSFDYSNYIQAIKQKYPRTVYFL
AWNDKWSPHNNRGAWDLFNDSWVVNRGEIDYGQSNPATVLYDFENNTLSWSGCEFTDGGP
WTSNEWSANGTQSLKADVVLGNNSYHLQKTVNRNLSSFKNLEIKVSHSSWGNVGSGMTAR
VFVKTGSAWRWNAGEFCQFAGKRTTALSIDLTKVSNLHDVREIGVEYKAPANSNGKTAIY
LDHVTVR
>MANB_BACSU.1 [25,360]  P55278 Mannan endo-1,4-beta-mannosid
HTVYPVNPNAQQTTKDIMNWLAHLPNRSENRVMSGAFGGYSDVTFSMTEENRLKNATGQS
PAIYGCDYGRGWLETADITDTIDYCCNSSLISYWKSGGLPQVSLHLANPAFPSGNYKTAI
SNSQYKNILDPSTVEGKRLEALLSKIADGLTQLKNQGVTVLFRPLHEMNGEWFWWGLTGY
NQKDNERISLYKELYKKIYRYMTETRGLDNLLWVYSPDANRDFKTDFYPGSSYVDITGLD
AYFTDPYAISGYDEMLSLKKPFAFAETGPSGNIGSFDYAAFINAIRQKYPQTTYFLTWDE
QLSPAANQGAQSLYQNSWTLNKGEIWNGGSLTPIAE
>MANB_CALSA.1 [42,1331]  P22533 Beta-mannanase/endoglucanase
NDGVVKIDTSTLIGTNHAHCWYRDRLDTALRGIRSWGMNSVRVVLSNGYRWTKIPASEVA
NIISLSRSLGFKAIILEVHDTTGYGEDGAACSLAQAVEYWKEIKSVLDGNEDFVIINIGN
EPYGNNNYQNWVNDTKNAIKALRDAGFKHTIMVDAPNWGQDWSNTMRDNAQSIMEADPLR
NLVFSIHMYGVYNTASKVEEYIKSFVDKGLPLVIGEFGHQHTDGDPDEEAIVRYAKQYKI
GLFSWSWCGNSSYVGYLDMVNNWDPNNPTPWGQWYKTNAIGTSSTPTPTSTVTPTPTPTP
TPTPTVTATPTPTPTPVSTPATSGQIKVLYANKETNSTTNTIRPWLKVVNSGSSSIDLSR
VTIRYWYTVDGERAQSAISDWAQIGASNVTFKFVKLSSSVSGADYYLEIGFKSGAGQLQP
GKDTGEIQMRFNKDDWSNYNQGNDWSWIQSMTSYGENEKVTAYIDGVLVWGQEPSGATPA
PAPTATPTPTPTVTPTPTVTPTPTVTATPTPTPTPTPTPVSTPATGGQIKVLYANKETNS
TTNTIRPWLKVVNSGSSSIDLSRVTIRYWYTVDGERAQSAISDWAQIGASNVTFKFVKLS
SSVSGADYYLEIGFKSGAGQLQPGKDTGEIQIRFNKSDWSNYNQGNDWSWIQSMTSYGEN
EKVTAYIDGVLVWGQEPSGTTPSPTSTPTVTVTPTPTPTPTPTPTPTVTPTPTVTPTPTV
TATPTPTPTPIPTVTPLPTISPSPSVVEITINTNAGRTQISPYIYGANQDIEGVVHSARR
LGGNRLTGYNWENNFSNAGNDWYHSSDDYLCWSMGISGEDAKVPAAVVSKFHEYSLKNNA
YSAVTLQMAGYVSKDNYGTVSENETAPSNRWAEVKFKKDAPLSLNPDLNDNFVYMDEFIN
YLINKYGMASSPTGIKGYILDNEPDLWASTHPRIHPNKVTCKELIEKSVELAKVIKTLDP
SAEVFGYASYGFMGYYSLQDAPDWNQVKGEHRWFISWYLEQMKKASDSFGKRLLDVLDLH
WYPEARGGNIRVCFDGENDTSKEVVIARMQAPRTLWDPTYKTSVKGQITAGENSWINQWF
SDYLPIIPNVKADIEKYYPGTKLAISEFDYGGRNHISGGIALADVLGIFGKYGVNFAARW
GDSGSYAAAAYNIYLNYDGKGSKYGNTNVSANTSDVENMPVYASINGQDDSELHIILINR
NYDQKLQVKINITSTPKYTKAEIYGFDSNSPEYKKMGNIDNIESNVFTLEVPKFNGVSHS
ITLDFNVSIKIIQNEVIKFIRNLVFMRALV
>MED_BACSU.1 [18,317]   O32436 Transcriptional activator pro
CGQTPFKGKIEKVGMLFPDTINDLVWGTKGYKGLLNIQSKYNVDVYYKEGVKTEEDIINA
IEDFHKRGVNLLYGHGSEYAEVFNLVGEDYPDMEFVISNAKAKADNVTSVHFSGEAMGFF
GGMTAAHMSKTNQVGVIASFTWQPEVDGFIKGAKYENPDIEVNTKYTDHWDDDTTAVKLY
QKMKNEGADVVYPAGDGYNVPVIQQIKKDGLYAIGYVTDQSDLGENTVLTSTVQNVDKAY
EIIAEQFNKGTLEGGDHYYDLNTGVVEMGTFSPLVDQDFQQRIAKLIKTYNKTGELPKNE
>MGPC_MYCGE.1 [26,1052]  P22747 MgpC protein precursor. - My
NTFLVKEDSKNVTAYTPFATPITDSKSDLVSLAQLDSSYQIADQTIHNTNLFVLFKSRDV
KVKYESSGSNNISFDSTSQGEKPSYVVEFTNSTNIGIKWTMVKKYQLDVPNVSSDMNQVL
KNLILEQPLTKYTLNSSLAKEKGKTQREVHLGSGQANQWTSQRNQHDLNNNPSPNASTGF
KLTTGNAYRKLSESWPIYEPIDGTKQGKGKDSSGWSSTEENEAKNDAPSVSGGGSSSGTF
NKYLNTKQALESIGILFDDQTPRNVITQLYYASTSKLAVTNNHIVVMGNSFLPSMWYWVV
ERSAQENASNKPTWFANTNLDWGEDKQKQFVENQLGYKETTSTNSHNFHSKSFTQPAYLI
SGIDSVNDQIIFSGFKAGSVGYDSSSSSSSSSSSTKDQALAWSTTTSLDSKTGYKDLVTN
DTGLNGPINGSFSIQDTFSFVVPYSGNHTNNGTTGPIKTAYPVKKDQKSTVKINSLINAT
PLNSYGDEGIGVFDALGLNYNFKSNQERLPSRTDQIFVYGIVSPNELRSAKSSADSTGSD
TKVNWSNTQSRYLPVPYNYSEGIIDADGFKRPENRGASVTTFSGLKSIAPDGFANSIANF
SVGLKAGIDPNPVMSGKKANYGAVVLTRGGVVRLNFNPGNDSLLSTTDNNIAPISFSFTP
FTAAESAVDLTTFKEVTYNQESGLWSYIFDSSLKPSHDGKQTPVTDNMGFSVITVSRTGI
ELNQDQATTTLDVAPSALAVQSGIQSTTQTLTGVLPLSEEFSAVIAKDSDQNKIDIYKNN
NGLFEIDTQLSNSVATNNGGLAPSYTENRVDAWGKVEFADNSVLQARNLVDKTVDEIINT
PEILNSFFRFTPAFEDQKATLVATKQSDTSLSVSPRIQFLDGNFYDLNSTIAGVPLNIGF
PSRVFAGFAALPAWVIPVSVGSSVGILFILLVLGLGIGIPMYRVRKLQDASFVNVFKKVD
TLTTAVGSVYKKIITQTGVVKKAPSALKAANPSVKKPAAFLKPPVQPPSKPEGEQKAVEV
KSEETKS
>MGPC_MYCPN.1 [26,1218]  Q50341 MgpC protein precursor. - My
NTYLLQDHNTLTPYTPFTTPLNGGLDVVRAAHLHPSYELVDWKRVGDTKLVALVRSALVR
VKFQDTTSSDQSNTNQNALSFDTQESQKALNGSQSGSSDTSGSNSQDFASYVLIFKAAPR
ATWVFERKIKLALPYVKQESQGSGDQGSNGKGSLYKTLQDLLVEQPVTPYTPNAGLARVN
GVAQDTVHFGSGQESSWNSQRSQKGLKNNPGPKAVTGFKLDKGRAYRKLNESWPVYEPLD
STKEGKGKDESSWKNSEKTTAENDAPLVGMVGSGAAGSASSLQGNGSNSSGLKSLLRSAP
VSVPPSSTSNQTLSLSNPAPVGPQAVVSQPAGGATAAVSVNRTASDTATFSKYLNTAQAL
HQMGVIVPGLEKWGGNNGTGVVASRQDATSTNLPHAAGASQTGLGTGSPREPALTATSQR
AVTVVAGPLRAGNSSETDALPNVITQLYHTSTAQLAYLNGQIVVMGSDRVPSLWYWVVGE
DQESGKATWWAKTELNWGTDKQKQFVENQLGFKDDSNSDSKNSNLKAQGLTQPAYLIAGL
DVVADHLVFAAFKAGAVGYDMTTDSSASTYNQALAWSTTAGLDSDGGYKALVENTAGLNG
PINGLFTLLDTFAYVTPVSGMKGGSQNNEEVQTTYPVKSDQKATAKIASLINASPLNSYG
DDGVTVFDALGLNFNFKLNEERLPSRTDQLLVYGIVNESELKSARENAQSTSDDNSNTKV
KWTNTASHYLPVPYYYSANFPEAGNRRRAEQRNGVKISTLESQATDGFANSLLNFGTGLK
AGVDPAPVARGHKPNYSAVLLVRGGVVRLNFNPDTDKLLDSTDKNSEPISFSYTPFGSAE
SAVDLTTLKDVTYIAESGLWFYTFDNGEKPTYDGKQQQVKNRKGYAVITVSRTGIEFNED
ANTTTLSQAPAALAVQNGIASSQDDLTGILPLSDEFSAVITKDQTWTGKVDIYKNTNGLF
EKDDQLSENVKRRDNGLVPIYNEGIVDIWGRVDFAANSVLQARNLTDKTVDEVINNPDIL
QSFFKFTPAFDNQRAMLVGEKTSDTTLTVKPKIEYLDGNFYGEDSKIAGIPLNIDFPSRI
FAGFAALPSWVIPVSVGSSVGILLILLILGLGIGIPMYKVRKLQDSSFVDVFKKVDTLTT
AVGSVYKKIITQTSVIKKAPSALKAANNAAPKAPVKPAAPTAPRPPVQPPKKA
>MNTA_BACHD.1 [20,300]  Q9KFG3 Manganese-binding lipoprotein
CGAEDTGTSEDGEGLKIVTSFSILGDVLENIAGERSSVTYIVPIGEEPHEYEPVPSDFQA
VSDADVFYVNGLGLEEWLQRLVENTSDVDVVEVSPTIDALPLEESDGLDPHAWLDVKNVM
KYVEVIRDDLVERDPDGAEIYVANAEAYLQDLQELEEWIHDQVTTIPEEQRTIVISENAY
RYFGEAYGFDTVGIWELNSHEEGTPGQISRVVDIVKELDLPAVFVETTVNKSFMTTVSND
SGVDIAGEVYTDAVGLEGSGAETYIDMMKHNVDTFVSGLSQ
>MNTA_BACSU.1 [19,306]  O34385 Manganese-binding lipoprotein
CGTDSAGKSADQQLQVTATTSQIADAAENIGGKHVKVTSLMGPGVDPHLYKASQGDTKKL
MSADVVLYSGLHLEGKMEDVLQKIGEQKQSAAVAEAIPKNKLIPAGEGKTFDPHVWFSIP
LWIYAVDEIEAQFSKAMPQHADAFRKNAKEYKEDLQYLDKWSRKEIAHIPEKSRVLVTAH
DAFAYFGNEYGFKVKGLQGLSTDSDYGLRDVQELVDLLTEKQIKAVFVESSVSEKSINAV
VEGAKEKGHTVTIGGQLYSDAMGEKGTKEGTYEGMFRHNINTITKALK
>MNTA_LISIN.1 [19,310]  Q92AG1 Manganese-binding lipoprotein
CSSQNSDTKKTGDKLNVVATYSILADIVKNVGGDKIELHSIVPVGVDPHEYDPLPDNIQS
AADADLIFYNGLNLETGNGWFDRMLETADKSRDDKDQVVELSKGVKPKYLTEKGKTSETD
PHAWLDLHNGIIYTENVRDALVKADPDNANFYKENAKKYIDKLATLDKEAKQKFADLPEN
QKTLVTSEGAFKYFAARYGLKAAYIWEINTESQGTPDQMKQIISIVEKERVPNLFVETSV
DPRSMESVSKETGVPIFAKIFTDSTAKKGEEGDTYLEMMRYNLDKIHDGLAK
>MNTA_LISMO.1 [19,310]  Q8Y653 Manganese-binding lipoprotein
CSSQNSDSKKTDGKLNVVATYSILADIVKNVGGNKIELHSIVPVGVDPHEYDPLPANIQS
AADADLIFYNGLNLETGNGWFDRMLETADKSREDKNQVVELSKGVKPKYLTEKGKTSETD
PHAWLDLHNGIIYTENVRDALVKADPDNADFYKENAKKYIDKLATLDKEAKQKFADLPEN
QKTLVTSEGAFKYFAARYGLKAAYIWEINTESQGTPDQMKQIVGIVEKEKVPNLFVETSV
DPRSMESVSKETGVPIFAKIFTDSTAKKGEVGDTYLEMMRYNLDKIHDGLAK
>MPR_BACSU.1 [35,313]   P39790 Extracellular metalloprotease
AENPQTSVSNTGKEADATKNQTSKADQVSAPYEGTGKTSKSLYGGQTELEKNIQTLQPSS
IIGTDERTRISSTTSFPYRATVQLSIKYPNTSSTYGCTGFLVNPNTVVTAGHCVYSQDHG
WASTITAAPGRNGSSYPYGTYSGTMFYSVKGWTESKDTNYDYGAIKLNGSPGNTVGWYGY
RTTNSSSPVGLSSSVTGFPCDKTFGTMWSDTKPIRSAETYKLTYTTDTYGCQSGSPVYRN
YSDTGQTAIAIHTNGGSSYNLGTRVTNDVFNNIQYWANQ
>MRP4_STRPY.1 [42,388]  P30141 Fibrinogen- and Ig-binding pr
ESRRYQAPPRVLLQGKEANKVFEERKALEKQARDLGDTINHMSQTISEQSRKIAALKSEA
ELKNQQALEALNNKNKQISDLTNENAQLKEAIEGYVQTIQNASREIAAKQQELAAAKSQL
EAKNAEIEALKQQDASKTEEIAKLQSEAATLENLLGSAKRELTELQAKLDTATAEKAKLE
SQVTTLENLLGSAKRELTDLQAKLDAANAEKEKLQSQAATLEKQLEATKKELADLQAKLA
ATNQEKEKLEAEAKALKEQLAKQAEELAKLKADKASGAQKPDTKPGNKEVPTRPSQTRTN
TNKAPMAQTKRQLPSTGEETTNPFFTAAALTVIASAGVLALKRKEEN
>MRP_STRSU.1 [48,1256]   P32653 Muramidase-released protein 
DETVASSEPTIASSVAPASTEAVAEEAEKTNAENTSAVATTSTEVEKAKAVLEQVTSESP
LLAGLGQKELAKTEDATLAKAIEDAQTKLAAAKAILADSEATVEQVEAQVAAVKVANEAL
GNELQKYTVDGLLTAALDTVAPDTTASTLKVGDGEGTLLDSTTTATPSMAEPNGAAIAPH
TLRTQDGIKATSEPNWYTFESYDLYSYNKNMASSTYKGAEVDAYIRYSLDNDSSTTAVLA
ELVSRTTGDVLEKYTIEPGESVTFSHPTKVNANNSNITVTYDTSLASANTPGALKFSAND
DVYSTIIVPAYQINTTRYVTESGKVLATYGLQTIAGQVVTPSSVRVFTGYDYVATTTKAV
QGPYPKGTVYLAGTVQKDTVQYKVIREIVENDQAVLKFYYLDPTYKGEVDWRGTDTTGFI
ELLTTSPTTYKVGTIYDYNINSKITAPFTIDPTKNVMVFKESEQNEQGSKYRVIAQWSGD
ETTKGIYGKIYIATQVWTTKLGTNEWGWFDYSDDQAGIKFNNKGFWPAGVQNTLRNATPA
TAVETTYIYKESSKYGDVIVEYYDTDGKQIVNSVVDTPKSALGTEYNTDVDRRPASLVAA
DGTVYFYKEVKSDSAKTTGTVVAGTTTVKYVYEKAGSVNVNFVDINGKVIKAPVSDEKDA
KPGYNYDTDLDQKLASITFEGKEYKLVPAGDYPVGKVGKGNNLIEVGNNTAKGIDPTTGK
IEAGVNKEVTYVYRAVTGSVVVNYKDTEGNVIKDPETDVSDAPVGDAYTTTDKKPNEIIT
KDGSRYVLVPSKTDGEENGKVIEGTITVTYVYQKVANWIPEIPNVPETDRPKVPYPFDPT
EPDEPIDPTTPGTNGEVPNIPYVPGYTPVDPKDNTPLKPIDPNDPGKGYVPPTPENPGVD
TPIPYVPVKKVVTNHVDEEGNPIAPQEEGTKPNKSIPGYEFTGKTVTDEDGNTTHIYKKT
PEVKNGTVVVNYVTEDGTVIKEPVTDTPTSPEGTPYDTTDNKPKTITFKGEEYELVRVDG
TENGKVVEGETVVTYVYRKVETPAKKVVTNHVDEEGNPVAPQEEGTKPNKSIPGYEFTGK
TVTDEDGNTTHIYKKTPAKKVVTNHVDEEGNPIAPQEDGTTPKRQISGYEYVRTVVDEEG
NTTHIYRKLSNKPTTPEKETPAKPQAGKTASGKAQLPNTGEASSVAGALGTAMLVATLAF
ARKRRRNED
>MSME_STRMU.1 [23,420]  Q00749 Multiple sugar-binding protei
CNKSKASQSKEDKVTIEYFNQKKEMDATLKKIIKDFERENPKIHVKMTSVPDAGTVLKTR
VLSGDVPDVINIYPQNMDFQEWSKAGYFYNMTGKAYLNHLKNHYANEYKVNQKVYSVPLT
ANVSGIYYNKTKFKELGLKVPETWDEFVKLVEEIKAKKETPFALAGTEGWTLNGYHQLSL
ISVTGSANAANKYLRFSQPNSIKTSDKILKEDMVRLNLLADDGNQQKNWKGASYNDALVA
FANEKALMTPNGSWALPAIKQQDPKFEIGTFAFPGKKTGNGITVGAGDLALSISAKTKHL
KEAEKFVKYMTTARAMQKYYDVDGSPVAVKGVREDKNSPLQPLTKLAFTDKHYVWLGQHW
NSEDDFFTATTNYLMTKNAKGLADGLNAFFNPMKADVD
>MTA1_STRPN.1 [20,309]  P72538 Manganese ABC transporter sub
CASGKKDTTSGQKLKVVATNSIIADITKNIAGDKIDLHSIVPIGQDPHEYEPLPEDVKKT
SEADLIFYNGINLETGGNAWFTKLVENAKKTENKDYFAVSDGVDVIYLEGQNEKGKEDPH
AWLNLENGIIFAKNIAKQLSAKDPNNKEFYEKNLKEYTDKLDKLDKESKDKFNKIPAEKK
LIVTSEGAFKYFSKAYGVPSAYIWEINTEEEGTPEQIKTLVEKLRQTKVPSLFVESSVDD
RPMKTVSQDTNIPIYAQIFTDSIAEQGKEGDSYYSMMKYNLDKIAEGLAK
>MTA2_STRPN.1 [21,310]  P42363 Manganese ABC transporter sub
CSKGTSSKSSSDKLKVVTTNSILADITKNIAGDKIELHSIVPVGQDPHEYEPLPEDVKKT
SQADLIFYNGINLETGGNAWFTKLVKNANKVENKDYFAASDGVEVIYLEGQNQAGKEDPH
AWLNLENGIIYAKNIAKQLIAKDPKNKDFYEKNLAAYTEKLSKLDQEAKQAFNNIPAEKK
MIVTSEGCFKYFSKAYGVPSAYIWEINTEVEGTPEQIKTLLEKLRQTKVPSLFVESSVDE
RPMKTVSKDSNIPIFAKIFTDSIAKEGEEGDSYYSMMKWNLEKIAEGLNK
>MTSA_LACLA.1 [24,313]  Q9CFZ5 Metal ABC transporter substra
CSNKKTDQVTDKKINVVVTNSILADITKNIADDKINLHSIVPVGKDPHEYEPLPVDVQKT
SKADLIFYNGLNLETGGNAWFTKLVNNANKKENIDYFPVSTGVEVIYLEGKNTEGKEDPH
AWLNLENGIIYAKNIEQQLSKKDPVNKDFYKHNLDKYVKKLSDLDQQAKSKFSLIPENEK
MIVTSEGCFKYFSKAYNIPSAYIWEINTEEEGTPDQIKNLVRKLRATELKSLFVESSVDN
RPMKTVSKDTGIPIYSTIFTDSVAKKGENGDSYYSMMKWNLDQIYKGLAK
>MTSA_STRAP.1 [20,309]  Q9L5X1 Manganese ABC transporter sub
CASGKKDATSGQKLKVVATNSIIADITKNIAGDKIDLHSIVPVGQDPHEYEPLPEDVKKT
SQADLIFYNGINLETGGNAWFTKLVENAKKTENKDYFAVSEGVDVIYLEGQNEKGKEDPH
AWLNLENGMIYAKNIAKQLIAKDPSNKEFYEKNLKDYTEKLDKLDKEAKEKFNNIPAEKK
LIVTSEGCFKYFSKAYGVPSAYIWEINTEEEGTPEQIKTLVEKLRQTKVPSLFVESSVDD
RPMKTVSQDTNIPIYAQIFTDSIAEEGKEGDSYYSMMKYNLDKIAEGLSK
>MTSA_STRCR.1 [20,310]  Q53891 Metal ABC transporter substra
CSSQKSSTETGSSKLNVVATNSIIADITKNIAGDKINLHSIVPVGQDPHEYEPLPEDVKK
TSQADLIFYNGINLETGGNAWFTKLVENAKKKENKDYYAVSEGVDVIYLEGQSEKGKEDP
HAWLNLENGIIYAQNIAKRLSEKDPANKETYEKNLKAYVEKLSALDKEAKEKFNNIPGEK
KMIVTSEGCFKYFSKAYNVPSAYIWEINTEEEGTPDQIKTLVEKLRKTKVPSLFVESSVD
DRPMKTVSKDTNIPIYAKIFTDSVAEKGEEGDSYYSMMKYNLEKIAEGLSK
>MTSA_STRGC.1 [20,310]  P42364 Metal ABC transporter substra
CSSQKSSTDSSSSKLNVVATNSIIADITKNIAGDKINLHSIVPVGQDPHKYEPLPEDVKK
TSKADLIFYNGINLETGGNAWFTKLVENAQKKENKDYYAVSEGVDVIYLEGQNEKGKEDP
HAWLNLENGIIYAQNIAKRLIEKDPDNKATYEKNLKAYIEKLTALDKEAKEKFNNIPEEK
KMIVTSEGCPKYFSKAYNVPSAYIWEINTEEEGTPDQIKSLVEKLRKTKVPSLFVESSVD
DRPMKTVSKDTNIPIYAKIFTDSIAEKGEDGDSYYSMMKYNLDKISEGLAK
>MTSA_STRMT.1 [20,309]  Q9L5X0 Manganese ABC transporter sub
CASGKKDAASGQKLKVVATNSIIADITKNIAGDKIDLHSIVPIGQDPHEYEPLPEDVKKT
SEADLIFYNGINLETGGNAWFSKLVENAKKTENKDYFAVSEGVDVIYLEGKNEKGKEDPH
AWLNLENGIIFAKNIAKQLSAKDPNNKEFYEKNLKEYTDKLDKLDKESKDKFNNIPAEKK
LIVTSEGAFKYFSKAYGVPSAYIWEINTEEEGTPEQIKTLVEKLRQTKVPSLFVESSVDD
RPMKTVSQDTNIPIYAQIFTDSIAEQGKEGDSYYNMMKYNLDKIAEGLAK
>MTSA_STRMU.1 [20,306]  Q9KIJ3 Metal ABC transporter substra
CTSKKTADKKLTVVATNSIIADITKNIAGNKVVLHSIVPVGRDPHEYEPLPEDVKKTSQA
DVIFYNGINLENGGNAWFTKLVKNAHKKTDKDYFAVSDSVKTIYLENAKEKGKEDPHAWL
DLKNGIIYAKNIMKRLSEKDPKNKSYYQKNFQAYSAKLEKLHKVAKEKISRIPTEKKMIV
TSEGCFKYFSKAYDIPSAYIWEINTEEEGTPNQIKALVKKLRKSRVSALFVESSVDDRPM
KTVSKDTGIPIAAKIFTDSVAKKGQAGDSYYAMMKWNIDKIANGLSQ
>MTSA_STROR.1 [20,309]  Q9L5W9 Manganese ABC transporter sub
CASGKKDATSGQKLKVVATNSIIADITKNIAGDKIDLHSIVPVGQDPHEYEPLPEDVKKT
SEADLIFYNGINLETGGNAWFTKLVENAKKTENKDYFAVSEGVDVIYLEGQNEKGKEDPH
AWLNLENGMIYAKNIAKQLIAKDPSNKEFYEKNLKDYTEKLDKLDKEAKEKFNNIPAEKK
LIVTSEGCFKYFSKAYGVPSAYIWEINTEEEGTPEQIKTLVEKLRQTKVPSLFVESSVDD
RPMKTVSQDTNIPIYAQIFTDSIAEEGKEGDSYYSMMKYNLDKIAEGLSK
>MTSA_STRP8.1 [21,310]  Q8P280 Metal ABC transporter substra
CSSTGTKTAKSDKLKVVATNSIIADMTKAIAGDKIDLHSIVPIGQDPHEYEPLPEDVEKT
SNADVIFYNGINLEDGGQAWFTKLVKNAQKTKNKDYFAVSDGIDVIYLEGASEKGKEDPH
AWLNLENGIIYSKNIAKQLIAKDPKNKETYEKNLKAYVAKLEKLDKEAKSKFDAIAENKK
LIVTSEGCFKYFSKAYGVPSAYIWEINTEEEGTPDQISSLIEKLKVIKPSALFVESSVDR
RPMETVSKDSGIPIYSEIFTDSIAKKGKPGDSYYAMMKWNLDKISEGLAK
>MTSA_STRPA.1 [21,309]  P31305 Manganese ABC transporter sub
CSKGSSSGASGKLKVVTTNSILADITKNIAGDKIELHSIVPVGKDPHEYEPLPEDVKKTS
QADLIFYNGINLETGGNAWFTKLVKNANKVENKDYFAVSEGVDVIYLEGQNQAGKEDPHA
WLNLENGILYAKNIAKQLIAKDPKNKDFYEKNLAAYTEKLSKLDQKAKQAFKNIPEDKKM
IVTSEGCFKYFSKAYGVPSAYIWEINTEEEGTPEQIKTLVEKLRQTKVPALFVESSVDER
PMKTVAKDTNIPIYAKIFTDSIAKEGEKGDSYYSMMKWNLDKIAEGLSQ
>MTSA_STRPY.1 [21,310]  Q9A157 Metal ABC transporter substra
CSSTGTKTAKSDKLKVVATNSIIADMTKAIAGDKIDLHSIVPIGQDPHEYEPLPEDVEKT
SNADVIFYNGINLEDGGQAWFTKLVKNAQKTKNKDYFAVSDGIDVIYLEGASEKGKEDPH
AWLNLENGIIYSKNIAKQLIAKDPKNKETYEKNLKAYVAKLEKLDKEAKSKFDAIAENKK
LIVTSEGCFKYFSKAYGVPSAYIWEINTEEEGTPDQISSLIEKLKVIKPSALFVESSVDR
RPMETVSKDSGIPIYSEIFTDSIAKKGKPGDSYYAMMKWNLDKISEGLAK
>MTSA_STRSA.1 [20,309]  P31304 Manganese ABC transporter sub
CSNQKNASSDSSKLKVVATNSIIADITKNIAGDKIDLHSIVPVGKDPHEYEPLPEDVKKT
SQADLIFYNGINLETGGNAWFTKLVKNANKEENKDYYAVSDGVDVIYLEGQSEKGKEDPH
AWLNLENGIIYAQNIAKRLIEKDPDNKATYEKNLKAYVEKLTALDKEAKEKFNNIPEEKK
MIVTSEGCFKYFSKAYNVPSAYIWEINTEEEGTPDQIKSLVEKLRKTKVPSLFVESSVDD
RPMKTVSKDTNIPIHAKIFTDSIADQGEEGDTYYSMMKYNLDKISEGLAK
>MX_STRPY.1 [42,369]    P16946 Virulence factor-related M pr
EGVNATTSLTEKAKYDALKDENTGLRGDQTKLVKKLEEEQEKSKNLEKEKQKLENQALNF
QDVIETQEKEKEDLKTTLAKATKENEISEASRKGLSRDLEASRAAKKELEAKHQKLEAEN
KKLTEANQVSEASRKGLSNDLEASRAAKKELEAKYQKLETDHQALEAKHQKLEADLPKFQ
RPSRKGLSRDLEASREANKKVTSELTQAKAQLSALEESKKLSEKEKAELQAKLDAQGKAL
KEQLAKQTEELAKLRAEKAAGSKTPATKPANKERSGRAAQTATRPSQNKGMRSQLPSTGE
AANPFFTAAAATVMVSAGMLALKRKEEN
>NAGH_CLOPE.1 [31,1628]  P26831 Hyaluronoglucosaminidase pre
TDGITENFYEIYPKPQEISYSGGEFQISDEINIVYDDGIDTYTKKRVDEVLEASNLEATV
SNEIVPGKTNFLVGINESGGVVDNYFNKNIPHDESFFDEKMDANIVSVKDGVIGVIGEDT
DSAFYGVTTLKHVFNQLEEGNKIQSFRADDYAEVAHRGFIEGYYGNPWSNEDRAELMKFG
GDYKLNQYVFAPKDDPYHNSKWRDLYPEEKLSEIKKLAQVGNETKNRYVYALHPFMNNPV
RFDTEENYQNDLGVIKAKFTQLLENDVRQFAILADDASAPAQGASMYVKLLTDLTRWLEE
QQSTYPDLKTDLMFCPSDYYGNGSSAQLKELNKAEDNVSIVMTGGRIWGEVDENFANNFM
NNISTEGHPGRAPFFWINWPCSDNSKQHLIMGGNDTFLHPGVDPSKIDGIVLNPMQQAEA
NKSALFAIADYAWNIWDNKEEADENWNDSFKYMDHGTAEETNSSLALREISKHMINQNMD
GRVRPLQESVELAPKLEAFKQKYDSGASIKEDALELIAEFTNLQKAADYYKNNPGNERTR
DQIIYWLNCWEDTMDAAIGYLKSAIAIEEGDDEAAWANYSEAQGAFEKSKTYGFHYVDHT
EYAEVGVQHIVPFIKSMGQNLSVVIGSIVDPNRIIATYISNRQDAPTGNPDNIFDNNAST
ELVYKNPNRIDVGTYVGVKYSNPITLNNVEFLMGANSNPNDTMQKAKIQYTVDGREWIDL
EEGVEYTMPGAIKVENLDLKVRGVRLIATEARENTWLGVRDINVNKKEDSNSGVEFNPSL
IRSESWQVYEGNEANLLDGDDNTGVWYKTLNGDTSLAGEFIGLDLGKEIKLDGIRFVIGK
NGGGSSDKWNKFKLEYSLDNESWTTIKEYDKTGAPAGKDVIEESFETPISAKYIRLTNME
NINKWLTFSEFAIISDELENAGNKENVYTNTELDLLSLAKEDVTKLIPTDDISLNHGEYI
GVKLNRIKDLSNINLEISNDTGLKLQSSMNGVEWTEITDKNTLEDGRYVRLINTSNEAVN
FNLTKFEVNSNEVYEPSLVDAYVGDDGAKKAVDGDLKTRVKFLGAPSTGDTIVYDLGQEI
LVDNLKYVVLDTEVDHVRDGKIQLSLDGETWTDAITIGDGVENGVDDMFSTPLKNGYKHG
NQSGGIVPIDSAYVEGDNLNQKARYVRILFTAPYRHRWTVINELMINNGEYISTVNDPTY
ISNPIEERGFAPSNLRDGNLTTSYKPNTNNGEISEGSITYRLSEKTDVRKVTIVQSGSSI
SNAKVMARVGDGSENVTDQWVQLGTLSNSLNEFINRDYNNIYEIKIEWTDVAPNIYEIIT
LNQEFEFPVNDSLKAKYDELINLSGDEYTLSSFETLKEALNEAKSILDDSNSSQKKIDKA
LEKLNKAEERLDLRATDFEDFNKVLTLGNSLVEEEYTAESWALFSEVLEAANEANKNKAD
YTQDQINQIVIDLDASIKALVKETPEVDKTNLGELINQGKSLLDESVEGFNVGEYHKGAK
DGLTVEINKAEEVFNKEDATEEEINLAKESLEGAIARFNSLLIEESTGDFNGNGKIDIGD
LAMVSKNIGSTTNTSLDLNKDGSIDEYEISFINHRILN
>NANB_STRPN.1 [30,697]  Q54727 Sialidase B precursor (EC 3.2
NELNYGQLSISPIFQGGSYQLNNKSIDISSLLLDKLSGESQTVVMKFKADKPNSLQALFG
LSNSKAGFKNNYFSIFMRDSGEIGVEIRDAQKGINYLFSRPASLWGKHKGQAVENTLVFV
SDSKDKTYTMYVNGIEVFSETVDTFLPISNINGIDKATLGAVNREGKEHYLAKGSIDEIS
LFNKAISDQEVSTIPLSNPFQLIFQSGDSTQANYFRIPTLYTLSSGRVLSSIDARYGGTH
DSKSKINIATSYSDDNGKTWSEPIFAMKFNDYEEQLVYWPRDNKLKNSQISGSASFIDSS
IVEDKKSGKTILLADVMPAGIGNNNANKADSGFKEINGHYYLKLKKNGDNDFRYTVRENG
VVYNETTNKPTNYTINDKYEVLEGGKSLTVEQYSVDFDSGSLRERHNGKQVPMNVFYKDS
LFKVTPTNYIAMTTSQNRGESWEQFKLLPPFLGEKHNGTYLCPGQGLALKSSNRLIFATY
TSGELTYLISDDSGQTWKKSSASIPFKNATAEAQMVELRDGVIRTFFRTTTGKIAYMTSR
DSGETWSKVSYIDGIQQTSYGTQVSAIKYSQLIDGKEAVILSTPNSRSGRKGGQLVVGLV
NKEDDSIDWKYHYDIDLPSYGYAYSAITELPNHHIGVLFEKYDSWSRNELHLSNVVQYID
LEINDLTK
>NANH_CLOSE.1 [27,1014]  P29767 Sialidase precursor (EC 3.2.
DIKENVYINQYSEGNRSQPIAEKLVPRSEIQASATSALTGEGPEKAIDGNTSTLWHTPWA
GVDIQINPQSLTLKLGKTRNISSICVTPRQEGTNGMITDYKIYSGDDVIAEGKWKSDSSD
KYVVFDNPISTDNIRIEAISTVGDENNKHASIAEVEVYELADTPVKLAESNNKVINNGNG
GNYEGDISEISLLEEGTAIIRFTNNGSSLFSISNNERTNEHFHVYINGGAIGYELRKQSG
NLATGSVNKALNAGINTIAFKAEKGKGYSIYLNGEKILTSSSITANFLSTLEGLNTLSLG
KTDRPSGSNEYNFTGEIDFFELYSKPLADRYLKERTGETTSKDLPFPEGAVKTEPVDIFT
PGELGSNNFRIPALYTTKDGTVLASIDVRKGGGHDAPNNIDTGIKRSTDGGVTWDEGKII
LDYPGASSAIDTSLLQDDETGRIFLIVTHFAEGYGFGNSKTGSGYVEIEGKRYLKLLGAN
DTIYTVREGVVYDSNGEATNYTVDNNNELYENGNRIGNVLLSNSPLKVMGTSFLSLIYSD
DDGQTWSDPIDLNKEVKTDWMRFLGTGPGKGHQIKTGRYAGRLLFPVYLTNASGFQSSAV
IYSDDNGATWNIGETATDGRLMDNGDRASAETITTNTSGGVGQLTECQVVEMPNGQLKMF
MRNTGGNSGRVRIATSFDGGATWEDDVVRDENIKEPYCQLSVINYSQKIDGKDAIIFAIP
DANYPNRVNGTVRVGLITENGSYENGEPRYDIEWRYNKVVAPGTYGYSCLSEMPNGEIGL
FYEGRGSRQMSFTRMNIDYLKADLLQDVPAANIKSYTTNSENNIYDPGDKISLNVTFDQT
VSLIGDRTITADIGGKEVLLTLANSKGGSEYTFEGTVPADISNGNYTITIKGKSGLKIVN
VVNKVTDITEDRNTGLNVQVGEEVQSVDKTLLQDLVDSTSNLIKEDYTEESWILYEKALE
VANKFLVNEIAVQEEVDAAKPTLENAYK
>NANH_CLOSO.1 [28,404]  P15698 Sialidase precursor (EC 3.2.1
SNLNTTNEPQKTTVFNKNDNTWNAQYFRIPSLQTLADGTMLAFSDIRYNGAEDHAYIDIG
AAKSTDNGQTWDYKTVMENDRIDSTFSRVMDSTTVVTDTGRIILIAGSWNKNGNWASSTT
SLRSDWSVQMVYSDDNGETWSDKVDLTTNKARIKNQPSNTIGWLAGVGSGIVMSDGTIVM
PIQIALRENNANNYYSSVIYSKDNGETWTMGNKVPDPKTSENMVIELDGALIMSSRNDGK
NYRASYISYDMGSTWEVYDPLHNKISTGNGSGCQGSFIKVTAKDGHRLGFISAPKNTKGG
YVRDNITVYMIDFDDLSKGIRELCSPYPEDGNSSGGGYSCLSFNDGKLSILYEANGNIEY
KDLTDYYLSIENNKKLK
>NEP1_THEVU.1 [30,666]  Q60053 Neopullulanase 1 precursor (E
AANDNNVEWNGLFHDQGPLFDNAPEPTSTQSVTLKLRTFKGDITSANIKYWDTADNAFHW
VPMVWDSNDPTGTFDYWKGTIPASPSIKYYRFQINDGTSTAWYNGNGPSSTEPNADDFYI
IPNFKTPDWLKNGVMYQIFPDRFYNGDSSNDVQTGSYTYNGTPTEKKAWGSSVYADPGYD
NSLVFFGGDLAGIDQKLGYIKKTLGANILYLNPIFKAPTNHKYDTQDYMAVDPAFGDNST
LQTLINDIHSTANGPKGYLILDGVFNHTGDSHPWFDKYNNFSSQGAYESQSSPWYNYYTF
YTWPDSYASFLGFNSLPKLNYGNSGSAVRGVIYNNSNSVAKTYLNPPYSVDGWRLDAAQY
VDANGNNGSDVTNHQIWSEFRNAVKGVNSNAAIIGEYWGNANPWTAQGNQWDAATNFDGF
TQPVSEWITGKDYQNNSASISTTQFDSWLRGTRANYPTNVQQSMMNFLSNHDITRFATRS
GGDLWKTYLALIFQMTYVGTPTIYYGDEYGMQGGADPDNRRSFDWSQATPSNSAVALTQK
LITIRNQYPALRTGSFMTLITDDTNKIYSYGRFDNVNRIAVVLNNDSVSHTVNVPVWQLS
MPNGSTVTDKITGHSYTVQNGMVTVAVDGHYGAVLAQ
>NISI_LACLA.1 [20,245]  P42708 Nisin immunity protein precur
CYQTSHKKVRFDEGSYTNFIYDNKSYFVTDKEIPQENVNNSKVKFYKLLIVDMKSEKLLS
SSNKNSVTLVLNNIYEASDKSLCMGINDRYYKILPESDKGAVKALRLQNFDVTSDISDDN
FVIDKNDSRKIDYMGNIYSISDTTVSDEELGEYQDVLAEVRVFDSVSGKSIPRSEWGRID
KDGSNSKQSRTEWDYGEIHSIRGKSLTEAFAVEINDDFKLATKVGN
>NISP_LACLA.1 [23,682]  Q07596 Nisin leader peptide processi
ETTNSQQLLSNNINTELINHNSNAILSSTEGSTTDSINLGAQSPAVKSTTRTELDVTGAA
KTLLQTSAVQKEMKVSLQETQVSSEFSKRDSVTNKEAVPVSKDELLEQSEVVVSTSSIQK
NKILDNKKKRANFVTSSPLIKEKPSNSKDASGVIDNSASPLSYRKAKEVVSLRQPLKNQK
VEAQPLLISNSSEKKASVYTNSHDFWDYQWDMKYVTNNGESYALYQPSKKISVGIIDSGI
MEEHPDLSNSLGNYFKNLVPKGGFDNEEPDETGNPSDIVDKMGHGTEVAGQITANGNILG
VAPGITVNIYRVFGENLSKSEWVARAIRRAADDGNKVINISAGQYLMISGSYDDGTNDYQ
EYLNYKSAINYATAKGSIVVAALGNDSLNIQDNQTMINFLKRFRSIKVPGKVVDAPSVFE
DVIAVGGIDGYGNISDFSNIGADAIYAPAGTTANFKKYGQDKFVSQGYYLKDWLFTTANT
GWYQYVYGNSFATPKVSGALALVVDKYGIKNPNQLKRFLLMNSPEVNGNRVLNIVDLLNG
KNKAFSLDTDKGQDDAINHKSMENLKESRDTMKQEQDKEIQRNTNNNFSIKNDFHNISKE
VISVDYNINQKMANNRNSRGAVSVRSQEILPVTGDGEDFLPALGIVCISILGILKRKTKN
>NPRB_BACSU.1 [29,538]  P39899 Neutral protease B precursor 
EESIEYDHTYQTPSYIIEKSPQKPVQNTTQKESLFSYLDKHQTQFKLKGNANSHFRVSKT
IKDPKTKQTFFKLTEVYKGIPIYGFEQAVAMKENKQVKSFFGKVHPQIKDVSVTPSISEK
KAIHTARRELEASIGKIEYLDGEPKGELYIYPHDGEYDLAYLVRLSTSEPEPGYWHYFID
AKNGKVIESFNAIHEAAGTGIGVSGDEKSFDVTEQNGRFYLADETRGKGINTFDAKNLNE
TLFTLLSQLIGYTGKEIVSGTSVFNEPAAVDAHANAQAVYDYYSKTFGRDSFDQNGARIT
STVHVGKQWNNAAWNGVQMVYGDGDGSKFKPLSGSLDIVAHEITHAVTQYSAGLLYQGEP
GALNESISDIMGAMADRDDWEIGEDVYTPGIAGDSLRSLEDPSKQGNPDHYSNRYTGTED
YGGVHINSSIHNKAAYLLAEGGVHHGVQVEGIGREASEQIYYRALTYYVTASTDFSMMKQ
AAIEAANDLYGEGSKQSASVEKAYEAVGIL
>NPRE_BACAM.1 [28,521]  P06832 Bacillolysin precursor (EC 3.
AENPQLKENLTNFVPKHSLVQSELPSVSDKAIKQYLKQNGKVFKGNPSERLKLIDQTTDD
LGYKHFRYVPVVNGVPVKDSQVIIHVDKSNNVYAINGELNNDVSAKTANSKKLSANQALD
HAYKAIGKSPEAVSNGTVANKNKAELKAAATKDGKYRLAYDVTIRYIEPEPANWEVTVDA
ETGKILKKQNKVEHAATTGTGTTLKGKTVSLNISSESGKYVLRDLSKPTGTQIITYDLQN
REYNLPGTLVSSTTNQFTTSSQRAAVDAHYNLGKVYDYFYQKFNRNSYDNKGGKIVSSVH
YGSRYNNAAWIGDQMIYGDGDGSFFSPLSGSMDVTAHEMTHGVTQETANLNYENQPGALN
ESFSDVFGYFNDTEDWDIGEDITVSQPALRSLSNPTKYGQPDNFKNYKNLPNTDAGDYGG
VHTNSGIPNKAAYNTITKIGVNKAEQIYYRALTVYLTPSSTFKDAKAALIQSARDLYGSQ
DAASVEAAWNAVGL
>NPRE_BACBR.1 [29,527]  P43263 Bacillolysin precursor (EC 3.
KTKIDYHKQWDTPQYIGEVWEPEGAKGDDVVWSYLEKYKDEFRIQGNVEDHFEIVNEARN
KETDTKHYRLQEVYNGIPIYGFQQTVHIDADGNVTSFLGQFIPDLDSNKQLKKKPKLNEQ
KAVKQAIKDVEGEVGEKPDFIQDPEAKLYIYVHEDESYLAYAVELNFLDPEPGRWMYFID
AHSGDVINKYNMLDHVTATGKGVLGDTKQFETTKQGSTYMLKDTTRGKGIETYTANNRTS
LPGTLMTDSDNYWTDGAAVDAHAHAQKTYDYFRNVHNRNSYDGNGAVIRSTVHYSTRYNN
AFWNGSQMVYGDGDGTTFLPLSGGLDVVAHELTHAVTERTAGLVYQNESGALNESMSDIF
GAMVDNDDWLMGEDIYTPGRSGDALRSLQDPAAYGDPDHYSKRYTGSQDNGGVHTNSGIN
NKAAYLLAEGGTHYGVRVNGIGRTDTAKIYYHALTHYLTPYSNFSAMRRAAVLSATDLFG
ANSRQVQAVNAAYDAVGVK
>NPRE_BACCE.1 [28,566]  P05806 Bacillolysin precursor (EC 3.
DSKNVLSTKKYNETVQSPEFISGDLTEATGKKAESVVFDYLNAAKGDYKLGEKSAQDSFK
VKQVKKDAVTDSTVVRMQQVYEGVPVWGSTQVAHVSKDGSLKVLSGTVAPDLDKKEKLKN
KNKIEGAKAIEIAQQDLGVTPKYEVEPKADLYVYQNGEETTYAYVVNLNFLDPSPGNYYY
FIEADSGKVLNKFNTIDHVTNDDKSPVKQEAPKQDAKAVVKPVTGTNKVGTGKGVLGDTK
SLNTTLSGSSYYLQDNTRGATIFTYDAKNRSTLPGTLWADADNVFNAAYDAAAVDAHYYA
GKTYDYYKATFNRNSINDAGAPLKSTVHYGSNYNNAFWNGSQMVYGDGDGVTFTSLSGGI
DVIGHELTHAVTENSSNLIYQNESGALNEAISDIFGTLVEFYDNRNPDWEIGEDIYTPGK
AGDALRSMSDPTKYGDPDHYSKRYTGSSDNGGVHTNSGIINKQAYLLANGGTHYGVTVTG
IGKDKLGAIYYRANTQYFTQSTTFSQARAGAVQAAADLYGANSAEVAAVKQSFSAVGVN
>NPRE_BACCL.1 [26,544]  P23384 Bacillolysin precursor (EC 3.
KGKSMVWNEQWKTPSFVSGSLLGRCSQELVYRYLDQEKNTFQLGGQARERLSLIGNKLDE
LGHTVMRFEQAIAASLCMGAVLVAHVNDGELSSLSGTLIPNLDKRTLKTEAAISIQQAEM
IAKQDVADRVTKERPAAEEGKPTRLVIYPDEETPRLAYEVNVRFLTPVPGNWIYMIDAAD
GKVLNKWNQMDEAKPGGAQPVAGTSTVGVGRGVLGDQKYINTTYSSYYGYYYLQDNTRGS
GIFTYDGRNRTVLPGSLWADGDNQFFASYDAAAVDAHYYAGVVYDYYKNVHGRLSYDGSN
AAIRSTVHYGRGYNNAFWNGSQMVYGDGDGQTFLPFSGGIDVVGHELTHAVTDYTAGLVY
QNESGAINEAMSDIFGTLVEFYANRNPDWEIGEDIYTPGVAGDALRSMSDPAKYGDPDHY
SKRYTGTQDNGGVHTNSGIINKAAYLLSQGGVHYGVSVTGIGRDKMGKIFYRALVYYLTP
TSNFSQLRAACVQAAADLYGSTSQEVNSVKQAFNAVGVY
>NPRE_BACSU.1 [28,521]  P06142 Bacillolysin precursor (EC 3.
AEGHQLKENQTNFLSKNAIAQSELSAPNDKAVKQFLKKNSNIFKGDPSKRLKLVESTTDA
LGYKHFRYAPVVNGVPIKDSQVIVHVDKSDNVYAVNGELHNQSAAKTDNSQKVSSEKALA
LAFKAIGKSPDAVSNGAAKNSNKAELKAIETKDGSYRLAYDVTIRYVEPEPANWEVLVDA
ETGSILKQQNKVEHAAATGSGTTLKGATVPLNISYEGGKYVLRDLSKPTGTQIITYDLQN
RQSRLPGTLVSSTTKTFTSSSQRAAVDAHYNLGKVYDYFYSNFKRNSYDNKGSKIVSSVH
YGTQYNNAAWTGDQMIYGDGDGSFFSPLSGSLDVTAHEMTHGVTQETANLIYENQPGALN
ESFSDVFGYFNDTEDWDIGEDITVSQPALRSLSNPTKYNQPDNYANYRNLPNTDEGDYGG
VHTNSGIPNKAAYNTITKLGVSKSQQIYYRALTTYLTPSSTFKDAKAALIQSARDLYGST
DAAKVEAAWNAVGL
>NPRE_PAEPO.1 [25,590]  P29148 Bacillolysin precursor (EC 3.
ESSVSGPAQLTPTFHTEQWKAPSSVSGDDIVWSYLNRQKKSLLGVDSSSVREQFRIVDRT
SDKSGVSHYRLKQYVNGIPVYGAEQTIHVGKSGEVTSYLGAVINEDQQEEATQGTTPKIS
ASEAVYTAYKEAAARIEALPTSDDTISKDAEEPSSVSKDTYAEAANNDKTLSVDKDELSL
DKASVLKDSKIEAVEAEKSSIAKIANLQPEVDPKAELYYYPKGDDLLLVYVTEVNVLEPA
PLRTRYIIDANDGSIVFQYDIINEATGKGVLGDSKSFTTTASGSSYQLKDTTRGNGIVTY
TASNRQSIPGTLLTDADNVWNDPAGVDAHAYAAKTYDYYKSKFGRNSIDGRGLQLRSTVH
YGSRYNNAFWNGSQMTYGDGDGDGSTFIAFSGDPDVVGHELTHGVTEYTSNLEYYGESGA
LNEAFSDVIGNDIQRKNWLVGDDIYTPNICGDALRSMSNPTLYDQPHHYSNLYKGSSDNG
GVHTNSGIINKAYYLLAQGGTFHGVTVNGIGRDAAVQIYYSAFTNYLTSSSDFSNARAAV
IQAAKDLYGANSAEATAAAKSFDAVG
>NPRM_BACME.1 [25,562]  Q00891 Bacillolysin precursor (EC 3.
HTSSAAPNNVLSTEKYNKEIKSPEFISGKLSGPSSQKAQDVVFHYMNTNKDKYKLGNESA
QNSFKVTEVVKDPVEQATVVRLQQVYNNIPVWGSTQLAHVAKDGTLKVVSGTVAPDLDKK
EKLKGQKQVDSKKAIQAAEKDLGFKPTYEKSPSSELYVYQNASDTTYAYVVNLNFLSPEP
GNYYYFVDAISGKVLDKYNTIDSVAGPKADVKQAAKPAAKPVTGTNTIGSGKGVLGDTKS
LKTTLSSSTYYLQDNTRGATIYTYDAKNRTSLPGTLWADTDNTYNATRDAAAVDAHYYAG
VTYDYYKNKFNRNSYDNAGRPLKSTVHYSSGYNNAFWNGSQMVYGDGDGTTFVPLSGGLD
VIGHELTHALTERSSNLIYQYESGALNEAISDIFGTLVEYYDNRNPDWEIGEDIYTPGTS
GDALRSMSNPAKYGDPDHYSKRYTGSSDNGGVHTNSGIINKAAYLLANGGTHYGVTVTGI
GGDKLGKIYYRANTLYFTQSTTFSQARAGLVQAAADLYGSGSQEVISVGKSFDAVGVQ
>NPRS_BACST.1 [32,551]  P43133 Bacillolysin precursor (EC 3.
STEHVTWNQQFQTPQFISGDLLKVNGTSPEELVYQYVEKNENKFKFHENAKDTLQLKEKK
NDNLGFTFMRFQQTYKGIPVFGAVVTAHVKDGTLTALSGTLIPNLDTKGSLKSGKKLSEK
QARDIAEKDLVANVTKEVPEYEQGKDTEFVVYVNGDEASLAYVVNLNFLTPEPGNWLYII
DAVDGKILNKFNQLDAAKPGDVKSITGTSTVGVGRGVLGDQKNINTTYSTYYYLQDNTRG
NGIFTYDAKYRTTLPGSLWADADNQFFASYDAPAVDAHYYAGVTYDYYKNVHNRLSYDGN
NAAIRSSVHYSQGYNNAFWNGSQMVYGDGDGQTFIPLSGGIDVVAHELTHAVTDYTAGLI
YQNESGAINEAISDIFGTLVEFYANKNPDWEIGEDVYTPGISGDSLRSMSDPAKYGDPDH
YSKRYTGTQDNGGVHINSGIINKAAYLISQGGTHYGVSVVGIGRDKLGKIFYRALTQYLT
PTSNFSQLRAAAVQSATDLYGSTSQEVASVKQAFDAVGVK
>NUCB_BACSU.1 [29,136]  P42983 Sporulation-specific extracel
SYDKVLYFPLSRYPETGSHIRDAIAEGHPDICTIDRDGADKRREESLKGIPTKPGYDRDE
WPMAVCEEGGAGADVRYVTPSDNRGAGSWVGNQMSSYPDGTRVLFIVQ
>NUC_STAAU.1 [64,231]   P00644 Thermonuclease precursor (EC 
SQTDNGVNRSGSEDPTVYSATSTKKLHKEPATLIKAIDGDTVKLMYKGQPMTFRLLLVDT
PETKHPKKGVEKYGPEASAFTKKMVENAKKIEVEFDKGQRTDKYGRGLAYIYADGKMVNE
ALVRQGLAKVAYVYKPNNTHEQHLRKSEAQAKKEKLNIWSEDNADSGQ
>NUC_STAHY.1 [27,169]   P43270 Thermonuclease precursor (EC 
GPFKSAGLSNANEQTYKVIRVIDGDTIIVDKDGKQQNLRMIGVDTPETVKPNTPVQPYGK
EASDFTKRHLTNQKVRLEYDKQEKDRYGRTLAYVWLGKEMFNEKLAKEGLARAKFYRPNY
KYQERIEQAQKQAQKLKKNIWSN
>NUC_STAIN.1 [28,168]   P43269 Thermonuclease precursor (EC 
PFKKSSTDVRGESYLVKRVIDGDTIIIDKDGQDERVRLIGVDTPETVKPNTPVQPYGKAA
SNFTKKHLTNQRVRLEYDREPKDKYGRTLAYVWLGDEMFNVKLAKEGLARAKFYPPNDKY
RILIEQAQKEAQKKQLNIWER
>OMP7_STAAU.1 [31,121]  P21223 70 kDa outer membrane protein
AAKPLDKSSSSLHHGYSKVHVPYAITVNGTSQNILSSLTFNKNQNISYKDLEDRVKSVLK
SDRGISDIDLRLSKQAKYTVYFKNGTKKVID
>OPA1_LACLA.1 [23,600]  Q9CEK0 Oligopeptide-binding protein 
CGSNQNSSTSTKKLKAGNFDVAYQNPDKAIKGGNLKIAYQSDSPMKAEWLAPLSDDATFG
SMSSPGGGQDGLFFTNSSFKYINGGPANVSLYKDAKTATITLRKDLKWSDGSEVTAKDYE
FSYDLTANPAYGSDRWTDSLANIVGLSDYHAGKAKTISGITFPDGENGKVIKVQFKEMTP
GMNQTGNGYFLETVAPYQYLKDVAPKDLASSPKSTTKPLVTGPFKPENVVAGESIKYVPN
PYYWGEKPKLNSITYEIVSTAKSVAALSAHKYDYINDMRASQYKQVKDVKGYKVLGQQEL
YISLMYYNLGHYDVKKSISVQDRKTPLQDQNVREALGYARNVAAVQAKFSNGLATPANGL
IPPIFKEFTSPSVKGYEKQDLDKANKLLDEDGWKLNKSTGYREKDGKELSLVYAARVGDA
NSETIAQNYIQQWKKIGVKVSLYHGKLMEFNSWVDHMTTPPGSDDWDITDGAWSLSGEPS
QQDLFSAAAPYNFGHFNDPEITKDLNDIDSTKAEDSTYRKAAFIKYQEDMNKKAYVVPTA
YAINYTPVNKRVVGMTLDYGAMNTWSEIGVSSDKMATK
>OPA2_LACLA.1 [23,600]  Q07741 Oligopeptide-binding protein 
CGSNQSSSTSTKKLKAGNFDVAYQNPDKAIKGGNLKVAYQSDSPMKAQWLSGLSNDATFA
TMSGPGGGQDGLFFTDSGFKFIKGGAADVALDKESKTATITLRKDLKWSDGSEVTAKDYE
FTYETIANPAYGSDRWTDSLANIVGLSDYHTGKAKTISGITFPDGENGKVIKVQFKEMKP
GMTQSGNGYFLETVAPYQYLKDVAPKDLASSPKTTTKPLVTGPFKPENVVAGESIKYVPN
PYYWGEKPKLNSITYEVVSTAKSVAALSSSKYDIINGMVSSQYKQVKNLKGYKVLGQQAM
YISLMYYNLGHYDAKNSINVQDRKTPLQDQNVRQAIGYARNVAEVDNKFSNGLSTPANSL
IPPIFKQFTSSSVKGYEKQDLDKANKLLDEDGWKLNKSTGYREKDGKELSLVYAARVGDA
NAETIAQNYIQQWKKIGVKVSLYNGKLMEFNSWVDHMTTPPGANDWDITDGSWSLASEPS
QQDLFSAAAPYNFGHFNDSEITKDLNDIDSAKSENPTYRKAAFVKYQEDMNKKAYVIPTN
FMLNYTPVNKRVVGMTLDYGAMNTWSEIGVSSAKLATK
>OPAC_BACSU.1 [21,293]  P46922 Glycine betaine-binding prote
CGSENDENASAAEQVNKTIIGIDPGSGIMSLTDKAMKDYDLNDWTLISASSAAMTATLKK
SYDRKKPIIITGWTPHWMFSRYKLKYLDDPKQSYGSAEEIHTITRKGFSKEQPNAAKLLS
QFKWTQDEMGEIMIKVEEGEKPAKVAAEYVNKHKDQIAEWTKGVQKVKGDKINLAYVAWD
SEIASTNVIGKVLEDLGYEVTLTQVEAGPMWTAIATGSADASLSAWLPNTHKAYAAKYKG
KYDDIGTSMTGVKMGLVVPQYMKNVNSIEDLKK
>OPBC_BACSU.1 [23,306]  Q45462 Choline-binding protein precu
CSLPGLSAAADQTIKIGAQSMSESEIIASMLGQLIEHHTDLKTTTIKNLGSNAVQQQALM
NGEIDIAATRYTGDALTGTLRMEPEKDPDKALALTQREFKKRYDLKWYDSYGFDNTYAFT
VSKELADQYHLETVSDVKKWAPQLKLGVDNYWMKLKGNGYQDFTKTYGMTFGGTYPMQIG
LVYDAVKSGKMDIVLAYSTDGRIKSYGLKMLKDDKQFFPPYDCSPVVPEKVLKEHPELEG
IIKKMLGKIDTATMQELNYEVDGNLKEPSVVAKEYLEKHRYFES
>OPCC_BACSU.1 [21,303]  O32243 Glycine betaine/carnitine/cho
CSLPGLGGASDDTIKIGAQSMTESEIVANMIAQLIEHDTDLNTALVKNLGSNYVQHQAML
GGDIDISATRYSGTDLTSTLGKEAEKDPKKALNIVQNEFQKRFSYKWFDSYGFDNTYAFT
VTKKFAEKEHINTVSDLKKNASQYKLGVDNAWLKRKGDGYKGFVSTYGFEFGTTYPMQIG
LVYDAVKNGKMDAVLAYSTDGRIKAYDLKILKDDKRFFPPYDCSPVIPEKVLKEHPELEG
VINKLIGQIDTETMQELNYEVDGKLKEPSVVAKEFLEKHHYFD
>OPPA_BACSU.1 [21,545]  P24141 Oligopeptide-binding protein 
CGFGGTGSNGEGKKDSKGKTTLNINIKTEPFSLHPGLANDSVSGGVIRQTFEGLTRINAD
GEPEEGMASKIETSKDGKTYTFTIRDGVKWSNGDPVTAQDFEYAWKWALDPNNESQYAYQ
LYYIKGAEAANTGKGSLDDVAVKAVNDKTLKVELNNPTPYFTELTAFYTYMPINEKIAEK
NKKWNTNAGDDYVSNGPFKMTAWKHSGSITLEKNDQYWDKDKVKLKKIDMVMINNNNTEL
KKFQAGELDWAGMPLGQLPTESLPTLKKDGSLHVEPIAGVYWYKFNTEAKPLDNVNIRKA
LTYSLDRQSIVKNVTQGEQMPAMAAVPPTMKGFEDNKEGYFKDNDVKTAKEYLEKGLKEM
GLSKASDLPKIKLSYNTDDAHAKIAQAVQEMWKKNLGVDVELDNSEWNVYIDKLHSQDYQ
IGRMGWLGDFNDPINFLELFRDKNGGNNDTGWENPEFKKLLNQSQTETDKTKRAELLKKA
EGIFIDEMPVAPIYFYTDTWVQDENLKGVIMPGTGEVYFRNAYFK
>OPPA_LACLC.1 [23,600]  Q09144 Oligopeptide-binding protein 
CGSNQSSSTSTKKLKAGNFDVAYQNPDKAIKGGNLKVAYQSDSPMKAQWLSGLSNDATFA
TMSGPGGGQDGLFFTDSGFKFIKGGAADVALDKESKTATITLRKDLKWSDGSEVTAKDYE
FTYETIANPAYGSDRWTDSLANIVGLSDYHTGKAKTISGITFPDGENGKVIKVQFKEMKP
GMTQSGNGYFLETVVPYQYLKDVAPKDLASSPKTTTKPLVTGPFKPENVVAGESIKYVPN
PYYWGEKPKLNSITYEVVSTAKSVAALSSSKYDIINGMVSSQYKQVKNLKGYKVLGQQAM
YISLMYYNLGHYDAKNSINVQDRKTPLQDQNVRQAIGYARNVAEVDNKFSNGLSTPANSL
IPPIFKQFTSSSVKGYEKQDLDKANKLLDEDGWKLNKSTGYREKDGKELSLVYAARVGDA
NAETIAQNYIQQLKKIGVKVSLYNGKLMEFNSWVDHMTTPPGANDWDITDGSWSLASEPS
QQDLFSAAAPYNFGHFNDSEITKDLNDIDSAKSENPTYRKAAFVKYQEDMNKKAYVIPTN
FMLNYTPVNKRVVGMTLDYGAMNTWSEIGVSSAKLATK
>OXA1_BACAN.1 [21,255]  Q81JH1 Membrane protein oxaA 1 precu
CSEVNQPITPKSTGIWNEYFVYPLSQLITYFANLFGSNYGLAIVVTTLIIRFALLPLMIK
QTKSTKAMQALQPEMVKLKEKYSSKDQATQQKLQQEMMQLYQKNGVNPLAGCLPIFVQMP
ILFAFYHAIMRTSEISKHTFLWFDLGQADPYYILPVVAAITTFIQQKLAMAGTAGQNPQM
AMMLWLMPIMILIFAINFPAALSLYWVVGNIFGIAQMYLIKGPEIKASKAGGSSK
>OXA1_BACCR.1 [21,258]  Q814F4 Membrane protein oxaA 1 precu
CSETGQPITSKSTGIWNEYFVYPLSQLITYFADLFNSNYGLAIVITTLIIRFALLPLMIK
QTKSTKAMQALQPEMVKLKEKYSSKDQATQQKLQQEMMQLYQKNGVNPLAGCLPIFVQMP
ILFAFYHAIMRTAEIKQHSFLWFDLGHADPFYILPVVAAITTFIQQKLAMAGTAGQNPQM
AMMLWLMPIMILIFAINFPAALSLYWVVGNIFGIAQMYFIKGPEIKASKAGKAGGSSK
>OXA1_BACHD.1 [21,257]  Q9RCA5 Membrane protein oxaA 1 precu
CFNVNEPINAQSEGIWDSYFVYPLSWLMIYFANAFNGSFGLAIIVVTLLIRLLILPLMIK
QLKSTRAMQALQPEMQALREKYSAKDQRTQQKLQQETMALFQKHGVNPLAGCFPVLIQMP
ILLAFYHAIMRTREIGDEHFLWFVLNQPDPILLPIIAGITTFLQQKMMMVTDNPQMKVLL
YVMPVMILVFAMFLPSSLALYWVIGNLFMILQTYFITGPNVGAKKVAADVKVGGKKK
>OXA1_BACSU.1 [23,261]  Q01625 Membrane protein oxaA 1 precu
CSSVKEPITADSPHFWDKYVVYPLSELITYVAKLTGDNYGLSIILVTILIRLLILPLMIK
QLRSSKAMQALQPEMQKLKEKYSSKDQKTQQKLQQETMALFQKHGVNPLAGCFPILIQMP
ILIGFYHAIMRTQAISEHSFLWFDLGEKDPYYILPIVAGVATFVQQKLMMAGNAQQNPQM
AMMLWIMPIMIIVFAINFPAALSLYWVVGNLFMIAQTFLIKGPDIKKNPEPQKAGGKKK
>OXA1_LACLA.1 [21,269]  Q9CJ72 Membrane protein oxaA 1 precu
CGTTAVTSSSTNLWDQIVYGFAQVIRFLSFGGLTGVGIILFTIVIRAALLPLMNIQIKSS
QRMQEIQPEIKKIQAKYPSKDMESRRLMNEEIQKLYAENKVNPYMGCLPLVVQMPVLWAL
YQALSRVDFLKHGTFLWFEIGAKDPTFILPILAAVFTFLSSYLMMKSAPERNAMTTSMTY
IMPIFILIMGVNFAAGIALYWVISNAFQVFQTMLLANPYKIIAAREAKVQVEKDKIKARE
KALKKARKK
>OXA1_LACPL.1 [23,277]  Q88RX1 Membrane protein oxaA 1 precu
CSNTPITDKSTGFWDGLIILNFSRAIIWLSNLFGHSYGLGIIVFTLIIRIIILPLMIFQT
RNMVAMQEVQPQMKALQKKYSSRDMETQQKLQAEMKKLYAKHGVHPMASMLPLLVQLPIL
IALYQAIWRTQALKTGSFLWLQLGSKDPYYVLPILAAIFTFASSWLAMKSQPEQNGMTTS
MTYLMPVIILITAINVPSALSLYWVISNAFQVGQTLLLQNPFKINREREAKKQAERDRKR
TLEKARKRAIRNHKR
>OXA1_LISIN.1 [27,287]  Q926Q5 Membrane protein oxaA 1 precu
CGYSTDPITKDSTGFWSHYIVFPLSWVITWFSDLFGGNYAVGIIVVTILIRLLIMPLMIK
QLKSQKAMTSLQPKIKELQEKYSSKDNETKQKLQQETMRLYQENSVNPMMGCLPLLIQMP
ILLGFYQAISRTAEIKTDTFLWMQLGNPDPYYILPIVAALTTFLSSKISMMGQTQQNKSM
AMIVYIMPVMILFMGITLPSALALYWIIGNIFTVFQTLLINNPFKNKREQEALAAAQLEE
ERLKKKAANMKASKKGGKKRK
>OXA1_LISMO.1 [27,287]  Q8Y3I2 Membrane protein oxaA 1 precu
CGYSTDPITSESTGFWSHYIVFPLSWTITWFSDLFGGSYAVGIIVVTILIRLLIMPLMIK
QLKSQKAMTNLQPKIKELQEKYSSKDNETKQKLQQETMRLYQENSVNPMMGCLPLLIQMP
ILLGFYQAISRTAEIKTDSFLWMQLGNPDPYYILPVVAALTTFLSSKISMMGQTQQNKSM
AMIVYIMPVMILFMGITLPSALALYWIIGNIFTVFQTLLINNPFKNKREQEALAAAQVAE
DRLKKKAANMKASKKGGKKRK
>OXA1_STRA3.1 [21,271]  Q8E6W4 Membrane protein oxaA 1 precu
CGRGEVSSHSATLWEQIVYAFAKSIQWLSFNHSIGLGIILFTLIIRAIMMPLYNMQMKSS
QKMQEIQPRLKELQKKYPGKDPDSRLKLNDEMQSMYKAEGVNPYASVLPLLIQLPVLWAL
FQALTRVSFLKVGTFLSLELSQPDPYYILPVLAALFTFLSTWLTNKAAVEKNIALTLMTY
VMPFIILVTSFNFASGVVLYWTVSNAFQVFQILLLNNPYKIIKVREEAVRVAHEKEQRVK
RAKRKASKKRK
>OXA1_STRA5.1 [21,271]  Q8CX16 Membrane protein oxaA 1 precu
CGRGEVSSHSATLWEQIVYAFAKSIQWLSFNHSIGLGIILFTLIIRAIMMPLYNMQMKSS
QKMQEIQPRLKELQKKYPGKDPDNRLKLNDEMQSMYKAEGVNPYASVLPLLIQLPVLWAL
FQALTRVSFLKVGTFLSLELSQPDPYYILPVLAALFTFLSTWLTNKAAVEKNIALTLMTY
VMPFIILVTSFNFASGVVLYWTVSNAFQVFQILLLNNPYKIIKVREEAVRVAHEKEQRVK
RAKRKASKKRK
>OXA1_STRMU.1 [21,271]  Q8DVX3 Membrane protein oxaA 1 precu
CGRSQVTSHSSDAWEKFVYFFAETIRFLSINGRIGIGIILFTFLIRTILLPLFNLQLKSG
QKMQELQPELKALQTKYPGKDRESRMRMAEESQELYKKYGVNPYASLFPLLIQMPVLWAL
YQALTRVEFLKTGSFLWMDIGNKDPYFILPVLAAIFTFLSSWLTNKAAKERNGMMITMNI
ILPIFILLIGFNLASGVALYWVVSNAYQVFQILLLNNPFKIIAERQRLEDEARELEAKKR
RAKKKAHKKRK
>OXA1_STRP8.1 [26,275]  Q8P2P8 Membrane protein oxaA 1 precu
CGRGEVTAQSSSGWDQLVYLFARAIQWLSFDGSIGVGIILFTLTIRLMLMPLFNMQIKSS
QKMQDIQPELRELQKKYAGKDTQTRMKLAEESQALYKKYGVNPYASLLPLLIQMPVMIAL
FQALTRVSFLKTGTFLWVELAQHDHLYLLPVLAAVFTFLSTWLTNLAAKEKNVMMTVMIY
VMPLMIFFMGFNLASGVVLYWTVSNAFQVVQLLLLNNPFKIIAERQRLANEEKERRLRER
RARKKAMKRK
>OXA1_STRPN.1 [21,274]  Q97NI6 Membrane protein oxaA 1 precu
CATNGVTSDITAESADFWSKLVYFFAEIIRFLSFDISIGVGIILFTVLIRTVLLPVFQVQ
MVASRKMQEAQPRIKALREQYPGRDMESRTKLEQEMRKVFKEMGVRQSDSLWPILIQMPV
ILALFQALSRVDFLKTGHFLWINLGSVDTTLVLPILAAVFTFLSTWLSNKALSERNGATT
AMMYGIPVLIFIFAVYAPGGVALYWTVSNAYQVLQTYFLNNPFKIIAEREAVVQAQKDLE
NRKRKAKKKAQKTK
>OXA1_STRPY.1 [26,275]  Q9A1J3 Membrane protein oxaA 1 precu
CGRGEVTAQSSSGWDQLVYLFARAIQWLSFDGSIGVGIILFTLTIRLMLMPLFNMQIKSS
QKMQDIQPELRELQRKYAGKDTQTRMKLAEESQALYKKYGVNPYASLLPLLIQMPVMIAL
FQALTRVSFLKTGTFLWVELAQHDHLYLLPVLAAVFTFLSTWLTNLAAKEKNVMMTVMIY
VMPLMIFFMGFNLASGVVLYWTVSNAFQVVQLLLLNNPFKIIAERQRLANEEKERRLRER
RARKKAMKRK
>OXA1_STRR6.1 [23,276]  Q8DN93 Membrane protein oxaA 1 precu
CATNGVTSDITAESADFWSKLVYFFAEIIRFLSFDISIGVGIILFTVLIRTVLLPVFQVQ
MVASRKMQEAQPRIKALREQYPGRDMESRTKLEQEMRKVFKEMGVRQSDSLWPILIQMPV
ILALFQALSRVDFLKTGHFLWINLGSVDTTLVLPILAAVFTFLSTWLSNKALSERNGATT
AMMYGIPVLIFIFAVYAPGGVALYWTVSNAYQVLQTYFLNNPFKIIAEREAVVQAQKDLE
NRKRKAKKKAQKTK
>OXA2_BACAN.1 [23,260]  Q81XH4 Membrane protein oxaA 2 precu
CSNATPIDAHSTGIWDHYFVYPISFMIQFVAHHIPGASFGIAIIIMTLVIRSAMIPLAVS
QYRSQAKMKKMQPELQKLKQKYGDVSKDLEKQKQYQKEMSELMKSGGWNPLAGCWPLLIQ
MPIFSALYYAISRTEEIRTSTFLWVNLGHADPYHILPIIAALTTFIQMKVFQSNSTSGEQ
VQMLKMQQIMMPAMILFMGFAAPSGLVLYWITGNLFTMMQTIVLRKIMEREELQLQKA
>OXA2_BACCR.1 [23,260]  Q815V9 Membrane protein oxaA 2 precu
CSNAAPIDAHSTGIWDHYFVYPISFMIQFVAHHIPGASFGIAIIIMTLVIRSAMIPLAVS
QYRSQAKMKKMQPELQKLKKKYGDVSKDLEKQKQYQKEMSELMKSGGWNPLAGCWPLLIQ
MPIFSALYYAISRTEEIRTSSFLWVNLGHADPYHILPIIAALTTFIQMKVFQSNITPGEQ
VQMLKMQQIMMPAMILFMGFAAPSGLVLYWITGNLFTMTQTIVLRKIMEREELQLQKA
>OXA2_BACHD.1 [23,280]  Q9KDP2 Membrane protein oxaA 2 precu
CSTTDPITSESEGIWNHFFVYPMSWLITTVANLLNGSYGLSIIIVTILIRLALLPLTLKQ
QKSMRAMQVIRPEMEAIQKKYKEKGSKDPKVQQEMQKELLGLYQKHGVNPMAGCLPLFIQ
LPILMAFYFAIMRTEEIRYHTFLWFDLGQPDYILPFVAGITTYFQFKMTMSHQQQMQKTN
PSDSDNPMANMMQMQMKVMLYVMPVMIIIAGLSLPSALSLYWVIGNIFMIIQTYFIVVKA
PPLEVEQTKQKSSKPNKA
>OXA2_BACSU.1 [19,275]  P54544 Membrane protein oxaA 2 precu
CSGNAAFAATNQVGGLSNVGFFHDYLIEPFSALLKGVAGLFHGEYGLSIILVTIIVRIVV
LPLFVNQFKKQRIFQEKMAVIKPQVDSIQVKLKKTKDPEKQKELQMEMMKLYQEHNINPL
AMGCLPMLIQSPIMIGLYYAIRSTPEIASHSFLWFSLGQSDILMSLSAGIMYFVQAYIAQ
KLSAKYSAVPQNPAAQQSAKLMVFIFPVMMTIFSLNVPAALPLYWFTSGLFLTVQNIVLQ
MTHHKSKKTAALTESVK
>OXA2_LACLA.1 [24,320]  Q9CHZ9 Membrane protein oxaA 2 precu
CVQTHVVDGVRVPTEAATHGITYNFLVRPMSAFVDLFANNLHMGYGWGIIFVTLIIRFLI
LPLGLNQAYKSTYMQEKMAYLAPVFAPLQERLKKAQTPEEKMAAQQALMAAQKDNGINML
SSIGCLPMLIQWPFFIALYNAAAYTTGISSSTFYGIPLGHPSVVLVIISGVLYFIQTWIS
TLSMTPEQKKSGMAMLIMSPAMIVVFSFMSPAGVALYWAVGGFVIVIQQIIITFIMKPRM
RRRIDEEFTKNPPKINNEGLKDVTPTSVQENFKEITSERNEKERKSGGRNAGKQNRK
>OXA2_LACPL.1 [23,307]  Q88WR8 Membrane protein oxaA 2 precu
CVQTTKAGKPYGFVYEYLAKPGQNVMEWLSQLFGNNYGWAIIGLTVIVRLVLLPMMINQQ
RKSTYQQEKMSAVRPQMEKIQARQKAATTQEEKAAISNELMQLYRDNGISMTGGIGCLPL
LIQLPIFSALYYAIRYSPELSKATFMGISLGKSSLILAILAFLSYLAQGYLSMIGLPEEQ
KKTMRLMLIMSPVMILFVSMSAPAGLGLYFFVGGLFACLQTLIINFFRPRIRREVEAELK
KHPIKTPTPTQPKPINATESKPSHPRPQNNAGRGRNAGKQQRHHK
>OXA2_LISIN.1 [22,275]  Q92BX6 Membrane protein oxaA 2 precu
CSMDPSQNTDGFFSTYLIQPFTSFIMFVAKFVGGNYGIAIIITTLLIRALIMPLNLRTAK
AQMGMQSKMAVAKPEIDEIQARLKRATSKEEQANIQKEMMAVYSKYNINPIQMGCLPLLI
QMPILMAFYYAIRGSSEIASHTFLWFNLGSPDMVLAIIAGLVYLAQYFVSMIGYSPEQKK
QMKIIGLMSPIMILFVSFTAPSALALYWAVGGLFLAGQTLLTKKLYMNKHPEIKVMEQEE
KEFEQIVEEQNKEK
>OXA2_LISMO.1 [22,275]  Q8Y7A9 Membrane protein oxaA 2 precu
CSMDPSQNTDGFFSTYLIQPFTSFIMFVAKFVGGNYGIAIIITTLLIRALIMPLNLRTAK
AQMGMQSKMAVAKPEIDEIQARLKRATSKEEQATIQKEMMAVYSKYNINPMQMGCLPLLI
QMPILMAFYYAIRGSSEIASHTFLWFNLGSPDMVLAIIAGLVYLAQYFVSMIGYSPEQKK
QMKIIGLMSPIMILFVSFTAPSALALYWAVGGLFLAGQTLLTKKLYMNKHPEIKVMEQEE
KEFEQIVEEQKKEK
>OXA2_STRA3.1 [24,310]  Q8E3U9 Membrane protein oxaA 2 precu
CVSVDKAGKPYGVIWNTLGVPMANLITYFAQHQGLGFGVAIIIVTIIVRVIILPLGLYQS
WKASYQAEKMAYFKPLFEPINERLRNAKTQEEKLAAQTELMTAQRENGLSMFGGIGCLPL
LIQMPFFSAIFFAARYTPGVSSATFLGLNLGQKSLTLTVIIAILYFVQSWLSMQGVPDEQ
RQQMKTMMYVMPIAMVFMSISLPASVALYWFIGGIFSIIQQLVTTYVLKPKLRRKVEEEY
TKNPPKAYKSNNARKDVTSSTKTTESNQAIITSKKTNRNAGKQKRRG
>OXA2_STRA5.1 [24,310]  Q8DY84 Membrane protein oxaA 2 precu
CVSVDKAGKPYGVIWNTLGVPMANLITYFAQHQGLGFGVAIIIVTVIVRVVILPLGLYQS
WKASYQAEKMAYFKPLFEPINERLRNAKTQEEKLAAQTELMTAQRENGLSMFGGIGCLPL
LIQMPFFSAIFFAARYTPGVSSATFLGLNLGQKSLTLTVIIAILYFVQSWLSMQGVPDEQ
RQQMKTMMYLMPIMMVFMSISLPASVALYWFIGGIFSIIQQLVTTYVLKPKLRRKVEEEY
TKNPPKAYKANNARKDVTNSTKATESNQAIITSKKTNRNAGKQKRRG
>OXA2_STRMU.1 [24,310]  Q8DSP8 Membrane protein oxaA 2 precu
CVQMKNGKPTGEGWVYKFFAAPMGSVIQYLANNLGLGFGFAIIIVTVIVRLLILPLGLSQ
VRKMTYQSEKMAYLKPVFDPIQERMKNAKTQEEKMAAQTELMQAQRHYGMSMFGGLGCLP
LLIQMPFFSALYISTRYTKGIASASFLGIKLGSPNMIITVIIGILYLVQSWVSTLSVPEA
QRQQTRNMMFMMPIMMVMISIGAPAGGALYWLVSGIFGLIQQLITNHIIKPKLRKQIDEE
FKKNPPKPFKSNARKDITPQANNDKKLITSKKQKSNRNAGKQRHHKQ
>OXA2_STRP3.1 [24,307]  Q8K8J2 Membrane protein oxaA 2 precu
CVGRDAHGNPKGMIWEFLGKPMSYFIDYFANNAGLGYGLAIIIVTIIVRTLILPLGLYQS
WKASYQSEKMAFLKPVFEPINKRIKQANSQEEKMAAQTELMAAQRAHGINPLGGIGCLPL
LIQMPFFSAMYFAAQYTKGVSTSTFMGIDLGSRSLVLTAIIAALYFFQSWLSMMAVSEEQ
REQMKTMMYTMPIMMIFMSFSLPAGVGLYWLVGGFFSIIQQLITTYLLKPRLHKQIKEEY
AKNPPKAYQSTSSRKDVTPSQNMEQANLPKKIKSNRNAGKQRKR
>OXA2_STRP8.1 [24,307]  Q8P2D8 Membrane protein oxaA 2 precu
CVGRDAHGNPKGMIWEFLGKPMSYFIDYFANNAGLGYGLAIIIVTIIVRTLILPLGLYQS
WKASYQSEKMTFLKPVFEPINKRIKQASSQEEKMAAQTELMAAQRAHGINPLGGIGCLPL
LIQMPFFSAMYFAAQYTKGVSTSTFMGIDLGSRSLVLTAIIAALYFFQSWLSMMAVSEEQ
REQMKTMMYTMPIMMIFMSFSLPAGVGLYWLVGGFFSIIQQLITTYLLKPRLHKQIKEEY
AKTPPKAYQSTSSRKDVTPSQNMEQANLPKKIKSNRNAGKQRKR
>OXA2_STRPN.1 [23,308]  Q97NP5 Membrane protein oxaA 2 precu
CVNVDKTTGQPTGFIWNTIGAPMAEAIKYFATDKGLGFGVAIIIVTIIVRLIILPLGIYQ
SWKATLHSEKMNALKHVLEPHQTRLKEATTQEEKLEAQQALFAAQKEHGISMFGGVGCFP
ILLQMPFFSAIYFAAQHTEGVAQASYLGIPLGSPSMILVACAGVLYYLQSLLSLHGVEDE
MQREQIKKMIYMSPLMIVVFSLFSPASVTLYWVVGGFMMILQQFIVNYIVRPKLRKKVRE
ELAKNPPKASAFSKPSGRKDVTPEQPTAITSKKKHKNRNAGKQRSR
>OXA2_STRPY.1 [24,307]  Q9A1C3 Membrane protein oxaA 2 precu
CVGRDAHGNPKGMIWEFLGKPMSYFIDYFANNAGLGYGLAIIIVTIIVRTLILPLGLYQS
WKASYQSEKMAFLKPVFEPINKRIKQANSQEEKMAAQTELMAAQRAHGINPLGGIGCLPL
LIQMPFFSAMYFAAQYTKGVSTSTFMGIDLGSRSLVLTAIIAALYFFQSWLSMMAVSEEQ
REQMKTMMYTMPIMMIFMSFSLPAGVGLYWLVGGFFSIIQQLITTYLLKPRLHKQIKEEY
AKNPPKAYQSTSSRKDVTPSQNMEQANLPKKIKSNRNAGKQRKR
>OXA2_STRR6.1 [23,308]  Q8DNE1 Membrane protein oxaA 2 precu
CVNVDKTTGQPTGFIWNTIGAPMAEAIKYFATDKGLGFGVAIIIVTIIVRLIILPLGIYQ
SWKATLHSEKMNALKHVLEPHQTRLKEATTQEEKLEAQQALFAAQKEHGISMFGGVGCFP
ILLQMPFFSAIYFAAQHTEGVAQASYLGIPLGSPSMILVACAGVLYYLQSLLSLHGVEDE
MQREQIKKMIYMSPLMIVVFSLFSPASVTLYWVVGGFMMILQQFIVNYIVRPKLRKKVHE
ELAKNPSKASAFSTPSGRKDVTPEQPTAITSKKKHKNRNAGKQRSR
>OXAA_BACPF.1 [20,108]  O87567 Membrane protein oxaA precurs
CGANGQPITAETEGIWNHFFVYPLSWVLISVADLLNGSFGLSIIVVTIGIRLFLLPLMIK
QQKSSRAMQALRPEMEALQKKYGQGTKRD
>OXAA_ENTFA.1 [23,275]  Q82YV1 Membrane protein oxaA precurs
CGTAPVSESSTGIWDRYIVYYFAQAIKFLSLGGSVGIGIILFTLVIRIILLPLMHFQTKS
MRKTQELQPQLKALQQKYSSKDPETQRLFREEQQRLYAENNVNPYIGCLPLLVQLPIMMA
LYQAISRVPELKEGTFLWLSLDKPDPYLILPILAAVFTFASTYLSSMSQLETNASLKIMN
YVMPAMIFFMGISLASSLSLYWVVSNAFQTGQTLLLNNPFKIRKEREEAARQAKARERAL
ERAKSPKKKGKKK
>OXAA_OCEIH.1 [21,252]  Q8EKU1 Membrane protein oxaA precurs
CTEINEPITPNSDGIWNTIFVYPVSWLITNVAGVFNEGYGLAIIIVTLFVRLLLMPLNVK
QIKSSKAMQEIQPKLQEIQKKYTSKDANTQQKLQQETMELFQKNGVNPLAGCLPILVQMP
IFVAMYHAIMRTPEISTHSFLWFQLGSPDYILPILTGLFTFLQQKLMMSTNTSMNSNPQM
KLQMQIMLYVMPIMIGVMAFFFPAALALYWVTGNIFMVFQTLLINKPMMAKK
>OXAA_STAAM.1 [20,290]  Q99SG7 Membrane protein oxaA precurs
CDYSKPEKRSGFFYNTFVDPMKNVLDWLGNNLLNDNYGLAIIILVLVIRIILLPFMLSNY
KNSHMMRQKMKVAKPEVEKIQEKVKRARTQEEKMAANQELMQVYKKYDMNPIKSMLGCLP
MLIQLPIIMGLYFVLKDQLVDGLFKYPHFLWFDLGRPDIWITIIAGVLYFIQAYVSSKTM
PDEQRQMGYMMMVISPIMIIWISLSSASALGLYWSVSAAFLVVQTHFANIYYEKVAKKEV
QPFIEAYEREHNGGSNKKGKNTQVVSKKKKK
>OXAA_STACA.1 [20,225]  Q9RGS4 Membrane protein oxaA precurs
CDYSKPENRTGFFYNTFVKNMDNIIHWLGASFNNDYGLAIIVLVLAIRIIVLPFMLSNYK
NSHMMREKMIIAKPDMDAVKEKVQRARTQEDKMAANQEMMEVYKKYDMNPMQSMLGCLPM
LIQMPIIMGLFFVLKYPSPGGITEHSHFLWFNLAKPDIWITVIAGVLYFLQAYVSTFSMP
PEQKQMSYMMMIISPIMIIWVSLTSA
>P1P_LACLC.1 [34,1902]   P16271 PI-type proteinase precursor
AISQQTKGSSLANTVTAATAKQAATDTTAATTNQAIATQLAAKGIDYNKLNKVQQQDIYV
DVIVQMSAAPASENGTLRTDYSSTAEIQQETNKVIAAQASVKAAVEQVTQQTAGESYGYV
VNGFSTKVRVVDIPKLKQIAGVKTVTLAKVYYPTDAKANSMANVQAVWSNYKYKGEGTVV
SVIDSGIDPTHKDMRLSDDKDVKLTKSDVEKFTDTAKHGRYFNSKVPYGFNYADNNDTIT
DDTVDEQHGMHVAGIIGANGTGDDPAKSVVGVAPEAQLLAMKVFTNSDTSATTGSSTLVS
AIEDSAKIGADVLNMSLGSDSGNQTLEDPELAAVQNANESGTAAVISAGNSGTSGSATEG
VNKDYYGLQDNEMVGTPGTSRGATTVASAENTDVITQAVTITDGTGLQLGPGTIQLSSND
FTGSFDQKKFYVVKDASGNLSKGALADYTADAKGKIAIVKRGELSFDDKQKYAQAAGAAG
LIIVNNDGTATPVTSMALTTTFPTFGLSSVTGQKLVDWVTAHPDDSLGVKIALTLVPNQK
YTEDKMSDFTSYGPVSNLSFKPDITAPGGNIWSTQNNNGYTNMSGTSMASPFIAGSQALL
KQALNNKNNPFYAYYKQLKGTALTDFLKTVEMNTAQPINDINYNNVIVSPRRQGAGLVDV
KAAIDALEKNPSTVVAENGYPAVELKDFTSTDKTFKLTFTNSTTHELTYQMDSNTDTNAV
YTSATDPNSGVLYDKKIDGAAIKAGSNITVPAGKTAQIEFTLSLPKSFDQQQFVEGFLNF
KGSDGSRLNLPYMGFFGDWNDGKIVDSLNGITYSPAGGNFGTVPLLTNKNTGTQYYGGMV
TDADGNQTVDDQAIAFSSDKNALYNDISMKYYLLRNISNVQVDILDGQGNKVTTLSSSTN
LTKTYYNAHSQQYIYYNAPAWDGTYYDQRDGNIKTADDGSYTYRISGVPEGGDKRQVFDV
PFKLDSKAPTVRHVALSAKTENGKTQYYLTAEAKDDLSGLDATKSVKTAINEVTNLDATF
TDAGTTADGYTKIETPLSDEQAQALGNGDNSAELYLTDNASNATDQDASVQKPGSTSFDL
IVNGGGIPDKISSTTTGYEANTQGGGTYTFSGTYPAAVDGTYTNAQGKKHDLNTTYDAAT
NSFTASMPVTNADYAAQVDLYADKAHTQLLKHFDTKVRLTAPTFTDLKFNNGSDQTSEAT
IKVTGTVSADTKTVNVGDTVAALDAQHHFSVDVPVNYGDNTIKVTATDEDGNTTTEQKTI
TSSYDPDMLKNSVTFDQGVTFGANEFNATSAKFYDPKTGIATITGKVKHPTTTLQVDGKQ
IPIKDDLTFSFTLDLGTLGQKPFGVVVGDTTQNKTFQEALTFILDAVAPTLSLESSTDAP
VYTNDPNFQITGTATDNAQYLSLSINGSSVASQYVDININSGKPGHMAIDQPVKLLEGKN
VLTVAVTDSEDNTTTKNITVYYEPKKTLAAPTVTPSTTEPAKTVTLTANSAATGETVQYS
ADGGKTYQDVPAAGVTVTANGTFKFKSTDLYGNESPAVDYVVTNIKADDPAQLQAAKQEL
TNLIASAKTLSASGKYDDATTTALAAATQKAQTALDQTNASVDSLTGANRDLQTAINQLA
AKLPADKKTSLLNQLQSVKAALGTDLGNQTDPSTGKTFTAALDDLVAQAQAGTQTDDQHQ
ATLAKVLDAVLAKLAEGIKAATPAEVGNAKDAATGKTWYADIADTLTSGQASADASDKLA
HLQALQSLKTKVAAAVEAAKTVGKGDGTTGTSDKGGGQGTPAPAPGDIGKDKGDEGSQPS
SGGNIPTNPATTTSTSTDDTTDRNGQLTSGKGALPKTGETTERPAFGFLGVIVVILMGVL
GLKRKQREE
>P2P_LACLC.1 [34,1902]   P15293 PII-type proteinase precurso
AISQQTKGSSLANTVTAATAKQAATDTTAATTNQAIATQLAAKGIDYNKLNKVQQQDIYV
DVIVQMSAAPASENGTLRTDYSSTAEIQQETNKVIAAQASVKAAVEQVTQQTAGESYGYV
VNGFSTKVRVVDIPKLKQIAGVKTVTLAKVYYPTDAKANSMANVQAVWSNYKYKGEGTVV
SVIDSGIDPTHKDMRLSDDKDVKLTKSDVEKFTDTAKHGRYFNSKVPYGFNYADNNDTIT
DDTVDEQHGMHVAGIIGANGTGDDPAKSVVGVAPEAQLLAMKVFTNSDTSATTGSATLVS
AIEDSAKIGADVLNMSLGSDSGNQTLEDPELAAVQNANESGTAAVISAGNSGTSGSATEG
VNKDYYGLQDNEMVGTPGTSRGATTVASAENTDVITQAVTITDGTGLQLGPETIQLSSND
FTGSFDQKKFYVVKDASGNLSKGKVADYTADAKGKIAIVKRGELTFADKQKYAQAAGAAG
LIIVNNDGTATPVTSMALTTTFPTFGLSSVTGQKLVDWVAAHPDDSLGVKIALTLVPNQK
YTEDKMSDFTSYGPVSNLSFKPDITAPGGNIWSTQNNNGYTNMSGTSMASPFIAGSQALL
KQALNNKNNPFYAYYKQLKGTALTDFLKTVEMNTAQPINDINYNNVIVSPRRQGAGLVDV
KAAIDALEKNPSTVVAENGYPAVELKDFTSTDKTFKLTFTNRTTHELTYQMDSNTDTNAV
YTSATDPNSGVLYDKKIDGAAIKAGSNITVPAGKTAQIEFTLSLPKSFDQQQFVEGFLNF
KGSDGSRLNLPYMGFFGDWNDGKIVDSLNGITYSPAGGNFGTVPLLTNKNTGTQYYGGMV
TDADGNQTVDDQAIAFSSDKNALYNDISMKYYLLRNISNVQVDILDGQGNKVTTLSSSTN
RKKTYYNAHSQQYIYYHAPAWDGTYYDQRDGNIKTADDGSYTYRISGVPEGGDKRQVFDV
PFKLDSKAPTVRHVALSAKTENGKTQYYLTAEAKDDLSGLDATKSVKTAINEVTNLDATF
TDAGTTADGYTKIETPLSDEQAQALGNGDNSAELYLTDNASNATDQDASVQKPGSTSFDL
IVNGGGIPDKISSTTTGYEANTQGGGTYTFSGTYPAAVDGTYTDAQGKKHDLNTTYDAAT
NSFTASMPVTNADYAAQVDLYADKAHTQLLKHFDTKVRLTAPTFTDLKFNNGSDQTSEAT
IKVTGTVSADTKTVNVGDTVAALDAQHHFSVDVPVNYGDNTIKVTATDEDGNTTTEQKTI
TSSYDPDMLKNSVTFDQGVTFGANEFNATSAKFYDPKTGIATITGKVKHPTTTLQVDGKQ
IPIKDDLTFSFTLDLGTLGQKPFGVVVGDTTQNKTFQEALTFILDAVAPTLSLDSSTDAP
VYTNNPNFQITGTATDNAQYLSLSINGSSVASQYVDININSGKPGHMAIDQPVKLLEGKN
VLTVAVTDSEDNTTTKNITVYYEPKKTLAAPTVTPSTTEPAKTVTLTANSAATGETVQYS
ADGGKTYQDVPAAGVTVTANGTFKFKSTDLYGNESPAVDYVVTNIKADDPAQLQAAKQEL
TNLIASAKTLSASGKYDDATTTALAAATQKAQTALDQTNASVDSLTGANRDLQTAINQLA
AKLPADKKTSLLNQLQSVKAALETDLGNQTDSSTGKTFTAALDDLVAQAQAGTQTDDQLQ
ATLAKVLDAVLAKLAEGIKAATPAEVGNAKDAATGKTWYADIADTLTSGQASADASDKLA
HLQALQSLKTKVAAAVEAAKTVGKGDGTTGTSDKGGGQGTPAPTPGDIGKDKGDEGSQPS
SGGNIPTNPATTTSTSTDDTTDRNGQLTSGKGALPKTGETTERPAFGFLGVIVVSLMGVL
GLKRKQREE
>P2P_LACPA.1 [34,1902]   Q02470 PII-type proteinase precurso
AISQQTKVSSLANTVKAATAKQAATDTTAATTNQAIATQLAAKGIDYNKLNKVQQQDTYV
DVIVQMSAAPASENGTLRTDYSSTAEIQQETNKVIAAQASVKAAVEQVTQQTAGESYGYV
VNGFSTKVRVVDIPKLKQIAGVKTVTLAKVYYPTDAKANSMANVQAVWSNYKYKGEGTVV
SVIDTGIDPTHKDMRLSDDKDVKLTKYDVEKFTDTAKHGRYFTSKVPYGFNYADNNDTIT
DDTVDEQHGMHVAGIIGANGTGDDPTKSVVGVAPEAQLLAMKVFTNSDTSATTGSATLVS
AIEDSAKIGADVLNMSLGSDSGNQTLEDPEIAAVQNANESGTAAVISAGNSGTSGSATQG
VNKDYYGLQDNEMVGTPGTSRGATTVASAENTDVISQAVTITDGKDLQLGPETIQLSSND
FTGSFDQKKFYVVKDASGDLSKGAAADYTADAKGKIAIVKRGELNFADKQKYAQAAGAAG
LIIVNNDGTATPLTSIRLTTTFPTFGLSSKTGQKLVDWVTAHPDDSLGVKIALTLLPNQK
YTEDKMSDFTSYGPVSNLSFKPDITAPGGNIWSTQNNNGYTNMSGTSMASPFIAGSQALL
KQALNNKNNPFYADYKQLKGTALTDFLKTVEMNTAQPINDINYNNVIVSPRRQGAGLVDV
KAAIDALEKNPSTVVAENGYPAVELKDFTSTDKTFKLTFTNRTTHELTYQMDSNTDTNAV
YTSATDPNSGVLYDKKIDGAAIKAGSDITVPAGKTAQIEFTLSLPKSFDQQQFVEGFLNF
KGSDGSRLNLPYMGFFGDWNDGKIVDSLNGITYSPAGGNYGTVPLLTNKNTGHQYYGGMV
TDADGKQTVDDQAIAFSSDKNALYNDISMQYYLLRNISNVQVDILDGQGNKVTTLSSSTN
QTKTYYDAHSQKYIYYNAPAWDGTYYDQRDGNIKTADDGSYTYRISGVPEGGDKRQVFDV
PFKLDSKAPTVRHVALSAKTENGKTQYYLTAEAKDDLSGLDATKSVKTAINEVTNLDATF
TDAGTTADGYTKIETPLSDEQAQALGNGDNSAELYLTDNASNATNQDASVQKPGSTSFDL
IVNGGGIPDKISSTTTGYEANTQGGGTYTFSGTYPAAVDGTYTDAQGKKHDLNTTYDAAT
NSFTASMAVTNADYAAQVDLYADKAHTQLLKHFDTKVRLTAPTFTDLKFNNGSDQTSEAT
IKVTGTVSSDTKTVNVGDTVAALDAQHHFSVDVPVNYGDNTIKVTATDEDGNTTTEQKTI
TSSYDPDVLKNAVTFDQGVKFGANEFNATSAKFYDPKTGIATITGKVKHPTTTLQVDGKQ
ISIKNDLTFSFTLDLGTLGQKPFGVVVGDTTQNKTFQEALTFILDAVAPTLSLDSSTDAP
VYTNDPNFQITGTATDNAQYLSLAINGSHVASQYADININSGKPGHMAIDQPVKLLEGKN
VLTVAVTDSENNTTTKKITVYYEPKKTLAAPTVTPSTTEPAKTVTLTANAAATGETVQYS
ADGGKTYQDVPAAGVTVTANGTFKFKSTDLYGNESPAVDYVVTNIKADDPAQLQTAKQAL
TNLIASAKTLSASGKYDDATTTALAAATQKAQTALDQTDASVDSLTGANRDLQTAINQLA
AKLPADKKTSLLNQLQSVKAALGTDLGNQTDPSTGKTFTAALDDLVAQAQAGTQTADQLQ
ASLAKVLDAVLAKLAEGIKAATPAEVGNAKDAATGKTWYADIADTLTSGQASADASDKLA
HLQALQSLKTKVAAAVEAAKTAGKGDDTTGTSDKGGGQGTPAPAPGDTGKDKGDEGSQPS
SGGNIPTKPATTTSTSTDDTTDRNGQHTSGKGALPKTAETTERPAFGFLGVIVVSLMGVL
GLKRKQREE
>P33_MYCPE.1 [31,376]   Q50368 Lipoprotein p33 precursor. - 
CSSTDNNGGTGDNNTGGGGSGTDQQQGTTYTPAIKSDVTLSGALSKIYDTTNTGDSRKNT
NTLIAEDIKANPENYFTNGEDLKKVEGWSVTVDGSFDSNSVWTGDAYSKWSAVADTHKGV
YKSTSKQLNINSLKDLKSQLDTSAKIKAICDESNLVFSTADADSYKIQNELGFTGGDLLH
INVTATQAGKTLNMDLGIPVSDLNLKITDLKVSVTASNNSTGNNVAAVSDLTTNFTYNIG
IKEEVTAPTEKPNLAKTDKGEVMKVLKALGYTQTGDETKLDNDKVSNSLGLYNCEFTAVS
ATPVEGSEDKFTIKLKAKPLTDYVWEDGTNTEKEISFEATFTMTGN
>P35_MYCPE.1 [31,362]   Q50367 Lipoprotein p35 precursor. - 
CSSTSENNGNGNGNGGTDGNTQQTEVTPAIKSEVSLTGALSKIYDTKTGTDRETTSQLIV
KDIKANPENYFTNGEALKDVIASATVTVDGGFTESTFTGEAYSVWSAKADVKKGTYSQAS
KQLDIKSINDLQTVLGDSAAIKGICDLIPNLKLNNGTDYKVTNNGLSLSEDLLHINVTAK
DGQTDVSMDLAIPVSDLNLKIDGLKISVSGTGIKTSELTTNYKFNIGIDNTVKTLTPAAV
TLAEADRTNAEKVLEKLGYATVSGSTYTLDQDKLADALGLYNCKFEAVKSEKDSTNNNKY
TVTLKATPNDGYFWEDGTNGAKEDISFVATFS
>P37_MYCGE.1 [26,368]   Q49410 High affinity transport syste
CATKSDNTLIFNISLDHNADTSIEKFFTVFSKKLSGKLNKKINVNFNIVDDSFTKINNIQ
ANKADFAFVNSQAIASNNWFGYTPLIQTLTTAFKEDLELDYYEDGNLQKKAEKTNLLFLS
PPYKEWDDIKQKWTGNRYDFLYEPSKLVSFYRSMILITGSASEITAIKKAWNEKNWNQFM
KFGIGHGQTNSASRFELPDLLFRKHFAKNYPGLQNAINSDPDKFAVVRGREIGINKNIKI
VFDDANSFSWTQNIKGSKRPFYTPIDPNDRLEILTYSDPLLYDIGIVSNNLSRIYQKAIG
EIFIELAQSSEDLYGPSIGYNGYKMINDFEKEVVEIIEKTYGK
>P37_MYCHR.1 [24,403]   P15363 High affinity transport syste
CSNTGVVKQEDVSVSQGQWDKSITFGVSEAWLNKKKGGEKVNKEVINTFLENFKKEFNKL
KNANDKTKNFDDVDFKVTPIQDFTVLLNNLSTDNPELDFGINASGKLVEFLKNNPGIITP
ALETTTNSFVFDKEKDKFYVDGTDSDPLVKIAKEINKIFVETPYASWTDENHKWNGNVYQ
SVYDPTVQANFYRGMIWIKGNDETLAKIKKAWNDKDWNTFRNFGILHGKDNSFSKFKLEE
TILKNHFQNKFTTLNEDRSAHPNAYKQKSADTLGTLDDFHIAFSEEGSFAWTHNKSATKP
FETKANEKMEALIVTNPIPYDVGVFRKSVNQLEQNLIVQTFINLAKNKQDTYGPLLGYNG
YKKIDNFQKEIVEVYEKAIK
>P37_MYCPN.1 [27,380]   P75371 High affinity transport syste
CARRESNHLIFNISLDHDADASISKFFELYSNNLSKKLDKKVTVSFNIIDDSFTKISNIQ
TAKADFAFVNSQSIKDNGIEEFNLILQTQTDAFKEDTNLDYYSDGQLKSKAEKMTTLFSK
TPYKDWEDTAQQWTGSRYNFLYETNKLINFYRGMILITGSEEEIKKIKEAWDQKKWSDFM
NYGIGHGSSGSAGKFQLPDLLLRKHFGSSYPGLQNAINQNPDKFANVRGREIGRDNKIKI
VFDDANSFAWTHNDKNATNHFYTPTENNGKGDSEKSNNKNNKVEILTYTDPMLYDIGIVS
DTLSDRYQKAIAEVFVELAKTKQDIYGPSYGYNGYNLITDPNKEILDVIHKTYG
>P3P_LACLC.1 [34,1902]   P15292 PIII-type proteinase precurs
AISQQTKGSSLANTVTAATAKQAATDTTAATTNQAIATQLAAKGIDYNKLNKVQQQDIYV
DVIVQMSAAPASENGILRTDYSSTAEIQQETNKVIAAQASVKAAVEQVTQQTAGESYGYV
VNGFSTKVRVVDIPKLKQIAGVKTVTLAKVYYPTDAKANSMANVQAVWSNYKYKGEGTVV
SVIDSGIDPTHKDMRLSDDKDVKLTKSDVEKFTDTVKHGRYFNSKVPYGFNYADNNDTIT
DDKVDEQHGMHVAGIIGANGTGDDPAKSVVGVAPEAQLLAMKVFSNSDTSAKTGSATVVS
AIEDSAKIGADVLNMSLGSNSGNQTLEDPELAAVQNANESGTAAVISAGNSGTSGSATEG
VNKDYYGLQDNEMVGSPGTSRGATTVASAENTDVITQAVTITDGTGLQLGPETIQLSSHD
FTGSFDQKKFYIVKDASGNLSKGALADYTADAKGKIAIVKRGEFSFDDKQKYAQAAGAAG
LIIVNTDGTATPMTSIALTTTFPTFGLSSVTGQKLVDWVTAHPDDSLGVKITLAMLPNQK
YTEDKMSDFTSYGPVSNLSFKPDITAPGGNIWSTQNNNGYTNMSGTSMASPFIAGSQALL
KQALNNKNNPFYAYYKQLKGTALTDFLKTVEMNTAQPINDINYNNVIVSPRRQGAGLVDV
KAAIDALEKNPSTVVAENGYPAVELKDFTSTDKTFKLTFTNRTTHELTYQMDSNTDTNAV
YTSATDPNSGVLYDKKIDGAAIKAGSNITVPAGKTAQIEFTLSLPKSFDQQQFVEGFLNF
KGSDGSRLNLPYMGFFGDWNDGKIVDSLNGITYSPAGGNFGTVPLLKNKNTGTQYYGGMV
TDADGNKTVDDQAIAFSSDKNALYNDISMKYYLLRNISNVQVDILDGQGNKVTTLSSSTN
RKKTYYNAHSQQYIYYNAPAWDGTYYDQRDGNIKTADDGSYTYRISGVPEGGDKRQVFDV
PFKLDSKAPTVRHVALSAKTENGKTQYYLTAEAKDDLSGLDATKSVKTEINEVTNLDATF
TDAGTTADGYTKIETPLSDEQAQALGNGDNSAELYLTDNASNATDQDASVQKPGSTSFDL
IVNGGGIPDKISSTTTGYEANTQGGGTYTFSGTYPAAVDGTYTDAQGKKHDLNTTYDAAT
NSFTASMPVTNADYAAQVDLYADKAHTQLLKHFDTKVRLMAPTFTDLKFNNGSDQTSEAT
IKVTGTVSADTKTVNVGHTVAALDAQHHFSVDVPVNYGDNTIKVTATDKDGNTTTEQKTI
TSSYDPDMLKKSVTFDQGVKFGTNKFNATSAKFYDPKTGIATITGKVKHPTTTLQVDGKQ
IPIKDDLTFSFTLDLGTLGQKPFGVVVGDTTQNKTFQEALSFILDAVAPTLSLDSSTDAP
VYTNDPNFQITGTATDNAQYLSLSINGSSVASQYEDININSGKPGHMAIDQPVKLLEGKN
VLTVAVTDSEDNTTTKNITVYYEPKKTLAAPTVTPSTTEPAQTVTLTANAAATGETVQYS
ADGGKTYQDVPAAGVTITANGTFKFKSTDLYGNESPAVDYVVTNIKADDPAQLQAAKQEL
TNLIASAKTLSASGKYDDATTTALAAATQKAQTALDQTNASVDSLTGANRDLQTAINQLA
AKLPADKKTSLLNQLQSVKDALGTDLGNQTDPSTGKTFTAALDDLVAQAQAGTQTDDQLQ
ATLAKILDEVLAKLAEGIKAATPAEVGNAKDAATGKTWYADIADTLTSGQASADASDKLA
HLQALQSLKTKVAAAVEAAKTVGKGDGTTGTSDKGGGQGTPAPAPGDTGKDKGDEGSQPS
SGGNIPTKPATTTSTTTDDTTDRNGQLTSGKGALPKTGETTERPAFGFLGVIVVSLMGVL
GLKRKQREE
>P46_MYCHY.1 [28,416]   P46192 46 kDa surface antigen precur
CGQTESGSTSDSKPQAETLKHKVSNDSIRIALTDPDNPRWISAQKDIISYVDETEAATST
ITKNQDAQNNWLTQQANLSPAPKGFIIAPENGSGVGTAVNTIADKGIPIVAYDRLITGSD
KYDWYVSFDNEKVGELQGLSLAAGLLGKEDGAFDSIDQMNEYLKSHMPQETISFYTIAGS
QDDNNSQYFYNGAMKVLKELMKNSQNKIIDLSPEGENAVYVPGWNYGTAGQRIQSFLTIN
KDPAGGNKIKAVGSKPASIFKGFLAPNDGMAEQAITKLKLEGFDTQKIFVTGQDYNDKAK
TFIKDGDQNMTIYKPDKVLGKVAVEVLRVLIAKKNKASRSEVENELKAKLPNISFKYDNQ
TYKVQGKNINTILVSPVIVTKANVDNPDA
>P54_ENTFC.1 [28,516]   P13692 P54 protein precursor. - Ente
DDFDSQIQQQDKKIADLQNQQASAQSQIEALEGQVSAINTKAQDLLTKQDTLRKESAQLK
QEIKDLQERIEKREATIQKQARETQVKNTSSNYIDAVLNADSLADAVGRIQAMSTIVKAN
QDLVQQQKEDKQAVEAKKAENEAKQKELADNQAALESQKGDLLAKQADLNVLKTSLAAEQ
ATAEDKKADLNRKKAEAEAEQARIREQARLAEQARQQAAQEKAEKEAREQAAAQAAQTQA
LSSASTTTESSSAAQSSSEESKAPESSTTEESTSTESSTTTENSSTGSSSTESSSTEEST
VPESSTQESTPANTESSSSSSNTNVNNNTNNSTNNSTNNSTTNNNNNNNTVTPAPTPTPT
PAPAPAPNPSGSVNGAAIVAEAYKYIGTPYVWGGKDPSGFDCSGFTRYVYLQVTGRDIGG
WTVPQESAGTKISVSQAKAGDLLFWGSAGGTYHVAISLGGGQYIHAPQPGENVKVGSVQW
YTPDFAVSM
>P60_LISGR.1 [28,511]   Q01835 Protein p60 precursor (Invasi
NTVVVASGDTLWGIASKTGTTVDQLKQLNKLDSDRIVPGQKLTIKEVAAQKVEKSVSATW
LNVRHAPDANEKILTSLKGRTVVKVESSEANGWNKISFDNGKTGYVNGKYLSDAKVAAPV
VTKAVTHKAEAKVAATSTHAVKVDTNASTYKVKSGDTIWALSVKYGVPVQKLIEWNNLSS
SSIYVGQTIAVKEAAAKAAPTTVKQAAPAKVAPKQEVKQTAPAKQEQAKPAAKETVKPAV
SKPKAATPAPTAKPAVEQKASTPAVDTNAATYKVQNGDSLGKIASLFKVSVADLTNWNNL
NATITIYAGQELSVKASAAKPKPAAPAKPAVSKPATSTPAKVTPTNTTNNSTPTTNVNNN
TSQSSSASFSALYAEAKKHLGKPYTWGARGPSTFDCSGFTSYVFNQVGLSLSGNSATQYA
NSTKISESQAQPGDLVFFNYGSGIAHVGIYIGGGQMIDAQDNGVSIDNIHGNGWGQYLVG
FGRV
>P60_LISIN.1 [28,467]   Q01836 Protein p60 precursor (Invasi
STVVVEAGDTLWGIAQSKGTTVDAIKKANNLTTDKIVPGQKLQVNEVATEEKAEKSVSAT
WLNVRSGAGVDHSILTSIKGGTKVTVETTESNGWHKITYNDGKTGYVNGKYLTDKATSTP
VVKQEVKKETTQQVKPATEAKTEVKQPTTQQTAPAPKAAETKEAPVVDQNATTHNVKSGD
TIWALSVKYGVSVQDIMSWNNLSSSSIYVGQKLAIKQPTKTVAPKAETKTQAPAAEKQTA
PAVKENSNANTATTEKKETATEQQTTTKAPTQAAKPAPAPSTNTNKTNTTNNNTNASTPS
KNTNTNTNTNTNTNTNQGSTNNASASALIAEAQKHLGKAYSWGGNGPTTFDCSGFTKYVF
AKSGISLPRTSGAQYASTTRISESQAKPGDLVFFDYGSGISHVGIYVGNGQMINAQDNGV
KYDNIHGAGWGKFLVGFGRV
>P60_LISIV.1 [28,524]   Q01837 Protein p60 precursor (Invasi
STVVVEAGDTLWGIAQDKGTTVDALKKANNLTSDKIVPGQKLQITEVASEKTEKSVTATW
LNVRSGAGVDNSIVTSLKGGTKVTVESTEANGWYKISYGEGKTGYVNGKYLGTTVTSAPA
PEVKEETTTQAQAAPAAETKPEVKQSTPATVLPKAETKTETPAVDTTASTYTVKSGDTIW
ALSSKYGTSVQNIMSWNNLSSSSIYVGQVLAVKQEAAKTASPKAEVKTEAPTAEKQVSAP
VVKENTQTTTAKKEVTPQKQTNTQAPAQAAKPAPAPAPTVNTNASSYTVKSGDTLSKIAT
TFGTTVSKIKALNGLNSDNLQVGQVLKVKGTVPTANTNSNSNATAPTTNTNNNTSNTSTS
TPSKNTNTNSNASQGSSSTASASSLIAEAQKHLGKAYSWGGNGPTTFDCSGFTKYVFAKS
GVTLPRTSGAQYASSTKISESQAKPGDLVFFDYGNGIAHVGIYVGNGQMINAQDNGVKYD
NIHGSGWGQFLVGFGRV
>P60_LISMO.1 [28,484]   P21171 Protein p60 precursor (Invasi
STVVVEAGDTLWGIAQSKGTTVDAIKKANNLTTDKIVPGQKLQVNNEVAAAEKTEKSVSA
TWLNVRSGAGVDNSIITSIKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKAVST
PVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPAPKVAETKETPVVDQNATTHAVKS
GDTIWALSVKYGVSVQDIMSWNNLSSSSIYVGQKLAIKQTANTATPKAEVKTEAPAAEKQ
AAPVVKENTNTNTATTEKKETATQQQTAPKAPTEAAKPAPAPSTNTNANKTNTNTNTNTN
TNNTNTNTPSKNTNTNSNTNTNTNSNTNANQGSSNNNSNSSASAIIAEAQKHLGKAYSWG
GNGPTTFDCSGYTKYVFAKAGISLPRTSGAQYASTTRISESQAKPGDLVFFDYGSGISHV
GIYVGNGQMINAQDNGVKYDNIHGSGWGKYLVGFGRV
>P60_LISSE.1 [28,523]   Q01838 Protein p60 precursor (Invasi
STVVVEAGDTLWGIAQDNGTTVDALKKANKLTTDKIVPGQKLQVTEVASEKTEKSVSATW
LNVRSGAGVDNSIVTSLKGGTKVTVESTEANGWNKITYGEGKTGYVNGKYLGNAVTSAPS
ATPEVKQEETTQAAPAQQTKTEVKQATPAATTEKDAVETKTTAPAVDTNATTHTVKSGDT
IWALSVKYGASVQDLMSWNNLSSSSIYVGQNIAVKQSAAKNTAPKAEAKTEAPAAEKQTA
APVVKESTNTSTTTTVKKETTTEKQTSTTKAPAQAAKPAPAPAPTVNTNASSYTVKSGDT
LGKIASTFGTTVSKIKALNGLTSDNLQVGDVLKVKGTVPATNTNTATAPTTNTNNNTSSS
NTSTPSKNNNTNQSSSNSSSASAIIAEAQKHLGKAYSWGGNGPTTFDCSGFTSYVFAQSG
ITLPRTSGAQYASTTKVSESEAQPGDLVFFDYGSGIAHVGIYVGNGQMINAQDNGVKYDN
IHGSGWGQYLVGFGRV
>P60_LISWE.1 [28,524]   Q01839 Protein p60 precursor (Invasi
STVVVEAGDTLWGIAQSKGTTVDALKKANNLTSDKIVPGQKLQVTEVASEKTEKSVSATW
LNVRSGAGVDNSIVTSLKGGTKVTVEAAESNGWNKISYGEGKTGYVNGKYLGDAVTSAPV
AKQEVKQETTKQTAPAAETKTEVKQSTPAPTAPKAAETKTAPVVDTNATTHTVKSGDTIW
ALSVKYGASVQDLMSWNNLSSSSIYVGQKIAVKQSAAKTAAPKAEVKTEAPAVEKETSTP
VVKENTNTTVKKEVTTQTQTNTTKAPAQAAKPAPAPAPAPTVNTNASTYTVKSGDSLSKI
ANTFGTSVSKIKALNNLTSDNLQVGTVLKVKGTVPTTNTNNNSNTTAPTTNTSNNNTSSN
TSTPSKNTNTNTNQGSSNSASASALIAEAQKHLGKAYSWGGNGPTTFDCSGFTSYVFAKS
GISLPRTSGAQYASTSRISESQAKPGDLVFFDYGSGIAHVGIYVGNGQMINAQDNGVKYD
NIHGSGWGKYLVGFGRV
>P72_MYCMS.1 [25,532]   P55801 Immunodominant protein p72 pr
CSTRNSNAKQPDKKPEKPNENTPKTPSKPDESKQPDNNNTNPGDSNNGSNNPEIKPDPSE
NPQSDQPMDKPDEKIDKPSHSDKPQADDSNNNRDIFSDLDKISKEISFETFSFYTQRDAV
TALVDLQKDPSTIYTIFSKDYKTIFDKYHIQFLANNEESANNEKGLIEKVKLKFTHKKFD
QSKILDFIFTGFKKNEYTSITNNKEKYITKREKVEKITDLFPSLIGYVLLYSQDHNQYKN
LMEAKNVINFEDLENGNSSLFIDKAPLLNVATIKDYLFEFNPELGKLYKEKITAVKYDDY
NGILGVKLEIENRDFDPKTTKEPIIEKEFVFDNFRKVNIKDNEKNPLSLFLTQDKFKEMT
KSGLLKTKIQELRSSNKLEKKELLQDKKIDFLKQQIFKNLLVDINDNSHNIYRSQSTLSL
GSNKTYKSILGLAGGFSIYPFHTSINKDSIKNIYLSINKDEENVHKAIIEFEVYIPVFST
GFSDLKSYATSGDEKYLVLKIVQTTSIQ
>PAB_PEPMA.1 [27,387]   Q51911 Peptostreptococcal albumin-bi
ADEPGAIKVDKAPEAPSQELKLTKEEAEKALKKEKPIAKERLRRLGITSEFILNQIDKAT
SREGLESLVQTIKQSYLKDHPIKEEKTEETPKYNNLFDKHELGGLGKDKGPGRFDENGWE
NNEHGYETRENAEKAAVKALGDKEINKSYTISQGVDGRYYYVLSREEAETPKKPEEKKPE
DKRPKMTIDQWLLKNAKEDAIAELKKAGITSDFYFNAINKAKTVEEVNALKNEILKAHAG
KEVNPSTPEVTPSVPQNHYHENDYANIGAGEGTKEDGKKENSKEGIKRKTAREEKPGKEE
KPAKEDKKENKKKENTDSPNKKKKEKAALPEAGRRKAEILTLAAASLSSVAGAFISLKKR
K
>PAC_BACME.1 [25,802]   Q60136 Penicillin G acylase precurso
GEDKNEGVKVVRDNFGVPHLYAKNKKDLYEAYGYVMAKDRLFQLEMFRRGNEGTVSEIFG
EDYLSKDEQSRRDGYSNKEIKKMIDGLDRQPKELIAKFAEGISRYVNEALKDPDDKLSKE
FHEYQFLPQKWTSTDVVRVYMVSMTYFMDNHQELKNAEILAKLEHEYGTEVSRKMFDDLV
WKNDPSAPTSIVSEGKPKRDSSSQSLQILSSAVIKASEKVGKERENFVQTSEELGLPLKI
GSNAAIVGSEKSATGNALLFSGPQVGFVAPGFLYEVGLHAPGFDMEGSGFIGYPFIMFGA
NNHFALSATAGYGNVTDIFEEKLNAKNSSQYLYKGKWRDMEKRKESFTVKGDNGEKKTVE
KIYYRTVHGPVISRDETNKVAYSKSWSFRGTEAQSMSAYMKANWAKNLKEFENAASEYTM
SLNWYYADKKGDIAYYHVGRYPVRNSKIDERIPTPGTGEYEWKGFIPFKENPHVINPKNG
YVVNWNNKPSKEWVNGEYSFYWGEDNRVQQYINGMEARGKVTLEDINEINYTASFAQLRA
NLFKQLLIDVLDKNKSTNGNYIYLIEKLEEWNNLKEDENKDGYYDAGIAAFFDEWWNNLH
DKLFMDELGDFYGITKEITDHRYGASLAYKILNKESTNYKWVNVDQEKIIMESTNEVLAK
LQSEKGLKAEKWRMPIKTMTFGEKSLIGIPHGYGSMTPIIEMNRGSENHYIEMTPTGPSG
FNITPPGQIGFVKKDGTISDHYDDQLVMFAEWKFKPYLFNKKDINKAAKNVSALNMSK
>PAC_STRMU.1 [39,1565]   P11657 Pac protein precursor. - Str
DETTTTSDVDTKVVGTQTGNPATNLPEAQGSASKEAEQSQTKLERQMVHTIEVPKTDLDQ
AAKDAKSAGVNVVQDADVNKGTVKTPEEAVQKETEIKEDYTKQAEDIKKTTDQYKSDVAA
HEAEVAKIKAKNQATKEQYEKDMAAHKAEVERINAANAASKTAYEAKLAQYQADLAAVQK
TNAANQAAYQKALAAYQAELKRVQEANAAAKAAYDTAVAANNAKNTEIAAANEEIRKRNA
TAKAEYETKLAQYQAELKRVQEANAANEADYQAKLTAYQTELARVQKANADAKATYEAAV
AANNAKNAALTAENTAIKQRNENAKATYEAALKQYEADLAAVKKANAANEADYQAKLTAY
QTELARVQKANADAKAAYEAAVAANNAANAALTAENTAIKKRNADAKADYEAKLAKYQAD
LAKYQKDLADYPVKLKAYEDEQTSIKAALAELEKHKNEDGNLTEPSAQNLVYDLEPNANL
SLTTDGKFLKASAVDDAFSKSTSKAKYDQKILQLDDLDITNLEQSNDVASSMELYGNFGD
KAGWSTTVSNNSQVKWGSVLLERGQSATATYTNLQNSYYNGKKISKIVYKYTVDPKSKFQ
GQKVWLGIFTDPTLGVFASAYTGQVEKNTSIFIKNEFTFYHEDEKPINFDNALLSVTSLN
REHNSIEMAKDYSGKFVKISGSSIGEKNGMIYATDTLNFKQGEGGSRWTMYKNSQAGSGW
DSSDAPNSWYGAGAIKMSGPNNHVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSL
NGKIRAVNVPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRTPDQA
EPNKPTPPTYETEKPLEPAPVEPSYEAEPTPPTRTPDQAEPNKPTPPTYETEKPLEPAPV
EPSYEAEPTPPTPTPDQPEPNKPVEPTYEVIPTPPTDPVYQDLPTPPSDPTVHFHYFKLA
VQPQVNKEIRNNNDINIDRTLVAKQSVVKFQLKTADLPAGRDETTSFVLVDPLPSGYQFN
PEATKAASPGFDVTYDNATNTVTFKATAATLATFNADLTKSVATIYPTVVGQVLNDGATY
KNNFTLTVNDAYGIKSNVVRVTTPGKPNDPDNPNNNYIKPTKVNKNENGVVIDGKTVLAG
STNYYELTWDLDQYKNDRSSADTIQKGFYYVDDYPEEALELRQDLVKITDANGNEVTGVS
VDNYTNLEAAPQEIRDVLSKAGIRPKGAFQIFRADNPREFYDTYVKTGIDLKIVSPMVVK
KQMGQTGGSYENQAYQIDFGNGYASNIVINNVPKINPKKDVTLTLDPADTNNVDGQTIPL
NTVFNYRLIGGIIPANHSEELFEYNFYDDYDQTGDHYTGQYKVFAKVDITLKNGVIIKSG
TELTQYTTAEVDTTKGAITIKFKEAFLRSVSIDSAFQAESYIQMKRIAVGTFENTYINTV
NGVTYSSNTVKTTTPEDPADPTDPQDPSSPRTSTVIIYKPQSTAYQPSSVQETLPNTGVT
NNAYMPLLGIIGLVTSFSLLGLKAKKD
>PAG_BACAN.1 [30,764]   P13423 Protective antigen precursor 
EVKQENRLLNESESSSQGLLGYYFSDLNFQAPMVVTSSTTGDLSIPSSELENIPSENQYF
QSAIWSGFIKVKKSDEYTFATSADNHVTMWVDDQEVINKASNSNKIRLEKGRLYQIKIQY
QRENPTEKGLDFKLYWTDSQNKKEVISSDNLQLPELKQKSSNSRKKRSTSAGPTVPDRDN
DGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVT
GRIDKNVSPEARHPLVAAYPIVHVDMENIILSKNEDQSTQNTDSQTRTISKNTSTSRTHT
SEVHGNAEVHASFFDIGGSVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTARL
NANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPIA
LNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSEV
LPQIQETTARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGNL
QYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKRFHYDR
NNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRY
DMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNG
IKKILIFSKKGYEIG
>PAM_STRPY.1 [2,388]   P49054 Plasminogen-binding protein pa
KLKTGTASVAVALTVVGAGLASQTEVKANRADDARNEVLRGNLVRAELWYRQIQENDQLK
LENKGLKTDLREKEEELQGLKDDVEKLTADAELQRLKNERHEEAELERLKSERHDHDKKE
AERKALEDKLADKQEHLNGALRYINEKEAEAKEKEAEQKKLKEEKQISDASRQGLRRDLD
ASREAKKQVEKDLANLTAELDKVKEEKQISDASRQGLRRDLDASREAKKQVEKGLANLTA
ELDKVKEEKQISDASRQGLRRDLDASREAKKQVEKALEEANSKLAALEKLNKELEESKKL
TEKEKAELQAKLEAEAKALKEQLAKQAEELAKLRAEKASDSQTPDAKPGNKAVPGKGQAP
QAGTKPNQNKAPMKETKRQLPSTGETT
>PBPD_BACSU.1 [22,624]  P40750 Penicillin-binding protein 4 
FTVIASGKEVKQMKSLDQVLDKNIDLKDISLVQNSYMYDRDGSLVSEIVSDHENRVLVPF
NKIPEEVKQIFLTSEDRHFYEHKGFDFMGMVPPTASNVKDKKIDQGASTITQQLSRNLYL
SHERSFSRKLTELAYSYQLEKKYTKNEILEAYLNTIYFNNGVYGVGSAAQFYFSKPLKSL
TVGEMAFICAIPNNPTLYDPLKHFDYTKSRQERLLKGLKDAGVITDKELKKAVKQKIKLD
VEKREDKYPDYVSYVNDEFTQLVSESEGFDKRLQKASGKQKEKIENELSARVSTLMKDGV
KIYTALDPYMQNQVVAQMNSKLPYADVQGGAAVINHQTHQIIALSGGKNYQKYDFNRAYQ
AYRQPGSSIKPLLDYGPYIEQTGATTSSTIDASKFCSKDYCPQNYNNRTYGTVTLDTAFK
NSYNTPAIRMLDRVGIQKAFSYIEPYHFAKLVDSDYLLPAALGGFTNGMTPLEMTKAYTT
FGNSGSYTPSHAITKVTDLKGKTLYKWNDKATQIFSVRTNMQLKKLMSSVVKSGTGKKAY
FNAPYIGGKTGTSNDYHDMWFVGLTDTYTMGVWVGKDTPTSVEYLHSISPQLSIWKGTLQ
AAY
>PBP_BACSU.1 [30,491]   P39844 Putative penicillin binding p
AEKQDALSGQIDKILADHPALEGAMAGITVRSAETGAVLYEHSGDTRMRPASSLKLLTAA
AALSVLGENYSFTTEVRTDGTLKGKKLNGNLYLKGKGDPTLLPSDFDKMAEILKHSGVKV
IKGNLIGDDTWHDDMRLSPDMPWSDEYTYYGAPISALTASPNEDYDAGTVIVEVTPNQKE
GEEPAVSVSPKTDYITIKNDAKTTAAGSEKDLTIEREHGTNTITIEGSVPVDANKTKEWI
SVWEPAGYALDLFKQSLKKQGITVKGDIKTGEAPSSSDVLLSHRSMPLSKLFVPFMKLSN
NGHAEVLVKEMGKVKKGEGSWEKGLEVLNSTLPEFGVDSKSLVLRDGSGISHIDAVSSDQ
LSQLLYDIQDQSWFSAYLNSLPVAGNPDRMVGGTLRNRMKGTPAQGKVRAKTGSLSTVSS
LSGYAETKSGKKLVFSILLNGLIDEEDGKDIEDQIAVILANQ
>PDAA_BACSU.1 [24,263]  O34928 Probable polysaccharide deace
VPNEPINWGFKRSVNHQPPDAGKQLNSLIEKYDAFYLGNTKEKTIYLTFDNGYENGYTPK
VLDVLKKHRVTGTFFVTGHFVKDQPQLIKRMSDEGHIIGNHSFHHPDLTTKTADQIQDEL
DSVNEEVYKITGKQDNLYLRPPRGVFSEYVLKETKRLGYQTVFWSVAFVDWKINNQKGKK
YAYDHMIKQAHPGAIYLLHTVSRDNAEALDDAITDLKKQGYTFKSIDDLMFEKEMRLPSL
>PEL_BACSU.1 [22,420]   P39116 Pectate lyase precursor (EC 4
ADLGHQTLGSNDGWGAYSTGTTGGSKASSSNVYTVSNRNQLVSALGKETNTTPKIIYIKG
TIDMNVDDNLKPLGLNDYKDPEYDLDKYLKAYDPSTWGKKEPSGTQEEARARSQKNQKAR
VMVDIPANTTIVGSGTNAKVVGGNFQIKSDNVIIRNIEFQDAYDYFPQWDPTDGSSGNWN
SQYDNITINGGTHIWIDHCTFNDGSRPDSTSPKYYGRKYQHHDGQTDASNGANYITMSYN
YYHDHDKSSIFGSSDSKTSDDGKLKITLHHNRYKNIVQRAPRVRFGQVHVYNNYYEGSTS
SSSYPFSYAWGIGKSSKIYAQNNVIDVPGLSAAKTISVFSGGTALYDSGTLLNGTQINAS
AANGLSSSVGWTPSLHGSIDASANVKSNVINQAGAGKLN
>PGDS_BACSU.1 [33,413]  P96740 Gamma-DL-glutamyl hydrolase p
DTSSELIVSEAKNLLGYQYKYGGETPKEGFDPSGLIQYVFSKADIHLPRSVNDQYKIGTA
VKPENLKPGDILFFKKEGSTGTVPTHDALYIGDGQMVHSTQSKGVIITNYKKSSYWSGTY
IGARRIAADPATADVPVVQEAEKYIGVPYVFGGSTPSEGFDCSGLVQYVFQQALGIYLPR
SAEQQWAVGEKVAPQNIKPGDVVYFSNTYKTGISHAGIYAGAGRFIQASRSEKVTISYLS
EDYWKSKMTGIRRFDNLTIPKENPIVSEATLYVGEVPYKQGGVTPETGFDTAGFVQYVYQ
KAAGISLPRYATSQYNAGTKIEKADLKPGDIVFFQSTSLNPSIYIGNGQVVHVTLSNGVT
ITNMNTSTYWKDKYAGSIRVQ
>PHL1_BACCE.1 [28,333]  P09599 Sphingomyelinase C precursor 
DTSTDQNNTLKVMTHNVYMLSTNLYPNWGQSQRADLIGAADYIKNQDVVILNEVFDNSAS
DRLLGNLKKEYPNQTAVLGRSNGNEWDKTLGSYSSSTPEDGGVAIVSKWPIVEKIQYVFA
KGCGPDNLSNKGFVYTKIKKNDRFVHVIGTHLQAEDSMCGKTSPASVRTNQLKEIQDFIK
NKNIPNDEYVLFGGDMNVNKINAENNSDSEYASMFKTLHASIPSYTGHTATWDATTNSIA
KYNFPDSPAEYLDYIIASKDHANPSFIENKVLQPKSPQWTVTSWLKKYTYDDYSDHYPVA
ATISMK
>PHL2_BACCE.1 [28,333]  P11889 Sphingomyelinase C precursor 
EASTNQNDTLKVMTHNVYMLSTNLYPNWGQTERADLIGAADYIKNQDVVILNEVFDNSAS
DRLLGNLKKEYPNQTAVLGRSSGSEWDKTLGNYSSSTPEDGGVAIVSKWPIAEKIQYVFA
KGCGPDNLSNKGFVYTKIKKNDRFVHVIGTHLQAEDSMCGKTSPASVRTNQLKEIQDFIK
NKNIPNNEYVLIGGDMNVNKINAENNNDSEYASMFKTLNASVPSYTGHTATWDATTNSIA
KYNFPDSPAEYLDYIIASKDHANPSYIENKVLQPKSPQWTVTSWFQKYTYNDYSDDYPVE
ATISMK
>PHL3_BACCE.1 [27,333]  P33377 Sphingomyelinase C precursor 
AEASTNQNDTLKVMTHNVYMLSTNLYPNWGQTERADLFGAADYIKNQDVVILNEVFDNSA
SDRLLGNLKKEYPNQTAVLGRSSGSEWDKTLGNYSSSTPEDGGVAIVSKWPIAEKIQYVF
AKGCGPDNLSNKGFVYTKIKKNDRFVHVIGTHLQAEDSMCGKTSPASVRTNQLKEIQDFI
KNKNIPNNEYVLIGGDMNVNKINAENNNDSEYASMFKTLNASVPSYTGHTATWDATTNSI
AKYNFPDSLAEYLDYIIASKDHANPSYIENKVLQPKSPQWTVTSWFKNIRIMITLIIIQV
EATISMK
>PHLC_BACCE.1 [25,283]  P09598 Phospholipase C precursor (EC
HENDGGSKIKIVHRWSAEDKHKEGVNSHLWIVNRAIDIMSRNTTLVKQDRVAQLNEWRTE
LENGIYAADYENPYYDNSTFASHFYDPDNGKTYIPFAKQAKETGAKYFKLAGESYKNKDM
KQAFFYLGLSLHYLGDVNQPMHAANFTNLSYPQGFHSKYENFVDTIKDNYKVTDGNGYWN
WKGTNPEEWIHGAAVVAKQDYSGIVNDNTKDWFVKAAVSQEYADKWRAEVTPMTGKRLMD
AQRVTAGYIQLWFDTYGDR
>PHLC_CLOBI.1 [27,398]  P20419 Phospholipase C precursor (EC
WDGKKDGTGTHSLIAEHGLSMLNNDLSGNESQQVKDNIKILNEYLGDLKLGSTYPDYDPN
AYDLYQDHFYDPDTGNNFTIDNSWYASYPIYDTSRNSVRKFATLAKNEWEKGNFKEATFL
LGQGLHYLGDLNTPYHASNVTAVDSPGHVKYETFVEERKDNYALNTSGNDTTSGVYKEAM
ENPSFNKWMTQNSIKYAKIAKDLYYSHSTMSHSWDDWDYSGREAIKNSQVCTAGFLYRFM
NEVSNGNTGDNDSLTNEFNIVLKTADNKYAGTDDNVYFGFETNEGKKFEWKLDNAGNDFE
RNQVDNYILKTKDGEEVDINNISNYWIRKERLTSISDDWELSNFKLIANGKVIQQQDVNK
VFTGNETYYINK
>PHLC_CLOHA.1 [29,399]  P59026 Phospholipase C precursor (EC
DGKVDGTGTHALIVTQAVEILKNDVISTSPLSVKENFKILESNLKKLQRGSTYPDYDPKA
YALYQDHFWDPDTDNNFTKDSKWYLAYGINETGESQLRKLFALAKDEWKKGNYEQATWLL
GQGLHYFGDFHTPYHPSNVTAVDSAGHTKFETYVEGKKDSYKLHTAGANSVKEFYPTTLQ
NTNLDNWITEYSRGWAKKAKNMYYAHATMSHSWKDWEIAATETMHNVQIGSAGIIYRFLN
EVSGTINTTENSKINEIMVVIKTANEDKAGTDHYIHFGIEAKDGKKYEWTLDNPGNDFEK
NQEDSYRINLKDNKLTLQDIAKTWIRKERGAGVRDDWKPEYVKVIINSDVKYQANINEWF
GDNKTFYINNK
>PHLC_CLONO.1 [29,398]  Q46150 Phospholipase C precursor (EC
WDGKKDGTGTHSMIVTQAVKVLENDMSKDEPEIVKQNFKILQDNMHKFQLGSTYPDYDPN
AYKLFQDHFWDPDTDHNFSKDNLWYLSYSIKDTAESQVRKFTALARNEWEKGNYEKATWY
FGQAMHYFGDLNTPYHAANVTAVDSIGHTKYEGFAEKRKDQYRINTTGIKTNEGFYADAL
KNSNFDSWSKEYCKGWAKQAKNLYYSHSTMKHTNEDWDYSASHALKNAQMGTAGCIYRFL
YDVSKDLLPTENHKINGLMVVIKTANEIAAGTDDYVYFGIERKDGTVQEWTLDNPGNDFE
ANQEDTYILKIKKPSIKFSDINRMWIRKANFTPVSDDWKVKGIKVIADGSVQYEKQINKW
IHGNEKYYIN
>PHLC_CLOSO.1 [29,399]  Q8VUZ6 Phospholipase C precursor (EC
WDGKKDGTGTHALIAEHGLTMLNNDLNQNEPKPIKQNIEILNKYLKDLKLGSTFPDYDPN
AYDLFQDHFFDPDTGNNFTLDNKWYVASPIYDTAETQVRKFATLAENEWKKGNYKEATFL
LGQGMHYLGDLNTPYHAANVTAVDSPGHVKYETFVENRKENYALNTAGNDTTQGIYKDAV
ANKDFDQWMTQNSVKYAKKAKALYYSHSTMKHNWDDWDYSGREAIKNSQVCTAGFLYRFI
NEVSEDQISGNNLTNEFNVVLKTADNEYAGTDDNVYFGFETKDGSKYEWNLDNAGNDFEK
NQTDNYILKVKNDVKVNTNDITKYWVRKENRTPISDDWELSNIKLISNGKVILQKDINKV
FSGNQVYDINK
>PHLC_LISMO.1 [26,289]  P33378 Phospholipase C precursor (EC
NACCDEYLQTPAAPHDIDSKLPHKLSWSADNPTNTDVNTHYWLFKQAEKILAKDVNHMRA
NLMNELKKFDKQIAQGIYDADHKNPYYDTSTFLSHFYNPDRDNTYLPGFANAKITGAKYF
NQSVTDYREGKFDTAFYKLGLAIHYYTDISQPMHANNFTAISYPPGYHCAYENYVDTIKH
NYQATEDMVAKRFCSDDVKDWLYENAKRAKADYPKIVNAKTKKSYLVGNSEWKKDTVEPT
GARLRDSQQTLAGFLEFWSKKTNE
>PHLC_STAAU.1 [35,330]  P09978 Phospholipase C precursor (EC
ESKKDDTDLKLVSHNVYMLSTVLYPNWGQYKRADLIGQSSYIKNNDVVIFNEAFDNGASD
KLLSNVKKEYPYQTPVLGRSQSGWDKTEGSYSSTVAEDGGVAIVSKYPIKEKIQHVFKSG
CGFDNDSNKGFVYTKIEKNGKNVHVIGTHTQSEDSRCGAGHDRKIRAEQMKEISDFVKKK
NIPKDETVYIGGDLNVNKGTPEFKDMLKNLNVNDVLYAGHNSTWDPQSNSIAKYNYPNGK
PEHLDYIFTDKDHKQPKQLVNEVVTEKPKPWDVYAFPYYYVYNDFSDHYPIKAYSK
>PHLD_BACCE.1 [25,283]  P33376 Phospholipase C precursor (EC
HENDGGQRFGVIPRWSAEDKHKEGVNSHLWIVNRAIDIMSRNTTLVKQDRVALLNEWRTE
LENGIYAADYENPYYDNSTFASHFYDPDNGKTYIPYAKQAKETGAKYFKLAGESYKNKDM
KQAFFYLGLSLHYLGDVNQPMHAANFTNLSYPQGFHSKYENFVDTIKDNYKVTDGNGYWN
WKGTNPEDWIHGAAVVAKQDYAGIVNDNTKDWFVRAAVSQEYADKWRAEVTPMTGKRLMD
AQRVTAGYIQLWFDTYGNR
>PHYC_BACSU.1 [27,383]  O31097 3-phytase precursor (EC 3.1.3
KHKLSDPYHFTVNAAAETEPVDTAGDAADDPAIWLDPKTPQNSKLITTNKKSGLVVYSLD
GKMLHSYNTGKLNNVDIRYDFPLNGKKVDIAAASNRSEGKNTIEIYAIDGKNGTLQSMTD
PDHPIATAINEVYGFTLYHSQKTGKYYAMVTGKEGEFEQYELKADKNGYISGKKVRAFKM
NSQTEGMAADDEYGRLYIAEEDEAIWKFSAEPDGGSNGTVIDRADGRHLTRDIEGLTIYY
AADGKGYLMASSQGNSSYAIYDRQGKNKYVADFRITDGPETDGTSDTDGIDVLGFGLGPE
YPFGIFVAQDGENIDHGQKANQNFKIVPWERIADQIGFRPLANEQVDPRKLTDRSGK
>PHYT_BACSD.1 [27,383]  O66037 3-phytase precursor (EC 3.1.3
KHKLSDPYHFTVNAAAETEPVDTAGDAADDPAIWLDPKNPQNSKLITTNKKSGLAVYSLE
GKMLHSYHTGKLNNVDIRYDFPLNGKKVDIAAASNRSEGKNTIEIYAIDGKNGTLQSITD
PNRPIASAIDEVYGFSLYHSQKTGKYYAMVTGKEGEFEQYELNADKNGYISGKKVRAFKM
NSQTEGMAADDEYGSLYIAEEDEAIWKFSAEPDGGSNGTVIDRADGRHLTPDIEGLTIYY
AADGKGYLLASSQGNSSYAIYERQGQNKYVADFQITDGPETDGTSDTDGIDVLGFGLGPE
YPFGLFVAQDGENIDHGQKANQNFKMVPWERIADKIGFHPQVNKQVDPRKMTDRSGK
>PHYT_BACSU.1 [27,382]  P42094 3-phytase precursor (EC 3.1.3
HYVNEEHHFKVTAHTETDPVASGDDAADDPAIWVHEKHPEKSKLITTNKKSGLVVYDLDG
KQLHSYEFGKLNNVDLRYDFPLNGEKIDIAAASNRSEGKNTIEVYAIDGDKGKLKSITDP
NHPISTNISEVYGFSLYHSQKTGAFYALVTGKQGEFEQYEIVDGGKGYVTGKKVREFKLN
SQTEGLVADDEYGNLYIAEEDEAIWKFNAEPGGGSKGQVVDRATGDHLTADIEGLTIYYA
PNGKGYLMASSQGNNSYAMYERQGKNRYVANFEITDGEKIDGTSDTDGIDVLGFGLGPKY
PYGIFVAQDGENIDNGQAVNQNFKIVSWEQIAQHLGEMPDLHKQVNPRKLKDRSDG
>PLC1_CLOPE.1 [29,398]  P15310 Phospholipase C precursor (EC
WDGKIDGTGTHAMIVTQGVSILENDLSKNEPESVRKNLEILKENMHELQLGSTYPDYDKN
AYDLYQDHFWDPDTDNNFSKDNSWYLAYSIPDTGESQIRKFSALARYEWQRGNYKQATFY
LGEAMHYFGDIDTPYHPANVTAVDSAGHVKFETFAEERKEQYKINTAGCKTNEDFYADIL
KNKDFNAWSKEYARGFAKTGKSIYYSHASMSHSWDDWDYAAKVTLANSQKGTAGYIYRFL
HDVSEGNDPSVGKNVKELVAYISTSGEKDAGTDDYMYFGIKTKDGKTQEWEMDNPGNDFM
TGSKDTYTFKLKDENLKIDDIQNMWIRKRKYTAFPDAYKPENIKIIANGKVVVDKDINEW
ISGNSTYNIK
>PLC2_CLOPE.1 [29,398]  Q9RF12 Phospholipase C precursor (EC
WDGKADGTGTHAMIATQGVTILENDLSSNEPEVIRNNLEILKQNMHDLQLGSTYPDYDKN
AYDLYQDHFWDPDTDNNFTKDSKWYLSYSIPDTAESQIRKFSALARYEWKRGNYKQATFY
LGEAMHYFGDADTPYHAANVTAVDSPGHVKFETFAEDRKDQYKINTTGSKTNDAFYSNIL
TNEDFNSWSKEFARSFAKTAKDLYYSHANMSCSWDEWDYAAKVALANSQKGTSGYIYRFL
HDVSDGKDSSANKNVNELVAYITTGGEKYAGTDDYMYFGIKTKDGQTQEWTMDNPGNDFM
TGSQDTYTFKLKDKNLKIDDIQNMWIRKSKYTEFGDDYKPANIKVIANGNVVLNKDINEW
ISGNSTYNIK
>PLC_BACCE.1 [32,329]   P14262 1-phosphatidylinositol phosph
ASSVNELENWSKWMQPIPDSIPLARISIPGTHDSGTFKLQNPIKQVWGMTQEYDFRYQMD
HGARIFDIRGRLTDDNTIVLHHGPLYLYVTLHEFINEAKQFLKDNPSETIIMSLKKEYED
MKGAEDSFSSTFEKKYFVDPIFLKTEGNIKLGDARGKIVLLKRYSGSNEPGGYNNFYWPD
NETFTTTVNQNANVTVQDKYKVSYDEKVKSIKDTMDETMNNSEDLNHLYINFTSLSSGGT
AWNSPYYYASYINPEIANYIKQKNPARVGWVIQDYINEKWSPLLYQEVIRANKSLIKE
>PLC_BACTU.1 [32,329]   P08954 1-phosphatidylinositol phosph
ASSVNELENWSKWMQPIPDNIPLARISIPGTHDSGTFKLQNPIKQVWGMTQEYDFRYQMD
HGARIFDIRGRLTDDNTIVLHHGPLYLYVTLHEFINEAKQFLKDNPSETIIMSLKKEYED
MKGAEGSFSSTFEKNYFVDPIFLKTEGNIKLGDARGKIVLLKRYSGSNESGGYNNFYWPD
NETFTTTVNQNVNVTVQDKYKVNYDEKVKSIKDTMDETMNNSEDLNHLYINFTSLSSGGT
AWNSPYYYASYINPEIANDIKQKNPTRVGWVIQDYINEKWSPLLYQEVIRANKSLIKE
>PLC_LISMO.1 [23,317]   P34024 1-phosphatidylinositol phosph
FPLGGKAYSLNNWNKPIKNSVTTKQWMSALPDTTNLAALSIPGTHDTMSYNGDITWTLTK
PLAQTQTMSLYQQLEAGIRYIDIRAKDNLNIYHGPIFLNASLSGVLETITQFLKKNPKET
IIMRLKDEQNSNDSFDYRIQPLINIYKDYFYTTPRTDTSNKIPTLKDVRGKILLLSENHT
KKPLVINSRKFGMQFGAPNQVIQDDYNGPSVKTKFKEIVQTAYQASKADNKLFLNHISAT
SLTFTPRQYAAALNNKVEQFVLNLTSEKVRGLGILIMDFPEKQTIKNIIKNNKFN
>PLS_STAAU.1 [49,1637]   P80544 Surface protein precursor (P
AENNTTQKQDDSSDASKVKGNVQTIEQSSANSNESDIPEQVDVTKDTTEQASTEEKANTT
EQASTEEKADTTEQATTEEAPKAEGTDKVETEEAPKAEETDKATTEEAPKAEETDKATEE
APKTEETDKATTEEAPAAEETSKAATEEAPKAEETSKAATEEAPKAEETEKTATEEAPKT
EETDKVETEEAPKAEETSKAATEKAPKAEETNKVETEEAPAAEETNKAATEETPAVEDTN
AKSNSNAQPSETERTQVVDTVAKDLYKKSEVTEAEKAEIEKVLPKDISNLSNEEIKKIAL
SEVLKETANKENAQPRATFRSVSSNARTTNVNYSATALRAAAQDTVTKKGTGNFTAHGDI
IHKTYKEEFPNEGTLTAFNTNFNPNTGTKGALEYNDKIDFNKDFTITVPVANNNQGNTTG
ADGWGFMFTQGNGQDFLNQGGILRDKGMANASGFKIDTAYNNVNGKVDKLDADKTNNLSQ
IGAAKVGYGTFVKNGADGVTNQVGQNALNTKDKPVNKIIYADNTTNHLDGQFHGQRLNDV
VLNYDAATSTITATYAGKTWKATTDDLGIDKSQKYNFLITSSHMQNRYSNGIMRTNLEGV
TITTPQADLIDDVEVTKQPIPHKTIREFDPTLEPGSPDVIVQKGEDGEKTTTTPTKVDPD
TGDVVERGEPTTEVTKNPVDEIVHFTPEEVPQGHKDEFDPNLPIDGTEEVPGKPGIKNPE
TGEVVTPPVDDVTKHGPKAGEPEVTKEEIPFEKKREFNPDLKPGEEKVTQEGQTGEKTTT
TPTTINPLTGEKVGEGEPTTEVTKEPVDEITQFGGEEVPQGHKDEFDPNLPIDGTEEVPG
KPGIKNPETGEVVTPPVDDVTKHGPKAGEPEVTKEEIPFEKKREFNPDLKPGEEKVTQEG
QTGEKTTTTPTTINPLTGEKVGEGEPTTEVTKEPVDEITQFGGEEVPQGHKDEFDPNLPI
DGTEEVPGKPGIKNPETGEVVTPPVDDVTKHGPKAGEPEVTKEEIPFEKKREFNPDLKPG
EEKVTQEGQTGEKTTTTPTTINPLTGEKVGEGEPTTEVTKEPVDEITQFGGEEVPQGHKD
EFDPNLPIDGTEEVPGKPGIKNPETGEVVTPPVDDVTKHGPKAGEPEVTKEEIPYETKRV
LDPTMEPGSPDKVAQKGENGEKTTTTPTTINPLTGEKVGEGEPTTEVTKEPIDEIVNYAP
EIIPHGTREEIDPNLPEGETKVIPGKDGLKDPETGEIIEEPQDEVIIHGAKDDSDADSDS
DADSDSDADSDSDADSDSDADSDSDSDSDSDSDSDSDADSDSDSDSDSDADSDSDADSDS
DADSDSDSDADSDSDSDADSDSDSDSDSDADSDSDSDSDSDADSDSDADSDSDSDSDSDA
DSDSDSDSDSDADSDSDADSDSDADSDSDADSDSDSDSDSDADSDSDADSDSDADSDSDA
DSDSDSDSDSDADSDSDSDSDSDSDADSDSDADSDSDSDADSDSDADSDSDADGDSDADS
DSDADSDSDSDSDSDSDSDSDADSDSDSDSDSDADRDHNDKTDKPNNKELPDTGNDAQNN
GTLFGSLFAALGGLFLVGRRRKNKNNEEK
>PPB3_BACSU.1 [33,462]  P19405 Alkaline phosphatase III prec
QEKKKGNQDEIKNVIVLIGDGMGVSYTSAYRYLKDNKKTKVVEPTAFDQYLVGQQTTYPD
DPEQNVTDSAAAATAMSAGIKTYNNAIAVDNDGSEAKTVLEAAKEKGKATGLVATSEITH
ATPASFGSHDHSRKNMNSIADDYFDEMVNGKHKIDVLLGGGKSNFDRKDRNLIKEFKKAG
YSYVDDRKDMLKNKDSQVLGLFADGGLPKKIDRTKDIPSLKDMTNTAIKKLNKDKDGFFL
MVEGSQIDWAGHDNDIVGAMSEMEDFEQAYKAAIDFAKKDKHTLVVATADHSTGGYSIGA
DSIYNWFSEPIKAAKRTPDFMAEKIADGADVEKTLKTYIDQKKLALTKAEIQSVEEAAKS
KEVLDIDNAIENIFNKRSHTGWTTGGHTGEDVPVYAYGPSSETFAGQIDNTEIAKNVFKA
LQYNIKINDK
>PPB4_BACSU.1 [42,461]  P19406 Alkaline phosphatase IV precu
KKQDKAEIRNVIVMIGDGMGTPYIRAYRSMKNNGDTPNNPKLTEFDRNLTGMMMTHPDDP
DYNITDSAAAGTALATGVKTYNNAIGVDKNGKKVKSVLEEAKQQGKSTGLVATSEINHAT
PAAYGAHNESRKNMDQIANSYMDDKIKGKHKIDVLLGGGKSYFNRKNRNLTKEFKQAGYS
YVTTKQALKKNKDQQVLGLFADGGLAKALDRDSKTPSLKDMTVSAIDRLNQNKKGFFLMV
EGSQIDWAAHDNDTVGAMSEVKDFEQAYKAAIEFAKKDKHTLVIATADHTTGGFTIGANG
EKNWHAEPILSAKKTPEFMAKKISEGKPVKDVLARYANLKVTSEEIKSVEAAAQADKSKG
ASKAIIKIFNTRSNSGWTSTDHTGEEVPVYAYGPGKEKFRGLINNTDQANIIFKILKTGK
>PRA1_BACAN.1 [19,287]  Q81U45 Foldase protein prsA 1 precur
CGTSSSDKIVTSKAGDITKDEFYEQMKTQAGKQVLNNMVMEKVLIKNYKVEDKEVDKKYD
EMKKQYGDQFDTLLKQQGIKEETLKTGVRAQLAQEKAIEKTITDKELKDNYKPEIKASHI
LVKDEATAKKVKEELGQGKSFEELAKQYSEDTGSKEKGGDLGFFGAGKMVKEFEDAAYKL
KKDEVSEPVKSQFGYHIIKVTDIKEPEKSFEQSKADIKKELVAKKSQDGEFMNDLMMKEI
KKADVKVDDKDLKDLFEEKKADAKKEEKK
>PRA1_BACCR.1 [19,286]  Q81GY5 Foldase protein prsA 1 precur
CGTSSSDKIVTSKAGDITKEEFYDQMKTQAGKQVLNNMVMEKVLIKNYKVEDKDVDKKFD
EMKKQYGDQFDTLLKQQGIKEETIKTGVRAQLAQEKAIEKTITDKELKENYKPEIKASHI
LVKDEATAKKVKEELGQGKSFEELAKQYSEDTGSKEKGGDLGYFTAGKMVKEFEDAAYKL
KKDEVSEPVKSQFGYHIIKVTDIKEQKPFDEVKGDIKKDLVQKKAQDAAFMNDLMMKEIK
KADVKVDDKDLKDLFEEKKADDKKEEKK
>PRA1_LACJO.1 [24,298]  P60750 Foldase protein prsA 1 precur
CSGGKAVVTYKGGKITESQYYDKMKESQAGQSTLASMIVSDALESQYGKDVTQKQVDKEY
NKYKKQYGSQFDSVLEQNGMTASTFKDNLKTNLLTEAALKHIKKITPAQEKKAWKNYQPE
VTVQHILVSKKSTAEDVIKQLQDGGDFKKLAKKYSTDTATKNDAGKLPAFDSTDSTLDSS
FKTAAFKLKTGEITTTPVKTQYGYHVIKMIKHPAKGTFKEHKKQIDNQIYQSMSEDQNVM
RSVIATVLKRADVSIKDKDLKNVLSQYVSSDSLSK
>PRA1_LACPL.1 [20,298]  Q88X05 Foldase protein prsA 1 precur
CGSKTVASTSGGKITESQYYSSMKGTSSGKQVLQQMILNKVLEKDYGSKVSTKQVTKQYN
TYKSQYGSSFSTVLSQNGLTTKTFKEQLRSNLLLKEAVKDKVKITDKALKKQWKSYEPKV
TVQHILVAKSATADKVLDALKKDSSQANFTKLAKKYSTDTTTKNDGGKLSAFDNTNTSYS
SKFLTAAFKLKNGEYTTSAVKTSNGYEIIRMIKNPGKGKMSDHTADLKKQIWDNDMSDST
VLQNVVSKVLKGGNVSIKDNDLKDILSSYLSTSSSSSSN
>PRA1_LISIN.1 [22,294]  Q92BR2 Foldase protein prsA 1 precur
CGSSAVVKTDAGNVTQDELYEAMKTTYGNEVVQQLTFKKILEDKYTVTEKEVNAEYKKYE
EQYGDSFESTLSSNNLTKTSFKENLEYNLLVQKATEANMNVSESKLKTYYKTWEPNITVR
HILVDDEATAKEIQTKLKNGEKFADLAKEYSTDTATSTNGGLLDPFGPGEMDETFEKAAY
ALKNKDDVSGIVKSTYGYHLIQLVKKTEKGTYAKEKANVKAAYIKSQLTSENMTAALKKE
LKAANIDIKDSDLKDAFADYTSTSSSSSTSTSN
>PRA1_LISMO.1 [22,294]  Q8Y759 Foldase protein prsA 1 precur
CGSSAVIKTDAGSVTQDELYEAMKTTYGNEVVQQLTFKKILEDKYTVTEKEVNAEYKKYE
EQYGDSFESTLSSNNLTKTSFKENLEYNLLVQKATEANMDVSESKLKAYYKTWEPDITVR
HILVDDEATAKEIQTKLKNGEKFTDLAKEYSTDTATSTNGGLLDPFGPGEMDETFEKAAY
ALENKDDVSGIVKSTYGYHLIQLVKKTEKGTYAKEKANVKAAYIKSQLTSENMTAALKKE
LKAANIDIKDSDLKDAFADYTSTSSTSSTTTSN
>PRA1_STRP3.1 [23,351]  P60751 Foldase protein prsA 1 precur
CQSTNDNTKVISMKGDTISVSDFYNETKNTEVSQKAMLNLVISRVFEAQYGDKVSKKEVE
KAYHKTAEQYGASFSAALAQSSLTPETFKRQIRSSKLVEYAVKEAAKKELTTQEYKKAYE
SYTPTMAVEMITLDNEETAKSVLEELKAEGADFTAIAKEKTTTPEKKVTYKFDSGATNVP
TDVVKAASSLNEGGISDVISVLDPTSYQKKFYIVKVTKKAEKKSDWQEYKKRLKAIIIAE
KSKDMNFQNKVIANALDKANVKIKDKAFANILAQYANLGQKTKAASESSTTSESSKAAEE
NPSESEQTQTSSAEEPTETEAQTQEPAAQ
>PRA1_STRP8.1 [23,351]  Q8P0E5 Foldase protein prsA 1 precur
CQSTNDNTKVISMKGDTISVSDFYNETKNTEVSQKAMLNLVISRVFEAQYGDKVSKKEVE
KAYHKTAEQYGASFSAALAQSSLTPETFKRQIRSSKLVEYAVKEAAKKELTTQEYKKAYE
SYTPTMAVEMITLDNDETAKSVLEELKAEGADFTAIAKEKTTTPEKKVTYKFDSGAINVP
TDVVKAASSLNEGGISDVISVLDPTSYQKKFYIVKVTKKAEKKSDWQEYKKRLKAIIIAE
KSKDMNFQNKVIANALDKANVKIKDKAFANILAQYANLGQKTKAASESSTTSESSKAAEE
NPSESEQTQTSSAEEPTETEAQTQEPAAQ
>PRA1_STRPY.1 [23,351]  P60811 Foldase protein prsA 1 precur
CQSTNDNTKVISMKGDTISVSDFYNETKNTEVSQKAMLNLVISRVFEAQYGDKVSKKEVE
KAYHKTAEQYGASFSAALAQSSLTPETFKRQIRSSKLVEYAVKEAAKKELTTQEYKKAYE
SYTPTMAVEMITLDNEETAKSVLEELKAEGADFTAIAKEKTTTPEKKVTYKFDSGATNVP
TDVVKAASSLNEGGISDVISVLDPTSYQKKFYIVKVTKKAEKKSDWQEYKKRLKAIIIAE
KSKDMNFQNKVIANALDKANVKIKDKAFANILAQYANLGQKTKAASESSTTSESSKAAEE
NPSESEQTQTSSAEEPTETEAQTQEPAAQ
>PRA2_BACAN.1 [21,285]  Q81TU1 Foldase protein prsA 2 precur
CGQKNSSATVATATDSTITKSDFEKQLKDRYGKDMLYEMIAQDVITKKYKVSDDDVDKEV
QKAKSQYGDQFKNVLKNNGLKDEADFKNQIKFKLSMNKAIKQSVTEKDVKDHYKPEIKAS
HILVSDENEAKEIKKKLDTGASFEELAKQESQDLLSKEKGGDLGYFHSGAMTPEFETAAY
KLKIGQISDPVQSPNGYHIIKLTGKKDLKPYDEVKNSIRKNLEEERTADPIFGKKLLQSE
LKKANIKINDSELEDTFTIVSPQGN
>PRA2_BACCR.1 [21,285]  Q81GN0 Foldase protein prsA 2 precur
CGQKNGSATVATATDSTITKDNFEKQLKDRYGKDMLYEMMAQDVITKKYKVPDEEVNKEV
EKVKKQYGDQFKKVLENYGLKDEEDFKNQIKFKLAMNEAIKKSITEKDVKDHYKPEIKAS
HILVSDENEAKEIKSKLDAGASFEELAKQESQDLLSKDKGGDLGYFNSGTMAPEFETAAY
KLNVGQISNPVKSSNGYHVIKLTDKKALKPYDEVKDSIRKNLEEERTADPVFSKKLLQEE
LKKANIKINDSDLKDTFTLVSPQGN
>PRA2_LACJO.1 [23,298]  P60810 Foldase protein prsA 2 precur
CSSNNKEVAQYGDKKISQEQFYQELNSSPTSKTILANMLIYGALKEAYGSKLNKDQVEAD
YNSYKKRYGSQFDSFLKENSYTKKSFKQMIELNHLSKIALKKQMKPTTSQLKEEWKDYQP
KITVQHISTTSRDTANTVIEKLNNGESFASLASKYSVDSLTSSNGGKLPAFDMQNRRYDS
TFKKGAYKLKNDEYTKEPIKVTNGYEVIKMINHPKKGNFADKQKELTEAIYNKWASNSRI
MNNVISQVLKEQHVSIKDKDLKSALDMYKGSNKANF
>PRA2_LACPL.1 [21,309]  Q88T16 Foldase protein prsA 2 precur
CQAKATTLVKSDAGQVTQAEVFKQIENQATTQQAVQELTLNKVLNQRYHVSQAEVTAKLK
AFKRQAGANYHMILERNHVTEPRLKSQIKANLLMEKAVSAKYPVTKAQLKKARAAYMPMT
TVQHIATTNEKQAQKIIAELNAGASFDSQVRKYQNNRQAHTTAGKLAQFDSYNQTLAPAI
VQATAKLRVGHYVTKPVKTVMATADTKDKPTYEIINVVSRRSKTAAVTDDSGKQIDVTNY
LREKIQQQRMMDKQTQVATIRSVFKAAHVKVVDAHFAPAFNDYLTTQNS
>PRA2_LISIN.1 [21,291]  Q929F4 Foldase protein prsA 2 precur
CGGGGNVVKTDSGDVTQDELYDAMKDKYGSEFVQQLTFEKILGDKYKVSDEDVDKKFKEY
KSQYGDQFSAVLAQSGLTEKSFKSQLKYNLLVQKATEANADTSDKALKEYYKTWQPDITV
SHILVADENKAKEVEQKLKDGAKFADLAKEYSTDTATKENGGQLAPFGSGKMDPAFEKAA
YALKNKGDISAPVKTQYGYHIIQMDKPATKTTFDKDKKAVKEAYLASQLTTENMQKTLKK
EYKDANVKVEDKDLKDAFKDFDGSASKDSSK
>PRA2_LISMO.1 [21,293]  Q8Y557 Foldase protein prsA 2 precur
CGGGGDVVKTDSGDVTKDELYDAMKDKYGSEFVQQLTFEKILGDKYKVSDEDVDKKFNEY
KSQYGDQFSAVLTQSGLTEKSFKSQLKYNLLVQKATEANTDTSDKTLKKYYETWQPDITV
SHILVADENKAKEVEQKLKDGEKFADLAKEYSTDTATKDNGGQLAPFGPGKMDPAFEKAA
YALKNKGDISAPVKTQYGYHIIQMDKPATKTTFEKDKKAVKASYLESQLTTENMQKTLKK
EYKDANVKVEDKDLKDAFKDFDGSSSSDSDSSK
>PRA2_STRP3.1 [23,309]  Q8K5P3 Foldase protein prsA 2 precur
CQSSHNNTKLVSMKGDTITVSDFYNETKNTELAQKAMLSLVISRVFETQYANKVSDKEVE
KAYKQTADQYGTSFKTVLAQSGLTPETYKKQIRLTKLVEYAVKEQAKNETISKKDYRQAY
DAYTPTMTAEIMQFEKEEDAKAALEAVKAEGADFAAIAKEKTIAADKKTTYTFDSGETTL
PAEVVRAASGLKEGNRSEIITALDPATSKRTYHIIKVTKKATKKADWKAYQKRLKDIIVT
GKLKDPDFQNKVIAKALDKANVKIKDKAFANILAQFAKPNQKQPAQK
>PRA2_STRP8.1 [23,309]  P60813 Foldase protein prsA 2 precur
CQSSHNNTKLVSMKGDTITVSDFYNETKNTELAQKAMLSLVISRVFETQYANKVSDKEVE
KAYKQTADQYGTSFKTVLAQSGLTPETYKKQIRLTKLVEYAVKEQAKNETISKKDYRQAY
DAYTPTMTAEIMQFEKEEDAKAALEAVKAEGADFAAIAKEKTTAADKKTTYTFDSGETTL
PAEVVRAASGLKEGNRSEIITALDPATSKRTYHIIKVTKKATKKADWKAYQKRLKDIIVT
GKLKDPDFQNKVIAKALDKANVKIKDKAFANILAQFAKPNQKQPAQK
>PRA2_STRPY.1 [23,309]  P60812 Foldase protein prsA 2 precur
CQSSHNNTKLVSMKGDTITVSDFYNETKNTELAQKAMLSLVISRVFETQYANKVSDKEVE
KAYKQTADQYGTSFKTVLAQSGLTPETYKKQIRLTKLVEYAVKEQAKNETISKKDYRQAY
DAYTPTMTAEIMQFEKEEDAKAALEAVKAEGADFAAIAKEKTTAADKKTTYTFDSGETTL
PAEVVRAASGLKEGNRSEIITALDPATSKRTYHIIKVTKKATKKADWKAYQKRLKDIIVT
GKLKDPDFQNKVIAKALDKANVKIKDKAFANILAQFAKPNQKQPAQK
>PRA3_BACAN.1 [22,283]  Q81QT1 Foldase protein prsA 3 precur
CGSSDNVVTSKVGNITEKELSKELRQKYGESTLYQMVLSKALLDKYKVSDEEAKKQVEEA
KDKMGDNFKSTLEQVGLKNEDELKEKMKPEIAFEKAIKATVTEKDVKDNYKPEMKVSHIL
VKDEKTAKEVKEKVNNGEDFAALAKQYSEDTGSKEQGGEITGFAPGQTVKEFEEAAYKLD
AGQVSEPVKTTYGYHIIKVTDKKELKPFDEVKDSIRKDIEQQRLQDTTGKWKQQVVNELL
KDADIKVNDKEFKNTFEFLEKK
>PRA3_BACCR.1 [22,283]  Q81DT1 Foldase protein prsA 3 precur
CGSSDNVVTSKVGNVTEKELSKELRQQYGESTLYQMMLSKALLDKYKVSDEEAKKKVEEA
KDKMGENFKSTLEQLGLKNEDELKEKMKPEIAFEKAIKATVTDKDVKNNYKPEMKVSHIL
VKDEKTAKEIKEKVNNGEDFAALANQYSEDTGSKEQGGEISGFAPGQTVKEFEEAAYKLD
AGQVSDPVKTTYGYHIIKVTDKKELKPFDEVKDKIRKDIEQQRLQDTTGKWKQQVVNDLL
KDADIKVNNKEFKDTFKFLEKK
>PRA4_BACCR.1 [22,280]  Q81CB1 Foldase protein prsA 4 precur
CGSSDNIVTTKSGSISESDFNKKLKENYGKQNLSEMVVEKVLHDKYKVTDEEVTKQLEEL
KDKMGDNFNTYMESNGVKNEDQLKEKLKLTFAFEKAIKATVTEKDIKDHYKPKLQVSHIL
VKDEKTAKEIKEKLNSGEDFAALAKQYSEDPGSKEKGGELSEFGPGMMVKEFEDAAYKLE
VGQLSEPVKSSFGYHIIKLTDKKELKPYEEEKENIRKELEQQRIQDPQFHQQVTRDLLKN
ADIKVSDKDLKDTFKELEK
>PRO1_LISMO.1 [25,510]  P23224 Zinc metalloproteinase precur
DSVGEEKLQNNTQAKKTPADLKALPDSCEAKDFYKNFKILDMTKDKLGVTHYTLALSSGG
YLTDNDEIKVHVTPDNKITFINGDLQQGQLRITNQIKITEKNAIEKAFEAIGQSEAHVKS
YVGNPVKEKEIILNSRTKRLVYNIKLIFAEPEVASWIVQVDVETGAILKKQNMLSEVERA
DTHKDFQALGKGANRLLQRPLHVMKINDLFYLVDRTHKGLIRTFDLKHNTDTSFGKVVSN
KTNMFTDPEFSSAVDAHFYASEVYEYYKNVHQLESLDGKGGEIDSFVHYGLNCNNAFWDG
QEILYGDGDKKNFKPFSCAKTIVGHELTHAVIQYSAGLEYEGQSGALNESFADVFGYFIA
PNHWLIGEDVCVRGSRDGRIRSIKDPDKYNQAAHMKDYESLPLTEEGDWGGVHYNSGIPN
KAAYNTITKLGKEKTEQLYFRALKYYLTKKSQFTDAKKALQQAAKDLYGEDASKKVAEAW
EAVGVN
>PRO2_LISMO.1 [25,510]  P34025 Zinc metalloproteinase precur
DSVGEERLRNNIQAKRNPADLKTLPDSCEAKDFYKNFKILDMTKDKLGVTHYTLALSSDG
YLTDNDEIKVHVTPDNKITFINGDLQQGQLRITNQIKITEKNAIEKAFEAIGQSEAHVKS
YIGNPVKEKEIIINSRTKRLVYNIKLIFAEPEVASWIIQVDAETGAILKKQNMLSEVERA
DTHKDFQALGKGANRLLQRPLHVMKINDLFYLVDRTHKGLIRTFDLNHKTDASFGKVVSN
KTNMFTDPEFSSAVDAHFYASEVYDYYKNVHQLESLDGKGGEIDSFVHYGLNCNNAFWDG
REILYGDGDKKNFKPFSCAKTIVGHELTHAVIQYSAGLEYEGQSGALNESFADVFGYFIA
PNHWLIGEDVCVRGLRDGRIRSIKDPDKYNQAAHMKDYESLPITEEGDWGGVHFNSGIPN
KAAYNTITKLGKEKTEQLYFRALKYYLTKKAQFTDAKKALQQAAKDLYGEDASKKVAEAW
EAVGVN
>PRSA_BACSU.1 [20,292]  P24327 Foldase protein prsA precurso
CSSGDKEVIAKTDAGDVTKGELYTNMKKTAGASVLTQLVQEKVLDKKYKVSDKEIDNKLK
EYKTQLGDQYTALEKQYGKDYLKEQVKYELLTQKAAKDNIKVTDADIKEYWEGLKGKIRA
SHILVADKKTAEEVEKKLKKGEKFEDLAKEYSTDSSASKGGDLGWFAKEGQMDETFSKAA
FKLKTGEVSDPVKTQYGYHIIKKTEERGKYDDMKKELKSEVLEQKLNDNAAVQEAVQKVM
KKADIEVKDKDLKDTFNTSSTSNSTSSSSSNSK
>PRSA_CLOAB.1 [23,333]  Q97E99 Foldase protein prsA precurso
CSMVEKRPEAINSKVVATIYGNQTITRGEIDKLAKGTVEQLKSQYGDSYEKNEEAVAALK
KQKEQILTSLIDQKIFLKKAKDQKITLTKDEIKTNVDDVYAQYQQEFKTESEFKSQLSQY
GYTVAEFKDQLKNRAISNKLIQQVVKDVKVSDDEAKKYYDSHKNSYTQSPNTVHLAHILV
KTEKEAKAVKARIDKGEDFATVAKQVSTDGSKEKGGDLGDIQENDSNYDKTFMAAALKLN
DNQVSAPVHTQFGWHVIKCIKKTEYPVKDFNSVKDDIKQTVLSTKQKSVYQKTLKKWESQ
ANIDKNEKNLM
>PRSA_CLOPE.1 [23,342]  Q8XHK0 Foldase protein prsA precurso
CNMVEKTQAAIDKTTVATVNGEKITLGEVDSHLKGVFAQMKSQYGDKYMDDPQVAQQILQ
QRQSVVQGLVTDKVLGIEADKLGIKPSEEEIKKKVDEQFENIKKGMGDNFDKALEAEGYT
EDTFKDVIKNQVINQAVQDYIIKDVKVTDEDAQKYYDENKQQFVAKDSGVLTKHLLFENE
EEAQKAYDEIQSGKTTFNDLFTKYQNNKSENKKPIAENLGVVPAENSGLVQEFVDGLKPL
KEGEISKPIKTQFGYHIIQAGATYEKGAQLPFDEVKSQIIQILKQQKDSEKFKADMDQWK
KDLNVKVYDDKLQEGLKISK
>PRSA_CLOTE.1 [27,339]  Q899I2 Foldase protein prsA precurso
CNMIEKTPEAIEKSPVAKVGKKTITRGELDTYPILAEQLTKLKEQFGGDLSKNAEIKDQL
IQFKSQVLEQMIQEEIVFEKSEELKVDNAKVEKEVEKNLKNFMDQGFQGNKDKYKEDLKK
MGTTEESIKRFFKAQVITEEVSKQVVKDVKVDDNTAKKHYEESKYTFTVNKPTFHAQHVL
VKTEEEAKKVKARLDKGEDIKKIAKELSIDPSAKENSGDLGKAPYSSMVKPFADAIVKLN
KGEISQPVKSQFGYHVIKLIDKDEVTFKDFNSVKEQIKKDLLETEKRKVFNEKIEQWKKE
LKVETKKYEKNII
>PRSA_ENTFA.1 [21,342]  Q837Y9 Foldase protein prsA precurso
CSSGSKDIATMKGSTITVDDFYNQIKEQSTSQQAFSQMVIYKVFEEKYGDKVTDKDIQKN
FDEAKEQVEAQGGKFSDALKQAGLTEKTFKKQLKQRAAYDAGLKAHLKITDEDLKTAWAS
FHPEVEAQIIQVASEDDAKAVKKEITDGGDFTKIAKEKSTDTATKKDGGKIKFDSQATTV
PAEVKEAAFKLKDGEVSEPIAATNMQTYQTTYYVVKMTKNKAKGNDMKPYEKEIKKIAEE
TKLADQTFVSKVISDELKAANVKIKDDAFKNALAGYMQTESSSASSEKKESKSSDSKTSD
TKTSDSEKATDSSSKTTESSSK
>PRSA_LACLA.1 [25,308]  Q9CEV9 Foldase protein prsA precurso
CSSSDSASKDIITMKGDTIRVSDLYKEAKQFPSQPTNTLLQNLTFDKIFTKDFGKEVTDK
DVSKKVKSIKDQYGSQFSSALQQQGLTEASFTPYMRTQMLEQAAIDHEIKETQYTDANLK
KAWESYHPDVTAYVVSETSKDAATKALDAAKKDDAGKASFEKTNAESKVTFNSTSTSVPT
EVQTAAFKLKNGEFSDVIESTSSSTGATSYYIVEMVKTSEKGTDMNKYKKELQNVIKTEK
EQDTTFVSGVIAKYLKKNNVTVKESAFASLFSQFTQTSSSSSSK
>PRSA_LACLC.1 [24,299]  P14308 Foldase protein prsA precurso
CQSNQTDQTVATYSGGKVTESSLYKELKQSPTTKTMLANMLIYRALNHAYGKSVSTKTVN
DAYDSYKQQYGENFDAFLSQNGFSRSSFKESLRTNFLSEVALKKLKKVSESQLKAAWKTY
QPKVTVQHILTSDEDTAKQVISDLAAGKDFAMLAKTDSIDTATKDNGGKISFELNNKTLD
ATFKDAAYKLKNGDYTQTPVKVTDGYEVIKMINHPAKGTFTSSKKALTASVYAKWSRDSS
IMQRVISQVLKNQHVTIKDKDLADALDSYKKLATTN
>PRSA_LACPA.1 [24,299]  Q02473 Foldase protein prsA precurso
CQSNQADQKVATYSGGKVTESNFYKELKQSPTTKTMLANMLIYRALNHAYGKSVSTKTVN
DAYDSYKQQYGENFDAFLSQNGFSRSSFKESLRTNFLSEVALKKLKKVSESQLKAVWKTY
QPKVTVQHILTSDEDTAKQVISDLAAGKDFATLAKTDSIDTATKDNGGKISFESNNKTLD
ATFKDAAYKLKNGDYTQTPVKVTNGYEVIKMINHPAKGTFTSSKKALTASVYAKWSRDSS
IMQRVISQVLKNQHVTIKDKDLADALDSYKKPATTN
>PRSA_OCEIH.1 [20,299]  Q8CXK4 Foldase protein prsA precurso
CNSDDEIVAETEAGNITKEEFYEELKDVNGESTLQQLVTVKVLEDNYEVTDEELEEEIST
MKEGFPSEEDFNTTVEQQFGGEEQLREIMYVSMLQEKAAAEDVEITEEDLQELYERKNTE
IQAQHILLENEEDVAEVQQKIEDGEDFGELAQEYSTDTGSAENGGDLGYFSAGSMVPEFE
EAAFSLEAGEISDPVQSTHGTHIIKVNDVREKEESIGEFEDVKKELEREILLNRVDQTQI
QEKINKLIQDAGVQINVEGMEDLFEAEETEENTTEEDAQG
>PRSA_STAAM.1 [21,320]  P60747 Foldase protein prsA precurso
CGASATDSKENTLISSKAGDVTVADTMKKIGKDQIANASFTEMLNKILADKYKNKVNDKK
IDEQIEKMQKQYGGKDKFEKALQQQGLTADKYKENLRTAAYHKELLSDKIKISDSEIKED
SKKASHILIKVKSKKSDKEGLDDKEAKQKAEEIQKEVSKDPSKFGEIAKKESMDTGSAKK
DGELGYVLKGQTDKDFEKALFKLKDGEVSEVVKSSFGYHIIKADKPTDFNSEKQSLKEKL
VDQKVQKNPKLLTDAYKDLLKEYDVDFKDRDIKSVVEDKILNPEKLKQGGAQGGQSGMSQ
>PRSA_STAAN.1 [21,320]  P60748 Foldase protein prsA precurso
CGASATDSKENTLISSKAGDVTVADTMKKIGKDQIANASFTEMLNKILADKYKNKVNDKK
IDEQIEKMQKQYGGKDKFEKALQQQGLTADKYKENLRTAAYHKELLSDKIKISDSEIKED
SKKASHILIKVKSKKSDKEGLDDKEAKQKAEEIQKEVSKDPSKFGEIAKKESMDTGSAKK
DGELGYVLKGQTDKDFEKALFKLKDGEVSEVVKSSFGYHIIKADKPTDFNSEKQSLKEKL
VDQKVQKNPKLLTDAYKDLLKEYDVDFKDRDIKSVVEDKILNPEKLKQGGAQGGQSGMSQ
>PRSA_STAAW.1 [21,320]  P60749 Foldase protein prsA precurso
CGASATDSKENTLISSKAGDVTVADTMKKIGKDQIANASFTEMLNKILADKYKNKVNDKK
IDEQIEKMQKQYGGKDKFEKALQQQGLTADKYKENLRTAAYHKELLSDKIKISDSEIKED
SKKASHILIKVKSKKSDKEGLDDKEAKQKAEEIQKEVSKDPSKFGEIAKKESMDTGSAKK
DGELGYVLKGQTDKDFEKALFKLKDGEVSEVVKSSFGYHIIKADKPTDFNSEKQSLKEKL
VDQKVQKNPKLLTDAYKDLLKEYDVDFKDRDIKSVVEDKILNPEKLKQGGAQGGQSGMSQ
>PRSA_STAEP.1 [21,325]  Q8CNR4 Foldase protein prsA precurso
CGSNATESKDNTLISSKAGDVKVADVMKKMGKEQIANTSFSIVLNKVLADKYKDKVDTKD
IDKDIKKEEKQYGGKDQFESMLKQQGMSFDDYKEQKKLSAYQKQLLLDKVNVSDKEIKEN
SKKASHILIKVKSKSSDKEGLSDKKAKEKAEKIQKEVEKNPNKFGEIAKKESMDSSSAKK
DGSLGYVIKGQMVDSFEKALFKLKEGEVSKVVKTDYGYHIIKADKETDFNSEKSNIKQKL
IEEKVQKKPKLLTDAYKELLKEYKVDYKDRDIKKAIEDSILDPDKIKQQQQQQSQGGSGL
TNSGS
>PRSA_STRA3.1 [23,309]  Q8E602 Foldase protein prsA precurso
CSGKTSNGTNVVTMKGDTITVSDFYDQVKTSKAAQQSMLTLILSRVFDTQYGDKVSDKKV
SEAYNKTAKGYGNSFSSALSQAGLTPEGYKQQIRTTMLVEYAVKEAAKKELTEANYKEAY
KNYTPETSVQVIKLDAEDKAKSVLKDVKADGADFAKIAKEKTTATDKKVEYKFDSAGTSL
PKEVMSAAFKLDKNGVSDVVSTVDSTTYKTSYYIIKVTDKTEKKSDWKSYKNRLKEVILK
DKTSDRSFQNKVISKALEKANVKIKDKAFAGILSQYATTSGSSSLKK
>PRSA_STRA5.1 [23,309]  Q8E0C6 Foldase protein prsA precurso
CSGKTSNGTNVVTMKGDTITVSDFYDQVKTSKAAQQSMLTLILSRVFDTQYGDKVSDKKV
SEAYNKTAKGYGNSFSSALSQAGLTPEGYKQQIRTTMLVEYAVKEAAKKELTEANYKEAY
KNYTPETSVQVIKLDAEDKAKSVLKDVKADGADFAKIAKEKTTATDKKVEYKFDSAGTTL
PKEVMSAAFKLDKNGVSDVVSTVDSTTYKTSYYIIKVTDKTEKKSDWKSYKNRLKEVILK
DKTSDRAFQNKVISKALEKANVKIKDKAFAGILSQYATTSGSSSLKK
>PRSA_STRMU.1 [22,333]  Q8CVC6 Foldase protein prsA precurso
CSKTNQNSKIATMKGDTITVADFYNEVKNSTASKQAVLSLLVSKVFEKQYGDKVSDKEVT
KAYNEAAKYYGDSFSSALASRGYTKEDYKKQIRSEKLIEYAVKEEAKKEITDASYKSAYK
DYKPEVTAQVIQLDSEDKAKSVLEEAKADGADFAKIAKDNTKGDKTEYSFDSGSTNLPSQ
VLSAALNLDKDGVSDVIKASDSTTYKPVYYIVKITKKTDKNADWKAYKKRLKEIIVSQKL
NDSNFRNAVIGKAFKKANVKIKDKAFSEILSQYAAASGSGSSGSTTTTTAASSAATTAAD
DQTTAAETTAAE
>PRSA_STRPN.1 [21,313]  Q97R51 Foldase protein prsA precurso
CSKGSEGADLISMKGDVITEHQFYEQVKSNPSAQQVLLNMTIQKVFEKQYGSELDDKEVD
DTIAEEKKQYGENYQRVLSQAGMTLETRKAQIRTSKLVELAVKKVAEAELTDEAYKKAFD
EYTPDVTAQIIRLNNEDKAKEVLEKAKAEGADFAQLAKDNSTDEKTKENGGEITFDSAST
EVPEQVKKAAFALDVDGVSDVITATGTQAYSSQYYIVKLTKKTEKSSNIDDYKEKLKTVI
LTQKQNDSTFVQSIIGKELQAANIKVKDQAFQNIFTQYIGGGDSSSSSSTSNE
>PRSA_STRR6.1 [21,313]  Q8DQ24 Foldase protein prsA precurso
CSKGSEGADLISMKGDVITEHQFYEQVKNNPSAQQVLLNMTIQKVFEKQYGSELDDKEVD
DTIAEEKKQYGENYQRVLSQAGMTLETRKAQIRTSKLVELAVKKVAEAELTDEAYKKAFD
EYTPDVTAQIIRLNNEDKAKEVLEKAKAEGADFAQLAKDNSTDEKTKENGGEITFDSAST
EVPEQVKKAAFALDVDGVSDVITATGTQAYSSQYYIVKLTKKTEKSSNIDDYKEKLKTVI
LTQKQNDSTFVQSIIGKELQAANIKVKDQAFQNIFTQYIGGGDSSSSSSTSNE
>PRSA_THETN.1 [21,306]  Q8R760 Foldase protein prsA precurso
CSSKKEAVSGDVVAVVNGEKITNAEYQQIFEQVKEQIESAPTYTKDIWNQDYQGKKFLDF
VKENVLDSLVAQKLLVQEAKKKNITVTDKEVEEEYNKEKQFNSKVTKEQIREYLLIDKLL
AEYTKDVKVTDEELKKYYDEHKESFEVMRARHILVADEKTAEDIYQRLMKGEDFAALAKE
YSIDTATKDNGGDLGEFPHGVMVPEFEEAAFSLKLGEISKPVKTQYGYHIIKSEGITVKP
FDEVKGTIESYLLNDKKNKVIKEKYDELVKASKIQKFPENIKVKVG
>QOX2_BACSU.1 [27,322]  P34957 Quinol oxidase polypeptide II
CSNASVLDPKGPVAEQQSDLILLSIGFMLFIVGVVFVLFTIILVKYRDRKGKDNGSYNPE
IHGNTFLEVVWTVIPILIVIALSVPTVQTIYSLEKAPEATKDKEPLVVYATSVDWKWVFS
YPEQDIETVNYLNIPVDRPILCKISSADSMASLWIPQLGGQKYAMAGMLMDQYLQADKVG
TYEGRNANFTGEHFADQEFDVNAVTEKDFNSWVKKTQNEAPKLTKEKYDELMLPENVDEL
TFSSTHLKYVDHGQDAEYAMEARKRLGYQAVSPHCKTDPFENVKKNEFKKSDDTEE
>RBSB_BACSU.1 [19,305]  P36949 D-ribose-binding protein prec
CSLEPPQWAKPSNSGNKKEFTIGLSVSTLNNPFFVSLKKGIEKEAKKRGMKVIIVDAQND
SSKQTSDVEDLIQQGVDALLINPTDSSAISTAVESANAVGVPVVTIDRSAEQGKVETLVA
SDNVKGGEMAAAFIADKLGKGAKVAELEGVPGASATRERGSGFHNIADQKLQVVTKQSAD
FDRTKGLTVMENLLQGHPDIQAVFAHNDEMALGALEAINSSGKDILVIGFDGNKDALASI
KDRKLSATVAQQPELIGKLATEAADDILHGKKVQKTISAPLKLETQK
>RNBR_BACAM.1 [35,157]  P00648 Ribonuclease precursor (EC 3.
AKTETSSHKAHTEAQVINTFDGVADYLQTYHKLPDNYITKSEAQALGWVASKGNLADVAP
GKSIGGDIFSNREGKLPGKSGRTWREADINYTSGFRNSDRILYSSDWLIYKTTDHYQTFT
KIR
>RN_BACIN.1 [30,162]    P00649 Ribonuclease precursor (EC 3.
ETPLTQTATNETATIQLTSDVHTLAVINTFDGVADYLIRYKRLPDNYITKSQASALGWVA
SKGNLAEVAPGKSIGGDVFSNREGRLPSASGRTWREADINYVSGFRNADRLVYSSDWLIY
KTTDHYATFTRIR
>RN_BACPU.1 [30,162]    P48068 Ribonuclease precursor (EC 3.
ETTLTPTATNKTASIQLTSDVHTLAVINTFDGVADYLIRYKRLPDNYITKSQASALGWVA
SKGNLAEVAPGKSIGGDVFSNREGRLPSASGRTWREADINYVSGFRNADRLVYSSDWLIY
KTTDHYATFTRIR
>SACB_BACAM.1 [30,472]  P21130 Levansucrase precursor (EC 2.
KENNQKAYKETYGVSHITRHDMLQIPKQQQNEKYQVPQFDQSTIKNIESAKGLDVWDSWP
LQNADGTVAEYNGYHVVFALAGSPKDADDTSIYMFYQKVGDNSIDSWKNAGRVFKDSDKF
DANDPILKDQTQEWSGSATFTSDGKIRLFYTDYSGKHYGKQSLTTAQVNVSKSDDTLKIN
GVEDHKTIFDGDGKTYQNVQQFIDEGNYTSGDNHTLRDPHYVEDKGHKYLVFEANTGTEN
GYQGEESLFNKAYYGGGTNFFRKESQKLQQSAKKRDAELANGALGIIELNNDYTLKKVMK
PLITSNTVTDEIERANVFKMNGKWYLFTDSRGSKMTIDGINSNDIYMLGYVSNSLTGPYK
PLNKTGLVLQMGLDPNDVTFTYSHFAVPQAKGNNVVITSYMTNRGFFEDKKATFGPSFLM
NIKGNKTSVVKNSILEQGQLTVN
>SACB_BACST.1 [30,473]  P94468 Levansucrase precursor (EC 2.
KETNQKPYKETYGISHITRHDMLQIPEQQKNEKYQVPEFDSSTIKNISSAKGLDVWDSWP
LQNADGTVANYHGYHIVFALAGDPKNADDTSIYMFYQKVGETSIDSWKTPGRVFKDSDKF
DANDSILKDQTQEWSGSATFTSDGKIRLFYTDFSGKHYGKQTLTTAQVNVSASDSSLNIN
GVEDYKSIFDGDSKTYQNVQQFIDEGNYSSGDNHTLRDPHYVEDKGHKYLVFEANTGTED
GYQGEESLFNKAYYGKSTSFFRQESQKLLQSDKNRTAELANGALGMIELNDDYTLKKVMK
PLIASNTVTDEIERANVFKMNGKWYLSTDSRGSQMTIDGITSNDIYMLGYVSNSLTGPYK
PLNKTGLVLKMDLDPNDVTFTYSHFAVPQATGNNVVITSYMTNRGFYADKQSTFAPSFLL
NIQGKKTSVVKASILDQGQLTVNQ
>SACB_BACSU.1 [30,473]  P05655 Levansucrase precursor (EC 2.
KETNQKPYKETYGISHITRHDMLQIPEQQKNEKYQVPEFDSSTIKNISSAKGLDVWDSWP
LQNADGTVANYHGYHIVFALAGDPKNADDTSIYMFYQKVGETSIDSWKNAGRVFKDSDKF
DANDSILKDQTQEWSGSATFTSDGKIRLFYTDFSGKHYGKQTLTTAQVNVSASDSSLNIN
GVEDYKSIFDGDGKTYQNVQQFIDEGNYSSGDNHTLRDPHYVEDKGHKYLVFEANTGTED
GYQGEESLFNKAYYGKSTSFFRQESQKLLQSDKKRTAELANGALGMIELNDDYTLKKVMK
PLIASNTVTDEIERANVFKMNGKWYLFTDSRGSKMTIDGITSNDIYMLGYVSNSLTGPYK
PLNKTGLVLKMDLDPNDVTFTYSHFAVPQAKGNNVVITSYMTNRGFYADKQSTFAPSFLL
NIKGKKTSVVKDSILEQGQLTVNK
>SACB_STRMU.1 [35,795]  P11701 Levansucrase precursor (EC 2.
QADEANSTQVSSELAERSQVQENTTASSSAAENQDKTEVKETPSTNPAAATVENTDQTTK
VITDNAAVESKASKTKDQAATVTKTSASTPEVGQTNEKAKATKEADITTPKNTIDEYGLT
EQARKIATEAGINLSSLTQKQVEALNKVKLTSDAQTGHQMTYQEFDKIAQTLIAQDERYA
IPYFNAKAIKNMKAATTRDAQTGQIADLDVWDSWPVQDAKTGEVINWNGYQLVVAMMGIP
NTNDNHIYLLYNKYGDNNFDHWKNAGSIFGYNETPLTQEWSGSATVNEDGSLQLFYTKVD
TSDKNSNNQRLATATVNLGFDDQDVRILSVENDKVLTPEGGDGYHYQSYQQWRSTFTGAD
NIAMRDPHVIEDENGDRYLVFEASTGTENYQGEDQIYNFTNYGGSSAYNVKSLFRFLDDQ
DMYNRASWANAAIGILKLKGDKKTPEVDQFYTPLLSSTMVSDELERPNVVKLGDKYYLFT
ASRLNHGSNNDAWNKANEVVGDNVVMLGYVSDQLTNGYKPLNNSGVVLTASVPADWRTAT
YSYYAVPVAGSSDTLLMTAYMTNRNEVAGKGKNSTWAPSFLIQVLPDGTTKVLAEMTQQG
DWIWDESSRTTDTVGTLDTAYLPGENDGYIDWNVIGGYGLKPHTPGQYQPTVPSTPIHTD
DIISFEVSFDGHLVIKPVKVNNDSAGRIDQSRNSGGSLNVAFNVYAGGNISVKPSQKSIN
NTKETKKAHHVSTEKKQKKGNSFFAALLALFSAFCVSIGFK
>SACC_BACSU.1 [25,677]  P05656 Levanase precursor (EC 3.2.1.
ADSSYYDEDYRPQYHFTPEANWMNDPNGMVYYAGEYHLFYQYHPYGLQWGPMHWGHAVSK
DLVTWEHLPVALYPDEKGTIFSGSAVVDKNNTSGFQTGKEKPLVAIYTQDREGHQVQSIA
YSNDKGRTWTKYAGNPVIPNPGKKDFRDPKVFWYEKEKKWVMVLAAGDRILIYTSKNLKQ
WTYASEFGQDQGSHGGVWECPDLFELPVDGNPNQKKWVMQVSVGNGAVSGGSGMQYFVGD
FDGTHFKNENPPNKVLWTDYGRDFYAAVSWSDIPSTDSRRLWLGWMSNWQYANDVPTSPW
RSATSIPRELKLKAFTEGVRVVQTPVKELETIRGTSKKWKNLTISPASHNVLAGQSGDAY
EINAEFKVSPGSAAEFGFKVRTGENQFTKVGYDRRNAKLFVDRSESGNDTFNPAFNTGKE
TAPLKPVNGKVKLRIFVDRSSVEVFGNDGKQVITDIILPDRSSKGLELYAANGGVKVKSL
TIHPLKKVWGTTPFMSNMTGWTTVNGTWADTIEGKQGRSDGDSFILSSASGSDFTYESDI
TIKDGNGRGAGALMFRSDKDAKNGYLANVDAKHDLVKFFKFENGAASVIAEYKTPIDVNK
KYHLKTEAEGDRFKIYLDDRLVIDAHDSVFSEGQFGLNVWDATAVFQNVTKES
>SAK_STAAM.1 [28,163]   P00802 Staphylokinase precursor (Neu
SSSFDKGKYKKGDDASYFEPTGPYLMVNVTGVDGKGNELLSPHYVEFPIKPGTTLTKEKI
EYYVEWALDATAYKEFRVVELDPSAKIEVTYYDKNKKKEETKSFPITEKGFVVPDLSEHI
KNPGFNLITKVVIEKK
>SARA_STRGC.1 [23,55]  P31306 76 kDa cell surface lipoprotei
CSNSTSNSSNSSSSGADQVFNYIYEVDPENLNY
>SCA1_STRPY.1 [32,1167]  P15926 C5a peptidase precursor (EC 
NTVTEDTPVTEQAVETPQPTAVSEEVPSSKETKTPQTPDDAEETIADDANDLAPQAPAKT
ADTPATSKATIRDLNDPSQVKTLQEKAGKGAGTVVAVIDAGFDKNHEAWRLTDKTKARYQ
SKEDLEKAKKEHGITYGEWVNDKVAYYHDYSKDGKTAVDQEHGTHVSGILSGNAPSETKE
PYRLEGAMPEAQLLLMRVEIVNGLADYARNYAQAIRDAVNLGAKVINMSFGNAALAYANL
PDETKKAFDYAKSKGVSIVTSAGNDSSFGGKTRLPLADHPDYGVVGTPAAADSTLTVASY
SPDKQLTETAMVKTDDQQDKEMPVLSTNRFEPNKAYDYAYANRGMKEDDFKDVKGKIALI
ERGDIDFKDKVANAKKAGAVGVLIYDNQDKGFPIELPNVDQMPAAFISRKDGLLLKDNPQ
KTITFNATPKVLPTASGTKLSRFSSWGLTADGNIKPDIAAPGQDILSSVANNKYAKLSGT
SMSAPLVAGIMGLLQKQYETQYPDMTPSERLDLAKKVLMSSATALYDEDEKAYFSPRQQG
AGAVDAKKASAATMYVTDKDNTSSKVHLNNVSDKFEVTVTVHNKSDKPQELYYQATVQTD
KVDGKHFALAPKVLYEASWQKITIPANSSKQVTVPIDASRFSKDLLAQMKNGYFLEGFVR
FKQDPTKEELMSIPYIGFRGDFGNLSAVEKPIYDSKDGSSYYHEANSDAKDQLDGDGLQF
YALKNNFTALTTESNPWTIIKAVKEGVENIEDIESSEITETIFAGTFAKQDDDSHYYIHR
HANGEPYAAISPNGDGNRDYVQFQGTFLRNAKNLVAEVLDKEGNVVWTSEVTEQVVKNYN
NDLASTLGSTRFEKTRWDGKDKDGKVVANGTYTYRVRYTPISSGAKEQHTDFDVIVDNTT
PEVATSATFSTEDRRLTLASKPKTSQPVYRERIAYTYMDEDLPTTEYISPNEDGTFTLPE
EAETMEGATVPLKMSDFTYVVEDMAGNITYTPVTKLLEGHSNKPEQDGSGQTPDKKPEAK
PEQDGSDQAPDKKPEAKPEQDGSGQTPDKKPETKPEKDSSGQTPGKTPQKGQPSRTLEKR
SSKRALATKASTRDQLPTTNDKDTNRLHLLKLVMTTFFFGLVAHIFKTKRQKETKK
>SCA2_STRPY.1 [32,1181]  P58099 C5a peptidase precursor (EC 
NTVTEDTPATEQAVETPQPTAVSEEAPSSKETKTPQTPDDAEETIADDANDLAPQAPAKT
ADTPATSKATIRDLNDPSQVKTLQEKAGKGAGTVVAVIDAGFDKNHEAWRLTDKTKARYQ
SKEDLEKAKKEHGITYGEWVNDKVAYYHDYSKDGKTAVDQEHGTHVSGILSGNAPSETKE
PYRLEGAMPEAQLLLMRVEIVNGLADYARNYAQAIIDAVNLGAKVINMSFGNAALAYANL
PDETKKAFDYAKSKGVSIVTSAGNDSSFGGKTRLPLADHPDYGVVGTPAAADSTLTVASY
SPDKQLTETATVKTADQQDKEMPVLSTNRFEPNKAYDYAYANRGMKEDDFKDVKGKIALI
ERGDIDFKDKIANAKKAGAVGVLIYDNQDKGFPIELPNVDQMPAAFISRKDGLLLKENPQ
KTITFNATPKVLPTASGTKLSRFSSWGLTADGNIKPDIAAPGQDILSSVANNKYAKLSGT
SMSAPLVAGIMGLLQKQYETQYPDMTPSERLDLAKKVLMSSATALYDEDEKAYFSPRQQG
AGAVDAKKASAATMYVTDKDNTSSKVHLNNVSDKFEVTVTVHNKSDKPQELYYQATVQTD
KVDGKLFALAPKALYETSWQKITIPANSSKQVTIPIDVSQFSKDLLAPMKNGYFLEGFVR
FKQDPTKEELMSIPYIGFRGDFGNLSALEKPIYDSKDGSSYYHEANSDAKDQLDGDGLQF
YALKNNFTALTTESNPWTIIKAVKEGVENIEDIESSEITETIFAGTFAKQDDDSHYYIHR
HANGKPYAAISPNGDGNRDYVQFQGTFLRNAKNLVAEVLDKEGNVVWTSEVTEQVVKNYN
NDLASTLGSTRFEKTRWDGKDKDGKVVANGTYTYRVRYTPISSGAKEQHTDFDVIVDNTT
PEVATSATFSTEDRRLTLASKPKTSQPVYRERIAYTYMDEDLPTTEYISPNEDGTFTLPE
EAETMEGATVPLKMSDFTYVVEDMAGNITYTPVTKLLEGHSNKPEQDGSDQAPDKKPETK
PEQDGSGQAPDKKPETKPEQDGSGQTPDKKPETKPEQDGSGQTPDKKPETKPEKDSSGQT
PGKTPQKGQPSRTLEKRSSKRALATKASTKDQLPTTNDKDTNRLHLLKLVMTTFFLGLVA
HIFKTKRTED
>SEPA_STAEP.1 [29,507]  P43148 Extracellular elastase precur
KDKVSATQNIDAKVTQESQATNALKELPKSENIKKHYKDYKVTDTEKDNKGFTHYTLQPK
VGNTYAPDKEVKVHTNKEGKVVLVNGDTDAKKVQPTNKVAISKESATDKAFEAIKIDRQK
AKNLKSDVIKTNKVEIDGEKNKYVYNIEIITTSPKISHWNVKIDAETGQVVDKLNMIKEA
ATTGTGKGVLGDTKQININSVSGGYALQDLTQQGTLSAYNYDANTGQAYLMQDKDKNFVD
DEQRAGVDANYYAKETYDYYKNTFGRESYDNQGSPIISIAHVNNFQGQDNRNNAAWIGDK
MIYGDGDGRTFTALSGANDVVAHEITHGVTQQTANLVYRSQSGALNESFSDVFGYFIDDE
DFLMGEDVYTPGVGGDALRSMSNPERFGQPSHMNDFVYTNSDNGGVHTNSGIPNKAAYNT
IRSIGKQRSEQIYYRALTVYLTSNSDFQDAKASLQQAAFDLYGDGIAQQVGQAWDSVGV
>SHPI_STAHY.1 [27,438]  Q08002 Neutral metalloprotease precu
DAHTYIINNEDINKNAQESSIGTLKQNNFKQSTIDSMKPRNLQSFQEDKVFKAPKEKTPI
TERARKSENALSNSKLNDVRSFTTVNMRTNENERTAAKLKYNGKNTNVWVADNYITDKQA
KNIGEEFDNKIDPLVKEKFGEPSDVDHDGKVNILVYDIKDDFETTGSYTGGYFHPRDLYD
VPHSNKAEVFYMDTYPSMGTDKNNLNEKKVYSTLAHEYQHMVNANQKLLKEQKEDGMDVW
LDEAFAMASEHMYLQKPLDHRIEYYNNSTSIANGHSLIKWNHRGDVLSNYALSYLFSQYL
SAQSDNGDKIFKEILQDPANTSEALENAIHKHVDPKMSLGEFMTNFRVALEKKEATGLHG
FNGAPGLNSISPKPVRELPQTLAPQGSVMFETTSPIKVPKDKDEKVNYVKVK
>SLA1_BACAN.1 [30,814]  P49051 S-layer protein sap precursor
AGKTFPDVPADHWGIDSINYLVEKGAVKGNDKGMFEPGKELTRAEAATMMAQILNLPIDK
DAKPSFADSQGQWYTPFIAAVEKAGVIKGTGNGFEPNGKIDRVSMASLLVEAYKLDTKVN
GTPATKFKDLETLNWGKEKANILVELGISVGTGDQWEPKKTVTKAEAAQFIAKTDKQFGT
EAAKVESAKAVTTQKVEVKFSKAVEKLTKEDIKVTNKANNDKVLVKEVTLSEDKKSATVE
LYSNLAAKQTYTVDVNKVGKTEVAVGSLEAKTIEMADQTVVADEPTALQFTVKDENGTEV
VSPEGIEFVTPAAEKINAKGEITLAKGTSTTVKAVYKKDGKVVAESKEVKVSAEGAAVAS
ISNWTVAEQNKADFTSKDFKQNNKVYEGDNAYVQVELKDQFNAVTTGKVEYESLNTEVAV
VDKATGKVTVLSAGKAPVKVTVKDSKGKELVSKTVEIEAFAQKAMKEIKLEKTNVALSTK
DVTDLKVKAPVLDQYGKEFTAPVTVKVLDKDGKELKEQKLEAKYVNKELVLNAAGQEAGN
YTVVLTAKSGEKEAKATLALELKAPGAFSKFEVRGLEKELDKYVTEENQKNAMTVSVLPV
DANGLVLKGAEAAELKVTTTNKEGKEVDATDAQVTVQNNSVITVGQGAKAGETYKVTVVL
DGKLITTHSFKVVDTAPTAKGLAVEFTSTSLKEVAPNADLKAALLNILSVDGVPATTAKA
TVSNVEFVSADTNVVAENGTVGAKGATSIYVKNLTVVKDGKEQKVEFDKAVQVAVSIKEA
KPATK
>SLA2_BACAN.1 [30,862]  P94217 S-layer protein EA1 precursor
AGKSFPDVPAGHWAEGSINYLVDKGAITGKPDGTYGPTESIDRASAAVIFTKILNLPVDE
NAQPSFKDAKNIWSSKYIAAVEKAGVVKGDGKENFYPEGKIDRASFASMLVSAYNLKDKV
NGELVTTFEDLLDHWGEEKANILINLGISVGTGGKWEPNKSVSRAEAAQFIALTDKKYGK
KDNAQAYVTDVKVSEPTKLTLTGTGLDKLSADDVTLEGDKAVAIEASTDGTSAVVTLGGK
VAPNKDLTVKVKNQSFVTKFVYEVKKLAVEKLTFDDDRAGQAIAFKLNDEKGNADVEYLN
LANHDVKFVANNLDGSPANIFEGGEATSTTGKLAVGIKQGDYKVEVQVTKRGGLTVSNTG
IITVKNLDTPASAIKNVVFALDADNDGVVNYGSKLSGKDFALNSQNLVVGEKASLNKLVA
TIAGEDKVVDPGSISIKSSNHGIISVVNNYITAEAAGEATLTIKVGDVTKDVKFKVTTDS
RKLVSVKANPDKLQVVQNKTLPVTFVTTDQYGDPFGANTAAIKEVLPKTGVVAEGGLDVV
TTDSGSIGTKTIGVTGNDVGEGTVHFQNGNGATLGSLYVNVTEGNVAFKNFELVSKVGQY
GQSPDTKLDLNVSTTVEYQLSKYTSDRVYSDPENLEGYEVESKNLAVADAKIVGNKVVVT
GKTPGKVDIHLTKNGATAGKATVEIVQETIAIKSVNFKPVQTENFVEKKINIGTVLELEK
SNLDDIVKGINLTKETQHKVRVVKSGAEQGKLYLDRNGDAVFNAGDVKLGDVTVSQTSDS
ALPNFKADLYDTLTTKYTDKGTLVFKVLKDKDVITSEIGSQAVHVNVLNNPNL
>SLAP_ACEKI.1 [27,762]  P22258 Cell surface protein precurso
ATTPFTDVKDDAPYASAVARLYALNITNGVGDPKFGVDQPVTRAQMITFVNRMLGYEDLA
EMAKSEKSAFKDVPQNHWAVGQINLAYKLGLAQGVGNGKFDPNSELRYAQALAFVLRALG
FKDLDWPYGYLAKAQDLGLVHGLNLAYNGVIKRGDLALILDRALEVPMVKYVDGKEVLGE
PLISKVATKAEYTVIATNAQDRSVEEGKVAVLDKDGKLTTINAGLVDFSEYLGKKVIVYS
ERFGDPVYVAEGDNDVVSFTEGQDSVGTTVYKNDDNKTAIKVDDNAYVLYNGYLTKVSKV
TVKEGAEVTIINNNYLIVNGSYDNSTIVYNDVQSGDKYLNRDSNYELKGTVTVTGAVSKV
TDIKANDYIYYGKQYDVNGNVVGTVIYVVRNQVTGTVTEKSVSGSTYKASIDNVSYTVAD
NNVWNQLEPGKKVTVILNKDNVIVGISSTTTTTAVNYAIFKEKSDPFTAWFAKVKLILPD
AAEKVFDAVYSDVYDKVNLAEGTIVTYTVDANGKLNDIQRANDQPFSSASYKADAKVLTE
GSTTYYITDNTVLLNNTSDGYKALKLTDLKDATNLNVKIVADNYNVAKVVVFNNASFVST
TTSTVYAYVTGTADVYVNGSTFTRLTVLENGQTKTYDANAQLATNYTHKAVVLTLTNAKI
ANIALPTVASGVKLTNIDQANLRITDTTNKGYLLDPNFIVVDTNGNLKGLSDITKDTGVN
LYTNDVGKVFVIEIVQ
>SLAP_BACCI.1 [31,1616]  P35824 S-layer related protein prec
QSLGQESGGVQPQSAGVTDDVYVLSRDGTFRLPVGHINVNVDAPPQKTNYVALFTSGAQV
TNSQETDKVFVKKTNTAIAVDKHDQVIRVIGPTAVPPTGSTWEENQNLPIPEGGYVLLAN
DSSWGTSVTRKPLFEHYKTGDTVSLHKGGQVVHAGDFLNPDPGLNLVTASGTTVTSPDFT
VSGQVVRYGSGQGISLTVNGTEAALKADGAFQSAVRLTAGTNAISVKLLKDGREIVSSTV
TVTYNDAQQPADLIEVEAAPIDITISIEGPAHAIGYVDQDIAGIDDTVALFTNDWGPQIT
VPQFNVAVQVDAGSKVTKVVNPSIDGKTPAWTGPTDLEIPSGGYVLVAQDTSYAGKNIKK
YLATYFKVGDAIKLRKNGFAVPVKDLMGTGGPIARVTLDNYAMYTETKPSTELSGTITNM
DDPSKIALTVNGTPLPFGPDGKFKTSYTLAEGINYLDLVVTKEGKEQDSKDLVVYSRPGF
STGKKVILWVDQAANARKFQTGDNVANFLRTAKENGVTSVVFDVKGVEGYVSYKKSTLTG
RPYVSAIKAPEKAGSNPDLDLLQEFIRYSRELGLDIHVSFNIFAEGSIASNEFALLDSHL
DWEERVYNAADNGQIKRLRESAKQGAVAFVNPSNDEVRDFQLKTIEEVLQNYDVDGVVLD
RARYDNESADFSDLTKAKFESFLGARGKQLQNWPDDVFTYAGNVRKDGPLIRDWWEFRSK
TIKSFTSEVRQLTDRVKAEKGKKIEVSAYVGSWFESYYLNGVHWGSTEFRYDERLRMKDK
SVYTPGYYESGYVKNLDFIMIGAYQTTAPEIEHYITLGNIVTNGEVPLYAGIALTNVQEP
ALQRDVFQAGLVNTHGLMLFDASQVNWPVAGAALRNLVYVRDYQLGISLPDSPDSFLEGS
YYNTNLIENNIGVLTDTFGYSTGNSRFGVEAVVDSSGKVTSVPNKTQAMTWNWGKPDETN
SVIPKGGFVVSTLDASGIRTKRQLVANAYETGDSVRAAALSGFLAYEGLRTSADSVTFRG
KVDVLGPGKASVTVNGQEAALREDGTFQADTVIRPGANPVVIIVRVDGFKTNEKTVTIIG
DEAAVKALKLDRGTYSMNKGESLRLAVTAEYSSSSTDVTGQAAYASLDPAVVSVDATGRI
TALREGSGTVQATYEGHTATARVSVTSGSTGGGSDTGSGTGSGSGGGSAGGGGTAPSGPE
RTSVTETKDSDGRNLTLVSADAGVMEAEIAALQGKAAPVLSYEIPGEEPAGIVSLPGTAL
AKRFAGSPGAILSVSSHLGAIELPAGLLEADLPAVGSFDLLVQIGRTAADETADLRPGGE
RRHAGTRHAGCFPCFAENRRRNKRNRRLRKLRPKNRKLAGSGRPLTAPRRWSWTRPPECS
ASCPPASNRPGARRRPLSATEAGGPTRWSPPRSASPTLHPTGRARMSSCWPRSIVDGMGA
GGFSPDEALTRAQFAALLTRALALDPAPAAADFTDIPGDAWYAGAVARRSGPARGRFRNR
GVPTRRGADTRTDERDAHARREAGRYPDGGELRCRCAGALRGPGRNLRLGGRCRFAGGGS
RPAGRTRGRTLRARPARLPVRKARPC
>SLAP_BACLI.1 [31,874]  P49052 S-layer protein precursor (Su
GKSFPDVPAGHWAEDSINYLVDKGAIVGKPDGTYGPTESIDRASAAVIFTKILNLPVDEN
AQPSFKDAKNLWSSKYIAAVEKAGVVKGDGKDNFYPEGKIDRASFASMLVGAYNLKEKVD
GTLVTKFDDLRGHWGEEKANILVNLGISVGTGGKWEPNKSVSRAEAAQFIALTDKKYAKP
ENSDAKVTNVAATEPTQLTLTGTGLNKLTAEDVTLEGNKAIALEASKDGKSAVVTLSGKI
APNKELPVKVKGNTFIVKYVYEVKKLRVEQLTFDDDRADQAVVFKLNDEKGNADIEYLDI
AGHDVKFVANNLDGTPANIFEGGTAESTTGKLAVGIAEGKYKVEVQVTKRGGITVSNTGI
IEVKNLDAEATAIKDVVFAVDTDKAGVNYAKPLSGTDFTLNSKTLVAGEKAGIHKVVAQI
NKENKVVDPSAISLKSSNPGVISVKNGEIKAEAAGSATLTVKVGDVTKTFDFVVKTDTRK
LTTVKANPDQLKVVDGKELPVTFVTTDQYGDPFGANSGAIKEVFPQTGVVKVLDVTTTNE
GSIGTSSIKVKGENVGAGTIHFQNPNASGEGYGSLHVEVTKSNIGHEAPRLELVSKAGQK
GEAADTTLGAGNTVAYQLSNYTTEGVYADAADLAGYEFRVGNDKIASAKIEGKTLKVTGK
TAGVTDVILTKDGATAGHATITVTQENIQITSVKFKDVEVEQFENRKVNIDRVLDVVKSD
KDDVLNGIKLNISTEHKVRIVDEGTEQGKVYLDRNDNATFDGNDVALGYVTAVKSNDTVS
KEGNDLFKFLTDETATNKNDVFKGVTTAFGDKGTVIFKVMKDRVAPTTEYGTKAVTINVI
KEEI
>SLAP_BACSH.1 [31,1176]  P38537 Surface-layer 125 kDa protei
AQLNDFNKISGYAKEAVQSLVDAGVIQGDANGNFNPLKTISRAEAATIFTNALELEAEGD
VNFKDVKADAWYYDAIAATVENGIFEGVSATEFAPNKQLTRSEAAKILVDAFELEGEGDL
SEFADASTVKPWAKSYLEIAVANGVIKGSEANGKTNLNPNAPITRQDFAVVFSRTIENVD
ATPKVDKIEVVDAKTLNVTLSDGTKETVTLEKALEPNKETEVTFKIKDVEYKAKVTYVVT
TATAVKSVSATNLKEVVVEFDGTVDKETAEDAANYALKSGKTIKSVSLAADNKTATVTLT
DKLNNNKADAISISNVKAGDKEINVKNVEFTAVDNKIPEVTEVKSLGTKAVKVTLSEPVE
NLSSTNFTLDGKAYFGNVVMGAGNKTVILTPYSSSALSVGDHKLTVSGAKDFAGFVSLNS
THEFKVVEDKEAPTVTEATATLETVTLTFSEDIDMDTVKASNVYWKSGDSKKEASEFERI
ADNKYKFVFKGSEKTLPTGKVDVYVEDIKDYSDNKIAKDTKVTVTPEIDQTRPEVRKVTA
LDEKTIKVTFSKTVDGESAIKTGNYTVKDKDDKVVSVDKVTVDSKDSKSVIIDLYSKVSV
GENTITIKNVKDATKLNNTMLDYTGKFTRSDKEGPDYEHVINADAKAKKVVLKFDKKMDA
ASLADYSNYLVKINDTLQTLSEDVATLSVSNDATVVTITFAETIKGDDVVFASGKAISGS
GKVNVNELQVMGVKDTSGNVHKKFNGSENKITLSSTSTPLKLAKIDKDYDAKYTAELVDR
KTVKVKFSTVINSAAANAFTSESHKIDSIQVNGTSTVTVKFKDEINTNASDLDLKVNLSK
LVDIAGNESTNNTPIAIKAGINLLDSVAPVVVGEPVVDKETITFTFSENLTSVSIGEVLS
TDFTVTRVSDNKDLAIKDYSVAIANNNQVVITLSDNREVATAYKVTAKNAKLITDDNGDK
KNAIADFTKTTATKVEASGTLSLDAAKTNLNNEITKAKDAKATGTEGTAATNQIVGSKDA
LQVAIDVAELVKNDTAATLQQLTDAKTDLTAAITAYNAAKVEDISSLLVAPDLVLGTTDN
GTITGFVAGTGETLKVTSDSAANVEVTDPTGLAVTAKAKGEANILVQVLKGDKVIKTGTV
KVTVSE
>SLAP_BACST.1 [31,1228]  P35825 S-layer protein precursor (S
ATDVATVVSQAKAQFKKAYYTYSHTVTETGEFPNINDVYAEYNKAKKRYRDAVALVNKAG
GAKKDAYLADLQKEYETYVFKANPKSGEARVATYIDAYNYATKLDEMRQELEAAVQAKDL
EKAEQYYHKIPYEIKTRTVILDRVYGKTTRDLLRSTFKAKAQELRDSLIYDITVAMKARE
VQDAVKAGNLDKAKAAVDQINQYLPKVTDAFKTELTEVAKKALDADEAALTPKVESVSAI
NTQNKAVELTAVPVNGTLKLQLSAAANEDTVNVNTVRIYKVDGNIPFALNTADVSLSTDG
KTITVDASTPFENNTEYKVVVKGIKDKNGKEFKEDAFTFKLRNDAVVTQVFGTNVTNNTS
VNLAAGTFDTDDTLTVVFDKLLAPETVNSSNVTITDVETGKRIPVIASTSGSTITITLKE
ALVTGKQYKLAINNVKTLTGYNAEAYELVFTANASAPTVATAPTTLGGTTLSTGSLTTNV
WGKLAGGVNEAGTYYPGLQFTTTFATKLDESTLADNFVLVEKESGTVVASELKYNADAKM
VTLVPKADLKENTIYQIKIKKGLKSDKGIELGTVNEKTYEFKTQDLTAPTVISVTSKNGD
AGLKVTEAQEFTVKFSENLNTFNATTVSGSTITYGQVAVVKAGANLSALTASDIIPASVE
AVTGQDGTYKVKVAANQLERNQGYKLVVFGKGATAPVKDAANANTLATNYIYTFTTEGQD
VTAPTVTKVFKGDSLKDADAVTTLTNVDAGQKFTIQFSEELKTSSGSLVGGKVTVEKLTN
NGWVDAGTGTTVSVAPKTDANGKVTAAVVTLTGLDNNDKDAKLRLVVDKSSTDGIADVAG
NVIKEKDILIRYNSWRHTVASVKAAADKDGQNASAAFPTSTAIDTTKSLLVEFNETDLAE
VKPENIVVKDAAGNAVAGTVTALDGSTNKFVFTPSQELKAGTVYSVTIDGVRDKVGNTIS
KYITSFKTVSANPTLSSISIADGAVNVDRSKTITIEFSDSVPNPTITLKKADGTSFTNYT
LVNVNNENKTYKIVFHKGVTLDEFTQYELAVSKDFQTGTDIDSKVTFITGSVATDEVKPA
LVGVGSWNGTSYTQDAAATRLRSVADFVAEPVALQFSEGIDLTNATVTVTNITDDKTVEV
ISKESVDADHDAGATKETLVINTVTPLVLDNSKTYKIVVSGVKDAAGNVADTITFYIK
>SLAP_LACAC.1 [25,444]  P35829 S-layer protein precursor (Su
AVSTVSAATTINASSSAINTNTNAKYDVDVTPSVSAVAANTANNTPAIAGNLTGTISASY
NGKTYTANLKADTENATITAAGSTTAVKPAELAAGVAYTVTVNDVSFNFGSENAGKTVTL
GSANSNVKFTGTNSDNQTETNVSTLKVKLDQNGVASLTNVSIANVYAINTTDNSNVNFYD
VTSGATVTNGAVSVNADNQGQVNVANVVAAINSKYFAAQYADKKLNTRTANTEDAIKAAL
KDQKIDVNSVGYFKAPHTFTVNVKATSNTNGKSATLPVVVTVPNVAEPTVASVSKRIMHN
AYYYDKDAKRVGTDSVKRYNSVSVLPNTTTINGKTYYQVVENGKAVDKYINAANIDGTKR
TLKHNAYVYASSKKRANKVVLKKGEVVTTYGASYTFKNGQKYYKIGDNTDKTYVKVANFR
>SLAP_LACBR.1 [31,465]  Q05044 S-layer protein precursor (Su
KSYATAGAYSTLKTDAATRNVEATGTNALYTKPGTVKGAKVVASKATMAKLASSKKSADY
FRAYGVKTTNRGSVYYRVVTMDGKYRGYVYGGKSDTAFAGGIKSAETTTKADMPARTTGF
YLTDTSKNTLWTAPKYTQYKASKVSLYGVAKDTKFTVDQAATKTREGSLYYHVTATNGSG
ISGWIYAGKGFSTTATGTQVLGGLSTDKSVTATNDNSVKIVYRTTDGTQVGSNTWVTSTD
GTKAGSKVSDKAADQTALEAYINANKPSGYTVTNPNAADATYGNTVYATVSQAATSKVAL
KVSGTPVTTALTTADANDKVAANDTTANGSSVAGSTVYAAGTKLAQLTTDLTGEKGQVVT
LTAIDTDLEDATFTGTTTYYSDLGKAYHYTYTYNKDSAASSNASTQFGSNVTGTLTATLV
MGKSTATANGTTWFN
>SLAP_LACHE.1 [31,439]  P38059 S-layer protein precursor (Su
ATTINADSAINANTNAKYDVDVTPSISAIAAVAKSDTMPAIPGSLTGSISASYNGKSYTA
NLPKDSGNATITDSNNNTVKPAELEADKAYTVTVPDVSFNFGSENAGKEITIGSANPNVT
FTEKTGDQPASTVKVTLDQDGVAKLSSVQIKNVYAIDTTYNSNVNFYDVTTGATVTTGAV
SIDADNQGQLNITSVVAAINSKYFAAQYDKKQLTNVTFDTETAVKDALKAQKIEVSSVGY
FKAPHTFTVNVKATSNKNGKSATLPVTVTVPNVADPVVPSQSKTIMHNAYFYDKDAKRVG
TDKVTRYNTVTVAMNTTKLANGISYYEVIENGKATGKYINADNIDGTKRTLKHNAYVYKT
SKKRANKVVLKKGTEVTTYGGSYKFKNGQRYYKIGANTEKTYVKVANFE
>SLEB_BACCR.1 [33,259]  P70874 Spore cortex-lytic enzyme pre
FSNQVIQRGASGEDVIELQSRLKYNGFYTGKVDGVFGWGTYWALRNFQEKFGLPVDGLAG
AKTKQMLVKATKYDKSTANKGTTTNKGNSGGTAQENKPPQNKGTNVPNGYSQNDIQLMAN
AVYGESRGEPYLGQVAVAAVILNRVTSASFPNTVSGVIFEPRAFTAVADGQIYLTPNETA
KKAVLDAINGWDPTGNALYYFNPDTATSKWIWTRPQIKKIGKHIFCK
>SLEB_BACHD.1 [30,330]  Q9KCE0 Spore cortex-lytic enzyme pre
FSDQVIQHGATGDDVVELQARLQYIGFYNKKIDGVFGWSTYWAVRNYQYEFGMEVDGLVG
PEMKAKLEKTTNFNRDFVDRALTQGRKFTHYGGVPKQIQKGPKGSADERRRGREGVRQPR
ADRPGRDAPAAPRDERAPRREERPAPTPEPTPAPPEEPTPYEEAPDAQDDEANIEKATNV
PAGYSDNDIQLMAQAVYGEARGEPYVGQVAVAAVILNRLNSPTFPDNVSGVIFEPLAFTA
VADGQIYMTPDETARRAVLDALNGQDPSGGATYYFNPDTATSGWIWSRPQIKRIGKHIFC
N
>SLEB_BACSU.1 [30,305]  P50739 Spore cortex-lytic enzyme pre
FSNQVIQRGATGDDVVELQARLQYNGYYNGKIDGVYGWGTYWAVRNFQDQFGLKEVDGLV
GAKTKQTLICKSKYYREYVMEQLNKGNTFTHYGKIPLKYQTKPSKAATQKARQQAEARQK
QPAEKTTQKPKANANKQQNNTPAKARKQDAVAANMPGGFSNNDIRLLAQAVYGEARGEPY
EGQVAIAAVILNRLNSPLFPNSVAGVIFEPLAFTAVADGQIYMQPNETAREAVLDAINGW
DPSEEALYYFNPDTATSPWIWGRPQIKRIGKHIFCE
>SLP1_CLOTM.1 [29,1664]  Q06852 Cell surface glycoprotein 1 
EATPSIEMVLDKTEVHVGDVITATIKVNNIRKLAGYQLNIKFDPEVLQPVDPATGEEFTD
KSMPVNRVLLTNSKYGPTPVAGNDIKSGIINFATGYNNLTAYKSSGIDEHTGIIGEIGFK
VLKKQNTSIRFEDTLSMPGAISGTSLFDWDAETITGYEVIQPDLIVVEAEPLKDASVALE
LDKTKVKVGDIITATIKIENMKNFAGYQLNIKYDPTMLEAIELETGSAIAKRTWPVTGGT
VLQSDNYGKTTAVANDVGAGIINFAEAYSNLTKYRETGVAEETGIIGKIGFRVLKAGSTA
IRFEDTTAMPGAIEGTYMFDWYGENIKGYSVVQPGEIVAEGEEPGEEPTEEPVPTETPVD
PTPTVTEEPVPSELPDSYVIMELDKTKVKVGDIITATIKIENMKNFAGYQLNIKYDPTML
EAIELETGSAIAKRTWPVTGGTVLQSDNYGKTTAVANDVGAGIINFAEAYSNLTKYRETG
VAEETGIIGKIGFRVLKAGSTAIRFEDTTAMPGAIEGTYMFDWYGENIKGYSVVQPGEIV
AEGEEPTEEPVPTETPVDPTPTVTEEPVPSELPDSYVIMELDKTKVKEGDVIIATIRVNN
IKNLAGYQIGIKYDPKVLEAFNIETGDPIDEGTWPAVGGTILKNRDYLPTGVAINNVSKG
ILNFAAYYVYFDDYREEGKSEDTGIIGNIGFRVLKAEDTTIRFEELESMPGSIDGTYMLD
WYLNRISGYVVIQPAPIKAASDEPIPTDTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTP
SETPEEPIPTDTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSETPEEPIPTDTPSDEP
TPSDEPTPSDEPTPSDEPTPSDEPTPSETPEEPIPTDTPSDEPTPSDEPTPSDEPTPSDE
PTPSDEPTPSETPEEPIPTDTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSD
EPTPSETPEEPIPTDTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPS
ETPEEPIPTDTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSETPEEPIPTDTPSDEPT
PSDEPTPSDEPTPSDEPTPSDEPTPSETPEEPIPTDTPSDEPTPSDEPTPSDEPTPSDEP
TPSDEPTPSETPEEPIPTDTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSETPEEPIP
TDTPSDEPTPSDEPTPSDEPTPSDEPTPSDEPTPSETPEEPIPTDTPSDEPTPSDEPTPS
DEPTPSDEPTPSDEPTPSDEPTPSDEPTPSETPEEPIPTDTPSDEPTPSDEPTPSDEPTP
SDEPTPSDEPTPSDEPTPSDEPTPSETPEEPTPTTTPTPTPSTTPTSGSGGSGGSGGGGG
GGGGTVPTSPTPTPTSKPTSTPAPTEIEEPTPSDVPGAIGGEHRAYLRGYPDGSFRPERN
ITRAEAAVIFAKLLGADESYGAQSASPYSDLADTHWAAWAIKFATSQGLFKGYPDGTFKP
DQNITRAEFATVVLHFLTKVKGQEIMSKLATIDISNPKFDDCVGHWAQEFIEKLTSLGYI
SGYPDGTFKPQNYIKRSESVALINRALERGPLNGAPKLFPDVNESYWAFGDIMDGALDHS
YIIEDEKEKFVKLLED
>SLP2_CLOTM.1 [28,688]  Q06853 Cell surface glycoprotein 2 p
ETSSIPSRISMELDKTKANIGDIIIATIRIDNINNFSGYQLNIKYDPSYLQAVNPLTGEP
IKKRTMPAVNGTVLLKGDQYSITEVVENNVDEGILNFGKGYANLTEYRKSGKPETTGIIG
KIGFKALKLGKTEIKFENTPVMPGAKEGTLLFDWDAETITEYNVIQPKELAITLPDDAHI
ALELDKTKVKVGDVIVATVKAKNMTSMAGIQVNIKYDPEVLQAIDPATGKPFTKETLLVD
PELLSNREYNPLLTAVNDINSGIINYASCYVYWDSYRESGVSESTGIIGKVGFKVLKAAN
TTVKLEETRFTPNSIDGTLVIDWYGQQIVGYKVIQPDKITVISEPEVPTQTPTQTPPTTT
APSQTPTQTPPTTTAPSQTPTQTPAVTPTQSATPSDPGGGGGGLPGGGGGAVNPSASPTP
TPTSKPTPTATKKPEPTEIEEPEPEIPGTVGIHYSYLTGYPDKMFRPEKSITRAEAAVIF
AKLLGANENTKINYNVSYTDVDSSHWASWAIKFVSYKKLFTGYPDGSFKPNQNITRAEFS
TVVFKLLVSEKGLKEEKIEKSKFGDTKGHWAQQFIEQLSDLGYINGYPDGTFKPNNNIKR
SESVALINRAMGRGPLHGAPQVFEDVPQTHWAFKDIAEGVLNHRYKLDNEGKEQLLEIID
N
>SLPM_BACBR.1 [24,1053]  P06546 Middle cell wall protein pre
AEEAATTTAPKMDADMEKTVKRLEALGLVAGYGNGEYGVDKTITRAEFATLVVRARGLEQ
GAKLAQFSNTYTDVKSTDWFAGFVNVASGEEIVKGFPDKSFKPQNQVTYAEAVTMIVRAL
GYEPSVKGVWPNSMISKASELNIARSITTPNNAATRGDIFKMLDNALRVDLMEQVEFGTD
IRHEITKETLLTKYLKVTVRDMEWAQEAGNDSEDLPLVTNVPAIGLGKIKANEVTLNGKD
AGIGNTTYKVADGINANDFDGQHVQVWIKDDKEDVIVWMEGSTDQEVIMDRVGEFTLKGK
TFEDPKDLSNSDLADLKLELDASEKSYRFNKNTKVTYNFTRFNDPVDGLKEIIKDNADGG
FTFGAKVVLDNNNEIAYIHVIDDQSMNKEDEGVKYGSEVISKIDTDKKKITNRDNDKFND
LDGKEEGKDFLVFLNGKPAKFSDLKEGMVYSVYYADGDEDKLLVFATDTVVEGKVDKVVS
RNNNDYRLTIGDKTYRVYEGATFSDDGNKDVQDIDKDHWDLVDSLDDETVKLYLDASGRV
RHIETKDAIDDRKQKAIVTRSATFNTSKDTWDFRVLTQKGKEITVSLEAKNIYDFDGKNF
SRDNKNQDDLEDILVPSKDKDTLLLEVTLDADGKPGKVEFLKPVKVEQESGKAWDDLADE
DDDMVGDYEVTDKTAVFNMTGKLEESSKRKELKNAKTAKFKDVADENDLSVIYTVNDKDE
VEAIFVVEGDGLTGDAHYGQVIDFGRKGGKDTIRVWEKDGDKVVEKEYKLDGDQDDLKDE
DIRRNDFIAFTVDSNDEVVVDDVVEVVNKNAKGMLAEVTDEKGMKDANIDKMVVGLVSDV
RKDTITYKDADDNKKKASIKSATVYFDLYDDFGEADGVNEGDYVVMIDSGDISGTKYDYV
LIVSDAKTVRKDKLEDDAEAFLKQEPSEKPDPDTKWDALPSKVEGKFTSAGPVKLYRATV
ELNSKVKAEDVDAIEFYFNGKKVEPSLLNFKDGVITIGYNTEDKVTSSKIKVTNKNGKDS
DEATVTFVEA
>SLPO_BACBR.1 [25,1004]  P09333 Outer cell wall protein prec
APKDGIYIGGNIKKYYSTDVLFEMTPQAKATYASELNAMASDFNNVVFVDYKGKGASIEE
LFTKGSKVALGEPLKKEDFADLYKVVNKDGSSTATEDARAKVDPTPTGDLNVESVSANNL
KEVVVTFDKAVDADTAGDKAYYTFTANKLAVDKVTVSGKTVVLTLAAKAENQASYELNVD
GIKGLVKTTKEVKFFDNTTPTVAAVAAIGPKQVKVTFSEPLSAKPSFSVNNGAIAVVADN
FVEGTKEVILTLGAQPTASTNTVTVEGGADYASYKVEKVTKDFTVVADTTPPTVSVKKAS
AKQVVLEFSEDVQNVQDKNVVFYHTTKGHEGYKGTILGVDGKEVTISFVNPLPEGQFKIF
VDYVVDNGTQISDLWGNKLPEQVITGTFAADTTPPTVTKVEAKTNTEIHVTFSETVNGAD
NKANFTLKGVTGNVIPLTKAEVVDAAKNIYKVVTTEPLNGGSYYLTVKGIEDASKNKLVE
YTATVAVADTVPPNVKDLDPATPGTDAQLISPTKVKIAFTEPMDKASIENKNNYMFNGFN
LDSKVTLTATDSNTAVVVDFTNVVGFNGFKNGDAISVGRVLDTAGNPKTEMQTKVNLPNS
VSAPLFDKAEVTGKNTVKLYFKELIINAKADDFAVDNGEGYKAVNSISNDVVENKSVITL
TTGNDLPTTAAGVKVKTVGEVDAKNQYGVAVALTDVPADDKIGPNWLKAETVDTNNNGKI
DQFKLTFSEALYVASVQDSDFRIEGYTIAGVETKGEVVTIKVTELDIDDSDATPTVAVIG
SVEDLKRNASGPFEPQKAIDGVSAPDKEAPVVTGVEAGKTYNTAVTPDSADKDIKTVVLK
KDGKELAGYALKTPISENGSYELVVTDNAGNTTTVKFKVDIPAEDKKAPEIKTVTDDKVA
VADAPKWEAPKATATDDVDGDISDKIAVTYSSEDAGSKVTDLASAQTHLGTAGNTVKVTY
NVTDKAGNPATAVSATFTAI
>SLP_BACSU.1 [19,124]   P39910 Pal-related lipoprotein precu
CTLSTINPMKKSRIDNIHHTQILFFSDENQIDQEAPYYDALLDLEKDYPEQIDKMKVYDK
KEGWEDEIETVPTLMVVDQRHVVVKIEGCVKKKEDIIKPLQHVLSK
>SPA1_STAAU.1 [37,524]  P02976 Immunoglobulin G binding prot
AQHDEAQQNAFYQVLNMPNLNADQRNGFIQSLKDDPSQSANVLGEAQKLNDSQAPKADAQ
QNNFNKDQQSAFYEILNMPNLNEAQRNGFIQSLKDDPSQSTNVLGEAKKLNESQAPKADN
NFNKEQQNAFYEILNMPNLNEEQRNGFIQSLKDDPSQSANLLSEAKKLNESQAPKADNKF
NKEQQNAFYEILHLPNLNEEQRNGFIQSLKDDPSQSANLLAEAKKLNDAQAPKADNKFNK
EQQNAFYEILHLPNLTEEQRNGFIQSLKDDPSVSKEILAEAKKLNDAQAPKEEDNNKPGK
EDNNKPGKEDNNKPGKEDNNKPGKEDNNKPGKEDNNKPGKEDGNKPGKEDNKKPGKEDGN
KPGKEDNKKPGKEDGNKPGKEDGNKPGKEDGNGVHVVKPGDTVNDIAKANGTTADKIAAD
NKLADKNMIKPGQELVVDKKQPANHADANKAQALPETGEENPFIGTTVFGGLSLALGAAL
LAGRRREL
>SPA2_STAAU.1 [37,508]  P38507 Immunoglobulin G binding prot
AQHDEAQQNAFYQVLNMPNLNADQRNGFIQSLKDDPSQSANVLGEAQKLNDSQAPKADAQ
QNKFNKDQQSAFYEILNMPNLNEEQRNGFIQSLKDDPSQSTNVLGEAKKLNESQAPKADN
NFNKEQQNAFYEILNMPNLNEEQRNGFIQSLKDDPSQSANLLAEAKKLNESQAPKADNKF
NKEQQNAFYEILHLPNLNEEQRNGFIQSLKDDPSQSANLLAEAKKLNDAQAPKADNKFNK
EQQNAFYEILHLPNLTEEQRNGFIQSLKDDPSVSKEILAEAKKLNDAQAPKEEDNNKPGK
EDGNKPGKEDGNKPGKEDNKKPGKEDGNKPGKEDNKKPGKEDGNKPGKEDGNKPGKEDGN
KPGKEDGNKPGKEDGNGVHVVKPGDTVNDIAKANGTTADKIAADNKLADKNMIKPGQELV
VDKKQPANHADANKAQALPETGEENPFIGTTVFGGLSLALGAALLAGRRREL
>SPAP_STRMU.1 [39,1562]  P23504 Cell surface antigen I/II pr
DETTTTSDVDTKVVGTQTGNPATNLPEAQGSASKEAEQSQNQAGETNGSIPVEVPKTDLD
QAAKDAKSAGVNVVQDADVNKGTVKTAEEAVQKETEIKEDYTKQAEDIKKTTDQYKSDVA
AHEAEVAKIKAKNQATKEQYEKDMAAHKAEVERINAANAASKTAYEAKLAQYQADLAAVQ
KTNAANQAAYQKALAAYQAELKRVQEANAAAKAAYDTAVAANNAKNTEIAAANEEIRKRN
ATAKAEYETKLAQYQAELKRVQEANAANEADYQAKLTAYQTELARVQKANADAKAAYEAA
VAANNAKNAALTAENTAIKQRNENAKATYEAALKQYEADLAAVKKANAANEADYQAKLTA
YQTELARVQKANADAKAAYEAAVAANNAANAALTAENTAIKKRNADAKADYEAKLAKYQA
DLAKYQKDLADYPVKLKAYEDEQASIKAALAELEKHKNEDGNLTEPSAQNLVYDLEPNAN
LSLTTDGKFLKASAVDDAFSKSTSKAKYDQKILQLDDLDITNLEQSNDVASSMELYGNFG
DKAGWSTTVSNNSQVKWGSVLLERGQSATATYTNLQNSYYNGKKISKIVYKYTVDPKSKF
QGQKVWLGIFTDPTLGVFASAYTGQVEKNTSIFIKNEFTFYDEDGKPINFDNALLSVASL
NRENNSIEMAKDYTGKFVKISGSSIGEKNGMIYATDTLNFRQGQGGARWTMYTRASEPGS
GWDSSDAPNSWYGAGAIRMSGPNNSVTLGAISSTLVVPADPTMAIETGKKPNIWYSLNGK
IRAVNVPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRTPDQAEPN
KPTPPTYETEKPLEPAPVEPSYEAEPTPPTRTPDQAEPNKPTPPTYETEKPLEPAPVEPS
YEAEPTPPTPTPDQPEPNKPVEPTYEVIPTPPTDPVYQDLPTPPSVPTVHFHYFKLAVQP
QVNKEIRNNNDINIDRTLVAKQSVVKFQLKTADLPAGRDETTSFVLVDPLPSGYQFNPEA
TKAASPGFDVTYDNATNTVTFKATAATLATFNADLTKSVATIYPTVVGQVLNDGATYKNN
FTLTVNDAYGIKSNVVRVTTPGKPNDPDNPNNNYIKPTKVNKNENGVVIDGKTVLAGSTN
YYELTWDLDQYKNDRSSADTIQKGFYYVDDYPEEALELRQDLVKITDANGNEVTGVSVDN
YTNLEAAPQEIRDVLSKAGIRPKGAFQIFRADNPREFYDTYVKTGIDLKIVSPMVVKKQM
GQTGGSYENQAYQIDFGNGYASNIIINNVPKINPKKDVTLTLDPADTNNVDGQTIPLNTV
FNYRLIGGIIPADHSEELFEYNFYDDYDQTGDHYTGQYKVFAKVDITFKDGSIIKSGAEL
TQYTTAEVDTAKGAITIKFKEAFLRSVSIDSAFQAESYIQMKRIAVGTFENTYINTVNGV
TYSSNTVKTTTPEDPTDPTDPQDPSSPRTSTVINYKPQSTAYQPSSVQETLPNTGVTNNA
YMPLLGIIGLVTSFSLLGLKAKKD
>SPA_STAAM.1 [37,450]   Q99XA2 Immunoglobulin G binding prot
AQHDEAQQNAFYQVLNMPNLNADQRNGFIQSLKDDPSQSANVLGEAQKLNDSQAPKADAQ
QNNFNKDQQSAFYEILNMPNLNEAQRNGFIQSLKDDPSQSTNVLGEAKKLNESQAPKADN
NFNKEQQNAFYEILNMPNLNEEQRNGFIQSLKDDPSQSANLLSEAKKLNESQAPKADNKF
NKEQQNAFYEILHLPNLNEEQRNGFIQSLKDDPSVSKEILAEAKKLNDAQAPKEEDNKKP
GKEDGNKPGKEDGNKPGKEDNKKPGKEDGNKPGKEDNNKPGKEDGNKPGKEDNNKPGKED
GNKPGKEDGNKPGKEDGNGVHVVKPGDTVNDIAKANGTTADKIAADNKLADKNMIKPGQE
LVVDKKQPANHADANKAQALPETGEENPFIGTTVFGGLSLALGAALLAGRRREL
>SPEA_STRPY.1 [31,251]  P08095 Exotoxin type A precursor (Sc
QQDPDPSQLHRSSLVKNLQNIYFLYEGDPVTHENVKSVDQLLSHDLIYNVSGPNYDKLKT
ELKNQEMATLFKDKNVDIYGVEYYHLCYLCENAERSACIYGGVTNHEGNHLEIPKKIVVK
VSIDGIQSLSFDIETNKKMVTAQELDYKVRKYLTDNKQLYTNGPSKYETGYIKFIPKNKE
SFWFDFFPEPEFTQSKYLMIYKDNETLDSNTSQIEVYLTTK
>SPEB_STRPY.1 [28,398]  P00788 Streptopain precursor (EC 3.4
DQNFARNEKEAKDSAITFIQKSAAIKAGARSAEDIKLDKVNLGGELSGSNMYVYNISTGG
FVIVSGDKRSPEILGYSTSGSFDANGKENIASFMESYVEQIKENKKLDTTYAGTAEIKQP
VVKSLLDSKGIHYNQGNPYNLLTPVIEKVKPGEQSFVGQHAATGCVATATAQIMKYHNYP
NKGLKDYTYTLSSNNPYFNHPKNLFAAISTRQYNWNNILPTYSGRESNVQKMAISELMAD
VGISVDMDYGPSSGSAGSSRVQRALKENFGYNQSVHQINRSDFSKQDWEAQIDKELSQNQ
PVYYQGVGKVGGHAFVIDGADGRNFYHVNWGWGGVSDGFFRLDALNPSALGTGGGAGGFN
GYQSAVVGIKP
>SPEC_STRPY.1 [28,235]  P13380 Exotoxin type C precursor (SP
DSKKDISNVKSDLLYAYTITPYDYKNCRVNFSTTHTLNIDTQKYRGKDYYISSEMSYEAS
QKFKRDDHVDVFGLFYILNSHTGEYIYGGITPAQNNKVNHKLLGNLFISGESQQNLNNKI
ILEKDIVTFQEIDFKIRKYLMDNYKIYDATSPYVSGRIEIGTKDGKHEQIDLFDSPNEGT
RSDIFAKYKDNRIINMKNFSHFDIYLEK
>SPEG_STRPY.1 [25,234]  Q9X5C7 Exotoxin type G precursor (SP
DENLKDLKRSLRFAYNITPCDYENVEIAFVTTNSIHINTKQKRSECILYVDSIVSLGITD
QFIKGDKVDVFGLPYNFSPPYVDNIYGGIVKHSNQGNKSLQFVGILNQDGKETYLPSEAV
RIKKKQFTLQEFDFKIRKFLMEKYNIYDSESRYTSGSLFLATKDSKHYEVDLFNKDDKLL
SRDSFFKRYKDNKIFNSEEISHFDIYLKTH
>SPEH_STRPY.1 [33,236]  Q9X5C8 Exotoxin type H precursor (SP
NSYNTTNRHNLESLYKHDSNLIEADSIKNSPDIVTSHMLKYSVKDKNLSVFFEKDWISQE
FKDKEVDIYALSAQEVCECPGKRYEAFGGITLTNSEKKEIKVPVNVWDKSKQQPPMFITV
NKPKVTAQEVDIKVRKLLIKKYDIYNNREQKYSKGTVTLDLNSGKDIVFDLYYFGNGDFN
SMLKIYSNNERIDSTQFHVDVSIS
>SPG1_STRSG.1 [34,448]  P06654 Immunoglobulin G binding prot
VDSPIEDTPIIRNGGELTNLLGNSETTLALRNEESATADLTAAAVADTVAAAAAENAGAA
AWEAAAAADALAKAKADALKEFNKYGVSDYYKNLINNAKTVEGIKDLQAQVVESAKKARI
SEATDGLSDFLKSQTPAEDTVKSIELAEAKVLANRELDKYGVSDYHKNLINNAKTVEGVK
ELIDEILAALPKTDTYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDD
ATKTFTVTEKPEVIDASELTPAVTTYKLVINGKTLKGETTTKAVDAETAEKAFKQYANDN
GVDGVWTYDDATKTFTVTEMVTEVPGDAPTEPEKPEASIPLVPLTPATPIAKDDAKKDDT
KKEDAKKPEAKKDDAKKAETLPTTGEGSNPFFTAAALAVMAGAGALAVASKRKED
>SPG2_STRSG.1 [34,593]  P19909 Immunoglobulin G binding prot
VDSPIEDTPIIRNGGELTNLLGNSETTLALRNEESATADLTAAAVADTVAAAAAENAGAA
AWEAAAAADALAKAKADALKEFNKYGVSDYYKNLINNAKTVEGVKDLQAQVVESAKKARI
SEATDGLSDFLKSQTPAEDTVKSIELAEAKVLANRELDKYGVSDYHKNLINNAKTVEGVK
DLQAQVVESAKKARISEATDGLSDFLKSQTPAEDTVKSIELAEAKVLANRELDKYGVSDY
YKNLINNAKTVEGVKALIDEILAALPKTDTYKLILNGKTLKGETTTEAVDAATAEKVFKQ
YANDNGVDGEWTYDDATKTFTVTEKPEVIDASELTPAVTTYKLVINGKTLKGETTTEAVD
AATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEKPEVIDASELTPAVTTYKLVINGKTL
KGETTTKAVDAETAEKAFKQYANDNGVDGVWTYDDATKTFTVTEMVTEVPGDAPTEPEKP
EASIPLVPLTPATPIAKDDAKKDDTKKEDAKKPEAKKEDAKKAETLPTTGEGSNPFFTAA
ALAVMAGAGALAVASKRKED
>SPH_STRPY.1 [42,376]   P50470 Immunoglobulin G binding prot
EGAKIDWQEEYKKLDEDNAKLVEVVETTSLENEKLKSENEENKKNLDKLSKENQGKLEKL
ELDYLKKLDHEHKEHQKEQQEQEERQKNQEQLERKYQREVEKRYQEQLQKQQQLETEKQI
SEASRKSLSRDLEASRAAKKDLEAEHQKLEAEHQKLKEDKQISDASRQGLSRDLEASRAA
KKELEANHQKLEAEHQKLKEDKQISDASRQGLSRDLEASRAAKKELEANHQKLEAEAKAL
KEQLAKQAEELAKLRAGKASDSQTPDTKPGNKAVPGKGQAPQAGTKPNQNKAPMKETKRQ
LPSTGETANPFFTAAALTVMATAGVAAVVKRKEEN
>SPIR_SPICI.1 [24,241]  P19215 Spiralin precursor. - Spiropl
CNKTESNNLSIVKTIAVPATVATANPKQVTNAEIKTALEANVLKAVQGVVKTATAADFQF
DVYQDNKGTSLTTINLEEGNVEVYVQITPAKDKTVVIGETGYIKVTLPKIKVDISGVVID
QQIVEIKAADPKQVTKDELNAVNTYATLASAVLEAIKNKAPNAGASDFEITNNCDAGDYS
AQKDVKVTVKAKDESPNISGEFKVNAKVKATLAPPKAG
>SPIR_SPIME.1 [24,242]  P21625 Spiralin precursor. - Spiropl
CNKTESNNLSRVKTIAAPATVAASTPKAVTKPEIKTALEANVLKAVQGVVKTATAADFQF
EVYKNSKGTALETIDLEAGKVEVYLQITPAKDKTVVIGETRYIKVTLPKHGEVTKVDIKD
VTVTEQTVGIKASTPKAVKKDELNAVNTYATLAKAVLDAIQNIAPNAGASDFEITNNGAE
GDYEAAKEVEVTVKAKNDSANISGQFKFKAKVTATAPTE
>SPI_BRECH.1 [25,326]   P43131 Protease inhibitor precursor 
TSEPVKELSVNVNGQHIEQAAIFDKGQQTVLVPLRDVAESLGFQVKWNAETKAAEVNKGA
IFSYAKVGEDRYPFAKMYKTLGAEPRLLNGNTYVPVAFVDEILQAEVNVTDDAVTVVDEE
SDVAPVRTGTITTLNKREDGGVSFQLNGYETGIILHVDKETKITTADGKELKPEDLQLGM
EVEATHQKFMAMSMPQSGAVSIVVKSGLETPEVLGTAGKVASIDKDQEGSYKMLVEGQAL
AENAPEKVALIVGKDTKIVSAKDNKELAPEDLKAEMKVFAYYGPKLTRSLPPIGVAEKIV
VE
>SSP5_STRGN.1 [39,1500]  P16952 Agglutinin receptor precurso
DEVTETTSTSTVEVATTGNPATNLPEAQGEMSQVAKESQAKAGSKESALPVEVSSADLDK
AVADAKSAGVKVVQDETKDKGTATTATDNAQKQDEIKSDYAKQAEEIKTTTEAYKKEVAA
HQAETDKINAENKAADDKYQKDLKSHQEEVEKINTANATAKAEYEAKLAQYQKDLATVKK
ANEDSQQDYQNKLSAYQTELARVQKANAEAKEAYEKAVKENTAKNEALKVENEAIKQRNE
TAKATYEAAMKQYEADLAAIKKANEDNDADYQAKLAAYQTELARVQKANAEAKEAYDKAV
KENTAKNTAIQAENEAIKQRNETAKATYDAAVKKYEADLAAVKQANATNEADYQAKLAAY
QTELARVQKANADAKATYEKAVEDNKAKNAAIKAENEEIKQRNAVAKTDYEAKLAKYEAD
LAKYKKEFAAYTAALAEAESKKKQDGYLSEPRSQSLNFKSEPNAIRTIDSSVHQYGQQEL
DALVKSWGISPTNPDRKKSRAYSYFNAINSNNTYAKLVLEKDKPVDVTYTGLKNSSFNGK
KISKVVYTYTLKETGFNDGTKMTMFASSDPTVTAWYNDYFTSTNINVKVKFYDEEGQLMN
LTGGLVNFSSLNRGNGSGAIDKDAIESVRNFNGRYIPISGSSIKIHENNSAYADSSNAEK
SLGARWNTSEWDTTSSPNNWYGAIVGEITQSEISFNMASSKSGNIWFAFNSNINAIGVPT
KPVAPTAPTQPMYETEKPLEPAPVAPSYENEPTPPVKTPDQPEPSKPEEPTYETEKPLEP
APVAPSYENEPTPPVKTPDQPEPSKPEEPNYETEKPLEPAPVAPSYENEPTPPVKIPDQP
EPSKPEEPTYDPLPTPPLAPTPKQLPTPPVVPTVHFHYSSLLAQPQINKEIKNEDGVDID
RTLVAKQSIVKFELKTEALTAGRPKTTSFVLVDPLPTGYKFDLDATKAASTGFDTTYDEA
SHTVTFKATDETLATYNADLTKPVETLHPTVVGRVLNDGATYTNNFTLTVNDAYGIKSNV
VRVTTPGKPNDPDNPNNNYIKPTKVNKNKEGLNIDGKEVLAGSTNYYELTWDLDQYKGDK
SSKEAIQNGFYYVDDYPEEALDVRPDLVKVADEKGNQVSGVSVQQYDSLEAAPKKVQDLL
KKANITVKGAFQLFSADNPEEFYKQYVATGTSLVITDPMTVKSEFGKTGGKYENKAYQID
FGNGYATEVVVNNVPKITPKKDVTVSLDPTSENLDGQTVQLYQTFNYRLIGGLIPQNHSE
ELEDYSFVDDYDQAGDQYTGNYKTFSSLNLTMKDGSVIKAGTDLTSQTTAETDATNGIVT
VRFKEDFLQKISLDSPFQAETYLQMRRIAIGTFENTYVNTVNKVAYASNTVRTTTPIPRT
PDKPTPIPTPKPKDPDKPETPKEPKVPSPKVEDPSAPIPVSVGKELTTLPKTGTNDATYM
PYLGLAALVGFLGLGLAKRKED
>SSUA_BACSU.1 [18,332]  P40400 Putative aliphatic sulfonates
CGANGASGDHKQLKEIRIGIQQSLSPLLIAKEKGWFEDAFEKEGIKVKWVEFQSGPPQFE
GLAADKLDFSQVGNSPVIAGQAAGIDFKEIGLSQDGLKANGILVNQNSGIQDVKGLKGKK
IAVAKGSSGFDFLYKALDQVGLSANDVTIIQLQPDEAASAFENGSVDAWSIWEPYLSLET
MKHGAKILVNGESTDLYSPGFTLVRTKFSEEHPDEVVRFLKVFNKAVVWQKEHLDEAADL
YSDIKDLDKKVVENVLKNTEPLNEIISDDIVKAQQETADFQFRTKAIDKKIDVKDVVDNT
FIKKALEEHSSGGDQ
>STC1_STAAU.1 [27,658]  P07767 Staphylocoagulase precursor. 
IVTKDYSKESRVNEKSKKGATVSDYYYWKIIDSLEAQFTGAIDLLENYKYGDPIYKEAKD
RLMTRVLGEDQYLLKKKIDEYELYKKWYKSSNKNTNMLTFHKYNLYNLTMNEYNDIFNSL
KDAVYQFNKEVKEIEHKNVDLKQFDKDGEDKATKEVYDLVSEIDTLVVTYYADKDYGEHA
KELRAKLDLILGDTDNPHKITNERIKKEMIDDLNSIIDDFFMETKQNRPNSITKYDPTKH
NFKEKSENKPNFDKLVEETKKAVKEADESWKNKTVKKYEETVTKSPVVKEEKKVEEPQLP
KVGNQQEVKTTAGKAEETTQPVAQPLVKIPQETIYGETVKGPEYPTMENKTLQGEIVQGP
DFLTMEQNRPSLSDNYTQPTTPNPILEGLEGSSSKLEIKPQGTESTLKGIQGESSDIEVK
PQATETTEASQYGPRPQFNKTPKYVKYRDAGTGIREYNDGTFGYEARPRFNKPSETNAYN
VTTNQDGTVSYGARPTQNKPSETNAYNVTTHANGQVSYGARPTQNKPSKTNAYNVTTHAN
GQVSYGARPTQKKPSKTNAYNVTTHANGQVSYGARPTYKKPSETNAYNVTTHANGQVSYG
ARPTQKKPSETNAYNVTTHADGTATYGPRVTK
>STC2_STAAU.1 [27,715]  P17855 Staphylocoagulase precursor. 
IVTKDYSKESRVNENSKYGTLISDWYLKGRLTSLESQFINALDILETYHYGEKEYKDAKD
KLMTRILGEDQYLLERKKVQYEEYKKLYQKYKEENPTSKGLKLKTFDQYTIEDLTMREYN
ELTESLKSAVKDFEKDVEKIENQHHDLKPFTDEMEEKATSRVDDLANKAYSVYFAFVRDT
QHKTEALELKAKVDLVLGDEDKPHRISNERIEKEMIKDLESIIEDFFIETGLNKPGNITS
YDSSKHHYKNHSEGFEALVKETREAVANADESWKTKTVKKYGESETKSPVVKEENKVEDP
QSPKFDNQQEVKTTAGKAEETTQPVAQPLVKIPQGTITGEIVKGPEYPTMENKTLQGEIV
QGPDFPTMEQSGPSLSDNYTQPTTPNPILEGLEGSSSKLEIKPQGTESTLKGIQGESSDI
EVKPQATETTEASQYGPRPQFNKTPKYVKYRDAGTGIREYNDGTFGYEARPRFNKPSETN
AYNVTTNQDGTVSYGARPTQNKASETNAYNVTTHANGQVSYGARPTQKKPSETNAYNVTT
HANGQVSYGARPTYNKPSETNAYNVTTHGNGQVSYGARPTYKKPSKTNAYNVTTHANGQV
SYGARPTQNKPSETNAYNVTTHANGQVSYGARPTQNKPSETNAYNVTTHGNGQVSYGARP
TYNKPSKTNAYNVTTHADGTATYGPRVTK
>STPA_STAAM.1 [26,388]  Q99SX8 Staphopain precursor (EC 3.4.
ESNSNIKAKDKKHVQVNVEDKSVPTDVRNLAQKDYLSYVTSLDKIYNKEKASYTLGEPFK
IYKFNKKSDGNYYFPVLNTEGNIDYIVTISPKITKYSSSSSKYTINVSPFLSKVLNQYKD
QQITILTNSKGYYVVTQNHKAKLVLKTPRLEDKKLKKTESIPTGNNVTQLKQKASVTMPT
SQFKSNNYTYNEQYINKLENFKIRETQGNNGWCAGYTMSALLNATYNTNKYHAEAVMRFL
HPNLQGQRFQFTGLTPREMIYFGQTQGRSPQLLNRMTTYNEVDNLTKNNKGIAVLGSRVE
SRNGMHAGHAMAVVGNAKLDNGQEVIIIWNPWDNGFMTQDAKNNVIPVSNGDHYRWYSSI
YGY
>STPA_STAAW.1 [26,388]  Q8NVS9 Staphopain precursor (EC 3.4.
ESNSNIKAKDKKHVQVNVEDKSIPTEVRNLAQKDYLSYVTSLDKIYNKEKASYTLGEPFK
IYKFNKKSDGNYYFPVLNTEGNIDYIVTISPKVTKYSSSSSKYTINVSPFLSKVLNQYKD
QQITILTNSKGYYVVTQNHKAKLVLKTPRLEDKKLKKTESIPTGNNVTQLKQKASVTMPT
SQFKSNNYTYNEQYVNKLENFKIRETQGNNGWCAGYTMSALLNATYNTNKYHAEAVMRFL
HPNLQGQRFQFTGLTPREMIYFGQTQGRSPQLLNRMTTYNEVDNLTKNNKGIAVLGSRVE
SRNGMHAGHAMAVVGNAKLDNGQEVIIIWNPWDNGFMTQDAKNNVIPVSNGDHYQWYSSI
YGY
>STRH_STRPN.1 [34,1312]  P49610 Beta-N-acetylhexosaminidase 
ADGVTPTTTENQPTIHTVSDSPQSSENRTEETPKAVLQPEAPKTVETETPATDKVASLPK
TEEKPQEEVSSTPSDKAEVVTPTSAEKETANKKAEEASPKKEEAKEVDSKESNTDKTDKD
KPAKKDEAKAEADKPATEAGKERAATVNEKLAKKKIVSIDAGRKYFSPEQLKEIIDKAKH
YGYTDLHLLVGNDGLRFMLDDMSITANGKTYASDDVKRAIEKGTNDYYNDPNGNHLTESQ
MTDLINYAKDKGIGLIPTVNSPGHMDAILNAMKELGIQNPNFSYFGKKSARTVDLDNEQA
VAFTKALIDKYAAYFAKKTEIFNIGLDEYANDATDAKGWSVLQADKYYPNEGYPVKGYEK
FIAYANDLARIVKSHGLKPMAFNDGIYYNSDTSFGSFDKDIIVSMWTGGWGGYDVASSKL
LAEKGHQILNTNDAWYYVLGRNADGQGWYNLDQGLNGIKNTPITSVPKTEGADIPIIGGM
VAAWADTPSARYSPSRLFKLMRHFANANAEYFAADYESAEQALNEVPKDLNRYTAESVTA
VKEAEKAIRSLDSNLSRAQQDTIDQAIAKLQETVNNLTLTPEAQKEEEAKREVEKLAKNK
VISIDAGRKYFTLNQLKRIVDKASELGYSDVHLLLGNDGLRFLLDDMTITANGKTYASDD
VKKAIIEGTKAYYDDPNGTALTQAEVTELIEYAKSKDIGLIPAINSPGHMDAMLVAMEKL
GIKNPQAHFDKVSKTTMDLKNEEAMNFVKALIGKYMDFFAGKTKIFNFGTDEYANDATSA
QGWYYLKWYQLYGKFAEYANTLAAMAKERGLQPMAFNDGFYYEDKDDVQFDKDVLISYWS
KGWWGYNLASPQYLASKGYKFLNTNGDWYYILGQKPEDGGGFLKKAIENTGKTPFNQLAS
TKYPEVDLPTVGSMLSIWADRPSAEYKEEEIFELMTAFADHNKDYFRANYNALREELAKI
PTNLEGYSKESLEALDAAKTALNYNLNRNKQAELDTLVANLKAALQGLKPAVTHSGSLDE
NEVAANVETRPELITRTEEIPFEVIKKENPNLPAGQENIITAGVKGERTHYISVLTENGK
TTETVLDSQVTKEVINQVVEVGAPVTHKGDESGLAPTTEVKPRLDIQEEEIPFTTVTCEN
PLLLKGKTQVITKGVNGHRSNFYSVSTSADGKEVKTLVNSVVAQEAVTQIVEVGTMVTHV
GDENGQAAIAEEKPKLEIPSQPAPSTAPAEESKVLPQDPAPVVTEKKLPETGTHDSAGLV
VAGLMSTLAAYGLTKRKED
>STRP_STREQ.1 [27,440]  P00779 Streptokinase C precursor. - 
IAGPEWLLDRPSVNNSQLVVSVAGTVEGTNQDISLKFFEIDLTSRPAHGGKTEQGLSPKS
KPFATDSGAMSHKLEKADLLKAIQEQLIANVHSNDDYFEVIDFASDATITDRNGKVYFAD
KDGSVTLPTQPVQEFLLSGHVRVRPYKEKPIQNQAKSVDVEYTVQFTPLNPDDDFRPGLK
DTKLLKTLAIGDTITSQELLAQAQSILNKNHPGYTIYERDSSIVTHDNDIFRTILPMDQE
FTYRVKNREQAYRINKKSGLNEEINNTDLISEKYYVLKKGEKPYDPFDRSHLKLFTIKYV
DVDTNELLKSEQLLTASERNLDFRDLYDPRDKAKLLYNNLDAFGIMDYTLTGKVEDNHDD
TNRIITVYMGKRPEGENASYHLAYDKDRYTEEEREVYSYLRYTGTPIPDNPNDK
>STRP_STRPY.1 [27,440]  P10520 Streptokinase A precursor. - 
IAGYGWLPDRPPINNSQLVVSMAGIVEGTDKKVFINFFEIDLTSQPAHGGKTEQGLSPKS
KPFATDNGAMPHKLEKADLLKAIQKQLIANVHSNDGYFEVIDFASDATITDRNGKVYFAD
KDGSVTLPTQPVQEFLLKGHVRVRPYKEKPVQNQAKSVDVEYTVQFTPLNPDDDFRPGLK
DTKLLKTLAIGDTITSQELLAQAQSILNKTHPGYTIYERDSSIVTHDNDIFRTILPMDQE
FTYHVKNREQAYEINPKTGIKEKTNNTDLVSEKYYVLKQGEKPYDPFDRSHLKLFTIKYV
DVNTNELLKSEQLLTASERNLDFRDLYDPRDKAKLLYNNLDAFDIMDYTLTGKVEDNHDK
NNRVVTVYMGKRPKGAKGSYHLAYDKDLYTEEERKAYSYLRDTGTPIPDNPKDK
>STRP_STRS1.1 [27,440]  P10519 Streptokinase G precursor. - 
IAGPEWLLDRPSVNNSQLVVSVAGTVEGTNQDISLKFFEIDLTSRPAHGGKTEQGLSPKS
KLFATDSGAMPHKLEKADLLKAIQEQLIANVHSNDDYFEVIDFASDATITDRNGKVYFAD
KDGSVTLPIQPVQEFLLKGHVRVRPYKEKPVQNQAKSVDVEYTVQFTPLNPDDDFRPALK
DTKLLKTLAIGDTITSQELLAQAQSILNKNHPGYTIYERDSSIVTHDNDIFRTILPMDQE
FTYHVKNREQAYRINKKSGLNEEINNTDLISEKYYVLKKGEKPYDPFDRSHLKLFTIKYV
DVNTNELLKSEQLLTASERNLDFRDLYDPRDKAKLLYNNLDAFGIMDYTLTGKVEDNHDD
TNRIITVYMGKRPEGENASYHLAYDKDRYTEEEREVYSYLRYTGTPIPDNPNDK
>STRQ_STRPY.1 [27,440]  P96471 Streptokinase precursor. - St
IAGPEWLLGRPSVNNSQLVVSVAGTVEGTNQEISLKFFEIDLTSRPAQGGKTEQGLRPKS
KPLATDKGAMSHKLEKADLLKAIQEQLIANVHSNDGYFEVIDFASDATITDRNGKVYFAD
RDDSVTLPTQPVQEFLLSGHVRVRPYRPKAVHNSAERVNVNYEVSFVSETGNLDFTPSLK
EQYHLTTLAVGDSLSSQELAAIAQFILSKKHPDYIITKRDSSIVTHDNDIFRTILPMDQE
FTYHIKDREQAYKANSKTGIEEKTNNTDLISEKYYILKKGEKPYDPFDRSHLKLFTIKYV
DVDTKALLKSEQLLTASERNLDFRDLYDPRDKAKLLYNNLDAFGIMGYTLTGKVEDNHDD
TNRIITVYMGKRPEGENASYHLAYDKDRYTEEEREVYSYLRDTGTPIPDNPKDK
>STSP_STAAU.1 [30,336]  P04188 Glutamyl endopeptidase precur
LSSKAMDNHPQQTQSSKQQTPKIQKGGNLKPLEQREHANVILPNNDRHQITDTTNGHYAP
VTYIQVEAPTGTFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFT
AEQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMSNNAETQVNQNITVTGYPGDKPVA
TMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIGIHWGGVPNEFNGAVFINEN
VRNFLKQNIEDIHFANDDQPNNPDNPDNPNNPDNPNNPDEPNNPDNPNNPDNPDNGDNNN
SDNPDAA
>SUBE_BACSU.1 [28,645]  P16396 Minor extracellular protease 
QNSSEKEVIVVYKNKAGKETILDSDADVEQQYKHLPAVAVTADQETVKELKQDPDILYVE
NNVSFTAADSTDFKVLSDGTDTSDNFEQWNLEPIQVKQAWKAGLTGKNIKIAVIDSGISP
HDDLSIAGGYSAVSYTSSYKDDNGHGTHVAGIIGAKHNGYGIDGIAPEAQIYAVKALDQN
GSGDLQSLLQGIDWSIANRMDIVNMSLGTTSDSKILHDAVNKAYEQGVLLVAASGNDGNG
KPVNYPAAYSSVVAVSATNEKNQLASFSTTGDEVEFSAPGTNITSTYLNQYYATGSGTSQ
ATPHAAAMFALLKQRDPAETNVQLREEMRKNIVDLGTAGRDQQFGYGLIQYKAQATDSAY
AAAEQAVKKAEQTKAQIDINKARELISQLPNSDAKTALHKRLDKVQSYRNVKDAKDKVAK
AEKYKTQQTVDTAQTAINKLPNGTDKKNLQKRLDQVKRYIASKQAKDKVAKAEKSKKKTD
VDSAQSAIGKLPASSEKTSLQKRLNKVKSTNLKTAQQSVSAAEKKSTDANAAKAQSAVNQ
LQAGKDKTALQKRLDKVKKKVAAAEAKKVETAKAKVKKAEKDKTKKSKTSAQSAVNQLKA
SNEKTKLQKRLNAVKPKK
>SUBF_BACSU.1 [31,1433]  P16397 Bacillopeptidase F precursor
SSKVTSPSVKKELQSAESIQNKISSSLKKSFKKKEKTTFLIKFKDLANPEKAAKAAVKKA
KSKKLSAAKTEYQKRSAVVSSLKVTADESQQDVLKYLNTQKDKGNADQIHSYYVVNGIAV
HASKEVMEKVVQFPEVEKVLPNEKRQLFKSSSPFNMKKAQKAIKATDGVEWNVDQIDAPK
AWALGYDGTGTVVASIDTGVEWNHPALKEKYRGYNPENPNEPENEMNWYDAVAGEASPYD
DLAHGTHVTGTMVGSEPDGTNQIGVAPGAKWIAVKAFSEDGGTDADILEAGEWVLAPKDA
EGNPHPEMAPDVVNNSWGGGSGLDEWYRDMVNAWRAADIFPEFSAGNTDLFIPGGPGSIA
NPANYPESFATGATDINKKLADFSLQGPSPYDEIKPEISAPGVNIRSSVPGQTYEDGWDG
TSMAGPHVSAVAALLKQANASLSVDEMEDILTSTAEPLTDSTFPDSPNNGYGHGLVNAFD
AVSAVTDGLGKAEGQVSVEGDDQEPPVYQHEKVTEAYEGGSLPLTLTAEDNVSVTSVKLS
YKLDQGEWTEITAKRISGDHLKGTYQAEIPDIKGTKLSYKWMIHDFGGHVVSSDVYDVTV
KPSITAGYKQDFETAPGGWVASGTNNNWEWGVPSTGPNTAASGEKVYGTNLTGNYANSAN
MNLVMPPIKAPDSGSLFLQFKSWHNLEDDFDYGYVFVLPEGEKNWEQAGVYNGKTSSWTD
EEIDLSAYKGQNIQVMFNLQSDESIAKEGWYIDDVVLSDKSAGKTVKKNKLGVEKPSGKQ
KKKPVNPKKAKPSANTAVKHQNKAIQPQVLPLKAQVSVVETGKSTYSDQSTGQYTLKHKA
GDYTLMAEAYGYQSKTQKVSLKTDQTTQANFTLEEMKKGTLKGTVINKTTGEPVTGASVY
VVEDAAVEPAMTNDKGEYMLEAYEGAYTIKVAAPGYYSDEFSVELKGDVTKETALKPFVG
YPGEIAYDDGTAENANSYFAAGNGWAVKMTLADGKDKGMLTGGLFRFWDTEFPDPGGTEF
KVEVYDATGKDGAPGKKIAGPFNAEALRNGEWTKVDLSSKGIMVDKDFYLVYIQSKPDPY
SPGLAMDETGQNSGRNWQYIDGKWQPGDKADGNYMIRALVDYEAAVPEITSPTDKSYTNK
DSVTVKGNASPGTTVHIYNGEKEAGETKAAADGTFHAGIILNKGENELTATASTDNGTTD
ASSPITVTLDQEKPELTLDNPKDGGKTNKETLTVKGAVSDDNLKDVKVNGKKATVADGSY
SARILLENGRNEIKVIATDLAGNKTTKKTVIDVNFDKPVISGLIPGEDKNLKAGESVKIA
FSSAEDLDATFTIRMPLTNARASVQNATELPLREISPGRYEGYWTATSSIKAKGAKVEVI
VRDDYGNETRKTANGKLNMNTEN
>SUBN_BACNA.1 [24,381]  P35835 Subtilisin NAT precursor (EC 
NMSAQAAGKSSTEKKYIVGFKQTMSAMSSAKKKDVISEKGGKVQKQFKYVNAAAATLDEK
AVKELKKDPSVAYVEEDHIAHEYAQSVPYGISQIKAPALHSQGYTGSNVKVAVIDSGIDS
SHPDLNVRGGASFVPSETNPYQDGSSHGTHVAGTIAALNNSIGVLGVAPSASLYAVKVLD
STGSGQYSWIINGIEWAISNNMDVINMSLGGPTGSTALKTVVDKAVSSGIVVAAAAGNEG
SSGSTSTVGYPAKYPSTIAVGAVNSSNQRASFSSVGSELDVMAPGVSIQSTLPGGTYGAY
NGTSMATPHVAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGKGLINVQAAAQ
>SUBT_BACAM.1 [33,382]  P00782 Subtilisin BPN' precursor (EC
KSNGEKKYIVGFKQTMSTMSAAKKKDVISEKGGKVQKQFKYVDAASATLNEKAVKELKKD
PSVAYVEEDHVAHAYAQSVPYGVSQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLKVA
GGASMVPSETNPFQDNNSHGTHVAGTVAALNNSIGVLGVAPSASLYAVKVLGADGSGQYS
WIINGIEWAIANNMDVINMSLGGPSGSAALKAAVDKAVASGVVVVAAAGNEGTSGSSSTV
GYPGKYPSVIAVGAVDSSNQRASFSSVGPELDVMAPGVSIQSTLPGNKYGAYNGTSMASP
HVAGAAALILSKHPNWTNTQVRSSLENTTTKLGDSFYYGKGLINVQAAAQ
>SUBT_BACLI.1 [30,379]  P00780 Subtilisin Carlsberg precurso
AQPAKNVEKDYIVGFKSGVKTASVKKDIIKESGGKVDKQFRIINAAKAKLDKEALKEVKN
DPDVAYVEEDHVAHALAQTVPYGIPLIKADKVQAQGFKGANVKVAVLDTGIQASHPDLNV
VGGASFVAGEAYNTDGNGHGTHVAGTVAALDNTTGVLGVAPSVSLYAVKVLNSSGSGTYS
GIVSGIEWATTNGMDVINMSLGGPSGSTAMKQAVDNAYARGVVVVAAAGNSGSSGNTNTI
GYPAKYDSVIAVGAVDSNSNRASFSSVGAELEVMAPGAGVYSTYPTSTYATLNGTSMASP
HVAGAAALILSKHPNLSASQVRNRLSSTATYLGSSFYYGKGLINVEAAAQ
>SUBT_BACS9.1 [27,420]  P28842 Subtilisin precursor (EC 3.4.
NEGNAAAEGNEKFRVLVDSVDQKNLKNAKQQYGVHWDFAGEGFTTDMNEKQFNALKKNKN
LTVEKVPELEIATATDKPEALYNAMAASQSTPWGIKAIYNNSSITQTSGGGGINIAVLDT
GVNTNHPDLRNNVEQCKDFTVGTTYTNNSCTDRQGHGTHVAGSALADGGTGNGVYGVAPD
ADLWAYKVLGDDGSGYADDIAAAIRHAGDQATALNTKVVINMSLGSSGESSLITNAVNYS
YNKGVLIIAAAGNSGPYQGSIGYPGALVNAVAVAALENKVENGTYRVADFSSRGYSWTDG
DYAIQKGDVEISAPGAAIYSTWFDGGYATISGTSMASPHAAGLAAKIWAQYPSASNVDVR
GELQYRAYENDILSGYYAGYGDDFASGFGFATVQ
>SUBT_BACSA.1 [31,381]  P00783 Subtilisin amylosacchariticus
GKSSTEKKYIVGFKQTMSAMSSAKKKDVISEKGGKVQKQFKYVNAAAATLDEKAVKELKK
DPSVAYVEEDHIAHEYAQSVPYGISQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLNV
RGGASFVPSETNPYQDGSSHGTHVAGTIAALNNSIGVLGVSPSASLYAVKVLDSTGSGQY
SWIINGIEWAISNNMDVINMSLGGPSGSTALKTVVDKAVSSGIVVAAAAGNEGSSGSSST
VGYPAKYPSTIAVGAVNSSNQRASFSSAGSELDVMAPGVSIQSTLPGGTYGAYNGTSMAT
PHVAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGKGLINVQAAAQ
>SUBT_BACST.1 [30,381]  P29142 Subtilisin J precursor (EC 3.
AGKSSTEKKYIVGFKQTMSAMSSAKKKDVISEKGGKVQKQFKYVNAAAATLDEKAVKELK
KDPSVAYVEEDHIAHEYAQSVPYGISQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLN
VRGGASFVPSETNPYQDGSSHGTHVAGTIAALNNSIGVLGVSPSASLYAVKVLDSTGSGQ
YSWIINGIEWAISNNMDVINMSLGGPSGSTALKTVVDKAVSSGIVVAAAAGNEGSSGSSS
TVGYPAKYPSTIAVGAVNSSNQRASFSSAGSELDVMAPGVSIQSTLPGGTYGAYNGTSMA
TPHVAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGKGLINVQAAAQ
>SUBT_BACSU.1 [24,381]  P04189 Subtilisin E precursor (EC 3.
NMSVQAAGKSSTEKKYIVGFKQTMSAMSSAKKKDVISEKGGKVQKQFKYVNAAAATLDEK
AVKELKKDPSVAYVEEDHIAHEYAQSVPYGISQIKAPALHSQGYTGSNVKVAVIDSGIDS
SHPDLNVRGGASFVPSETNPYQDGSSHGTHVAGTIAALNNSIGVLGVSPSASLYAVKVLD
STGSGQYSWIINGIEWAISNNMDVINMSLGGPTGSTALKTVVDKAVSSGIVVAAAAGNEG
SSGSTSTVGYPAKYPSTIAVGAVNSSNQRASFSSAGSELDVMAPGVSIQSTLPGGTYGAY
NGTSMATPHVAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGKGLINVQAAAQ
>SUBV_BACSU.1 [29,806]  P29141 Minor extracellular protease 
APASSKTSADLEKAEVFGDIDMTTSKKTTVIVELKEKSLAEAKEAGESQSKSKLKTARTK
AKNKAIKAVKNGKVNREYEQVFSGFSMKLPANEIPKLLAVKDVKAVYPNVTYKTDNMKDK
DVTISEDAVSPQMDDSAPYIGANDAWDLGYTGKGIKVAIIDTGVEYNHPDLKKNFGQYKG
YDFVDNDYDPKETPTGDPRGEATDHGTHVAGTVAANGTIKGVAPDATLLAYRVLGPGGSG
TTENVIAGVERAVQDGADVMNLSLGNSLNNPDWATSTALDWAMSEGVVAVTSNGNSGPNG
WTVGSPGTSREAISVGATQLPLNEYAVTFGSYSSAKVMGYNKEDDVKALNNKEVELVEAG
IGEAKDFEGKDLTGKVAVVKRGSIAFVDKADNAKKAGAIGMVVYNNLSGEIEANVPGMSV
PTIKLSLEDGEKLVSALKAGETKTTFKLTVSKALGEQVADFSSRGPVMDTWMIKPDISAP
GVNIVSTIPTHDPDHPYGYGSKQGTSMASPHIAGAVAVIKQAKPKWSVEQIKAAIMNTAV
TLKDSDGEVYPHNAQGAGSARIMNAIKADSLVSPGSYSYGTFLKENGNETKNETFTIENQ
SSIRKSYTLEYSFNGSGISTSGTSRVVIPAHQTGKATAKVKVNTKKTKAGTYEGTVIVRE
GGKTVAKVPTLLIVKEPDYPRVTSVSVSEGSVQGTYQIETYLPAGAEELAFLVYDSNLDF
AGQAGIYKNQDKGYQYFDWDGTINGGTKLPAGEYYLLAYAANKGKSSQVLTEEPFTVE
>TACY_BACCE.1 [29,485]  Q45105 Hemolysin precursor (Fragment
ETQAGHANDITKNASSIDTGIGNLTYNNQEVLAVNGDKVESFVPKESINSNGKFVVVDVR
KNHLQRHQSIFRLLDSVANRTYPGAVQLANKAFADNQPSLLVAKRKPLNISIDLPGMRKE
NTITVQNPTYGNVAGAVDDLVSTWNEKYSATHTLPARMQYTESMVYSKAQIASALNVNAK
YLDNSLNIDFNAVANGEKKVMVAAYKQIFYTVSAELPNNPSDLFDNSVTFGELTRKGVSN
SAPPVMVSNVAYGRTVYVKLETTSKSKDVQAAFKALLKNNSVETSGQYKDIFEESTFTAV
VLGGDAKEHNKVVTKDFNEIRNIIKDNAELSFKNPAYPISYTSTFLKDNATAAVHNNTDY
IETTTTEYSSAKMTLDHYGAYVAQFDVSWDGFTFDQNGKEILTHKTWEGSGKDKTAHYST
VIPLPPNSKNIKIVARECTGLAWEWWRTIIKMNKMFH
>TACY_CLOPE.1 [29,500]  P19995 Perfringolysin O precursor (T
KDITDKNQSIDSGISSLSYNRNEVLASNGDKIESFVPKEGKKTGNKFIVVERQKRSLTTS
PVDISIIDSVNDRTYPGALQLADKAFVENRPTILMVKRKPININIDLPGLKGENSIKVDD
PTYGKVSGAIDELVSKWNEKYSSTHTLPARTQYSESMVYSKSQISSALNVNAKVLENSLG
VDFNAVANNEKKVMILAYKQIFYTVSADLPKNPSDLFDDSVTFNDLKQKGVSNEAPPLMV
SNVAYGRTIYVKLETTSSSKDVQAAFKALIKNTDIKNSQQYKDIYENSSFTAVVLGGDAQ
EHNKVVTKDFDEIRKVIKDNATFSTKNPAYPISYTSVFLKDNSVAAVHNKTDYIETTSTE
YSKGKINLDHSGAYVAQFEVAWDEVSYDKEGNEVLTHKTWDGNYQDKTAHYSTVIPLEAN
ARNIRIKARECTGLAWEWWRDVISEYDVPLTNNINVSIWGTTLYPGSSITYN
>TACY_LISIV.1 [24,528]  P31831 Ivanolysin precursor (Thiol-a
ADASVYSYQGIISHMAPPASPPAKPKTPVEKKNAAQIDQYIQGLDYDKNNILVYDGEAVK
NVPPKAGYKEGNQYIVVEKKKKSINQNNADIQVINSLASLTYPGALVKANSELVENQPDV
LPVKRDSVTLSIDLPGMVNHDNEIVVQNATKSNINDGVNTLVDRWNNKYSEEYPNISAKI
DYDQEMAYSESQLVAKFGAAFKAVNNSLNVNFGAISEGKVQEEVINFKQIYYTVNVNEPT
SPSRFFGKSVTKENLQALGVNAENPPAYISSVAYGRDIFVKLSTSSHSTRVKAAFDTAFK
GKSVKGDTELENIIQNASFKAVIYGGSAKDEVEIIDGDLSKLRDILKQGANFDKKNPGVP
IAYTTNFLKDNQLAVVKNNSEYIETTSKAYSDGKINLDHSGAYVARFNVTWDEVSYDANG
NEVVEHKKWSENDKDKLAHFTTSIYLPGNARNINIHAKECTGLAWEWWRTVVDDRNLPLV
KNRNVCIWGTTLYPAYSDTVDNPIK
>TACY_LISMO.1 [26,529]  P13128 Listeriolysin O precursor (Th
DASAFNKENSISSMAPPASPPASPKTPIEKKHADEIDKYIQGLDYNKNNVLVYHGDAVTN
VPPRKGYKDGNEYIVVEKKKKSINQNNADIQVVNAISSLTYPGALVKANSELVENQPDVL
PVKRDSLTLSIDLPGMTNQDNKIVVKNATKSNVNNAVNTLVERWNEKYAQAYPNVSAKID
YDDEMAYSESQLIAKFGTAFKAVNNSLNVNFGAISEGKMQEEVISFKQIYYNVNVNEPTR
PSRFFGKAVTKEQLQALGVNAENPPAYISSVAYGRQVYLKLSTNSHSTKVKAAFDAAVSG
KSVSGDVELTNIIKNSSFKAVIYGGSAKDEVQIIDGNLGDLRDILKKGATFNRETPGVPI
AYTTNFLKDNELAVIKNNSEYIETTSKAYTDGKINIDHSGGYVAQFNISWDEVNYDPEGN
EIVQHKNWSENNKSKLAHFTSSIYLPGNARNINVYAKECTGLAWEWWRTVIDDRNLPLVK
NRNISIWGTTLYPKYSNKVDNPIE
>TACY_LISSE.1 [26,530]  P31830 Seeligeriolysin precursor (Th
DVPAYDRSEVTISPAETPESPPATPKTPVEKKHAEEINKYIWGLNYDKNSILVYQGEAVT
NVPPKKGYKDGSEYIVVEKKKKGINQNNADISVINAISSLTYPGALVKANRELVENQPNV
LPVKRDSLTLSVDLPGMTKKDNKIFVKNPTKSNVNNAVNTLVERWNDKYSKAYPNINAKI
DYSDEMAYSESQLIAKFGTAFKAVNNSLNVNFEAISDGKVQEEVISFKQIYYNINVNEPT
SPSKFFGGSVTKEQLDALGVNAENPPAYISSVAYGRQVYVKLSSSSHSNKVKTAFEAAMS
GKSVKGDVELTNIIKNSSFKAVIYGGSAKEEVEIIDGNLGELRDILKKGSTYDRENPGVP
ISYTTNFLKDNDLAVVKNNSEYIETTSKSYTDGKINIDHSGGYVAQFNISWDEVSYDENG
NEIKVHKKWGENYKSKLAHFTSSIYLPGNARNINIYARECTGLFWEWWRTVIDDRNLPLV
KNRNVSIWGTTLYPRHSNNVDNPIQ
>TACY_PAEAL.1 [33,501]  P23564 Alveolysin precursor (Thiol-a
APTEPNDIDMGIAGLNYNRNEVLAIQGDQISSFVPKEGIQSNGKFIVVERDKKSLTTSPV
DISIVDSITNRTYPGAIQLANKDFADNQPSLVMAARKPLDISIDLPGLKNENTISVQNPN
YGTVSSAIDQLVSTWGEKYSSTHTLPARLQYAESMVYSQNQISSALNVNAKVLNGTLGID
FNAVANGEKKVMVAAYKQIFYTVSAGLPNNPSDLFDDSVTFAELARKGVSNEAPPLMVSN
VAYGRTIYVKLETTSKSNDVQTAFKLLLNNPSIQASGQYKDIYENSSFTAVVLGGDAQTH
NQVVTKDFNVIQSVIKDNAQFSSKNPAYPISYTSVFLKDNSIAAVHNNTEYIETKTTEYS
KGKIKLDHSGAYVAQFEVYWDEFSYDADGQEIVTRKSWDGNWRDRSAHFSTEIPLPPNAK
NIRIFARECTGLAWEWWRTVVDEYNVPLASDINVSIWGTTLYPKSSITH
>TACY_STRCB.1 [37,574]  Q53957 Streptolysin O precursor (Thi
NKQNTANTETTTTNEQPKPESSELTTEKAGQKMDDMLNSNDMIKLAPKEMPLESAEKEEK
KSEDNKKSEEDHTEEINDKIYSLNYNELEVLAKNGETIENFVPKEGVKKADKFIVIERKK
KNINTTPVDISIIDSVTDRTYPAALQLANKGFTENKPDAVVTKRNPQKIHIDLPGMGDKA
TVEVNDPTYANVSTAIDNLVNQWHDNYSGGNTLPARTQYTESMVYSKSQIEAALNVNSKI
LDGTLGIDFKSISKGEKKVMIAAYKQIFYTVSANLPNNPADVFDKSVTFKELQAKGVSNE
APPLFVSNVAYGRTVFVKLETSSKSNDVEAAFSAALKGTDVKTNGKYSDILENSSFTAVV
LGADAAEHNKVVTKDFDVIRNVIKANATFSRKNPAYPISYTSVFLKNNKIAGVNNRSEYV
ETTSTEYTSGKINLSHQGAYVAQYEILWDEINYDDKGKEVITKRRWDNNWYSKTSPFSTV
IPLGANSRNIRIMARECTGLAWEWWRKVIDERDVKLSKEINVNISGSTLSPYGSITYK
>TACY_STREQ.1 [37,574]  Q54114 Streptolysin O precursor (Thi
NKQNTANTETTTTNEQPKPESSELTTEKAGQKMDDMLNSNDMIKLAPKEMPLESAEKEEK
KSEDNKKSEEDHTEEINDKIYSLNYNELEVLAKNGETIENFVPKEGVKKADKFIVIERKK
KNINTTPVDISIIDSVTDRTYPAALQLANKGFTENKPDAVVTKRNPQKIHIDLPGMGDKA
TVEVNDPTYANVSTAIDNLVNQWHDNYSGGNTLPARTQYTESMVYSKSQIEAALNVNSKI
LDGTLGIDFKSISKGEKKVMIAAYKQIFYTVSANLPNNPADVFDKSVTLKELQRKGVSNE
APPLFVSNVAYGRTVFVKLETSSKSNDVEAAFSAALKGTDVKTNGKYSDILENSSFTAVV
LGGDAAEHNKVVTKDFDVIRNVIKDNATFSRKNPAYPISYTSVFLKNNKIAGVNNRSEYV
ETTSTEYTSGKINLSHQGAYVAQYEILWDEINYDDKGKEVITKRRWDNNWYSKTSPFSTV
IPLGANSRNIRIMARECTGLAWEWWRKVIDERDVKLSKEINVNISGSTLSPYGSITYK
>TACY_STRPY.1 [34,571]  P21131 Streptolysin O precursor (Thi
NKQNTASTETTTTNEQPKPESSELTTEKAGQKTDDMLNSNDMIKLAPKEMPLESAEKEEK
KSEDKKKSEEDHTEEINDKIYSLNYNELEVLAKNGETIENFVPKEGVKKADKFIVIERKK
KNINTTPVDISIIDSVTDRTYPAALQLANKGFTENKPDAVVTKRNPQKIHIDLPGMGDKA
TVEVNDPTYANVSTAIDNLVNQWHDNYSGGNTLPARTQYTESMVYSKSQIEAALNVNSKI
LDGTLGIDFKSISKGEKKVMIAAYKQIFYTVSANLPNNPADVFDKSVTFKELQRKGVSNE
APPLFVSNVAYGRTVFVKLETSSKSNDVEAAFSAALKGTDVKTNGKYSDILENSSFTAVV
LGGDAAEHNKVVTKDFDVIRNVIKDNATFSRKNPAYPISYTSVFLKNNKIAGVNNRTEYV
ETTSTEYTSGKINLSHQGAYVAQYEILWDEINYDDKGKEVITKRRWDNNWYSKTSPFSTV
IPLGANSRNIRIMARECTGLAWEWWRKVIDERDVKLSKEINVNISGSTLSPYGSITYK
>TCSA_LISIN.1 [23,357]  Q92BW7 CD4+ T cell-stimulating antig
CGSSSDDKKSGDDKSSKDFTVAMVTDTGGVDDRSFNQSAWEGLQKFGKANDMEKGTDGYN
YLQSASEADYKTNLNTAVRSDYDLIYGIGYKLKDAIEEVSKQKPKNQFAIVDDTIDDRDN
VVSIGFKDNDGSYLVGVVAGLTTKTNKVGFVGGVKGAVIDRFEAGFTAGVKAVNPNAQID
VQYANDFAKADKGQQIASSMYSSGVDVIFHAAGGTGNGVFAEAKNLKKKDPSRAVWVIGV
DRDQWDEGKVTANDGKDYNVTLTSEIKRVDIAVDDLATRTKAGDFPGGTKIEYGLDKDAV
GLSEHQDNISKDVLAKVEEYKQKIVDGDIKVPEKP
>TCSA_LISMO.1 [23,357]  Q48754 CD4+ T cell-stimulating antig
CGSSSDDKKSSDDKSSKDFTVAMVTDTGGVDDRSFNQSAWEGLQKFGKANDMEKGTDGYN
YLQSASEADYKTNLNTAVRSDYDLIYGIGYKLKDAIEEVSKQKPKNQFAIVDDTIDDRDN
VVSIGFKDNDGSYLVGVVAGLTTKTNKVGFVGGVKGTVIDRFEAGFTAGVKAVNPNAQID
VQYANDFAKADKGQQIASSMYSSGVDVIFHAAGGTGNGVFAEAKNLKKKDPSRAVWVIGV
DRDQWDEGKVTANDGKDYNVTLTSEIKRVDIAVEDLATRAKAGDFPGGTKIEYGLDKDAV
GLSEHQDNISKDVLAKVEEYKQKIVDGDIKVPEKP
>TEE6_STRPY.1 [23,537]  P18481 Trypsin-resistant surface T6 
KDDTAQLKITNIEGGPTVTLYKIGEGVYNTNGDSFINFKYAEGVSLTETGPTSQEITTIA
NGINTGKIKPFSTENVSISNGTATYNARGASVYIALLTGATDGRTYNPILLAASYNGEGN
LVTKNIDSKSNYLYGQTSVAKSSLPSITKKVTGTIDDVNKKTTSLGSVLSYSLTFELPSY
TKEAVNKTVYVSDNMSEGLTFNFNSLTVEWKGKMANITEDGSVMVENTKIGIAKEVNNGF
NLSFIYDSLESISPNISYKAVVNNKAIVGEEGNPNKAEFFYSNNPTKGNTYDNLDRKPDK
GNGITSKEDSKIVYTYQIAFRKVDSVSKTPLIGAIFGVYDTSNKLIDIVTTNKNGYAIST
QVSSGKYKIKELKAPKGYSLNTETYEITANWVTATVKTSANSKSTTYTSDKNKATDNSEQ
VGWLKNGIFYSIDSRPTGNDVKEAYIESTKALTDGTTFSKSNEGSGTVLLETDIPNTKLG
ELPSTGSIGTYLFKAIGSAAMIGAIGIYIVKRRKA
>THER_ALIAC.1 [26,546]  Q43880 Thermolysin precursor (EC 3.4
KEKSMVWNEQWKTPSFVSGSLLKGEDAPEELVYRYLDQEKNTFQLGGQARERLSLIGKQT
DELGHTVMRFEQRYRGIPVYGAVLVAHVNDGELSSLSGTLIPNLDKRTLKTEAAISIQQA
EMIAKQDVADAVTKERPAAEEGKPTRLVIYPDGETPRLAYEVNVRFLTPVPGNWIYMIDA
ADGKVLNKWNQMDEAKPGGGQPVAGTSTVGVGRGVLGDQKYINTTYSSYYGYYYLQDNTR
GSGIFTYDGRNRTVLPGSLWADGDNQFFASYDAAAVDAHYYAGVVYDYYKNVHGRLSYDG
SNAAIRSTVHYGRGYNNAFWNGSQMVYGDGDGQTFLPFSGGIDVVGHELTHAVTDYTAGL
VYQNESGAINEAMSDIFGTLVEFYANRNPDWEIGEDIYTPGIAGDALRSMSDPAKYGDPD
HYSKRYTGTQDNGGVHTNSGIINKAAYLLSQGGVHYGVSVTGIGRDKMGKIFYRALVYYL
TPTSNFSQLRAACVQAAADLYGSTSQEVNSVKQAFNAVGVY
>THER_BACCL.1 [26,546]  Q59193 Thermolysin precursor (EC 3.4
KEKSMVWNEQWKTPSFVSGSLLKGEDAPEELVYRYLDQEKNTFQLGGQARERLSLIGKQT
DELGHTVMRFEQRYRGIPVYGAVLVAHVNDGELSSLSGTLIPNLDKRTLKTEAAISIQQA
EMIAKQDVADAVTKERPAAEEGKPTRLVIYPDGETPRLAYEVNVRFLTPVPGNWIYMIDA
ADGKVLNKWNQMDEAKPGGGQPVAGTSTVGVGRGVLGDQKYINTTYSSYYGYYYLQDNTR
GSGIFTYDGRNRTVLPGSLWADGDNQFFASYDAAAVDAHYYAGVVYDYYKNVHGRLSYDG
SNAAIRSTVHYGRGYNNAFWNGSQMVYGDGDGQTFLPFSGGIDVVGHELTHAVTDYTAGL
VYQNESGAINEAMSDIFGTLVEFYANRNPDWEIGEDIYTPGIAGDALRSMSDPAKYGDPD
HYSKRYTGTQDNGGVHTNSGIINKAAYLLSQGGVHYGVSVTGIGRDKMGKIFYRALVYYL
TPTSNFSQLRAACVQAAADLYGSTSQEVNSVKQAFNAVGVY
>THER_BACSO.1 [26,546]  Q59223 Thermolysin precursor (EC 3.4
KEKSMVWNEQWKTPSFVSGSLLKGEDAPEELVYRYLDQEKNTFQLGGQARERLSLIGKQT
DELGHTVMRFEQRYRGIPVYGAVLVAHVNDGELSSLSGTLIPNLDKRTLKTEAAISIQQA
EMIAKQDVADAVTKERPAAEEGKPTRLVIYPDGETPRLAYEVNVRFLTPVPGNWIYMIDA
ADGKVLNKWNQMDEAKPGGGQPVAGTSTVGVGRGVLGDQKYINTTYSSYYGYYYLQDNTR
GSGIFTYDGRNRTVLPGSLWADVDNQFFASYDAAAVDAHYYAGVVYDYYKNVHGRLSYDG
SNAAIRSTVHYGRGYNNAFWNGSQMVYGDGDGQTFLPFSGGIDVVGHELTHAVTDYTAGL
VYQNESGAINEAMSDIFGTLVEFYANRNPDWEIGEDIYTPGIAGDALRSMSDPAKYGDPD
HYSKRYTGTQDNGGVHTNSGIINKAAYLLSQGGVHYGVSVTGIGRDKMGKIFYRALVYYL
TPTSNFSQLRAACVQAAADLYGSTSQEVNSVKQAFNAVGVY
>THER_BACST.1 [26,548]  P06874 Thermolysin precursor (EC 3.4
KGESIVWNEQWKTPSFVSGSLLNGGEQALEELVYQYVDRENGTFRLGGRARDRLALIGKQ
TDELGHTVMRFEQRHHGIPVYGTMLAAHVKDGELIALSGSLIPNLDGQPRLKKAKTVTVQ
QAEAIAEQDVTETVTKERPTTENGERTRLVIYPTDGTARLAYEVNVRFLTPVPGNWVYII
DATDGAILNKFNQIDSRQPGGGQPVAGASTVGVGRGVLGDQKYINTTYSSYYGYYYLQDN
TRGSGIFTYDGRNRTVLPGSLWTDGDNQFTASYDAAAVDAHYYAGVVYDYYKNVHGRLSY
DGSNAAIRSTVHYGRGYNNAFWNGSQMVYGDGDGQTFLPFSGGIDVVGHELTHAVTDYTA
GLVYQNESGAINEAMSDIFGTLVEFYANRNPDWEIGEDIYTPGVAGDALRSMSDPAKYGD
PDHYSKRYTGTQDNGGVHTNSGIINKAAYLLSQGGVHYGVSVNGIGRDKMGKIFYRALVY
YLTPTSNFSQLRAACVQAAADLYGSTSQEVNSVKQAFNAVGVY
>THER_BACTH.1 [29,548]  P00800 Thermolysin precursor (EC 3.4
STEHVTWNQQFQTPQFISGDLLKVNGTSPEELVYQYVEKNENKFKFHENAKDTLQLKEKK
NDNLGFTFMRFQQTYKGIPVFGAVVTSHVKDGTLTALSGTLIPNLDTKGSLKSGKKLSEK
QARDIAEKDLVANVTKEVPEYEQGKDTEFVVYVNGDEASLAYVVNLNFLTPEPGNWLYII
DAVDGKILNKFNQLDAAKPGDVKSITGTSTVGVGRGVLGDQKNINTTYSTYYYLQDNTRG
NGIFTYDAKYRTTLPGSLWADADNQFFASYDAPAVDAHYYAGVTYDYYKNVHNRLSYDGN
NAAIRSSVHYSQGYNNAFWNGSQMVYGDGDGQTFIPLSGGIDVVAHELTHAVTDYTAGLI
YQNESGAINEAISDIFGTLVKFYANKNPDWEIGEDVYTPGISGDSLRSMSDPAKYGDPDH
YSKRYTGTQDNGGVHINSGIINKAAYLISQGGTHYGVSVVGIGRDKLGKIFYRALTQYLT
PTSNFSQLRAAAVQSATDLYGSTSQEVASVKQAFDAVGVK
>THES_BACSJ.1 [25,401]  Q45670 Thermophilic serine proteinas
ASNDGVESPKTVSEINVSHEKGAYVQGEVIVQFKEQVNAEEKAKALKEVGATAVPDNDRV
KSKFNVLKVGNVEAVVKALNNNPLVEYAEPNYLFNAAWTPNDTYYQGYQYGPQNTYTDYA
WDVTKGSSGQEIAVIDTGVDYTHPDLDGKVIKGYDFVDNDYDPMDLNNHGTHVAGIAAAE
TNNATGIAGMAPNTRILAVRALDRNGSGTLSDIADAIIYAADSGAEVINLSLGCDCHTTT
LENAVNYAWNKGSVVVAAAGNNGSSTTFEPASYENVIAVGAVDQYDRLASFSNYGTWVDV
VAPGVDIVSTITGNRYAYMSGTSMASPHVAGLAALLASQGRNNIEIRQAIEQTADKISGT
GTYFKYGRINSYNAVTY
>THI1_PANTH.1 [30,409]  P45741 Thiaminase I precursor (EC 2.
AAHSDASSDITLKVAIYPYVPDPARFQAAVLDQWQRQEPGVKLEFTDWDSYSADPPDDLD
VFVLDSIFLSHFVDAGYLLPFGSQDIDQAEDVLPFALQGAKRNGEVYGLPQILCTNLLFY
RKGDLKIGQVDNIYELYKKIGTSHSEQIPPPQNKGLLINMAGGTTKASMYLEALIDVTGQ
YTEYDLLPPLDPLNDKVIRGLRLLINMAGEKPSQYVPEDGDAYVRASWFAQGSGRAFIGY
SESMMRMGDYAEQVRFKPISSSAGQDIPLFYSDVVSVNSKTAHPELAKKLANVMASADTV
EQALRPQADGQYPQYLLPARHQVYEALMQDYPIYSELAQIVNKPSNRVFRLGPEVRTWLK
DAKQVLPEALGLTDVSSLAS
>TSST_STAAU.1 [41,234]  P06886 Toxic shock syndrome toxin-1 
STNDNIKDLLDWYSSGSDTFTNSEVLDNSLGSMRIKNTDGSISLIIFPSPYYSPAFTKGE
KVDLNTKRTKKSQHTSEGTYIHFQISGVTNTEKLPTPIELPLKVKVHGKDSPLKYGPKFD
KKQLAISTLDFEIRHQLTQIHGLYRSSDKTGGYWKITMNDGSTYQSDLSKKFEYNTEKPP
INIDEIKTIEAEIN
>US45_LACLC.1 [28,461]  P22865 Secreted 45 kDa protein precu
DTNSDIAKQDATISSAQSAKAQAQAQVDSLQSKVDSLQQKQTSTKAQIAKIESELKALNA
QIATLNESIKERTKTLEAQARSAQVNSSATNYMDAVVNSKSLTDVIQKVTAIATVSSANK
QILEQQEKEQKELSQKSETVKKNYNQFVSLSQSLDSQAQELTSQQAELKVATLNYQATIA
TAQDKKQALLDEKAAAEKAAQEAAKKQAAYEAQQKEAAQAQAASTAATAKAVEAATSSAS
ASSSQAPQVSTSTDNTTSNASASNSSNSSSNSSSSSSSSSSSSSSSSNSNAGGNTNSGTS
TGNTGGTTTGGSGINSSPIGNPYAGGGCTDYVWQYFAAQGIYIRNIMPGNGGQWASNGPA
QGVLHVVGAAPGVIASSFSADFVGYANSPYGHVAIVKSVNSDGTITIKEGGYGTTWWGHE
RTVSASGVTFLMPN
>VLPA_MYCHR.1 [30,176]  P29228 Variant surface antigen A pre
CGQTDNNSSQSQQPGSGTTNTSGGTNSSGSTNGTAGTNSSGSTNGSGNGSNSETNTGNKT
TSESNSGSSTGSQAGTTTNTGSGSNSESGMNSEKTENTQQSEAPGTNTGNKTTSESNSES
GMNSEKTENTQQSEAPGTKTENTQHTS
>VLPB_MYCHR.1 [30,174]  P29229 Variant surface antigen B pre
CGQTNTDKSQQPGSGSSTSGGQSGTGLGSGTTTGGQSGTTTGGRSGSGSSSSTTGGQTGT
GSDSQDSGAKGTGSDSQDSGAKGTGSDSQDSGAKGTGSDSQDSGAKGTGSDSQDSGAKGT
GSDSQDSGAKGTGSDSQDSGNGSTK
>VLPC_MYCHR.1 [30,160]  P29230 Variant surface antigen C pre
CGQTNTDKSQQPGSGSSTSGDQSGTTTGGHSGSGTSTSGGQSGTTSGSGTTTGEQTETAP
KSPESGSQEATPKSPESGSQEATPKSPESGSQEAAPKSSESGSQEAAPKSSESGSQEAAP
KSSESGSQKTT
>VLPD_MYCHR.1 [30,168]  Q49536 Variant surface antigen D pre
CGQTNTDQSQQPGSGSTTGGQSGTTTGTDSTTGGQTGSESGTTTGGQTGTTTGGQSDSTS
TSKEQGSSDSTSTSKEQGSSDSTSTSKEQGSSDSTSTSKEQGSSDSTSTSKEQGSSDSTS
TSKEQGSSDSTSTSNMNTR
>VLPE_MYCHR.1 [30,243]  Q49537 Variant surface antigen E pre
CGQTTDNLSQSQQPGSGTGSGSGTNTENGSNNGSGSGTTNSSGGTNQSGSASGNGSSNSS
VSTPDGQHSNPSNPTTSDPKESNPSNPTTSDPKESNPSNPTTSDGQHSNPSNPTTSDPKE
SNPSNPTTSDGQHSNPSNPTTSDGQHSNPSNPTTSDGQHSNPSNPTTSDGQHSNPSNPTT
SDGQHSNPSNPTTSDGQHSNPSNPTTSDGQNQNK
>VLPF_MYCHR.1 [30,174]  Q49538 Variant surface antigen F pre
CGQTNTDQSQQPGSGSGSGSGTSNGSGSTPTPEQGNNQGGSTPTPEQGNNQGGSTPTPEQ
GNNQGGSTPTPEQGNNQGGSTPTPEQGNNQGGSTPTPEQGNNQGGSTPTPEQGNNQGGST
PTPEQGNNQGGSTPTPEQGNSQVSK
>WAPA_BACSU.1 [29,2334]  Q07833 Wall-associated protein prec
DVLAKSTEEENGNRIAADDPEETLQKEQTEEAVPFDPKDINKEGEITSERTENTKLYYEG
DGVYKQEVYLDPIHTKETPDADWEDISPELKESTSKQVETENAILNSDFQKQMKNGLYAT
FEHNDHKVTYSLAEAKGPNKTSLTPKDTSADYKTDSNEIVYPDVFPNIDLQTFTFNENIK
EDLVLHQYNGYNTFTFQLKTDLQAKEQEDGSIDFSDEKGKVVFSVPKPFMTDSKLDELSG
EVERSDKVSYKLEKNEEGYLLHLTADENWLKDPERVYPVSIDPSTSLSVSSDTFVMSAYP
TTNYSASSQKWDANLKAYVLKTGYYDKTTGTNYAFMKFNNLKPIQNMTVTKATLKTYVAH
SYYGTKATGLWLDTVNSNYDNAKVTWNTKPASKNIGKADVHKGQWASYDVTAAVKSWNSG
GANYGFKLHTNGNGKEYWKKLISSANSANKPYIEVTYTIPKGNTPTIKAYHNGDSTGYFD
ISWKKVEGAKGYKVWIYNGKEYQAISAGNVTSWSTKGKKIWPTSAEIASKRYKLHLDGKD
GAELALDPSPVYKNSGGSYATSKNYWIGVSAIFDQGEGAMSAPAKPVIPNVGKAQAPSAK
GYNNGNATGYFDLSWKAVSGATGYKVQVFNGKGFETLDLGNQTSWTTKGKKIWPTSAEIK
AGKYALHLKDGSGAELPINPGPTYKNAGGDGAKRNYSFKIIAYNKDGEAIASPAATPALP
DIARPKNVTGYLYTNTKSSQTGYVNLIWEKVQNAKGYKVNIYNGKEYQSFDVGDADHWTT
QNKNIWPTSEEIKAGSYKLHTDGKGGELALDPSPVYNNANGNYKGKKNYSFTLVAYDANG
ETIPTAPFNPTFHEGAEFLGTEEYWSIIDIPSGQLNGATGNVIVNEEDLSIDGRGPGLGL
SRTYNSLDSSDHLFGQGWYADAETSVISTDGGAMYIDEDATTHRFTKKADGTYQPPTGVY
LELTETADQFILKTKDQTNAYFNKKGGKLQKVVDGHNNATVYTYNDKNQLTAITDASGRK
LTFTYDENGHVTSITGPKNKKVTYSYENDLLKKVTDTDGTVTSYDYDSEGRLVKQYSANS
TEAKPVFTEYQYSGHRLEKAINAKKETYVYSYDADKKTLLMTQPNGRKVQYGYNEAGNPI
QVIDDAEGLKITTNTKYEGNNVVEDVDPNDVGTGKATESYQYDKDGNVTSVKDAYGTETY
EYNKNNDVTKMKDTEGNVTDIAYDGLDAVSETDQSGKSSSAAVYDKYGNQIQSSKDLSAS
TNILKDGSFEAQKSGWNLTASKDRRKISVIADKSGVLSGSKALEVLSQSTSAGTDHGYSS
ATQTVELEPNTTYTLSGKIKTDLAKSRAYFNIDLRDKDQKRIQWIHNEYSALAGKNDWTK
RQITFTTPANAGKAVVYMEVDHKDKDGKGKAWFDEVQLEKGEVSSSYNPVQNSSFTSATE
NWNVSGASVDSEEGFNDDVSLKAARTSASQAGSVTKQTVVLGQSANDKPVYLTLTGMSKA
SSVKFTDEKDYSLQANVTYADGSTGIYNAKFPSGTQEWNRAAVVIPKTKPINKVDISILF
QKSATGTVWFDDIRLIEGSLLTKSTYDSNGNYVTKEEDELGYATSTDYDETGKKTSETDA
KGEKTTYTYDQADQLTNMTLSNGTSILHSYDKEGNEVSKTIRAGADQTYKFEYDVMGKLV
KTTDPLGNVLASEYDANSNLTKTISPNGNEVSLSYDGTDRVKSKSYNGTEKYIFTYDKNG
NETSVVNKEQNTTKKRTFDNKNRLTELTDRGGSQTWTYPSDSDKLKTFSWIHGDQKGTNQ
FTYNKLDQMIEMKDSTSSYSFDYDENGNVQTFITGNGGGTSFSYDERNLVSSLHIGDKNG
GDILTESYEYDANGNRTTINSSASGKVQYEYGKLNQLVKETHEDGTVIEYTYDGFGNRKT
VTTIKDGSSKTVNASFNIMNQLTKVNDESISYDKNGNRTSDGKFTYTWDAEDNLTAVTKK
GEDKPFATYKYDEKGNRIQKTVNGKVTNYFYDGDSLNVLYETDADNNVTKSYTYGDSGQL
LSYTENGKKYFYHYNAHGDIIAISDSTGKTVAKYQYDAWGNPTKTEASDEVKDNRYRYAG
YQYDEETGLYYLMARYYEPRNGVFLSLDPDPGSDGDSLDQNGYAYGNNNPVMNVDPDGHW
VWLVVNAGFAAYDGYKAYKSGKGWKGAAWAAASNFGPGKIFKGASRAYKFTKKAVKITGH
TRHGLNQSIGRNGGRGVNLRAKLNAVRSPKKVIKQPNGATKYVGKKATVVLNKRGKVITA
YGSSRAKGSKHVFHTHGKGNKSKRRR
>WAPA_STRMU.1 [30,453]  P11000 Wall-associated protein precu
DQVTNYTNTASITKSDGTALSNDPSKAVNYWEPLSFSNSITFPDEVSIKAGDTLTIKLPE
QLQFTTALTFDVMHTNGQLAGKATTDPNTGEVTVTFTDIFEKLPNDKAMTLNFNAQLNHN
NISIPGVVNFNYNNVAYSSYVKDKDITPISPDVNKVGYQDKSNPGLIHWKVLINNKQGAI
DNLTLTDVVGEDQEIVKDSLVAARLQYIAGDDVDSLDEAASRPYAEDFSKNVTYQTNDLG
LTTGFTYTIPGSSNNAIFISYTTRLTSSQSAGKDVSNTIAISGNNINYSNQTGYARIESA
YGRASSRVKRQAETTTVTETTTSSSSETTTSEATTETSSTTNNNSTTTETATSTTGASTT
QTKTTASQTNVPTTTNITTTSKQVTKQKAKFVLPSTGEQAGLLLTTVGLVIVAVAGVYFY
RTRR
>WPRA_BACSU.1 [32,894]  P54423 Cell wall-associated protease
AGAIDQAAALENGKEQTGAMKEPEQVKWYKVTPGATDIQKNSHMALTVKSDSVLNVSVYP
SKEKALKDETFEMYRSFTAEDGKSEVIFPYAWSGPYYVKVEYLGEEEPEDGGTAEAAAEA
KYTIGYKGTKKQPSDLEEEEACPVEMSVDQKKSGKGILDKLRSIRDEQLSQTAEGKELTS
LYYKAAPFIVAKLALNKTARNEIYQDLVTLKPLFDDVSENGASSSYKVTEKDQKAINRLY
DKALQSVPSFLKEEIKKQADRLNMKQLQGKTAGAILTENNIAAKSEVQTTKVIFKVKDNK
SLSSVHNEMKGFSASAQSKKDISNVKKAKKLFDNLYSFELPKDEKQNGAYTASAKRVKSA
AATLSKMSNVEFAEPVQEYKSLANDIQYPYQWPLKNNGENGGVKNADVKYEPANTLLSKR
KLNDTLIAVVDTGVDSTLADLKGKVRTDLGHNFVGRNNNAMDDQGHGTHVAGIIAAQSDN
GYSMTGLNAKAKIIPVKVLDSAGSGDTEQIALGIKYAADKGAKVINLSLGGGYSRVLEFA
LKYAADKNVLIAAASGNDGENALSYPASSKYVMSVGATNRMDMTADFSNYGKGLDISAPG
SDIPSLVPNGNVTYMSGTSMATPYAAAAAGLLFAQNPKLKRTEVEDMLKKTADDISFESV
DGGEEELYDDYGDPIEIPKTPGVDWHSGYGRLNVMKAVSAADLQLKVNKLESTQTAVRGS
AKEGTLIEVMNGKKKLGSAKAGKDNAFKVNIATQKQDQVLYLKATKGDAKTSYKVVVVKG
KPSGTPKVNAVKTKDTAVKGKANSKAMIRVKNKSKKVIASAKADAKGTFSVKIKKQKAGT
VLYVTAVDTDKKESKEAKVVVEK
>XYN1_BACST.1 [29,407]  P40943 Endo-1,4-beta-xylanase precur
KNADSYAKKPHISALNAPQLDQRYKNEFTIGAAVEPYQLQNEKDVQMLKRHFNSIVAENV
MKPISIQPEEGKFNFEQADRIVKFAKANGMDIRFHTLVWHSQVPQWFFLDKEGKPMVNET
DPVKREQNKQLLLKRLETHIKTIVERYKDDIKYWDVVNEVVGDDGKLRNSPWYQIAGIDY
IKVAFQAARKYGGDNIKLYMNDYNTEVEPKRTALYNLVKQLKEEGVPIDGIGHQSHIQIG
WPSEAEIEKTINMFAALGLDNQITELDVSMYGWPPRAYPTYDAIPKQKFLDQAARYDRLF
KLYEKLSDKISNVTFWGIADNHTWLDSRADVYYDANGNVVVDPNAPYAKVEKGKGKDAPF
VFGPDYKVKPAYWAIIDHK
>XYNA_BACCI.1 [29,213]  P09850 Endo-1,4-beta-xylanase precur
ASTDYWQNWTDGGGIVNAVNGSGGNYSVNWSNTGNFVVGKGWTTGSPFRTINYNAGVWAP
NGNGYLTLYGWTRSPLIEYYVVDSWGTYRPTGTYKGTVKSDGGTYDIYTTTRYNAPSIDG
DRTTFTQYWSVRQSKRPTGSNATITFTNHVNAWKSHGMNLGSNWAYQVMATEGYQSSGSS
NVTVW
>XYNA_BACHD.1 [29,396]  P07528 Endo-1,4-beta-xylanase A prec
AQGGPPKSGVFGENEKRNDQPFAWQVASLSERYQEQFDIGAAVEPYQLEGRQAQILKHHY
NSLVAENAMKPESLQPREGEWNWEGADKIVEFARKHNMELRFHTLVWHSQVPEWFFIDED
GNRMVDETDPDKREANKQLLLERMENHIKTVVERYKDDVTSWDVVNEVIDDGGGLRESEW
YQITGTDYIKVAFETARKYGGEEAKLYINDYNTEVPSKRDDLYNLVKDLLEQGVPIDGVG
HQSHIQIGWPSIEDTRASFEKFTSLGLDNQVTELDMSLYGWPPTGAYTSYDDIPAELLQA
QADRYDQLFELYEELAADISSVTFWGIADNHTWLDGRAREYNNGVGIDAPFVFDHNYRVK
PAYWRIID
>XYNA_BACPU.1 [28,228]  P00694 Endo-1,4-beta-xylanase A prec
RTITNNEMGNHSGYDYELWKDYGNTSMTLNNGGAFSAGWNNIGNALFRKGKKFDSTRTHH
QLGNISINYNASFNPGGNSYLCVYGWTQSPLAEYYIVDSWGTYRPTGAYKGSFYADGGTY
DIYETTRVNQPSIIGIATFKQYWSVRQTKRTSGTVSVSAHFRKWESLGMPMGKMYETAFT
VEGYQSSGSANVMTNQLFIGN
>XYNA_BACST.1 [20,210]  P45705 Endo-1,4-beta-xylanase A prec
LFGATSSAATDYWQYWTDGGGMVNAVNGPGGNYSVTWQNTGNFVVGKGWTVGSPNRVINY
NAGIWEPSGNGYLTLYGWTRNALIEYYVVDSWGTYRPTGNYKGTVNSDGGTYDIYTTMRY
NAPSIDGTQTFQQFWSVRQSKRPTGSNVSITFSNHVNAWRSKGMNLGSSWAYQVLATEGY
QSSGRSNVTVW
>XYNA_BACSU.1 [29,213]  P18429 Endo-1,4-beta-xylanase A prec
ASTDYWQNWTDGGGIVNAVNGSGGNYSVNWSNTGNFVVGKGWTTGSPFRTINYNAGVWAP
NGNGYLTLYGWTRSPLIEYYVVDSWGTYRPTGTYKGTVKSDGGTYDIYTTTRYNAPSIDG
DRTTFTQYWSVRQSKRPTGSNATITFSNHVNAWKSHGMNLGSNWAYQVMATEGYQSSGSS
NVTVW
>XYNA_BUTFI.1 [34,411]  P23551 Endo-1,4-beta-xylanase A prec
ASYNLMETYGAKYGYSGNCVHTHMLRDSRIVNAIKKDSNIVTLGNEMKPDYLLGSRQATL
ISVDEAKRLGYYIPSNYKERYVPKIDFRTVDEAVKICYENGLKMRGHTLVWHSQTPTWLF
RENYSGNGRFVNTATMDARLEFYVKSVMGHFYSGKYGSTLVYWDVCNETLHAQNSGWEAV
YGSNKTNAVYVKKAFNYAYQVLEQYKLTNSVKLFYNDYNTYMEVNDVIKLVNYINQGKKV
CAGVGMQSHLGTGFPSVDYYTNALNSFLRAGFEVQITELDITNKGDYDLNNYAYRLFKNI
NAAKKNGGNISCITWWGPSDAETWIRNEKPLIWSNIGVAKPAYDEVVKAFTETFGNPGSF
TPQPTITPQPTPTPSGQT
>XYNA_CALSR.1 [35,684]  P40944 Endo-1,4-beta-xylanase A prec
NQLASKSKYIEYNFENKSVSPLAKYPSNVVLKVTNSTCAEGTFSVLVAGRKNANDGVIVD
ITKFLDFSREYEVSFYVLQTTKKLQRISVTLEILDSNDKNQVIAAEKVLLPNIWTKVSAK
VQASNYKKAKRINLIVNMPTSKSDSFYIDLFTIKDLENAYVLKQENFENKNTGGFLPEDK
NCKITLAKDRAYSSAYSLKVQPSQKTKNGKILFPIKGLLQKGGTYDFSLLVYQDSSKPVN
FSAGIKLNDGKSTKEIVLAKQNVAPKKWTQLFATLDLDTRFSAKDVSFFVKPAAAISYYL
DLYSISDENWGQPVPDYNLPSLCEKYKNYFKIGVAVPYRALTNPVDVEVIKRHFNSITPE
NEMKPESLQPYEGGFSFSIADEYVDFCKKDNISLRGHTLVWHQQTPSWFFTNPETGEKLT
NSEKDKEILLDRLKKHIQTVVGRYKGKVYAWDVVNEAIDENQPDGYRRSDWYNILGPEYI
EKAFIWAHEADPKAKLFYNDYSTEDPYKREFIYKLIKNLKAKGVPVHGVGLQCHISLDWP
DVSEIEETVKLFSRIPGLEIHFTEIDISIAKNMTDDDAYNRYLLVQQAQKLKAIFDVLKK
YRNVVTSVTFWGLKDDYSWLRGDMPLLSDKDYQPKFAFWSLIDPSVVPKE
>XYNA_CLOSA.1 [29,261]  P17137 Endo-1,4-beta-xylanase precur
ATNLNTTESTFSKEVLSTQKTYSAFNTQAAPKTITSNEIGVNGGYDYELWKDYGNTSMTL
KNGGAFSCQWSNIGNALFRKGKKFNDTQTYKQLGNISVNYDCNYQPYGNSYLCVYGWTSS
PLVEYYIVDSWGSWRPPGGTSKGTITVDGGIYDIYETTRINQPSIQGNTTFKQYWSVRRT
KRTSGTISVSKHFAAWESKGMPLGKMHETAFNIEGYQSSGKADVNSMSINIGK
>XYNA_CLOSR.1 [31,512]  P33558 Endo-1,4-beta-xylanase A prec
GRIIYDNETGTHGGYDYELWKDYGNTIMELNDGGTFSCQWSNIGNALFRKGRKFNSDKTY
QELGDIVVEYGCDYNPNGNSYLCVYGWTRNPLVEYYIVESWGSWRPPGATPKGTITQWMA
GTYEIYETTRVNQPSIDGTATFQQYWSVRTSKRTSGTISVTEHFKQWERMGMRMGKMYEV
ALTVEGYQSSGYANVYKNEIRIGANPTPAPSQSPIRRDAFSIIEAEEYNSTNSSTLQVIG
TPNNGRGIGYIENGNTVTYSNIDFGSGATGFSATVATEVNTSIQIRSDSPTGTLLGTLYV
SSTGSWNTYQTVSTNISKITGVHDIVLVFSGPVNVDNFIFSRSSPVPAPGDNTRDAYSII
QAEDYDSSYGPNLQIFSLPGGGSAIGYIENGYSTTYKNIDFGDGATSVTARVATQNATTI
QVRLGSPSGTLLGTIYVGSTGSFDTYRDVSATISNTAGVKDIVLVFSGPVNVDWFVFSKS
GT
>XYNA_RUMFL.1 [28,954]  P29126 Bifunctional endo-1,4-beta-xy
SAADQQTRGNVGGYDYEMWNQNGQGQASMNPGAGSFTCSWSNIENFLARMGKNYDSQKKN
YKAFGNIVLTYDVEYTPRGNSYMCVYGWTRNPLMEYYIVEGWGDWRPPGNDGEVKGTVSA
NGNTYDIRKTMRYNQPSLDGTATFPQYWSVRQTSGSANNQTNYMKGTIDVTKHFDAWSAA
GLDMSGTLYEVSLNIEGYRSNGSANVKSVSVTQGGSSDNGGQQQNNDWNQQNNNQQQNND
WNNWGQQNNDWNQWNNQGQQNNDWNNWGQQNNDWNQWNNQGQQQNNDWNNWGQQNNDWNQ
WNNQGQQQNNDWNNWGQQNNDWNQWNNQGQQQNNDWNNWGQQNNDWNQWNNQNNNQQNAW
NGWDNNNNWNQNNQQQNNWDWNNQNNWNNNQQQNNDWNQWNNQNNWNNNQQQNNDWNQWN
NQGQQNNDWNQWNNQNNWNQNNNQQNAWNGWDNNNNWNQWDQNNQWNNQQQNNTWDWNNQ
NNWNNNQQNNDWNQWNNQGQQQNNDWNQWNNQNNNQNNGWDWNNQNNWNQNNNQQNAWNG
WDNNNNWNQWGGQNNDWNNQQQNNDWNQWNNQGQQQNNDWNNQNNWNQGQQNNNNSAGSS
DSLKGAFSKYFKIGTSVSPHELNSGADFLKKHYNSITPENELKPESILDQGACQQKGNNV
NTQISLSRAAQTLKFCEQNGIALRGHTFVWYSQTPDWFFRENFSQNGAYVSKDIMNQRLE
SMIKNTFAALKSQYPNLDVYSYDVCNELFLNNGGGMRGADNSNWVKIYGDDSFVINAFKY
ARQYAPAGCKLYLNDYNEYIPAKTNDIYNMAMKLKQLGYIDGIGMQSHLATNYPDANTYE
TALKKFLSTGLEVQITELDITCTNSAEQADLYEKIFKLAMQNSAQIPAVTIWGTQDTVSW
RSSQNPLLFSAGYQPKPAYDRVMALAK
>XYNA_THESA.1 [34,1157]  P36917 Endo-1,4-beta-xylanase A pre
DDTNINLVSNGDFESGTIDGWIKQGNPTLAVTTEQAIGQYSMKVTGRTQTYEGPAYSFLG
KMQKGESYSVSLKVRLVSGQNSSNPLITVTMFREDDNGKHYDTIVWQKQVSEDSWTTVSG
TYTLDYIGTLKTLYMYVESPDPTLEYYIDDVVVTTQNPIQVGNVIANETFENGNTSGWIG
TGSSVVKAVYGVAHSGDYSLLTTGRTANWNGPSYDLTGKIVPGQQYNVDFWVKFVNGNDT
EQIKATVKATSDKDNYIQVNDFANVNKGEWTEIKGSFTLPVADYSGISIYVESQNPTLEF
YIDDFSVIGEISNNQITIQNDIPDLYSVFKDYFPIGVAVDPSRLNDADPHAQLTAKHFNM
LVAENAMKPESLQPTEGNFTFDNADKIVDYAIAHNMKMRGHTLLWHNQVPDWFFQDPSDP
SKSASRDLLLQRLKTHITTVLDHFKTKYGSQNPIIGWDVVNEVLDDNGNLRNSKWLQIIG
PDYIEKAFEYAHEADPSMKLFINDYNIENNGVKTQAMYDLVKKLKSEGVPIDGIGMQMHI
NINSNIDNIKASIEKLASLGVEIQVTELDMNMNGNISNEALLKQARLYKQLFDLFKAEKQ
YITAVVFWGVSDDVTWLSKPNAPLLFDSKLQAKPAFWAVVDPSKAIPDIQSAKALEGSPT
IGANVDSSWKLVKPLYVNTYVEGTVGATATVKSMWDTKNLYLLVQVSDNTPSNNDGIEIF
VDKNDDKSTSYETDDERYTIKRDGTGSSDITKYVTSNADGYVAQLAIPIEDISPAVNDKI
GFDIRINDDKGNGKIDAITVWNDYTNSQNTNTSYFGDIVLSKSAQIATAIYGTPVIDGKV
DDIWNNVEPISTNTWILGSNGATATQKMMWDDKYLYVLADVTDSNLNKSSINPYEQDSVE
VFVDQNNDKTTYYENDDGQYRVNYDNEQSFGGSTNSNGFKSATSLTQSGYIVEEAIPWTS
ITPSNGTIIGFDLQVNNADENGKRTGIVTWCDPSGNSWQDTSGFGNLLLTGKPSGALKKG
VTFDDIKNSWAKDAIEVLASRHIVEGMTDTQYEPNKTVTRAEFTAMILRLLNIKEEQYSG
EFSDVNSGDWYANAIEAAYKAGIIEGDGKNARPNDSITREEMTQ
>XYND_PAEPO.1 [27,635]  P45796 Endo-1,4-beta-xylanase D prec
ANRPLAKIPGNSNPLMDHKLGADPYSLVYDGRVYIFMSSDTYVYNKDGSIKENDFSALDR
IQVISSTDMVNWTDHGTIPVAGANNKNSGRGIAKWASNSWAPAVAHKKINGRDKFFLYFA
NGGAGIGVLTADTPIGPWTDPLGKALVTHSTPGMAGVTWLFDPAVLVDDDGTGYLYSGGG
IPNESDPASIANPKTARVIKLGADMTSVIGSATTIDAPYLFEDSGIHKYNGKYYYSYCIN
FAGTHPQQYPAGEIGYMVSDNPMGPFTYKGHFLKNPYTFFGVGGNNHHAVFNFKNEWYVV
YHAQTVSKAQIGAGKGYRSPHINKLVHKEDGSISEVQGNMTGIAQLSNMNPYTRVEAETI
AWQAGVTTEPTQASGGPISNLNVTNIHNGDWIAVGKADFGSAGAKTFKANVATNVGGNIE
VRLDSETGPLVGSLKVPSTGGMQTWREVETTINNATGVHNIYLVFTGSGSGNLLNLDAWQ
FTPNTGGNTITKVEAENMKIGGTYAGKISAPFDGVALYANADYVSYSQYFANSTHNISVR
GASSNAGTAKVDLVIGGVTVGSFNFTGKTPTVQTLSNITHATGDQEIKLALTSDDGTWDA
YVDFIEFSL
>XYND_RUMFL.1 [32,802]  Q53317 Xylanase/beta-glucanase precu
ADDQKTGKVGGFDWEMWNQNYTGTVSMNPGAGSFTCSWSGIENFLARMGKNYDDQKKNYK
AFGDIVLTYDVEYTPRGNSYMCIYGWTRNPLMEYYIVEGWGDWEPPGNDGVDNFGTTTID
GKTYKIRKSMRYNQPSIEGTKTFPQYWSVRTTSGSRNNTTNYMKDQVSVTKHFDAWSKAG
LDMSGTLYEVSLNIEGYRSNGSANVKSISFDGGIDIPDPEPIKPDENGYYLKENFESGEG
NWSGRGSAKVKSSSGYDGTKGIFVSGREDTWNGASINLDELTFKAGETYSLGTAVMQDFE
SSVDFKLTLQYTDADGKENYDEVKTVTAAKGQWVDLSNSSYTIPSGATGLVLYVEVPESK
TDFYMDGAYAGVKGTKPLISISSQSVDPPVTEPTNPTNPTGPSVTKWGDANCDGGVDLSD
AIFIMQFLANPNKYGLTGTETNHMTNQGKVNGDVCEHGSGLTEDDAVSIQKYLIRAISEL
PESYLEGHDPSKTTTTTTRITTTTTTTTTTTTSKTTTTTTTTSPAMHGGYRDLGTPMNTS
ATMISDFRTGKAGDFFASDGWTNGKPFDCWWYKRNAVINDGCLQLSIDQKWTNDKNPDWD
PRYSGGEFRTNNFYHYGYYECSMQAMKNDGVVSSFFTYTGPSDDNPWDEIDIEILGKNTT
QVQFNYYTNGQGKHEKLYDLGFDSSEAYHTYGFDWQPNYIAWYVDGREVYRATQDIPKTP
GKIMMNAWPGLTVDDWLKAFNGRTPLTAHYQWVTYNKNGVQHSSQGQNPWG
>XYNX_CLOTM.1 [31,1087]  P38535 Exoglucanase xynX precursor 
FADDNNANLVSNGDFESGTIDGWIKQGNPTLAATTEEAIGQYSMKVAGRTQTYEGPAYSF
LGKMQKGQSYNVSLKVRLVSGQNSSNPLITVTMFREDDNGKHYDTIVWQKQVSEDSWTTV
NGTYTLDYTGTLKTLYMYVESPDPTLEYYIDDVVVTPQNPIQVGEISNNQITIQNDIPDL
SSVFKDYFPIGVAVDPSRLNDTDPHAQLTAKHFNMLVAENAMKPESLQPTEGNFTFDNAD
RIVDYAIAHNMKMRGHTLLWHNQVPDWFFQDPSDPTKPASRDLLLQRLKTHITTVLDHFK
TKYGAQNPIIGWDVVNEVLDDNGSLRNSKWLQIIGPDYIEKAFEYAHEADPSMKLFINDY
NIENNGVKTQAMYDLVKKLKSEGVPISGIGMQMHININSNIDNIKASIEKLASLGVEIQV
TELDMNMNGNVSNEALLKQARLYKQLFDLFKAEKQYITAVVFWGVSDDVTWLSKPNAPLL
FDSKLQAKPAYWAIADPSKAIPDIQSAKALEGSPTIGANVDSSWKLVKPLYANTYVEGTV
GATATVKSMWDTKNLYLLVQVSDNTPSSNDGIEIFVDKNDNKSTSYETDDEHYTIKSDGT
GSSDITKYVTSNADGYIVQLAIPIEDISPTLNDKIGLDVRLNDDKGSGSIDTVTVWNDYT
NSQDTNTSYFGDIVLSKPAQVATAIYGTPVIDGKIDDIWNKVDAITTNTWVLGSDGATAT
AKMMWDDKYLYVLADVTDSNLNKSSVNPYEQDSVEVFVDQNNDKTSYYESDDGQYRVNYD
NEQSFGGSTNSNGFKSATSLTQSGYIVEEAIPWTSITLLNGTIIGFDLQVNDADENGKRT
GIVTWCDPSGNSWQDTSGFGNLLLTGKPSGVLKKSVTFNDIKDNWAKDVIEVLASRHIVE
GMTDTQYEPSKTVTRAEFTAMILKLLNIKEEAYNGEFSDVKNGDWYANAIEAAYKAGIIE
GDGKNMRPNDSITREEMTSIAMRAYEMLTSYKEENIGATSFNDDKSISDWAKNVVANAAK
LGIINGEPSNVFAPKGIATRAEAAAIIYGLLEKSNNL
>XYNY_CLOTM.1 [27,1077]  P51584 Endo-1,4-beta-xylanase Y pre
ISQLYADYEVVHDTFEVNFDGWCNLGVDTYLTAVENEGNNGTRGMMVINRSSASDGAYSE
KGFYLDGGVEYKYSVFVKHNGTGTETFKLSVSYLDSETEEENKEVIATKDVVAGEWTEIS
AKYKAPKTAVNITLSITTDSTVDFIFDDVTITRKGMAEANTVYAANAVLKDMYANYFRVG
SVLNSGTVNNSSIKALILREFNSITCENEMKPDATLVQSGSTNTNIRVSLNRAASILNFC
AQNNIAVRGHTLVWHSQTPQWFFKDNFQDNGNWVSQSVMDQRLESYIKNMFAEIQRQYPS
LNLYAYDVVNEAVSDDANRTRYYGGAREPGYGNGRSPWVQIYGDNKFIEKAFTYARKYAP
ANCKLYYNDYNEYWDHKRDCIASICANLYNKGLLDGVGMQSHINADMNGFSGIQNYKAAL
QKYINIGCDVQITELDISTENGKFSLQQQADKYKAVFQAAVDINRTSSKGKVTAVCVWGP
NDANTWLGSQNAPLLFNANNQPKPAYNAVASIIPQSEWGDGNNPAGGGGGGKPEEPDANG
YYYHDTFEGSVGQWTARGPAEVLLSGRTAYKGSESLLVRNRTAAWNGAQRALNPRTFVPG
NTYCFSVVASFIEGASSTTFCMKLQYVDGSGTQRYDTIDMKTVGPNQWVHLYNPQYRIPS
DATDMYVYVETADDTINFYIDEAIGAVAGTVIEGPAPQPTQPPVLLGDVNGDGTINSTDL
TMLKRSVLRAITLTDDAKARADVDKNGSINSTDVLLLSRYLLRVIDKFPVAENPSSSFKY
ESAVQYRPAPDSYLNPCPQAGRIVKETYTGINGTKSLNVYLPYGYDPNKKYNIFYLMHGG
GENENTIFSNDVKLQNILDHAIMNGELEPLIVVTPTFNGGNCTAQNFYQEFRQNVIPFVE
SKYSTYAESTTPQGIAASRMHRGFGGFSMGGLTTWYVMVNCLDYVAYFMPLSGDYWYGNS
PQDKANSIAEAINRSGLSKREYFVFAATGSDHIAYANMNPQIEAMKALPHFDYTSDFSKG
NFYFLVAPGATHWWGYVRHYIYDALPYFFHE
>XYNZ_CLOTM.1 [29,837]  P10478 Endo-1,4-beta-xylanase Z prec
ASLPTMPPSGYDQVRNGVPRGQVVNISYFSTATNSTRPARVYLPPGYSKDKKYSVLYLLH
GIGGSENDWFEGGGRANVIADNLIAEGKIKPLIIVTPNTNAAGPGIADGYENFTKDLLNS
LIPYIESNYSVYTDREHRAIAGLSMGGGQSFNIGLTNLDKFAYIGPISAAPNTYPNERLF
PDGGKAAREKLKLLFIACGTNDSLIGFGQRVHEYCVANNINHVYWLIQGGGHDFNVWKPG
LWNFLQMADEAGLTRDGNTPVPTPSPKPANTRIEAEDYDGINSSSIEIIGVPPEGGRGIG
YITSGDYLVYKSIDFGNGATSFKAKVANANTSNIELRLNGPNGTLIGTLSVKSTGDWNTY
EEQTCSISKVTGINDLYLVFKGPVNIDWFTFGVESSSTGLGDLNGDGNINSSDLQALKRH
LLGISPLTGEALLRADVNRSGKVDSTDYSVLKRYILRIITEFPGQGDVQTPNPSVTPTQT
PIPTISGNALRDYAEARGIKIGTCVNYPFYNNSDPTYNSILQREFSMVVCENEMKFDALQ
PRQNVFDFSKGDQLLAFAERNGMQMRGHTLIWHNQNPSWLTNGNWNRDSLLAVMKNHITT
VMTHYKGKIVEWDVANECMDDSGNGLRSSIWRNVIGQDYLDYAFRYAREADPDALLFYND
YNIEDLGPKSNAVFNMIKSMKERGVPIDGVGFQCHFINGMSPEYLASIDQNIKRYAEIGV
IVSFTEIDIRIPQSENPATAFQVQANNYKELMKICLANPNCNTFVMWGFTDKYTWIPGTF
PGYGNPLIYDSNYNPKPAYNAIKEALMGY
>Y040_MYCGE.1 [31,591]  P47286 Hypothetical lipoprotein MG04
CGATKIFDSSVQLLVSDNFSTLADKSFSQMSYEGIRSFFKKSKGVDLPEADSSQLQEGNG
LWKRPGFTLSDRIATFNNIKNDGSDVIVATGFNQQESLQAITSDDIRFQSDKESLAKTGF
IFVDGAIEKEFNKRNGVPQFKSTPTNISSVAFRSDDGSFLTGVATAVYLNLNQEYFLDKS
GWSTNSSNNNELTVSGFVGIALPSTLSFLNGFRLGIAYFNEVIYKHLSDAQDSSAQVTTS
KQTVLKQLQVANGEKRIKKIKWISPKQGSDGETINIQDHQSGSFSDTEPRAITIANNLID
KGVNAIIPIAGPQTNLVVTQIARRQAHTAVIGVDSAQELLDINIDAPNKDKLKMGNKKII
PFSSIKALDVAVESILSTLEKGSSQNGYQGFGYNNIGTVKNNSVGVSEAGYEFLIDPVFW
KNTSSMQAMSLSASLKANAASSSDNKKKLSEVATKKNENGSTKNGSNDIIDKYAKLLTKS
SSSTSMRNGSSDSNQQNFKTTDNDGDWTIVGDELGKYKSSELPIFTGSSSYPTFQTEAQN
VLDGGANVASTQGFKWSFKQI
>Y040_MYCPN.1 [27,657]  P75062 Hypothetical lipoprotein MG04
CGATRIWESSIQLLVSNDEATLADKSFSEMSYEGIRRYFRSQKHIELPSPNSSLLQDGNG
LWKRPGRTLSDRIATFKNIKNDGSDVIVATGFNQQEALQAISSDDRRYLADKNDLAKVGF
IFVDGQIEKEYNVINKTPQFRSTPLNISSVAFRSDDGSFLTGVATAVYLNLNQDYFLKKN
GATNNSSQDLTVSGFVGVPIPSTLSFLNGFRLGIAYFNEVIYTHLSDAETTSDNKSNSSS
ASNSVLVQLKQMQGNDKKIKKIKWISPKQGSDNNSNLSIDDHKSGSFSSTEPRATTIINN
LLDKGVSAIIPVAGPQVNLAVNEVARRKAHTAIIGVDSAQELLDINQDAPDKDQLIKGNK
KIIPFSSIKALDVAIENMLIAIQKGSDNNGYKGFGYNNIGTVGTSSVGISEAGYEFLIDP
VFWKTTQSQGKSMATNMTNLKRLSSDDTNTKKALKEVSTHKNGSDKDGIIGKYSNLLTKK
STTVTAVAQKSMTDNNSGTEQKKNLSEVDTKKKEKESKGKTQSNGQDSGQQNGKETNDII
SKYSKLLTMTTMNNKVMSSKKQSSDDNSFKKTSENGDWVIKGDELTKKKSTELPAFAKGA
DYPTFPTEAVSVINGSTALDGKGFKWSFKQI
>Y045_MYCGE.1 [23,483]  P47291 Hypothetical lipoprotein MG04
CGSTTFVLANFESYISPLLLERVQEKHPLTFLTYPSNEKLINGFANNTYSVAVASTYAVS
ELIERDLLSPIDWSQFNLKKSSSSSDKVNNASDAKDLFIDSIKEISQQTKDSKNNELLHW
AVPYFLQNLVFVYRGEKISELEQENVSWTDVIKAIVKHKDRFNDNRLVFIDDARTIFSLA
NIVNTNNNSADVNPKEDGIGYFTNVYESFQRLGLTKSNLDSIFVNSDSNIVINELASGRR
QGGIVYNGDAVYAALGGDLRDELSEEQIPDGNNFHIVQPKISPVALDLLVINKQQSNFQK
EAHEIIFDLALDGADQTKEQLIKTDEELGTDDEDFYLKGAMQNFSYVNYVSPLKVISDPS
TGIVSSKKNNAEMKSKQMSTDQMTSEKEFDYYTETLKALLEKEDSAELNENEKKLVETIK
KAYTIEKDSSIRWNQLVEKPISPLQRSNLSLSWLDFKLHWW
>Y045_MYCPN.1 [23,485]  P75056 Hypothetical lipoprotein MG04
CSSNQFVFANFESYVSPLLLERAEAKQPMTFLTYPTNEKLINGFANNTYTVAVASSYAVS
ELQQQGHLLPIDWAKFNLKKTQNGSNQATIQNKEDAKELFTKEIGDISGELLNWGVPYFL
QDLVFVYRGEKIQELEGQDVTWSTIIKAIVNHKDRFNNNRLALIDDARTIFSLANVVHHE
VKNTTVDVNPTGSTLNYFGNVYESFANLGLKRDNLNTLFVNSDSNIIINELANGRRQGGI
VYNGDAVYAALGGDLRDEINENNLPNGDNFHIVQPKHSPVALDFLIINQQQTHFRDAAHQ
LIYQLALEGADQTAEELLKTDEEKGTSDEDYYTYGAMQNFSYVNYVSPLKNISDETTGIV
FKENKQADTKQVVKQQSQSEQQSESAEKEETEQDDFYTATLKSLLKADSLDDKAKKLVDT
IKKTYKIKKADNINWANLIEKPITPLQRSNLTLSWLDFKQRFW
>Y067_MYCGE.1 [23,516]  P47313 Hypothetical lipoprotein MG06
CSFRSYIPTPSLRNTVGNHNSYVNNTVPKNNFYEKFYDLTFALNFTNQKTQEFGTGWLID
WKGDETKDLNTLTIASSSIISSVSNHSLKEKQDDKLFIAYIATNLHLIDGLKNDHDYQPY
NKDGNGLSFPFDQKTQSFLLGRFANPKINSKPEEMNYQVQTRLKQDAMVFIQTSTLPKTA
YAGIDPINFDYHETSDESGFWTKKQSTANFPRTRTLKSYADFAVLEVPLFLDNANDAKIY
QEWIRPAVQAYKELGDVENIFAKTPYAEYINNTYYLLGYPVTNNNKYQFILGQDEKWKFS
QQTSVLKHYQKQPLQQRTVYVERDDGLPTLTFNEDKLTHVQGTDLINVDQITDTNLGNGL
INYAGLSRFTLSYHNVEYKLFGYGTILNNTNFPGGSSGSAVFNKEKQLTSIYFGSLINVT
TGNNRNVNLGLGQILRTYNTNNSKHSAPSSYDLIFGDKNTIKFYAQFAKEKQTHLWNKIQ
TSVNSSISFYKDKK
>Y068_MYCGE.1 [24,474]  P47314 Hypothetical lipoprotein MG06
CSFVRPQFRRGFRTQFKINSIPTVSDPYHINYDLTFSLNFASNKRNTYGTGWLIDWKGDE
NNPEKNDPFKVYLATNLHVIDALRNNNDYEPYNKDSNNQAFNSEEITRFFSIGKYTYPSI
FSELNFIINAREAFVSIQTSTIPKTAYAAVNFVETQGEDESYTDSLSTDNKRDIYADFAV
IEIPLFLTNHRDYQVFNEFIKPAIETYKQLGNSSFEKKQLDQHKNDNFYMLGYPLVESSI
DALILNQRRQYNNSYTEKYTPQTLTKDQRTIDLSREVPTLIQNKTENSTGSQLLVNQSLS
STSEGIIEFIKLPEFKLNYHNKSYRQYGRGFALQNTNFRPGSSGTLMLNNQKQIAGIYFG
VLDFGEDVSLMSNIGVGQILRVPQKNNTRNRSIATNKSNYDLIFGDSNTTNFYAKFARQN
NTHLYQMISNSKDTKLKYVNTVEKTVKASIK
>Y095_MYCGE.1 [23,398]  P47341 Hypothetical lipoprotein MG09
CSTPQSSFFLPAQTTISTLKINGMENKTGYFLETQRSRGSYNPTASLTMIKLGDEKEFKN
VDTTKQDEVLFANIYGGISSLLNFRIIQPMLTYWNLVNNSLSQIGSTNDLITFKDSGYKD
QLAKALANNLIVADEGNNNFWFGLKALKFDTVKLQANNTATSSTRASTTQNTNNKIDARE
KITINGNGGTNNDQNATVQKLIGIENIEVEFSFVKTGFNGNEIKFEDYVTDSSPTTSLLK
QVWKSKWNTELTHTSFKFKLNSFNVLLTYQLEANQKSQYLPNGFSFLFPSNLEGKIDSSK
SYWNNLVDFSKRTTNEENTMLLTDLQKKQDQVNRFVGFIGQNHFTLSANSINEKQFNDAS
TADFFKAIFQKVSINE
>Y095_MYCPN.1 [22,454]  P75538 Hypothetical lipoprotein MG09
CSTPQSTFHLPVQTTVSAIKKDISGKTATAVKAASSSSSTTTSNDDNNQKGYFLETNRST
GTYDPNNSTRLIKLGESGDFHAADQNKPEEALFERLYGGIASLLNFRIIKPALTYWNTVT
PSLKAIGKSSNLITFSQDIDETELQRALANNLIVADDGNNNFWFGLKSLSFNSAKLTDNA
QTQMAQKTTQAVTLKSQAQMSSTNTKNTNKKIDLRDKITLSSTMNTQGSGDNKNPSSGLI
QKLVSVENIEAEFSFVKTGFNGNEIKFGDFVTENSPTTTQLKQVWKKKWGTELKKTNYKL
QLNNFSLLLTYTPEVNKVEKGNNGDSNKGTIATPNGFSFLYPANLNETPSSSSSYWTNVT
DLTKAATDTENTNLLNDLQKSQEQVNQFVAAITQNHLDVSEAALTKKQFGSLSISDFFKA
IFKENGKDTKAKS
>Y149_MYCGE.1 [24,281]  P47395 Hypothetical lipoprotein MG14
CASTNTYQDQRNALISLASNRDTLIANAKKSKEEVQKEVTKMNSSTSSMMTATQSVAITT
HQTTEKTNNSKYDLDKLFKDYILYVVDNFSGLVFKRTGGHRIQLIDKDKEILDGGNLTKH
THHDHNHMHNHEHEHEEHHDEEETEVVGRALSFTNGIFLVIDYKKDSERKNMSGSTTMMH
QHHHEAEEHKEERKLSLNLKAYKFNTPFNISEFISAWHHKESHNSDTEFNNLHNKYDKEE
LDIIDYNFEEKAVDETIA
>Y149_MYCPN.1 [24,320]  P75583 Hypothetical lipoprotein MG14
CATPNTYEVQRAALIQLVEEDERQNYIQKGSMGANAVMTAAKAETKTAEKTATSTKAASI
ELKKTDTDIKTTTTTENKSASGYKLDTLFGDYILWVVDHLSGLLFSPKTNNSTTTQKIQL
ITEDKMILDGGNLTVEKNHEHGHTHKNGETHEHDHDHHEGEEEVIVGRALSFANGLFLVV
DLKEEKHEEKKEAKSEMSMNSKDMVMMTKTEMMSKEMKSEQKMEKKEEHEHPHKKLSLST
TAYKFGQSFNILEFTGAMHHKTAHNNETEFKNLGKKYGGMTEYTIVDFDFNPPKPTK
>Y185_MYCGE.1 [23,701]  P47431 Hypothetical lipoprotein MG18
CSAVYRFDQVDDGKIKLATVTSASASGSLTTIISKYNSQKDPNDYPVELVSLDSRGSYSN
GKKDLQAKLLAKDKNNFYNLTFNYSDVVSILSRSQMELSFDTVDTSNFDPSFLSFNNNIS
NVNPNSIYALPATVSGEVLVLNGPVLHYILSSAKKDSNTTLSTHSASNNSNKGTMVVASD
SETSSLWTKLEAAAKMNAQTNETQVLKSNSSESNQTQASDTEIKKIWGDYQEVDGGLKNY
TFKASVFNNWKDLNDFATRIAKSFTKLQTTTKKGEEVQAVFGIGSLENALYTALFASGKA
DYNNFLFNIKNQRINFSNFFNKSSTAFQNLKTIFNSFKSLIDQNGLISNAHFNTPVNDYA
KFNQLAFYTSSTARFPYSFASDSVKRLIVNDKTIENKNNKSVFEVNLSSDSDNNSNLIGT
VSLENSKQVSLYEKQVDSNKQIGVDALLIKDETLINHLKSLKSQVSAKSASETSQTKQNK
TFLAFTTVNADQKAIFDVGKLNGKTAKIIINATETTNAKISTLQEKEAIVLKAPQRFEST
DPFPIALVQGPSLIGIHANEREDIETKKFVNWYLNTKVQWEENSIKTPAEYVADKASYLL
PFKNRLNNTNSYNEFVKTAVSQFADKNVTKFAEPADFLSNKVRDGVKSNLNAAINNHSID
FDSFINDLTDYLGSDVKNI
>Y186_MYCGE.1 [25,250]  P47432 Hypothetical lipoprotein MG18
CIAEKPVNNRFNFNSEQLARLRKARVNHWRDGDTLEVSFANNHQKPIRIYAIDTPEKAVL
SIQRKSEIELKEANKATEFAKSLIPIGSEVWIWPLNSYSYDREVAAVFFKTNPLQLHFES
FAVEMVANGHALPIAGNDFDFVFSDLDPFNPLKIVGIELANGLNNAFNNRKNIFSYLENS
FQSITMVYQQRGVDQSWTRYLAPSNDFSSTKLGLGLTIYELKLNNG
>Y186_MYCPN.1 [27,301]  P75265 Lipoprotein MG186 homolog pre
CTRDYTTKNEFQLTTAQQAKLKPATIEYWRDGDTPEINYASEERRKEAEQKSKENAKKED
KKEEKKTEDSQDSSSASTQVRSSKHGLRIYGIDTPEKHVSSKGDSTGDEKIEAEKASNYA
EKLIPKGSTVWVWSLNTYSYDREVGALFFKSNPKQTFFQSFEVAMVEAGHAIPIAGTGLN
LIADPELSADDPLSVIGLQLANAANKAYNAKINIWSHDTDGYRSLTAVYKLRGADISWTR
FLDEANGYSSASAGTGASLYQLWDQRQAKLAQKGS
>Y206_LISMO.1 [21,107]  P33383 Hypothetical protein Lmo0206 
VLILLIIKISVWKDEPFHLSDAKEIECLGSCEIKNTNQKIHFFSIKENLFEEKGDIAGIL
NEDEQKVADKSIFIVILDDEKGIANEE
>Y207_LISMO.1 [23,153]  P33385 Hypothetical lipoprotein Lmo0
CGDKEETKTYTLSQNGVDSKLTYTYKGDKVTKQTAENTMSYASLGVASKEDAEKMLKATS
DKFQGIDGLKEKIEYKDDKAIETLEVDYTKISSEDMNKIPGMSSNGDTSKGISMEESAKM
LESQGYKEVSK
>Y239_LISIN.1 [23,153]  Q92F67 Hypothetical lipoprotein Lin0
CGDKEESKTFSLSQNGVDSKLTYTYKGDKVTKQTAENTMLYTSMGIKTKEEAEKMLKETS
EKFQNIEGLKESIEYKDDKAIETLEVDYTKISSEDLKKLPGMASTGDVSKGISMKESEKM
LKSQGFKEVEK
>Y260_MYCGE.1 [23,765]  P47502 Hypothetical lipoprotein MG26
CSVVSQFDQVDDGKIKLASSLTSKRAAEALETVVKKYNDTKDPGDYPIEIVQIAGGYDGG
KKDVQTKVSTKDKNNFYNLILNYPEIVSTLSRSKMALNFDGVNVDKLHPNFLSFNSRIGG
IRDDGIYAIPISMSTDLMVINGPVLHYILNSARKEGTPTSTTVQATVSSRSAEKKGTLEI
ANDSETTKLWQNIQTTAQNNSNETTKEQKQVKRSSSSSSTTSTTGETKDTTKSDNKIKEF
WGEYQEVDGGLKNFTFKASIFENWNETLDFATRIANSFPEKVKNITNKTGLDLQGVLGVD
SSSNALYAAVFAAGQANYDNFFFNIDKRTGYADYSNFLNKDSSYQNLESVYNDFYKLIQA
NGLFVNRGGSYSSNFEKFHQLAFSVSSSGGYSYYFAKDNAKRLKFSNYAIEYPSFTQTIQ
APNSSETESNLLGTFKLSEKDINLYKGSIPSGKQQGVDAILISNPNLINILEQAKQKNTA
QGSESTTNKIIGYTTTANVNVDNQNIFSVSKLNNEQFQRKIIVNATEETLDQSQTLQSNE
SIVLPMPGKYKSTDKNKVMITQGPNLIGIHANEKENIETKKFVNWFLNQSITDWNSNNQQ
KNSDQTTKTAAEYFTDQASYILPLKEKFNKSSDLELKGSSSSSNLTTSSASASLLISNNS
STASSPAPKKTNNNSNTFTAKALELFQQAANNEIIPFSDPSDFRNGTFRNNISSSFNAAV
NSKVSFNQFVQNFINSLGSGFRR
>Y307_MYCGE.1 [27,1177]  P47549 Hypothetical lipoprotein MG3
CSTPTNSALQTVFSPTSTNFFHGQKGSLKEGLITALKTPSANKHFVIGPLLKALEAWYEN
NEDKAINKFLKDTKKNVDDQYKNTVNGLISPPRNRAVFIQQDLLDKSGGSEASWKSQQLF
NQLISDFTAKLFAKDFLVYKPNGQLSTGPYIYDELSQPEKWKDFGFQEPRFSETNDALFA
KLQAQIFNLWVEYTDPTLISQATFKYAAPQQGLGQVYNTEKLKDKLTPSYAFPFFPKDGE
IPQNQNVGNKRWEQLIEGKDGLNTAKTGLEKYILDQNQGNLIDFPTTLSDNTQTKQIVDS
LNIVDQLEAANLGASLNLKLDLLNQDKDQLPTIKELNKELNNTIVVESTKIENHTKSNTL
FCEHNTTDSSQNNLKSLIKDAFISSNDSSNLGKLAKQIHQTTTSDMMVSTKASSSTTSSY
LVWDAAIPNNKTNNGASTVSANCANATVQNTSHNSNNQLKLRLVRNGEGVAVIGIDGGSY
YLTKNSSSKTERDIEKQKQFLMWRAFQAKTNTFKNSLYSFSFPLNETLKTWFEKNQELIL
VNALINTDFQKKDKGSDAMQKAFNDYKELMQKFAPVALATNVIRDLFLQMDALDNKLTSR
TTELNTNVNQINPTPWLNGLSSHLPYVRKSGHYEKLNNYFLFLITKTLWKKVGSEKINIS
ENNNKLKTTKADVDKIRDEILSDINNKVTEFVNQLKVTEKSKPNFSNIILVDINNDQSLT
NSANWSLNALLDVTTVNPLSFALLKNAFTSNQQFEKAKKLFEEIKSKNGSSSTSSSSDAD
SLAKVISNYYYMTWSKLTNKAMYGNPNNGNIDELFKKAFLESVDESGFNVNFKAVIDHYR
FIFTLQWLIENNLKNFKDILQANLKYGEIAYIAYDKNIISNNTNNPQGIFGSVFNYENDE
HATTANANQTIDPNNFFFKTKTSPNTTPATTMLSTRQAVSTSNNGTYGFTGLNTTNSSML
ENNTNQALLNHIAANSLKQYGSKDDLKKFISETKDQLVLDNIARQLSRLTPSSSSSNGKT
LSAYFQVDAINNSALDFKAKQALLLAVLDQYSSYFNSSNSPSISKRSTQTNQKFSEFNFG
GDSYNYLQFTKSDIDSLSLTSSTNIESDIVAALVLFQASDTGTQQLALSAIEKPQFRIGD
KRIQSGLNLLK
>Y307_MYCPN.1 [28,1244]  P75342 Hypothetical lipoprotein MG3
CATPSNSALQTVFKARSSQFFNGEQGSLQSALTTALKNPVANKQFIAAPLLKALEAWYEN
NEDKKITQFLKDTKSNVDSQYTTAVDKVVSASRNKSLFVQQDLLDNAGGSEATWKAQKLL
EQLISDFASRVFQKNYLNYKKDGQVSTGPFTYDELHKEESWKNFEFSAPRFSETNDDFFA
KIQSQVFDQWVEYTDPTLISQVNYKYSAPSQGLGQIYNREKLKDKLTPSYAFPFFAEEKD
IAPNQNVGNKRWKQLVKGEGAITDNNIGQSGTNSQKTGLLKYRNESNKGDFLDFPLNLSD
TNETKQLVDASNIVDQLEAANLGAALNLKLQVFEQDNDELPQIKELKEDLNNTIVVDKSK
DVEKASKTNALFYNDQEGKQQQSDSDPIAGALDDIFAQNTSEGTNLSKLAEQVKKAAATK
MEAKTAVLRTNNSKGQQNNYVVLDAAIPTFNSTTSKSKNNSASNEVLVALKSGSINLRQV
QQTDQNSYSPIKFRIVRNSTGVTVFGLDGGSYYLKQDSTNKKSVSKQSLTLLTKSSSGNS
NKVLRDLDKQKQFLKFRAFQAKTNTFYSTNFAFSFPLNETLKSWFDKHRELILANALVNA
SLDQKDKASKALTEAFNPYKELIKEFAPVALATTMISFYFDQMKALNNKLLERARNLNQN
VNQANPTPWLNGLSAKLPYVNTNGNYEKLNNYFTFLITKTLWPKVGQEETSISEESNKLK
TKTADVDKIRDKILENIQTKVNDFVKNKLKPALAPRPAYSNVILLNVNNDKVLSSGANWS
LASLLQSDKVNPLSFMLLKQAFDNNDLFKKAQKLFKDIQEKSSNNGGMQSSSTTNSDADA
LSKVIGNYYYTTWAKLTDKSIYGNPKDNKFDELFKLAFEASIDEKSFNVDYKAVIDHYRF
IYTLQWLVDQKLKNFKSLLKTNLKFGEVAFIAYKNTETTNFSNPQGVFGSYFNYENSASE
VKESTQTLDPNNFFYKTTTKPTVQAIQQVASLALVQKQQMQQNSTDHYGFTGLSTSTSSM
FDASSRDAILQQITKTSLQQYGSKDQLKKIIQGTNNQLLLDRIAVQLSGLNPSTTNGGSG
KTIATYFQVDAVGNPTLDFQAKRKLLLDLLDQYQNYFGNGAQKSQRDSTPSGTGNYLTYQ
NGSDKYTYTQFTYQDIDSLSLTTTSGTNNKIASDVVAALLLFQAADKGTQQLALSAINKP
QLNIGDKRIESGLKLLK
>Y309_MYCGE.1 [28,1225]  P47551 Hypothetical lipoprotein MG3
CAQPNSRTIENLFRPSSAFTDKNDGSINATLYKALENREGLTQYLTMRLAPVLRNFYEEN
VDDDIKRNLRTFNTDTDNSFVNQEQNLRNQYRGDYLVRLQTDILDNTGGNQANWKLRDVN
NKIVDDFINKLFTKNFVEYVDKSVGVLSTPLKGLIENQSNWNNIKIQAKFVDKNKRLRIN
NDAVYAAIQDKLLDQFVTNENPNLVSRVVFTNETPNDGFDNYFNPDLIKSPTPSYQFQVF
NKYNQQDNSIKGANGFHILASNLQSYVNTNNKTIDIPNKFSSDSGGKLLLKASDMFDTFD
PSFSAAFIQGYLALQKKSKGAEQTEYTKLEKDKSIIENFFVENNSAKAAMKSASSSSQTT
TVHKTDLAKIFKENETTKSTDVFKGEYQKKFSNATSTSNSDSSNNSAIVDLKELKKDNNS
QPDLILARGKDGIHLMGVDGGGYYLSESGRDVNKQKQFLLFRALQTKYGLIDTNTTYDFK
LFDEVKKHFDKNRVLFLFNALFKLVDSKESNFLSFPQFKKFSDSIITVKNELKDLVESQY
QQIVFNEVATAENKVALKLAERNQPFIDNERNKQIWMNGLAAVLPYEQDSKTGHYNELGI
YYKDIIDKVSSNTSNSNSNSNSSSSDPFSKKIIDKLKENKKKVEAAVKKHVDELKVSVIP
SPQYSQIILVDTKLSSDPRNTSLALNLALNAVLSSDELQNTIRRDYFVNDDQFKQAIDLD
KLTFKNWNSLNNENWNIFKYTYLFDLFQKQANPSIFGNGVNESSTDNKPKINGVLDSLYN
SLNLEERLDSNDLINYYSYLYTVQWLLKDNLKNLKQDLQAKLSRTTNSFLVWSLASDKDR
NNTASQAMSVSSSKSVLVKMANNVASQTNQDFTKQEQQNPNYVFGSSAYNWTNNKTPTVN
SAANDISSLYYTKNNGSSSTSLTLMQKSAQQTNNQQRRFGFHGIVTNTSSNNLPDAVRNR
LFTSFVSQSEKSSSNGGQAQLQSTQSSGSNETIYKGALFSFGSLTKLIETIDNIPTQAEF
DALYNHLTSNLNINVTGVDRSKSLQEQKTNLKNFANSNFNNTQTVQLKQAQSKTNNSNFN
DVFSRFEGYIGTNKTSNYSSYNFLQDNQIYHAVYAKQINLEDVSMLGSDSLNSTDSNNSK
RLDLSLEEFLSTVALEALNPNNQTQAINALIANAKNGLVRVGDNRLFSAISSQWVRKF
>Y309_MYCPN.1 [28,1325]  P75334 Hypothetical lipoprotein MG3
CAQPTASTVEGLFKPSSAFADRTDFSLSSILQKSLINRESFNQYLAMRLAPVLRTFYEDN
YDTDIKERLNGFTADTDNAFVSQEQNLRNQFRENYLVHLQTDIFDNTGGNQAAWKLRDVN
NKIIDDFISRIFAKNFVEYVQDGVGPLTKPTKSLIENTSNFKNIKLQPKFVNKNAKLKIN
NDAVYAAIQDKLLDQFITNENPNLVSRVVFTNETPVDGFDNYFNTKVIQSPTPSYQFQVF
NKYNQQSGGTKGANGFNLLASNLKSYKNDQSKGIDIPNKFSSDSGGKLLLKASDMFDTFD
PSFSAAFIQGYLALQKKSKGADSKEVDSLIKDKSIIENFFVDNNTQAAAAARAASSSSEG
TIQLKTASDGGGTTQSTVHKTDLVKIFGDKDVFAGEYKQQIGNTNANQTGGGGSGGGGGT
STGSSTGSSTETTTGNSSKAVVDLIEVKKDSSSQPDYILSRGKDGIHLMAVDGGSHYLTE
SGRDVAKQKKFLLFRALQTKYGLVDTDTTYDFKLFDEVKKYFDTNRILFLFEALLDLSSD
TNNKDNFLSYPQFKKFADSIKSIEKDLKELVQAHYKQAVFNETAVAENKVTLKLAERNQP
FIDNERNNQIEQNGLAAKLPYEQDAKTGHYNDLGNYYKDIIDNVDKKGTSTVKTTSSNTG
QTKNFSEEVVSKLKDNKKKVEEAAKKHVEALKVFTIPSPLYSQVILVQTKLSFTPESTSL
GLNLALNNYLTSTELQNSIKLSYFQEDEAFKKIIDITNLTFSQQSGGTGGTNGNNNLTAD
NWKIFKETYLLDLFESQAQKSIFGHVGSSDKNSSTKTGIEGVLDTLYSSLNLEERLDSDD
VIDYLSYLYTAHWLLKDNLKNYKQSLQSKLSRTSNAFLVWSVDSEKNKNDSQSTLSSTAS
STSNTGLIQLRSVVSLAQNQAAGQGGDNNSDITQTEVKNPNFVFGSSVYDWTNSKTPEVN
RAADDTSSFFYTKSSSSSTGAAQSSATVLRSLNQASGMTTKTAKNRYGFRGIVTSSTSGS
LPEAVSRRLFKQFVNQTEKGVKVGGQMLITTAKSGKATLVLKQQADDAESTTNNAYKGAL
FSFGSMDNLKNIINGIQTQTEFDALYNHLTSDLNIDVTGVDKNKTLTEQKTSLTSFVDSN
FKQSTQSAQRGDTSARSARSATVQIKKTQEDNQNTNYKDVFSRFDGYIGDNKVEEKNYTS
YQFLSDGGKYHATFVKQVNLDDVEKIGTDSLKQEDSSKDKRLNLSLEEFLAAIALEALDP
NNQTQAINALISGNKKGLVKVGDFRIFSSISAQWVRRF
>Y321_MYCGE.1 [25,934]  P47563 Hypothetical lipoprotein MG32
CASSQLNKGVFFTSSSADLLKNNSVPLSMFNVSPTSSFFGNAYAGLTNYVATGTNRDDGV
NVTDQIKEKLVLELALSVTGYKKTTHSGLKGRAQKNGSTDSSDGSSKNDYTKFNEWDAIG
TIYRDSSKSITEDPNYHKITQEATRYEFTINTSLSWVDNAGREVKQNNQPVKLSSKDFER
GFETYILSSNLGFNRNGYFIDLMGLDVEKTVGMDKTNGSSDGNGKGIEITDENYDVENYR
SVDDNKFNVYLTSPFPFFLSMMSKEFFFPIPHTHPKVKALKLGKDSPLKYNQNNNRKILD
QANTNFDGIYGGGVNAWKDTWSVGPYYVESFNQAQIVFKRNQIYDAIITPNLPKTRQENE
KPIPAIVSYFQPGATPEVFYSSYIAGGLSASAVPYSQQQDARSRFNGTGDLRWLKIQKTA
QSAQVTYSGKPYVANDSTVQLNANITETEAKFLYNSESEEALTIRAGINGLINWKNLAII
DLPNSGDVNYSTVPFGIFKEKPANGTSSGTNTDGIENDYYYKINNNQRLGLIPEQTGTFQ
KDKNVLDTATVKLSYYSSTKTNGAQVRTASTSGSSSQTSQVSSKQVSVTKQSFISALKKV
GFTGNNPLHFNIKLGNASLSSNQVDYYNALKQALTELGNDNGENLIIPEIILGDAQGPTR
NEWYIGLSSVLGFSYWSPDYDGVGTWLDAATQLNSEGIGEVITYNSGSHIVRTLLLAASQ
NNVFNQIENKLQNNTTTNGKDWCSCITSADLFKDDPYVIKNFGTNGNNGTSASLAFTKKA
LSLLKFLVDNKVLKADKVKEAIKDPDKYLSKRSKIDDNKPANVSDIHIGYELKDLYDNAA
QLNRFNSIWAEQDTDNAKFLITVVDSYFPVLPVSAPGLNETIPSLLKPWFSLRNAPSGIA
TMRDSGYIDE
>Y321_MYCPN.1 [25,1005]  P75327 Lipoprotein MG321 homolog pr
CAAQARDVYVTSSASDLLKNNSVPMSMFNVSPTSSFFGSKYAGLTTYIATGSNKDDGVNV
ATQTQEKLVLELATSVKGYKKKDKATSSQKTSTNSSCTTTSSGTSTSGEDDWECIGEIKR
QSSSNGQNNQQSKSITEEEKFQEISQKATRYEFAIDTGIKWVDNNGKPVKDASGNDVKLS
SKDFERGFEAYILSSELRFNRNGYFIDLMGLDVKKTVGMTKKNGAQVQMKVASSDEKDGE
EKTVKITDDAYNPEDYQSTDDSKFNVYLTSPFPFLLSMMSKEFFFPIPHTHPKVKAIKVG
KDSPLVYNEKNGSKILDQTKTNFDGIYGGGVNAWRDTWSVGPYYVESFNQSQIVFKRNSE
YDTHITPNLPKTREDNEKPIPTMINYFQPGATPEVFYSNYIAGGLSSAEVPYSQQEDARS
RFAGTGDLRWVKVQKTAQSAQITYSSRPYVVEGETVKTNSNITETEAKFLYNSESEEALT
IRAGINGLINWQNLAIILLPNSGDLNYSIVPFGIFKEKGKNGASVQQKAVSTTEGSDLMN
DYYYKIEKEQRLGLIPQREGNYEKNKNVLESATVKINYYSSKATSGQAGAAASAAFAKNN
NTSDNTQQNQTSSVEAKSVNVTKHSFVQALKKVGFSGSNPLHFNMKLGNSSLSANGVDYY
NAVKQALTELGTADNGEKLIVPEIILGDAQGPTRNEWYIGLSSVLGFSSWSPDYDGVGTW
LDAATQLNDQGGGDVITYSSGAHIVRTLLLAASQKDVHSKFTQKIDQQNTASTTSDVTVK
KADSSQDSSKSNTEEEKWDDVTSADLFKDDPYVLKNFGDAKAQAAQRSTGSTTSGNGTQA
SLEFTKKALSLLKFLVDNGILDKEKVKEAIKDPNKYLGKRDKIENGTNKPSKNEDFIGYE
LKDIYKKAAQLNRFNSIWAEKDTDNAKFLITVVDSYFPVLPVPAAGLNETSPTLLKPWFQ
FRSAPSGNGTIRDYGFIPENK
>Y338_MYCGE.1 [27,1271]  P47580 Hypothetical lipoprotein MG3
CSTINTANLFPTLNRSQKLIGFSDQNIINPDVVLKSALNDGSGVDSILRVSFGSALQKWY
QANADRNISNRLKIFEENVEDEHDNLIDEKKRADRVKWPIEVQKEYDQFGGNQESWKKLK
LYDRLITDFQSLIFNNISANVSLVNSSDTSVATTKENIEKTENKLKFINSNLNDVNGDFF
TNLQAYLFSQWLIEENPFLLNQASFNYQSPIAGLGSIYDENAIGASNLNLSYNFPAFQDP
SESGGQTNSAKLFEEFDKQLQTANSSGSSQSSAATNTRNDLLDFENKYSASKVLISKNNI
LSVLKTVNLSAAVIDQYHYLLNNKTELTTTTTTTTTTTGGTSSNLNPLDKFIKSSSATTV
MMKSAMTKSQEVTSDNNGFNVKSEFLKINPSLSSSGSDNSSNTQSFWKQVQALNNSSQTA
TIFDAVRMESNSSQAQVVTSNLLVSLSSKTTQKQQQKPVYVRGDDAIYAFHIDGGNYFLE
NSSPNKRNFEKQAEVLLMRFLQGQTNNFSKDNVSFSVDLFGSNSEFRSWANRNTTLKLYT
ALTTMLENGTSNNNGQKDVCDLAKKLLKNNTNLSETIKKQQDFNNSLSQIKSSYESYIKA
ANKLNNFRTDLANIEKLEQAIVDRANNYIKLQKEAKESSIGWGQPLPYKRANDGSYPSLA
KFFNNNSDQSSAQTLTLKTTAAAITSDNEPTREKNNQTLKTLTTEVENKAKELVEKWKAT
TYSSSQYSEIITLKSSQLNDLDLDLILSLLTDSGIRTGTVANIFKNWYFKNTNSFTNNFD
TSNKELKGEFSDFNDLVKQALYIRSWQNLTSKERFGYYKDLGSVNSTSTMLQMQNKAAQS
HTSSSVNQTLLDLAKKAFEKELEDPNQDAEYKYMRFLQALMWLVKNGAQNYKNLLQQAIP
IGTRAFVSWTVGYDKNPSATVSQKTKSSTSSANENPFNRFLQNPNYTQGSEINWFNDKQT
PIQPDSLLESENTYRFTDEPFNNSVALSNKSQGSSDKKYFYGFNGLTINSNQSISTASAG
LTQQLFNNYGQLITATDKAGALSQYKDKFTLWSLINKTSSDAELNAFGELLHRSVNVDTN
NLSRFNSRGEPLISFDNKKKFLLNVVDRLDDLYFHKFEGYVGLSKAANTDGSNTEGYKTV
QTVPLTNDSSIQTLSYVIQITNDDVNKISSNWKNNKANSLGLKKEIFMSLLIEQALDEGT
QELAFLDLIRENQKQHQREHQQILVGDKRLYDILGQTLAINAKNF
>Y338_MYCPN.1 [27,1300]  P75296 Hypothetical lipoprotein MG3
CSALNTSNLFPRQNRSKQLIGFTENNIIKPEAVLKAALAEDNGTETILRVNFGEALKSWY
QNNKDRNIATRLTIFSENVEDEHDNLLDQKQQAEPINWPIELQKEYDQWGGSESSWKALK
LYDRLIADFQSLIFSNIVANVQLTDGSDQFKPTTKDNLDSTSNKIKFVNSKPNDPNGEFF
ANLQAYLFAQWVVEENPLPLTQAFFAYQAPKDGLDSLYDQAAIGSALQLGYAFPAFREPN
NGQSQGKTTFDPTPNSAQNFGDFIKAVFPEQKNGQTQQSNTSSRTGLFDWQTKWNTNGAA
NKLLVTKSNLRGAFKGVGLATAIIDQYEYLVGGSKTSSLPEVKVDSNKSNQNPLDSFFME
GKDAVAIRSIVSRAKIAMTDQTPGFKVNPAFVKVKQSQQNDTFYQNQRKLSGGQSGDNNS
QGKHHYLQDAVRLTSSQAMAAASTGADSSSGTNVGGSSGGNSVLIPLPRSAALTHTQQQV
QQTTSTLQTPVYARGDDGTYALAIDGGDYFLANNKRDFTKQADILLYRYLQAKSNNFKEN
GVEFSLNLLESGSLFQTWAQTGLTAKLYGALVAMMGSGQGTQVKGSVQGSSRAASVSVQT
TQQNRQQSTDTQESEVVKLAKSLLKSSADLAKPFTDNPTFKKALTDIQSEYKDYLAAAGK
LSEFKKDLGEVSGLQQAIIDRADKYIQLEKQAQKSAIGLGQPLPYQRASDGSYPALEKFF
IPEDSAADGKVKASESGSAALVTLKTTDSQKSTNTVKQPDIKPTRENNDKKLKQLTSDVE
TKASSLITKWGATPQIGSQFSEIVSLKSKDNKPQTNMILALLSDVGIKWTKILNSFKEWF
FTNTNDFKNNYDSEKKELKGNEYKDFNDLVKQTLYLRSWQRLTSKEKFGYYKELGSVKAQ
AAQSGMVSLSSSAAVANAVASSGMQKSGDQTLLELGKKAFESELEASSSDGQYKYLRFLS
TLMWLVKDGAKNYKRLLQQAITVGTRAFVSWTVSYDDTATASAAAAKAQVAVLKTAQATN
TQSDNPFNKFVQNPDYVQGSETNWFNDKSTPIKPDSLLESESTYNFTAEPFDDKTKSQKR
STGGTTNEKHFFGFNGLTINSPQSVSTASAGLTEQIFNNFGQLVTSSDKSGALSQYKDKA
TLKRLIQNTNSDAELNAFGEVLHRAVNVDTSNLGRFNSSGEPLISFDNKKKFLVDVVDKL
DDVYFNKFEGYVGQTKVKMSDSSSSSQGTKTIRKPKPHHSPRTRVSRLWAMSFRLPTRTL
TKFLLVEKLIRTVL
>Y348_MYCGE.1 [28,322]  P47590 Hypothetical lipoprotein MG34
CSNIDQSFFRELSVESVEKNTAYNQLPVNSTTFRNLVFGTRSYNDGNYVVVIATETDSSQ
INFLNGSTNQGTSSLSWGGTLGTTIRQVQNRYSTYPNGVKFLIWNDIAPGSVKWNPYARF
PVVDRKNELASQEDKDNSNKLRRSDASAVRYREIVDFIQRTYGGNVANLINQSNVHAQTV
GNDVTKAIVIAFRKDNLNKIRANFYGLDNSTNPNAPGSGQGDSTPPASSGEGGGSDGSSG
GDSSSGNGQNTTPTSPQSSQPAVQRSQKSYGIKQHAVRVSVDFLNFLDSVYTPLN
>Y348_MYCPN.1 [30,305]  P75255 Hypothetical lipoprotein MG34
CSNIDKPNVFRTLSQQSVENKVDYSKLPKENKTVRNLVFGTAEYNDGNYVLVVTTETDSS
QINFLNGSNNQAVSTENWAGDLGTTVKQVQNRYSTYPKGVKFLIWNDIDPNPVKWNPFAR
YPVIASDNELAKQTDKDNSDKLRRNDESAIQYREIVTFIQTVYSGSVNNLINQSNVHAQT
VGTDVTKAIVIAFRKNNLDQISAHFYNPDNSNGSNAPGSNQPNQDSGNNGSTTPAAPAAA
AAKKSYSAGSFGVKRHAVQVSINFLNFLDSVYTPLN
>Y395_MYCGE.1 [27,524]  P47635 Hypothetical lipoprotein MG39
CSAVSPVPVPIEEKNDSTTDNNATPFKDEQSDQGTEVNQQPKVEQKVYNRNFKFNTSFIP
EESDIYRKGYDLTFTLNFTSFSNDSYGTGWLIDWKGDENTTQKQGSFFAYIATNLHVADG
LRNIGDHWPYSKTDDQREFNEYESTVYFSIGKYTNKTDITKLYQEEKLEQRKVNDSLLSI
QTSNIPKTAYTATNFLKGVNSIKPVYADFAVIELELNLENLRDWQIFNEFIKPAINTYKS
LGDSTNIFETKDLEQHWNHSHYLLGYPVLERGYDQNRLLEQKEEFARTHNFNQKSQLWSK
NTYLVSTAKEIPVITKNARKDGQIGSEIFSKKTQDSHVDKVIKHEKGIVTFQNFKNFKLK
YHDKEYQQYGYGLMLDDTNLPGGSSGSAIFNNNQKINSIYFGVLEVYKNSKTHKDNIGMS
QLLRTSKRESEKNKTRTTNNRDKFQHYDLIFGDSNTKSFYAQFAKKHNTHLYDQIKSSEK
EEFKYVDKNNQKTPFLLR
>Y412_MYCGE.1 [24,377]  P47652 Hypothetical lipoprotein MG41
CANINLISAVGSSSVQPLLNKLSSYYVLNENNDNDKLVEISVQAGGSNAGIRAIINGFAD
IGNVSKNPKEYAKENEKKWRDKKLKTLTIGKDAIAVIYKAPQELKGKLLLTKDNINDLYD
LFAGVKTINIDKFVKKDTKNMSNEKDYPLTSFPRTGGSFASGTAEAFLNFSALKSDKTLD
SQTRDILKGIINYGPLAKPTSETNIEAFNTFVTNLQDPNLFGMIYLSLGFIQNNLQAIKN
NGFEILPIKYENKEVLPSNQTVSQNEYKWVRPLNSIVSLSEENKNIDEIKTFFNWLFFNG
KKDVIKNIYDEFGILQLTEDEKKKMFKTNDSSPMNLENFWVDDFAFSNPIFGAF
>Y412_MYCPN.1 [23,372]  P75184 Hypothetical lipoprotein MG41
CANINLISAVGSSSVQPLLSKLSSHYVLNHNDKDNLVEISVQAGGSSAGVKAITKGLADI
GNVSKNTKSYAEENKQLWMDKKLKTITLGKDAIAVIYKAPSEFKGKLVLTKDNLNDLYDL
FAGSKSVDINKFVENGQTTKNSNHNLIGFPRTGGAFASGTAEAFLKFSGLTQTKTLDKDS
KEILEGQRNYGPNARPTSETNIEAFNTFVTTLRQPNLYGMVYLSLGFVNNNMNLIKSEGF
EVLKVKYDNNAVTPSSQAVSSNTYKWVRPLNSVVSLLPKQKTLPSIQRFFNWLLFSNNSE
IKKIYDDFGVLELTADEKKKMFKTGNAEMSNIANFWVDDYSLNNQTFGAL
>Y439_MYCGE.1 [21,272]  P47677 Hypothetical lipoprotein MG43
CSSTDPGLEKAQAYFQRNNIELSKNNAVTFLKKGYSSDKEEVINTVFASWKTTLLDYQLL
EKPLDYSRFAKAFGVNKSKEDVTPNISAKGLYFDETYPGISGQIALVLGVKSQKVVNFQY
SWKNNLDFKVQIHLKMTGIVGSDNTSTSLIKSFLASTSGVSESDFTGDKANFDGDVIFTY
TPPTDNRRVSESTFSSIPASINFPFDIKIDMSTSHEKLNLLLSTNEQVKKIRTRTFKGKS
IDLLPFFYYTLL
>Y43A_MYCPN.1 [26,290]  P75150 Hypothetical lipoprotein MG43
CSSATTEVISSFSSAQKYFSANKKELNKRNLVTILKDSYNSDPKSTVNSLLAGWKYSLLD
QKLLENPMDPSRFSKAFGSNTKDDVNPNISEKGLYLAETYPGVSSQIAQVLGVQSQKVTG
FSYSWTSKTKFEVKILIKMKGKVGSDGTSQTLIKSFLGTDSKGSGSNNQNGGVTEKDFEG
DQANFDGNFIFTYTQPSDGRRLASNNFDPITGTINFPADLQIEVSTSHEKLNTLMTTNTQ
VGMIKNRSFKGKSFNLLPFFYYALL
>Y43B_MYCPN.1 [22,283]  P75152 Hypothetical lipoprotein MG43
CSSAATQVISSLSSAQKYFESSQGELNKKNVIKILKEGYESDANKAVHALLAGWKYTLMD
QQLLSKEVDSRFIKAFGSGRDKGDVTPSVSEKGLYLNETYTGFSSQIAKVLGVQSQTVKQ
FNYKWSSNSDFKVQIQISMKGKVGSDSESQQLIKSFLSSDNNGSNQNGGVKETDFNGDSA
NFDGFFTFTYTPPTQSRKFGATSFDPLTTKINFPADLQIDVSTTHQKLNTLMEANEQVKQ
IKSRKFTGKTFDLLPFFYYALL
>Y43C_MYCPN.1 [26,283]  P75153 Hypothetical lipoprotein MG43
CSSTATNVISSLSSAQKYFDAHKSELIKKNVINLLKEGYSTDSKATVNSLFAGWKYTLMD
QKILERNLDASRFTKAFGTNKGKDDVIPSISEKGLFLDETYSGVSQQIAKVLGVQSQKVT
GFSYSWSSTTNFKVVISFMMQGIVGSGEESNSLIKSFLSSGNNGNVTENDFNNGNANFDG
TFIFTFTPPTDGRRFAFSNFDPITGTINFPANLQIDASTTHEKLNILMQNNEHVKKIKSR
SFTGKSFDLLPFYFYALL
>Y43D_MYCPN.1 [20,279]  P75155 Hypothetical lipoprotein MG43
CSSTTSQVISSLSSAQKYFEANKGELNKNNVINILKDGYNSDPNKTVNALLAGWKYTLMD
QKLLENNLDPSRFKNTFGPNKNKDDVTPNISEKGLFLNETFTGLGSQIAEVFNVQKQIVS
GFSYSWTSPKSFKVNIHIKMEGMINEKSKETIKSFLSNKDSNGSNSVEESEYTGDKAKFT
ADFIFSYTPPTGGTRSLTDKSFDVITNMINFPADVKIDVNTSHNKLNELLEKNDQVKRMK
SRTFNGRNIDLLPFFYYALL
>Y43E_MYCPN.1 [20,300]  P75157 Hypothetical lipoprotein MG43
CSSATSQVISSLSSAQKYFEANKGELNKKNVINILKDGYNSDPNKTVNALLAGWKYTLMD
QKLLERNLDASRFASAFGSTSKKDDITPNISEKSLFLADTFPGISSEIAKVFKVEKQTVS
GFSYSWNSPKKFQVNIQIKMDGKIDESSKALIKSFLEGNSSGGKGSNGKNSIDESEYTGE
KAKFTGNFIFTYTPPTGGARNFSDKSFDVPTSSINFPANVKIDVTTSHTKLNELLESNEQ
VKKMKSRQLTGKLFNLLPFFTTLCFNSFSPFTVFAVIFTIV
>Y43F_MYCPN.1 [23,283]  P75158 Hypothetical lipoprotein MG43
CSALVASVELKSLSELQNLADRNTELTKNKRTLITTLRESYGLNPKGTLNLLFEGWRYTL
LSQRILERWQTEVGRFAKSFGNGSNQNSVQPNATLKGLKLSERSTTEIQLLAEQAITVSK
QEVKEFTYKVESNKQFEATVKIKADLKIDPTKAMSHIENIFKDDETKKKDAQNSLTMSMG
QNEALEATFTYSPATQGIFGRASFDRFTSNIKLNTKLRIQVSSTSDLMKKLLENSLTSSL
KDQSFDNEGVNLFPYTLFALL
>Y440_MYCGE.1 [26,274]  P47678 Hypothetical lipoprotein MG44
CSNLSSGTNFSSLNQLRNSFSKNSELNQDKKELVTSLRDSFEVDSKSATNVLLDAWRFSL
QDEKILEKQDPSRFVKAFGSGKSKEDVEPSTGVKGLRLVERYTQNVASIINNVIKLSSQT
VTDFSFYYNSSRDFKVQIRLQATGTFDSAQAKSYLSQIGLSDSDIKDKNSISADLIFTYT
PPSSNLFSKSSFDTLLRKINFNTNLRLQIIGKDELMQKLLQSNFVGQLADQNFQDQTIDL
LPYVLYSIL
>Y44A_MYCPN.1 [26,277]  P75151 Hypothetical lipoprotein MG44
CSNYDFQANLTSLNQLRTSANKDINLTQDKNTLIDALKTAFENNSEGTTKVLLDAWKFSL
YDAKILEKQDPVKFVKAFGSGKSKEDIEPSAGVRGLRFVERFGDNTASLIKNAILLDQQK
VEVFNIRFKSSRDFTIQIKLNAKGNYKKSEVEKYKSQIGVQDNELGDKEEGTLEADLIFT
YTPPASNLFSKSNFDKLTKSINFNTNLKLEMVGKDEVMRKILNSSAFTNNLASVNYPNQA
VNLLPYVLYSIL
>Y44B_MYCPN.1 [25,274]  P75154 Hypothetical lipoprotein MG44
CSNSGFEANLTSLNQLRTSASKNTNLTQNKADLVTALKSAFENNPEGTTRVLLDAWKFTL
LDAQILEKQDFSKFSKSFGSGRSIEDVEPSAGVRGLRLVERYTQDTANIINNVIKLDKQK
VEAFSIQYKDPKNFRVQVKINAKGNYKKDTVKTYLSQVGLSDGDLNDTGTLEAEIIYTYM
PPAASFFSASKFDKLTRAINFNTNLRIQIIGKDSVMTKLLQQSSFVKQLADQKFQDQSIN
LLPYVLYSIL
>Y44C_MYCPN.1 [26,276]  P75156 Hypothetical lipoprotein MG44
CSNSDFQTNLTSLNQLREGVNQNTSLTQDKKAFVESLQKAFENNPEGTTKVLLDAWKFTL
LDSKILESKDPSRFVKAFGSGKSNEDVEPNASVKGLRLDKRFEPSTANIINNVISLNEQK
VEAFNIQYKSRTSFKVQVKLNAQGKYQKSQVQSYLQQIGLNDGDLKQESGTLSADLIFTY
TVPESNLFSRKNFDTLMKKINFNTTLKIDMVGKDEIMKKILQSTTFTNNLSSQTFQDQSI
DLLPYLLYSIL
>Y5G0_CLOAB.1 [30,967]  P33747 Hypothetical protein CAP0160 
DNNDAVLATAITLSKNEDKLLVNQTDTLTAVVTPDNASNKGVTWSSSDTNTAAVDQNGKI
TALKVGTVTITAATQDGSNLSSSCTVSITRLANSIVLNKMVDKLPVGQTDLLTALVRPLD
SAVKDVTWTTSDPSVVSVDDKGNIKALKLGMAVVTAAVNDGRNLHASCNVYVTNLLSKRK
KADLVVTLDNSMNIDKTTFKDKLNKYIESKLKGSNIDYTIQSIQGYKSKKVLIIQDQPAW
ESGTKVYDDIKQEGYTSDVITANQISSTELTQYSHIYIPSDQAQSFYDELNQNYSKLEAW
TKGGGILIFNAADEGHHSGQWQGSFLGLTHTPSDFQPTITIVKQDPILTANLKTTITGNY
AAHSQFTSYPSNSIIFAVGNKNLPTILEYRYGDGLVFAQTTTAEFYATNSGDLSPYLDNE
IKYTIQKTLGRSFSDILKKPTWRENSEKFVINLGDTLANDVKENSMAQTLAELESNKAYV
TLIGNNNNKDTLNSFINKNDGRGMFIDNSDLDGALSKAGDYIMTVLNKEEQNSNMFLTDD
YINYNESSSEDVSWSYTQDCKHLNYDNDFVNCSKTGDIALDNDLGISDFANGQWVNNEIN
EFKKPGKYTIAYKFKDNAIVNETVNVNRKPTPIFTAYTAQDAVSGKYDVVIKDEDKSYDI
DHENSDGDRKGIVNSKFQWKEVTQGVNDTWHDGKLPSGQDSNKDFIVKLEVQDLEGQWSN
PLVKYITTRNSNVAPHAQFTESAEEMPVDQLNNDASVGMDAIFTDESYDANGDSIREHWI
VTDNNGNTIYDSTSMPKASVFVGKPLGTYNVTLTCDDGPTPKVGAMLTSDSYTLQLKLVP
INHKPVAKFEVDNTSKVPADIKITEDSTDPDGDKITEKDWTVTDDKGKVVLQTENKLPDL
SNLNGSYTITLKVKDSPVGLPELWSDPLSKTIIVEGAK
>YA11_MYCPN.1 [20,231]  P75102 Hypothetical lipoprotein MPN0
CSATFEADLKNLIKETDGKDLDVSKLIITSEGKQILIGYLKKSYEVNSEKTTELLLNAWK
QSAEKNEIGIDLFNWTKSIFSGVNTFNKKQKVEYFNMTYKGISDVSVKAKLNHTLTWNEN
YSYRGFNIHKGDKHYFNSFLTLKANSYLPFTSKNFDVYSKRIRLSVSFHWILKGKDELSQ
KILDKTVLNGYIEYIVDNYQINLFRYLVYLIE
>YA12_MYCPN.1 [19,235]  P75101 Hypothetical protein MPN012 p
AYASIQSDLRNLIQETTKQDVDVYKVIKTSEGRKNLITSLKKSYEVNPDKTTKLLLDAWK
QSAEKGEIDIEKINFPDVGIYATGNDPLKIELKVEYFDMEYQDLNNFSINAKLNYNFNWH
GNYSSNGFAAKKGDKHVFDLPLAIKPSSKNQSKTISFITKTGEGVDTEWIEFPVSLSWSL
QGKINKVKEILRKSFWKAMILEQILNTQLISLDTCFS
>YA54_MYCPN.1 [20,123]  P75060 Hypothetical lipoprotein MPN0
CSSIQSDLRNLIKETTGKDFDVSKLIKTSEGRKNLINSLKKSYESKPDETASLLLIAWKQ
SAEMGEIGFDDIKEGGIYTRDNDPFKLEQKVEYFNMEYKILVMF
>YA83_MYCPN.1 [22,533]  P75610 Hypothetical lipoprotein MPN0
CSFKDYIPTPSFRKDFSTENNFVKNKVPGKDDIYSKFYDLTFSLNFVNNQAQEFGTGWLI
DWKGDENKNLSKNKEGQTASQTRSSSEQTTDQDANLFTAYIATNLHVADGLKNDQDYAPY
NKDGWGQPYPYQQKTQSFLLGKYTKPNVQLVKTNYEKPEDAVIEQKLKEDSLLFIQTSTL
PKTAYAAIDPVNFSYNPTRTNGFWTAGKYNVYNGGNSIGNYADFAVIEVPLVLSNPNDAK
IYQEWIRPATQAYKYLGDVEGLFAKKGYRSYIQDFYHLLGYPVTKNTKSEFILGQSQGTV
NHMSFSNDESNTTNTITKASLTQQPHKEQSAYVVRESGLPTLTMNVDKYTGAKGTHLVNV
DQITDLSLGDGLIDFGGLSRFILQYHNVNYKQFGYGTILWDTNFGGGSSGSAIFNQNKQI
NSIYFGALVNVTTDRNENVGLGLGQILRAPNTFNSSHEVPYSYDLIFGDVNTTNFYAQFA
KKHNTHMWSKIQSTQNGEIGFHKNSKTGQQRH
>YA84_MYCPN.1 [22,524]  P75609 Hypothetical lipoprotein MPN0
CGYVRLKRANFQTDFTINRIPTQGDVYHDNYDLTFSLNFATSSKDSYGTGWLIDWKGDEN
KPSNTDPFLIYLATNLHVVDALRNPQDYEPYNKDSNGQDYGNRDITHFFALGKYTDPGLL
GVETKEQSAFISIQTSAIPKTAYTANDFVDYQYDSLTKQWNKKSDQKDQTQEQTVIGQSW
SYKPAYADFAVIEVPLFLDNVRDKQVFDYFVKPAIETYKKLGDTAQLFTEQNLKELEKET
YIMLGYPVVESNIYAHILGQGKELRVTQQVNNQPVKKNYVLQTITKEQHTLDITREIPTL
IQNKSLSGDFVGSKLLSQEEQQQEHAFLGNLNQGIIDFARLSNFNLQYHNREYQQYGKGL
ALANTNFSGGSSGTLVLNQQKQISGVYFGVLEFGGTNGTNRESSIGVGQILRVKDDAQLQ
QHSHNNLLSQLGSSHNSITYDIIFGNKDTKNYYAQFAKKHQTHLYSQISSSNQQELKYVD
NDPNLKIKEEAAKSTVQNLTVYS
>YA97_MYCPN.1 [23,541]  P75595 Hypothetical lipoprotein MPN0
CGARGKFDQVDDGKIKLASSLTSRSASAALQKVVEKYNKVKGVNDYPIEITQIAGGYDGG
RTDLQTRVSVKDKTSFYNMILNYPDLVSVLARNGMELPFDGVNVDKLSPNFLKFNERISG
VAKKANYAIPISMSTDILILNAPVLHYILNSAKKNDGNTKVQVKAQSKDSQTKVKGTMEI
GTDESTKNLWSDIQKKAGENGKATTEGTKKAAAKSTHLTLLTKSEQSTQGNNGASESDKK
IEETWGTYSEVDGGLKNYTFKADVFDTWHGLIDFSTRVAKSFKNKVSDISTKKGTDIQGV
LGLDSTPNALFTSVFAAGDSNFDNFFYKVKDGRADFSNFNENGTSYKNLEKVFNDYKKLT
DSNGLFVNKGGSYTSNFQKFHQLAYSISSSSGYAYAFAGENSKRLKFNDDTFIEYPSFTQ
EIHAPGQSSQKEGGQQQSNSKDNGNLLGTFTIEAAKSKTKTEVKKTEDTQNQGKKAEGTP
NQGKKAEGTENQGKTIFLYKTSIPNDKQDGVDAVLIKDK
>YB52_MYCPN.1 [23,794]  P75034 Hypothetical lipoprotein MPN1
CGARGKFNQVDDGKIKLASSLTSRSASTALQKVVEKYNKVKGVNDYPIEITQIAGGYDGG
RTDLQTRVNVKDTTNFYNLILNYPDLVSTLGRVGMELPFDKVKTDKLADRFLDFNNRISA
ISKKGIYGIPVSLSTEVLSINGPVLHYILNSAQGKVSSVTSVQRTADSGSGTTNNNGVTK
PLKIDKENESTKKLWEEIENKAKENGKKTSSSRRKRNLSSSKQMSTQTQPTDNSNDANQS
DQAIEKTWGKYQEVEGGLKDYTFKASVFENWHDLLDFSNRVAKSFSNINTNTNKKGTDIQ
GVLGIDSTPNSLFTSVFAAGGGNYDNFFYKVANGRADFSNFKNKGTSYQNLQKVYGDYKG
LIDSNGLFVNKGGSYSSNFQKFHQLAYSISSTSGFFYSFAGENSKRLKFDGGNFIEFPGF
TQAIYAPENNSQSGGESGDQTTNNEANLLGTFKIKSSNKSKSSSSKSSTKAETGKTSGGD
QNQGKKGEGAQNQGKKGEGAQNQGKNGGVETTIYLYKNSIPSGKNKGENAILIDNKTIVE
QLESAAKKEDKKSGESTTEQTQIQSKSVTEQKQPKIIGYTTTGNVHEDNKHIFPIDKLTS
DRNFDRKIIVGATEETLDKSNTLQSNEAIVLPAPSKYKSTDTNKVTITQGPNIIGIHVNE
KENAETQKFVDWFLNSPQTWEGKGKGKEQTNKTAAEFFAESASYILPLKEIFEQKNEKKE
GSDQKDSKSNGRGKQTNLYTEKALELFRGISTDQIVSYSDQVTLGVVVSVME
>YB99_MYCPN.1 [21,760]  Q50289 Hypothetical lipoprotein MPN1
CGTGRFDQIDDGKIKLAVVTSPSAASSLQTLLDQYNNTKAPADYPVEVVSLDSTGSYTKG
KFDTQKRLAAKDKNNFYNLTFNYPDLVSSLAINGMELNLDGVNVSNFEQSFLDFNKNISG
VRKPGIYALPATMSGEVLVLNGPVLHYILNSAKKKDGTESKIKTAQLKTASTQAEVKGTM
TMASDEQTTKLWTNIQNAAKENAANGTTEKAEKTVSASSLQLKNTNKTTEGTLKIGTDDN
TKNLWKKIEDAAKTNGEKGNEKQEATQSNASASLVKLDQKNTSQDKTQNTQTSDDEIKKS
WGEYKEVEGGLKGYEFKADVFESWEKLNDFAVRVAKSFSKVSEEKKSGSDIQGVFGIGSL
ENALYTASFAAGGGDYNNFLFNIKKGRADFSNFFNHNSKTFQSLRDIFNSFKPLIDQKGL
ISNKHFDTPVNNYAKFHQLAFYVSSTARFPYSFAKDNVKRLIIGKRELEVNPKSMFAIKK
ENGNNGNSNLLGKVALDNNKSIELYENNIPNGKTDAILIKNQTLISALKNPKQTKSSQRS
SQSTNTQNDAICYLAFNSKIRPDDKDIFLLDKFGEKFVTAIVNFEEKTEVKINTLQEKEA
VVLPAPQKFKPTDPKSVALVQGPSLIGIHANANEDRSTIKFLNWYLNAEVDWKDGEKKTP
AEYLAEKASYLLPFKKVLEKSKQNIKATSKEGEQNQGKKGDGAQNQGKKGDGAQNGKNDK
AKHNGFCRYCRQPIFKRFCR
>YBBC_BACSU.1 [24,414]  P40407 Hypothetical protein ybbC pre
SPDSKNQTAKKPKVQTGIDTLLPDYKKQLKGKRIGLITNPAGVNTSLKSSVDILYENPDI
KLTALFGPEHGVRGDAQAGDEVGSYIDEKTGVPVYSLYGKTKKPTPEMLKNVDILMFDIQ
DVGTRFYTYIYTMAYAMEAAKENGIPFMVLDRPNPQGGNHIEGPILEPEYASFVGLYPIP
LKHGMTIGELASLFNKEFSIDADLTVVKMKHWKRKMDFDDTRLPFVLPSPNMPTVESTFV
YPATGLIEGTNISEGRGTTKPFELIGAPFIKSTELEETLNSLHLPGVTFRAASFTPTFSK
HQGTLCHGVQLYVTDRDKFEAVKTGLSVIKTIHDLYPEDFEFLSTGSFDKLAGNGWIRTK
IENGTSVENIINSYEKTLQQFSKTRKKYLIY
>YBBD_BACSU.1 [17,642]  P40406 Hypothetical lipoprotein ybbD
CFFGARQTEASASKRAIDANQIVNRMSLDEKLGQMLMPDFRNWQKEGESSPQALTKMNDE
VASLVKKYQFGGIILFAENVKTTKQTVQLTDDYQKASPKIPLMLSIDQEGGIVTRLGEGT
NFPGNMALGAARSRINAYQTGSIIGKELSALGINTDFSPVVDINNNPDNPVIGVRSFSSN
RELTSRLGLYTMKGLQRQDIASALKHFPGHGDTDVDSHYGLPLVSHGQERLREVELYPFQ
KAIDAGADMVMTAHVQFPAFDDTTYKSKLDGSDILVPATLSKKVMTGLLRQEMGFNGVIV
TDALNMKAIADHFGQEEAVVMAVKAGVDIALMPASVTSLKEEQKFARVIQALKEAVKNGD
IPEQQINNSVERIISLKIKRGMYPARNSDSTKEKIAKAKKIVGSKQHLKAEKKLAEKAVT
VLKNEQHTLPFKPKKGSRILIVAPYEEQTASIEQTIHDLIKRKKIKPVSLSKMNFASQVF
KTEHEKQVKEADYIITGSYVVKNDPVVNDGVIDDTISDSSKWATVFPRAVMKAALQHNKP
FVLMSLRNPYDAANFEEAKALIAVYGFKGYANGRYLQPNIPAGVMAIFGQAKPKGTLPVD
IPSVTKPGNTLYPLGYGLNIKTGRPL
>YBBE_BACSU.1 [26,441]  O05213 Hypothetical UPF0214 protein 
QTAGNLIEPKIINAETAQFSTKKLRKVDQMIERDIAAGFPGAVLVVVKDGRIIKKAAYGY
SKKYEGSELLRRPAKMKTRTMFDLASNTKMYATNFALQRLVSQGKLDVYEKVSAYLPGFK
DQPGDLIKGKTRYVSLMSSSTNSGLPSSFYFYTPEKAGKYYSQERDKTIEYLTKIPLDYQ
TGTKHVYSDIGYMLLGCIVEKLTGKPLDVYTEQELYKPLRLKHTLYNPLQKGFKPKQFAA
TERMGNTRDGVIQFPNIRTNTLQGEVHDEKAFYSMDGVSGHAGLFSNADDMAILLQVMLN
KGSYRNISLFDQKTADLFTAPSATDPTFALGWRRNGSKSMEWMFGPHASENAYGHTGWTG
TVTIIDPAYNLGIALLTNKKHTPVIDPEENPNVFEGDQFPTGSYGSVITAIYEAME
>YBCS_BACSU.1 [32,185]  O31425 Hypothetical protein ybcS pre
LLSKDEAKEISIQFIKEFVGIDVENWDFYSVYWYDHDTVNKLHHLGILKKNRKVLYDVGL
VESWRVRFVHQNQSFVVGVNANREITFFYADVPKKTLSGKFEQVSPETLKQRLMASPDGL
WSRANMTGTGKKEEDFREVSTYWYIAEAEIFGSK
>YBGL_BUTFI.1 [29,96]  P16085 Hypothetical protein in beta-g
AGDDLKPVIYLYPQEDNTEISVSLDYNGNLVDLIPEFNADKTWNVTANKDGKITFEGQTY
DYLFWEGD
>YBXI_BACSU.1 [24,267]  P54427 Probable beta-lactamase ybxI 
ASSAHEKHLNVSKMNVDDEFKDTDGTFILHDLQKDQTFVYNRKRANQRQTPQSTFKVVNA
LIGLQVKAVRDEYDVKRWDGVKREFESWNRDHTLGSAMRESAIWYYQALARDIGEERMKT
WLHTLSYGNEDISGGIDQFWLQSSLTISPLEQETFLEKLAKEELPFDKPVMKIVKRMMIQ
EEGDHYTLYGKTGTRLTDMGLGWFVGFIKTEHGSYVFVTNVDDSGTKAKNITVDILKKYG
LITS
>YC00_MYCPN.1 [23,798]  Q50288 Hypothetical lipoprotein MPN2
CGTRGKFDQIDDGKIKLASSLTSKGAANALQAIVKKYNEVKKPGDYPIEITQIAGGYDQA
RVDLQSRVGVKDKTNFYNLILNYPDVVSVLARNQMELPFDGVDVSKISPNFLNFNERISG
VSKKANYAIPVSVSTDILVLNGPVLHYILNSAKGESKGAQKDNKSAEVQRKSTGQKTVTQ
PLTIATDSATNGLWKKIEDAAKVNGKKKEEKKSTRSKRATEGTQTTKENTGGDAATSDTK
IKESWGAYQEVEGGLKGYQFKAIVFENWHDLIDFSTRVAKSFSKVKDNSNKKGNEIQGVL
GVDNSPNALLSSVFAAGNSDYNNFFYKVQNGRADFSNFNNKGSSYKNLKNVFNDYKNLIA
QNGLYVNKGGSYSSNFQKFHQLAYSISSTSGFAYSFAGQNSKRFKFTDDGTFVEYPSYTT
EVNAPESNNGNDGKQQGQSDQGNLLGTFEVVDKSTSDIKVKPKTQAESKKSSDSKQTANT
GKGSNSKQQTPKKTISLYKTKIPQDKTENVDAFLVTDSELISKLEKAKNKKEETKASGKS
ASARVAVQATQKKQSNEKQIVGYTTTSALSEDGKHIFKLGKLNSENYERKIIVGATVETL
EQSTTLQSEEAIVLAAPGKYKDSDQKRVMITQGPNLIGVHANTKENEETKKFVNWFLNKT
ESWEVKGNGKDSQTTKSLTPAQYFAESASYILPLKETVEKDHKEQTNKNTYVAKALEMLK
EVSENKSVSYSDPSDFRSGRFRDALGANFNATINSKANFEKFFQGFKAALGSDFDK
>YC71_MYCPN.1 [26,251]  P75505 Hypothetical lipoprotein MPN2
CTGIQADLRNLIKETTGKDIDLSKAIKTKEGKKNIIASLKKSYEVNPKDTTKLLLDAWKQ
SFEEGKLGIADFDFDHVAYPQTNDPFTMERKVDHFQMTYQSFKDLLVEARLSYTFNWFGD
YSSGDFTAKRGDKHYFYLFLKIKSDPKKQFSAKKFLTEGEAFTDQEGKQTTRNLEWIEFS
ASISWWTKGKDDVSQKSLKKFLESFATNTGYSSDINLFSYLEYLIK
>YC81_MYCPN.1 [23,377]  P75496 Hypothetical lipoprotein MPN2
CGARGKFDQFDDGKIKLASSLTSKAAANALQTIIEKYNIVKSGKDYPIEITQIAGGYDGG
RTDLQTRVSVKDKTNFYNLILNYPDLVSVLARSGMELLFDKVNVDKLEPNFLKFNEQISG
VAKSGNYGIPVSLSTDILVLNGPVLHYILNSAKKEEANSQVKSQIKTSQIQAKGSLTIDT
DENTKSLWEKIQNSAKANGETNQKGRKAAKSNKTALVQLKNGADTTTNEENKDTKTSDDK
VKQTWGDYVEKDDGLKNYTFRASVFENWHDFLDFSTRVAKSFTEKVSNITNKKGTDIQGV
LGVDSSPNVLFASVFAAGGGNYENFFYKLKDGRADFSNFKNKGSSYQNLQSVFKD
>YC84_MYCPN.1 [23,794]  P75493 Hypothetical lipoprotein MPN2
CGARGKFDQVDDGKIVLASSLTSKGAANALQTIVKKYNEVKNIDDYPIEIIQIAGGYDGG
RGNLQTKLSVKDKNSFYNLILNYPDVVSVLGRVGMELPFDKVRTDKLSPRFLDFNKRISA
ISKQGIYGIPVSLSTEVLVLNGPVLHYILSSAKGSSGKTQVSQTSSGSNQQKTLQKPLKI
DTSDSSTSSLWTQIENAAKNNGKKANNSKSNRRSTDQSTQTHNDQGDASESDKKIKESWG
DYEEVDGGLKGFTFKASIFDNWHDLLDFSTRAAKSFKKIKDNNTKKGTDIQGILGVDSSA
NSLFTSVFAAGNGDYDNFFYKVANGRADFSNFKNRGSSFQNLQSVFNDYKGLIDQNGLFV
NKGGSYSSNFQKFHQLAYSISSTSGFYYSFAGNSAKRLKFGDNSFIEYPQYTVPIKAPSK
NGDGNSTNSNSDLLGTFTLSSVKKSTDKSKSDSQQNQGKKVEGTPNQGKKAEGAQNQGKK
ENNSTTIEIYKNKIPDGKNAGKDAILIKDNNLIKQLEDAAKKNGAESNQKQGGESNVQKE
QIIGYTTTGNVREDGNHIFRVDKINDEQYDRKIIVGVTVETLEQSSTLQSEEAIVLAAPG
KYKSTDKKKVTITQGPNIIGIHANEKENAETQKFVDWFLNTEVDWPAKENSSNKQDQQNS
TKKQTAAEFFVESASYILPLKEIFENKEKKENTSNSDKNKSSSQRKNTYAEKALELFQQI
SKDEIVSYSDPSDFRSGKFRDGIGSNFNAAVSSKADFNKFVKGFIATLGSEI
>YC88_MYCPN.1 [23,787]  P75489 Hypothetical lipoprotein MPN2
CGARGKFDQVDDGKIKLAFSLTSKSASNALQAIVKKYNEVKKPGDYHIEITQIAGGYDGG
RSDLQTRVNVKDTTNFYNLILNYPDLVSTLGRVGMELLFDKVNTDKLSDRFLDFNKRISA
ISKPGIYGIPVSLSTEVLSINGPVLHYILKSAKGDSDNVKVSQRTGETTQKSKVTNPLKI
NTQNDPATKDLWEKIEASAKANGKSNKDGQTKGKKKVEKSSSSSLVNLKQSTDQTTTDDG
SQKSDNKIKESWGEYQEVDGGLKNFEFKASIFENWHDLLDFSTRVAKSFTNVKGKDIKKG
TDIQGVLGVDSTPNSLFTSVFAAGGGDYNNFFYKIENGRADFSNFKNKGTSYQNLQKVFG
DFKGLIDKNGIFVNKGGSYSSNFQKFHQLAYSISSTSGFFYSFAGNSAKRLKFGDNFIEF
PRFTQEIKAPSTENGGQSNLLGTFEVKDSSKSKEVKKTNRKEDGAQNQGKKESDKKTIYL
YKSQIPSDKTEGENAILIKEQNVINQLEQAAKKDEKGETVTNKVASLETKAANAKKDSSK
TIIGYTTTDNVHEDGKNIFKINKLKTEDYDRKIIVGATEEVLEQSSTLQSDEAIVLPAPG
KYQSGDAKKVTITQGPNIIGIHANEKENAETQKFVNWFLNNTESWEVKNGKDSSTKQQTA
AEFFAESASYILPLKEIFDKDNKKATENKDNNTSNKKQANTYAEKALDLFQQISKGDIVS
YSDPSDFRSGKFRDGIGSNFNAAVSSKADFDRFVKGFIATLGSEI
>YCDA_BACSU.1 [22,354]  O34538 Hypothetical lipoprotein ycdA
CSGSKTSAEKKESETEKSSDIAQVKIKDVSYTLPSKYDKSTSDDQLVLKVNVAVKNTGKD
PLNVDSMDFTLYQGDTKMSDTDPEDYSEKLQGSTINADKSVEGNLFFVVDKGKQYELNYT
PESYGDKKPKSVTFKIDGKDKKILATADKLQDSAKALSAYVDVLLFGKDNADFEKITGAN
KNEIVNDFNESAKDGYLSASGLSSTYADSKALDNIVNGIKEGLSKNSSIQAKTTSISKDE
AIVEATVKPVDASSLSDRIEDKVKDYYSKNSSASYEEAVKYALQVYPEEFKKLGPASSEK
TVEVKMKKNDIDQWQLDMDDYRAAELVEAFIKE
>YCKB_BACSU.1 [25,287]  P42400 Probable ABC transporter extr
CSGKNEADSKDTGWEQIKDKGKIVVATSGTLYPTSYHDTDSGSDKLTGYEVEVVREAAKR
LGLKVEFKEMGIDGMLTAVNSGQVDAAANDIDVTKDREEKFAFSTPYKYSYGTAIVRKDD
LSGIKTLKDLKGKKAAGAATTVYMEVARKYGAKEVIYDNATNEQYLKDVANGRTDVILND
YYLQTLALAAFPDLNITIHPDIKYMPNKQALVMKKSNAALQKKMNEALKEMSKDGSLTKL
SKQFFNKADVSKKIDADVQDVDL
>YCKD_BACSU.1 [24,110]  P42402 Hypothetical protein yckD pre
AEAAEKQQQSPANVTLTDQQKKEIEQLEAEILKKRKDVISKYVQYGILPKERGEHIKNHL
DKHFEMMKQNGFVPKHHPHPHKFEKRH
>YCKK_BACSU.1 [20,268]  P42199 Probable amino-acid ABC trans
CGAGNDNQSKDNAKDGDLWASIKKKGVLTVGTEGTYEPFTYHDKDTDKLTGYDVEVITEV
AKRLGLKVDFKETQWGSMFAGLNSKRFDVVANQVGKTDREDKYDFSDKYTTSRAVVVTKK
DNNDIKSEADVKGKTSAQSLTSNYNKLATNAGAKVEGVEGMAQALQMIQQARVDMTYNDK
LAVLNYLKTSGNKNVKIAFETGEPQSTYFTFRKGSGEVVDQVNKALKEMKEDGTLSKISK
KWFGEDVSK
>YCZF_BACSU.1 [23,73]  O31479 Hypothetical protein yczF prec
MLQGFSLTKAVYNNMSSFKMTTFAEWVVLLFFVLVLVREMYVIYKSKKKNP
>YD63_MYCPN.1 [23,102]  P75418 Hypothetical lipoprotein MPN3
CGAKGKFDQVDDGKIVLASSLTSKNAANALQAVVEKYNQVKGGNDYPIEITQITGGYDGG
RGNLQTKLSVKDKTTFYNLI
>YD69_MYCPN.1 [26,253]  P75412 Hypothetical lipoprotein MPN3
CTGIQADLRNLIKEATGKDIDVYKAIKTTEGKKNMITSLKKSYKVNPKDTTKLLLDAWKQ
SAEKGELGIPDFDFDDVIYPASKDPFTMERKIEYFQMTYQSFKDLSIEAKLSYTFNWFGD
YSSGDFTAKKGDKHYFDLFPKIKSNSDPGKQFTTEKFLTKEEKIKVNGKEITRNLEWIEF
SASLSFSLKGKDDVSEKSVNKFLSTFANNTEGYSSDINLFIYLEYLIK
>YDDH_BACSU.1 [30,329]  P96645 Hypothetical protein yddH pre
ISRENQVGDDFIGGGDGEYETVGIAPEVERFRAVFEKYARQEGVFDQVNIIMALTMQESG
GRSLDIMQSSESIGLPPNSITDPERSIEVGIKHFKKVFKQAGGDVRLTLQAYNFGSGFID
YVKKNGGKYTKKLALDFSRLQAFKMGWKSYGDPSYVDHVMRYVKGSDKNVKPVKGSMDFY
ETVMKEALKYEGQPYAWGGSNPETGFDCSGLVQWSFAKAGITLPRTAQEQHGATKKISEK
EATAGDLVFFGGTYEGKAITHVGIYVGNGRMFNSNDSGIQYSDLKSGYWRDHLVSFGRIK
>YDDJ_BACSU.1 [28,126]  P96647 Hypothetical protein yddJ pre
IDDVISQYKEHKGNDTEINIKRENAIVRVYEGGKYIQFAFYMPDNSSRELTTFKYYEKFG
DKYEKMTDMPGNGENDRLGLSKKTPDYEEVKGEETELEE
>YDHF_BACSU.1 [24,236]  O05497 Hypothetical protein ydhF pre
EKQHAGGEKTVKAEPQSTSSQKDSTDDYQPNSQVTDDRTLHKVGQTFSDDKGKAVLKDIK
QVNKTYKIGDVELTVKEMKLIHLRPDYSMIDYFHELTHDEEFDFVKVFVDIKNTSTKKVN
VAPIALMKTNTGETFDWNKDIYLEELNGELEGGAEKSGNLGFIVNASSGHAHDKAADAEK
KTKEIKWIEITTSDVFDHNHKKISDAQKIKIKF
>YDIN_BACSU.1 [27,71]  O34608 Hypothetical protein ydiN prec
LKRMIYPKQKPSFFHEFKVLYKLLKKFCIKGIMIKNIRSCMGYFL
>YE08_MYCPN.1 [24,760]  P75376 Hypothetical lipoprotein MPN4
CGARGKFDQVDDGVIKLATSIQNKDSIAALNTIYKKYKERHPGSYPVQNFQVPGGYSGLR
NDIRTRLSAKDGNNFYNIVLNYPDVVSSLATSDMQLILDNVDTKLLSKNFLSFNERIGGV
RQKGIYAIPISLSTELMVLNGPVLHYILNSAKKKENGAQMIKRSGSFSTVQKGTMAIDMN
DQKTKDLWQKIENAAKANGKTTSTQTSPQPKNAVSSLQLKQAAEGTSTDNSQDAENSDNE
IKKTWGEYKEEGNHTLKGYTFKASVFENWNELLDFSTRVANSFPDKIKNQASKKATELQG
VFGVDSVSGALFSATFAAGGGDYDKFFFNVKNGRGNFRNLLEKGSSYNNLQKVFNDYKQL
ISSNGLYINKGGAYSSNFLKFHQLAFSVGSSSGYHFAFAGESAKRLEFGQKAIEYPRDTY
EIKAPTNSQNGNGTLLGSFTKSKSNGKEQSGQDEDNQTSETIELYKSSVPSGKEAGKNAL
AITNQQLISALENAAKDNKTSQPQARSLTASDQVQITQSSDKVIGYITTSNLDIDNNNTF
DVGKLNGDKSTSKIIVNATLKTLNKINTLQSEEGIILPHPQKYKSTDPQAVATVQGPSII
GVHANAKENAETQKFINWFINQKETWPENSKGNKNGQNGQMTAAQYFAKSSGYVLPYSET
FTKQSEDEHSTTKDAYKILKDVNDGKLVGYSDPSDFRSGKFRDTIVAAFSGAVSSKADFN
KFFKGFEQQLGQEYRRG
>YE11_MYCPN.1 [26,252]  P75373 Hypothetical lipoprotein MPN4
CTGIQADLRNLIKEATGKDIDLSKSIKTTDGKKNIITSSKKSYEVNPKDTTKLLLEAWKQ
SFEEGKLGIAELAFDQATNPTKNSDFKMERKVEYFNMEYKSFSDFSVNARLSYIFNWYGS
YFGEKSFTANNGGKHNFDLFLSIKSHSKKQFTEKSFIVKDENFQDQDKSQQIITEWIQLD
LSLIWSLKGQDELSRKSLDKIFLKDYITYSANEKQINLFTYLQHLIK
>YE39_MYCPN.1 [28,237]  P75339 Hypothetical lipoprotein MPN4
CATPSNSALQAVFKPTSNQFFNGEHGTIQSALNTALRDPETNKKFVAAPLLKALEAWYEN
NQDKNITQFLKDTKTNVDNQYKTVVDKVVSAPRNKSLFVQQDLLDSSGGSEATWKARKLF
EQLISDFASRVFQKNYLSYKENGKVSAGPFLYDTISKNSNWQNIVFDAVNFPETNDDFFA
KIQSEVFDQWAEYTDPTIISSVTLKYSAPN
>YE42_MYCPN.1 [28,150]  P75336 Hypothetical lipoprotein MPN4
CATPSNSALQTVFKARSNQFFNGEQGSLQNALATALKDPEANKQFVAAPLLKALTAWYEN
NQDKQVTQFFKDTKKSVDEQYNQAVDKVVSASRNKNLFVQQDLLDSAGGVRNLKSPEVVW
TAH
>YE59_MYCPN.1 [25,569]  P75324 Hypothetical lipoprotein MPN4
CAAQARDVYVTSSASDLLKNNLVPMSMFNVSPTSSFFGSKYAGLTTYIATGSNKDDGVNV
TSQTQEKLVLELATSVKGYKKKTSTASNMKTASVSSSSSSTGNNGSTEDEWEVVGSEIKR
ESGKGDNGKSITEDSNFQTISQQATRYEFTIDTSIKWVDNNGKPVKDEKGQEVKLSSKDF
ERGFEAYILSSELRFNRNGYFIDLMGLDVEKTVGMTNGKNGTQVKKMTTDSSSTQQSEEK
KIEITDDNYDPEDYRSTSDDKFNVYLTSPFPFLLSMMSKEFFFPIPHTHPKVKAIKVGPN
SPLVYNEKNSAKILDQTKTNFDGIYGGGGVNAWRDAWSVGPYYVESFNQSQIVFKRNKEY
DDHITPNLPKTREGNEQPIPTMINYFQPGATPEVFYSNYIAGGLSSAGVSYSQQEDARSR
FASTGDLRWVKVQKTAQSAQITYSSRPYILEGETVKTNSNITETEAKFLYNSESEEALTI
RAGINGLINWQNLAIILLPNSGDLNYSIVPFGIFKEKGKDVQVKQKNTGQASQGSDLMND
YYYKI
>YE67_MYCPN.1 [26,101]  P75316 Hypothetical lipoprotein MPN4
CTGIQADLRNLIKETTGKDIDLSKAIKTKEGKKNIIASLKKSYEVNPRDTTKLLLDAWKQ
SFEEGKLGIPDFDLTM
>YF06_MYCPN.1 [23,793]  P75280 Hypothetical lipoprotein MPN5
CGTKGKFDQVDDGKIKLASSLTSKSASKALQAIVKKYNEVKKPGDYPIEITQIAGGYDGG
RSDLQTRVNVKDTTNFYNLILNYPDLVSTLGRVGMELPFDNVKVDKLSPRFLDFNNRISA
ISKPGIYGIPVSLSTEVLSINGPVLHYILNNAKKKEGTLNQKMTSSSEGKNSSGTLTVAT
DTETSSLWKKIEDSAKANGKSDEKGKGKKKDNKSATFSLVQLKQTQEKTDDSQDTKNSDD
QVKKSWGEYQEVDGVLKNFEFKASIFENWHDLLDFSTRVAKSFKKIHENSNKKGNDIQGI
LGVDSTPNSLFTSVFAAGGGDYNNFFYKIENGRADFSNFKNKGTSYQNLQKVFGDFKGLI
DKNGIFVNKGGSYSSNFQKFHQLAYSISSTSGFFYSFAGKSAKRLNFGDSFIEYPRFTQE
IKAPSKNGENGQTNEGNSTNGEQNLLGTFEVKDDSKPKEEVKSNKNSGKESSQNQGKKSN
NNKTIYLYETKIPDGKTAGDNAILIKDKNVIEKLKSAAKEENKEQTAEATKAAITSNKAK
STKKESSKVIGYTTTDSVREDGKNIFAIDRVNGENYDRKIIVGAKAETLNQSSTLQSEEA
IVLPAPGKYLNGDPKKVTITQGPNIIGIHANEKENAETQKFVDWFLNSPQTWEKQSRDKK
GSSEKQTAAEFFAESASYILPLKEIFDKNDTKTEKGKNSKTQQRTNTYAEKALELFKQIS
QNQIVSYSDPSDFRSGKFRDAIGATFNAAVSSKADFNKFVQNFTATLGSDI
>YF82_MYCPN.1 [23,439]  P75198 Hypothetical lipoprotein MPN5
CSAFRKPDKFEGYYINNIPGSAEIDHANYDLTFFLGFFNRIEKTEKDKSQIDFGSIHGTG
WLIDWKEVDKKDKKANKFTVYLATNLHVIQALKNREDHPPYNQFDINFVRTVDFRIGKYT
DVKQFVAPSKLGLPNSTQAFVAAQPTVLPKTAFIAHDFVNYTLSKDQKNKKQREQQWKVQ
IKPNKDEVHPYADSAVLELPLFLNNSSDRQIFDHFIQPAIRAYKQLGDSLNIFAYPTLDQ
FKHSHYYVLGYPYIAKKLPTLFVNQTGKEKTVPGETAQIPNDQPFVSTINEEGPHLGRIK
SDKFNGGTWAWNHDNTKNFPFNRQFRGKEYQMYGKGIGITNGSLSRGASGSLVLNNKRQI
VAIYFASRITETQEWGLAQLLRWKPRSVLNEEKDSVAYDLIFGNSNTKKYYAQFAKK
>YF85_MYCPN.1 [23,302]  P75195 Hypothetical lipoprotein MPN5
CAAFDKWQEFYINNIPSSTEIHRFNYDLNFSLTFTNRITSNGEAKFSVTYGTGWLIDWKE
PDKKKENDPFRAYLATNLHVAASLINPQDYEPYKNKDDAGWTTTFRLGKYTKVSDFVSPN
QFGLPNAAQALVNVQTSVIPKTAFAARDFVDYSFPQEQKDKEKRKQQWVKNSHTKNSDVQ
PFAEFAILEIPLFSKSKVDRKIFNHFIQPAIRTYKQLGDSLNIFANPTLDQLKQNRYYVL
GYPFLKNKVSSLFLNQTGKKKGIFRRKYTNIPWKTSYYLN
>YF87_MYCPN.1 [23,150]  P75193 Hypothetical lipoprotein MPN5
CATISLSDKSGEFYINNIPSSAELHRINYDLTFSLGFTNRIQTKKKNEVNFVAFYGTGLL
IDWKEGNQYQPFRVYLATNVHVAAGLKNEADYLPYSQPDAELGWTVDFRLGKYTNVKDFV
SPNENRIT
>YF88_MYCPN.1 [23,531]  Q50339 Hypothetical lipoprotein MPN5
CAATQPNFEPNNIEESGPITPTTPTTDVPKPTAEVVPVNRGFHFQTNKVPSESDVFKHNY
DLTFSLNFTNKSNDIYGTGWLFDWKGDEKALGIDGSFVPSITSNIDNSLLKDDQFTVYLA
TNLHVADALRNDQDYEPYKKDQNKQDFTENTKTEFFSLGKYLEGEQLKQYISKEENQSAN
QTDKALVSIQASNIPKTAYTATDFVDMNSYSYNNITTSLPGNYADFAVIEVNLNLKNQRD
QQILHDFVKPAIKAYKALGDTLELFSAKPLNQFIEQNYYLLGYPVINKGNNTANLLLAQQ
KSFDHNNSDHNQKSQWFTKDQSYINKLDRIPVLTNNYRAYNESTGSQLFANQQNESWLNG
VVIQDKGVVNFASFSNFTLKYHEKRFQQYGYGLMLNDTNFPGGSSGSPLIGKDNKLNSIY
FGVLEIYQSGSLARNDIGMSQILRTPQNDKGSSISKGSYDLIFGDKNTKNYYAKFAKDHQ
THLYQKIKESKDEQFRFVETQETTNNLGN
>YF90_MYCPN.1 [33,217]  Q50337 Hypothetical lipoprotein MPN5
CAPAVPVNNKSVSAVQPEDKQALKPDPALGEYTSDLKFNTNFIPKKDDPFRPFYDLSFTL
QFQDPYTATYGTGWLIDWKDNNQPNKFTAYIATNLHVADNLRNVNDYEFFNQFDYFDDPT
ESFTLGKFVDGNEIKQIVPDAMHEPSLVRIETSKLPKTAYTTTLFINDLGEYRLPAADFA
VLESI
>YF92_MYCPN.1 [23,521]  Q50335 Hypothetical lipoprotein MPN5
CSATLTVANTNHKNESDKFVIFEPQPPLSQTIPKPEAEPVIEPDAVATPPVQNAEVQIKP
DSSKGVYSPGFKFNTNFIPKVNTKYRPGYDLSFALKFGTSWKEAYGTGWLIDWKDVKQDN
KFTAYLATNLHVADSLRNKDDYKPYNKDGNQKEFLPGDITTEFSLGKYIDAQTVQKLTPE
YQNLKHLNNRNSDALVSIQTSKLPKTAYTATDFIKTAQYKYNHIVSNTVYELDLFQNAVS
YADFAVLELELNLANNRDQQIFDSFINPAVTAYEKLGNSLGLFSNLQLDQYVDDTHYLLG
YPLLKREKTSYWNLPQKGYSSPLYENSNKEVSRITRNIRKDDEIPGSRLVQNQINYLPFA
QNDPKGVMDFSKYLNYVFNYHEKQYQHHGYGLLLEDTDFPGGSSGSPLFNQNKQINSIYF
AALPSKSYGVSQILRATQNKDKSKNYDLIFGDSNTKKYYAQFAKEHKTHLYHQILQSNDE
QFRFVENDQTVTSQTPFKS
>YFKI_BACSU.1 [32,106]  O34418 Hypothetical protein yfkI pre
CGMRWLTCKHKLSLYKSNPELLKNTVITKVDEAKKLARTLSKEVDFVNQQVKELKKTTPQ
VMELVQETKEHFSKK
>YFU2_BACST.1 [24,265]  Q04729 Hypothetical 30.6 kDa protein
AVSNHPIHWGFQKNNNHQPPDAGKEWNELLNKYGAFYLGDPSKKEIYLTFDNGYENGYTS
KILDVLKKHDVHATFFVTGHYLKTAPDLVKRMVKEGHIVGNHSWSHPDMTTISADKIKKE
LDAVSDKVKELTGQEGTVYVRPPRGIFSERTLALSEKYGYRNIFWSLAFVDWKVNEQKGW
RYAYDNIINQIHPGAIILLHTVSKDNADALDEAIKTLKQQGYTFKSLDDLVMEKMFESPF
LY
>YG50_MYCPN.1 [20,101]  P75147 Hypothetical lipoprotein MPN6
CSSVNVGANLKSLIKETTDQDLDLSESVSTSEGKKNLISSLKKSYETNPSKTASVLLNAW
KQSVENGQIESSETNWTNWKFP
>YG54_MYCPN.1 [26,127]  P75137 Hypothetical lipoprotein MPN6
CTWIQANLRNLLKETTGKDFDLSKAIKIPEGRQNLINSLKKSYEVNPKDTTKLLLDAWKQ
SSEEGKLGIADLDFDQVTNPTEKDPFKNGAKGRAFRHWISKY
>YGAO_BACSU.1 [18,157]  P97029 Hypothetical lipoprotein ygaO
CWALISYFEASEGIASFFGTKSGGMVFDLNLTPFILFVAASAVYLYLQKKSRPARKQLLL
PDEFEEQDEREQMMTAKACRASYIAVYFSLPAAAVLLIFYPLFQSRIPFFPIIIVFIIMI
IQHLSYVISFKKNEKNSGAL
>YHBA_BACCE.1 [23,158]  Q45104 Hypothetical protein in hblA 
VIPIETFAIEIQQTNTENRSLSANEEQMKKALQDAGLFVKAMNEYSYLLIHNPDVSFEGI
TINGNTDLPSKIVQDQKNARAHAVTWNTHVKKQLLDTLTGIIEYDTKFENHYETLVEAIN
TGNGDTLKKGITDLQG
>YHCJ_BACSU.1 [20,263]  P54594 Hypothetical lipoprotein yhcJ
CSPSAEHESIKIGIAESDGAIWNYIAQKAEEAGLDIQLIPFSDYAESDIALANKEIDANA
FQTISYFQSFTEKYKLNLAPLGTTYITPMGIYSKRYERIRDISRGAVVSVPDKAFDFGRA
LTVLQEAGLLTLKNGFNGTGSVDMIKDNPRHLKLKAVRQQDAVSGADVFVMKPSEAKKAG
LNPKKHTLKSGGLMSEEEMNLIVVRAEDQDREALQTILELYQADDTAAFIEKEYQGDLVR
LFCL
>YHCN_BACSU.1 [21,189]  P54598 Lipoprotein yhcN precursor. -
CGVADQGEGRRDNNDVRNVNYRNPANDDMRNVNNRDNVDNNVNDNANNNRVNDDNNNDRK
LEVADEAADKVTDLKEVKHADIIVAGNQAYVAVVLTNGNKGAVENNLKKKIAKKVRSTDK
NIDNVYVSANPDFVERMQGYGKRIQNGDPIAGLFDEFTQTVQRVFPNAE
>YHJA_BACSU.1 [28,89]  O07555 Hypothetical protein yhjA prec
KTKVKVYKNCKELNKVYKGGVARTSKVKNKGGKTKYKPYVSKALYDANKNKDRDKDLIAC
ER
>YITM_BACSU.1 [30,194]  O06748 Hypothetical protein yitM pre
KQLEYSGEEIFKGFVFAQGEVGKQLPEVFNKAMTDKLNTKQAKAFANQVVADIKKEDADF
FDNLKKAVYSKDALKVDELLKKAGQIVEEKVEAAKEIAASKDDTSRVQAELVNTVDTANY
FYYVSYVAAAGALILIILAIDITPIAISDNVDREMAIRTLVDELN
>YJCN_BACSU.1 [32,106]  O31636 Hypothetical protein yjcN pre
ASSEKGAIRHEIYKRGYPYQSYFAVLQKREGDNESGNLYYVNWLDWKDETGQTPHLCYSK
KSSDGEYEVSCGTGP
>YJDJ_BACSU.1 [26,109]  O31651 Hypothetical protein yjdJ pre
YQGSELVSDRFDWNYTAKLSKLLNGIDAVSSPKQISQLDFFIYSAKHYPVMSALMIISFL
YVLAALFLLIYSVKCNKQEIHLDC
>YJEA_BACSU.1 [27,467]  O34798 Hypothetical protein yjeA pre
NHSLKKETVMNKVRTDSQYGNVEIATLVNDGKTFNYAVNYPVFKNEKMDSALKRFAEKEV
RQFQKETKDVDQEHTTKRNELNVDYKIVHYAKQTVAIVFNEYKYIGGAHGQTVKKTFNYD
FSKQAFLSIDDIFKEDADYLHKLSLIAYHELKKNKDIAADDALLKEGTAPKKENFSRFAI
KEDYIELYFDTYQVAAGYLGEQSIAIKKSLLKDILKEQYIDKAKNKNKIKEQKPKHEVIS
LPKEETVDPNQKVIALTFDDGPNPATTNQILDSLKKYKGHATFFVLGSRVQYYPETLIRM
LKEGNEVGNHSWSHPLLTRLSVKEALKQINDTQDIIEKISGYRPTLVRPPYGGINDELRS
QMKMDVALWDVDPEDWKDRNKKTIVDRVMNQAGDGRTILIHDIYRTSADAADEIIKKLTD
QGYQLVTVSQLEEVKKQREAK
>YJFA_BACSU.1 [29,157]  O34554 Hypothetical protein yjfA pre
ETHAYDGKSPYYNDCASSGSTKKSSNLVNASNQVIGVVELKFSSTCKTAWAKITMNNTLT
SGYEANAEITRNTDGKRYNCDSAGGNGKAVAGQKSCYTPMVYDLDPRTSYAFGKYSGPNL
NVWATTGSY
>YJGB_BACSU.1 [24,191]  O34960 Hypothetical protein yjgB pre
ASFSAPAKAAAQTNTLSENTNQSAAELVKNLYNTAYKGEMPQQAQGLTINKSTKGDVHAA
FGEPERPVGGDNRFDLYHWNMGQPGYGFSYHKDMTISEIRYFGTGVERQLNLGGVTPEVL
QKQLGPVNRVLTVPFTDEIDYVYDTGRYELHFVIGTDQTADHVNLKAK
>YJHA_BACSU.1 [20,213]  O34725 Hypothetical lipoprotein yjhA
CSQSSDASEKEKPKEKKSQEELEKELDKELKKGGEPKTKKDDQIHKIGETFKAGHTNFTV
NKVDRVQKGEYMNVGGAVNEETKTIKDDEERLIIEVTMENIGEDSISYNFIGFDLRDKND
QSVRPVFSIEEKGRILMGGTLVSGKKVTGVLSYVIPKGEQKHYTLVYNPFLADTNSSNTE
ERVKDDIDYLVKLD
>YKDA_MYCCA.1 [24,655]  P45615 Hypothetical lipoprotein in k
CVKQAKENNNKNQLISQFKQLIFILNSFDLDNKKLESKIIKAIEKSDFNKISNINLELTI
KFLTRIKNELETKTISQLNKNDKLDILTKIKVHLGSLNLIELVNIVDELVNKLNQKEEIK
NTHKDKIEKNKDNIEDIDDSKLEILESKYIPNQHNYPDYVKNFKTVSAEEIYKELYDRTF
SIKFLVKLKDGGLLSNGTGTGWLLDYHKYSNTNKYKMFIATNLHVLADFSNSLTDEQNKE
FNYYDPSGNKVIGLGLGKADNVTDFSRKNNNSKSENNIANYYLNNQDFENYLKNDFWSVN
KFSKGISEPKIVFGAVDFMKDRAIKNHYEALQKEAINYYNYKKNNNEINDDNKIAWNNFL
NNKDIPIMIDFAVFEFDVDLDLVDYNLKSWISNAISGLDNYLDRLNKAPILPNQDKKISK
YLQTTDYVSALFKKDKSEQNLYNAKDIYIAGYPTSQYSRSVWMQNNPIERNSSTLTSNWR
SPTNDKTFAFANEVEEKAGTGLNFNIHDNYWHRVFATFYGYQYNINFSSLYYGASGSLAY
NEFGQMIGIYNNVKSNVEFGDLLQSATIAPFLQSDNIKVGDNIIYAYNLIDGTDKTKYKY
QKSSFRENLQKLYPNGFSDGLKSTKLFDDIFN
>YKUH_BACSU.1 [30,182]  O31696 Hypothetical protein ykuH pre
FSPEYYQNTNLTSNEIIRFEKLYHIDFPDETKFIKAREYLAGPGGDTSAVLYVSLPTKRV
EKVLSDYTYMKINYTDNVGSMYGVDVSKSVAGLTTLTFGTYDKKGTFYNMKHDDDWMYKG
TDWNLYFWTAASYNAVIFVFVLVIVKQMNKILN
>YLAE_BACSU.1 [32,203]  O07629 Hypothetical protein ylaE pre
KTPVDNTAVQLQHQASTNEDLNTFIDILNQCIYEQDGVYYFDSEKAVELGMTKEEAQVIA
TLWESTSEFFSIVSQCVYLEDGNYKFDTEKAVELGFTEKEALALEQFFSAVSLKIHILQA
AIVLQDDVYSYDKDAALQAGATPLQADVYEKLFSALSQEQLAAIYDMIHPQA
>YLAJ_BACSU.1 [17,209]  O07634 Hypothetical lipoprotein ylaJ
CAYQQGKQGQNVEKESTRQQETKPIHVKDTTQETKDNGTRTDIAKHLVSVAEKNPDVKDA
TAVVLGGYAVVGIDVDDTLDRSKVETIKYSVAQALKNDRYGANAVVIADPDTVSRLREMS
REISEGHPVTGILDELAAIVGRVLPEVPNDVIDNEDEPQTKQQNDQLNRKQQQEMEKEQN
DQSDHHMKKNNND
>YLXL_BACSU.1 [20,167]  P40405 Hypothetical protein ylxL pre
VIILYTRLAAVKETEKQQKQILEETENTLAAFLLELKEENEKLIENKASSASQSDEESQK
SGLQTSETYQERDPVQEAENLPEHIEGLITEVDRREELVNSEVQSFEDQVIELYEQGYSA
SQIAQKMKSGKTEIELFLKFRSKGVKDS
>YLXY_BACSU.1 [28,319]  P50850 Hypothetical protein ylxY pre
LDYIGAMKKDTVTVTASKDPLYEELLQKAPEYEVKPQNARIDKVWKSIPGYNGLKVNIEQ
SYKKMKQHGKFREKDLVYSQVKPSVHLESLQPEPIYKGNPDKPMVAFLINVAWGNEYLEK
MLPILQKHQVKATFFLEGNWVRNNVQLAKKIAKDGHEIGNHSYNHPDMSKLTTGRISEQL
DKTNEQIEQTIGVKPKWFAPPSGSFRKAVIDIAAEKQMGTVMWTVDTIDWQKPAPSVLQT
RVLSKIHNGAMILMHPTDPTAESLEALITQIKDKGYALGTVTELMDETRLLK
>YNDA_BACSU.1 [26,132]  O31805 Hypothetical protein yndA pre
EKAGTAGAGEWDKLGTYTYTYSSPTVYSTGGDFRVCLSGSTPFSVSLHLYEDDPGDNPDD
YVGANYFSPGECHTFGSIGKFVDGSNNKAEFFVTDYSGKSKTVTFYD
>YOAO_BACSU.1 [35,162]  O34985 Hypothetical protein yoaO pre
KYEGSGKSGLWMSNLEKSDKTSIGPNYFLNLYWQGSKKEEKWTVVERITLYVDGEKYQDD
NVDEYDLSEYTGDEMPGGGRMEDHISTFDYMPEDEVIGHDVLVKVEWRTGQKKQTEAIKL
HKKPWYKK
>YOAW_BACSU.1 [25,143]  O34541 Hypothetical protein yoaW pre
VIVKDEEKVSFTMTENEKWFMKSDDLNSNHWTSHFGYRFTIFDTEGCTINARIMRMTLSG
YEITVSEKNFSGDHFDFSATDRVETMPYKTHYLILTKDPDCGDVKVKGLYGFQFDQPEW
>YOBA_BACSU.1 [28,120]  O31835 Hypothetical protein yobA pre
GDETKMQSLVGYVVLKDNERAILITDTKAPGKEDYNLSEGQLMNKFKNNIVIVGLSEIDN
TDDLKRGEKIKVWFHTRKESNPPSATIQKYELL
>YOBB_BACSU.1 [26,87]  O31836 Hypothetical protein yobB prec
AGTSSEVAVKNEEYDYDTIYRISPLPMDFQPTIEYNGYTYTLTRHYFDYSIGFYTAIYTK
VV
>YOEB_BACSU.1 [24,181]  O34841 Hypothetical protein yoeB pre
KNTSGDLSQKQALQLALSAREHFWNTMSGQNPKVKKAVCPSGTFEYQNLQYVYMCSDLGT
KAKAVNYLTPIFTKTAIEKGFKDYHFTVSKGKLAVPIGDGDNLLNWKKSTAKLISKKGST
ITYEFTVPTLDGSPSAKRKVTFVKENKKWKVNQFDAVI
>YOJL_BACSU.1 [27,414]  O31852 Hypothetical protein yojL pre
KTIKVKSGDSLWKLSRQYDTTISALKSENKLKSTVLYVGQSLKVPESSKKSTTSPSNSSK
TSTYTVAYGDSLWMIAKNHKMSVSELKSLNSLSSDLIRPGQKLKIKGTSSSSGSNGSKKN
SGSNSSGSSKSTYTVKLGDSLWKIANSLNMTVAELKTLNGLTSDTLYPKQVLKIKGSSSP
KNGNSGSKKPSNSNPSKTTTYKVKAGDSLWKIANRLGVTVQSIRDKNNLSSDVLQIGQVL
TISGASKSNPSNPTKPTKPKDNSGSNIQIGSKIDRMITEAKKYVGVPYRWGGNTPAGFDC
SGFIYYLINNVSSISRLSTAGYWNVMQKVSQPSVGDFVFFTTYKSGPSHMGIYLGGGDFI
HASSSGVDISNLSNSYWKQRYLGARSYF
>YOJM_BACSU.1 [18,196]  O31851 Hypothetical superoxide dismu
CGQKKPPDPPNRVPEKKVVETSAFGHHVQLVNREGKAVGFIEIKESDDEGLDIHISANSL
RPGASLGFHIYEKGSCVRPDFESAGGPFNPLNKEHGFNNPMGHHAGDLPNLEVGADGKVD
VIMNAPDTSLKKGSKLNILDEDGSAFIIHEQADDYLTNPSGNSGARIVCGALLGNNEKQ
>YOZF_BACSU.1 [26,83]  O31832 Hypothetical protein yozF prec
LTFTVLPITQKTDQWSVKVSEAKNVKEFTRPHKGEYQVYSLGSQKYRGKSSYSGCAIV
>YPBG_BACSU.1 [20,259]  P50733 Hypothetical protein ypbG pre
AKMYATAKGNHLKTHTFPLSKMKGKPPLTIFFISDIHKRLIDQDLLEKARSHAPHLVIIG
GDLAEGGVPSARIEENIKRLVHFGVPIVFVWGNNDYEVRQHKLYSIFKAHGVITLRNESV
PFSYNGHTIAIAGVDDIRMEMDHYEEAIKELDESQLNILVCHNPEIHEQINEDDGIDVIL
SGHTHGGQIRFGKFGPYELGKTGIVKNAAYLISNGYGTTKVPLRLGAEPETHIVTLCGPE
>YPJB_BACSU.1 [23,264]  P54393 Hypothetical protein ypjB pre
AERGSLEELNDLSDTVFQMTRQAKYEEALQVLEYFEKTLKSAEKKQQDPMLTGAQIRQIT
LGYNDMVRSLKQADTSDTQKLRAAAQFRMLMDAVDNRSDPLWGSLEKPIMEAFTELKRDV
QKNGSTSFHEKWNEFISLYDLIYPSLTIDVSEDQLETVGKHIDVIEQEEFQQMTESTKLE
RLSLLQHDLKNVFDRVEEDDADPSLLWVIITTGSIIITALTYVGYRKYKAEKNKLKKRDY
PK
>YQ11_BACAN.1 [25,214]  Q9X397 Hypothetical protein pXO1-141
QTKNDSRPAQAVQNGIQQHVEGKDIVDIPEAYKRKLKGLETVKGKVLHIKDGDTIDVNVK
GQKQTVRLLLLDTPESVSQKIPPQKMGKEASFFLKKQLDGKSVTLVYDQGPKEDKYGRKL
AYVFCNGIHINELMAKSGYGIIAYIFKPNTTLLPEMLEAEKEAKEAKAGVWSIKGFVDEK
NRHYNRNDAA
>YQGG_BACSU.1 [22,300]  P46338 Probable ABC transporter bind
CGNAGESKKSNSDSAKGEEKASGSLTISGSSAMQPLVLAAAEKFMEENPDADIQVQAGGS
GTGLSQVSEGAVQIGNSDVFAEEKEGIDAKALVDHQVAVVGMAAAVNPDAGVKDISKDEL
KKIFTGKIKNWKELGGKDQKITLVNRPDSSGTRATFVKYALDGAEPAEGITEDSSNTVKK
IIADTPGAIGYLAFSYLTDDKVTALSIDGVKPEAKNVATGEYPIWAYQHSYTKGEATGLA
KEFLDYLKSEDIQKSIVTDQGYIPVTDMKVTRDANGKQS
>YQGU_BACSU.1 [21,353]  P54498 Hypothetical lipoprotein yqgU
CKPSHQQQKQASAAKDEKKDIIPLSAEKADGAEGWLNNSTILYTASNPTKTELFPYRIFT
GKAKKLYQTDGQIVDVQINAREQMILLQITHSQKTAVVLLNAEGETLYEKDYETYELEAA
WNQYDPYQMMVTEFNENWDFHTYQVNAKKDESFLSPVQVPFIHWTSKNTFDYVKEGRDDK
TGPLYTFDTASKTEQKLEDNVLFFDSFHQMSFTVKSASGGKGTYQFKTPQSTSPVTAKWP
LQAKYTSLAPMEYDYDEAGSLFYTFKQSGDAYKLAAINVASGETKDLVSLREMEPIQISP
NGKYALYGFHFEQIILLKSHETKQLIIDQKEME
>YQIH_BACSU.1 [17,97]  P40770 Hypothetical lipoprotein yqiH 
CSVASADDSVPRFTEEGKYIGSADPHTIAVSLNGEETMIQVPKDKRDECESLPDQTHVLV
KYTKKDNGTLQLEDIQLRKTS
>YQIX_BACSU.1 [20,255]  P54535 Probable amino-acid ABC trans
CGSSNSGSESGKKKLIMGTSADYKPFEYKEGDNIVGFDVELAKALAKKAGYEIEVQDMDF
NSLITALKSKQVDLVLSGMTPTPERKKQVDFSDVYYTANHMIVSKKDSGIQSLKDLKGKT
VGVQLGSIQEEKGKELSPEYGFKTEDRNRISDLVQEIKSDRFDAAIIEDIVAEGYFKSND
DLQGFVIPDAKAEEAGSAIAFRKDSELTDKFNKALKEMEDNGELEKLKKKWFTGEK
>YSCB_BACSU.1 [25,210]  P94517 Hypothetical protein yscB pre
SESKVETTVKTTAAFPQKELEKELKKLKPVSLDMKFESPLATELGKRKAKEEAEKQRQIA
AEKKLEKEREAKRKKQQEEKAERQRLAEAERQAELERQRQAAIQKEQKANAEKKRQSQAQ
RQQTEAPSSNSQDPPSSSSQTDKTIQQPASELPDDDGYGYEERKKWHDDQVEWGIKQGYI
DPEDAP
>YTD1_BACAN.1 [25,162]  Q9RN00 Hypothetical protein pXO2-32/
CGGSSVPYKKDDTYKDSKDNFITITAENEWRVKGSQNSEANYKVESTEYKGDSHSVVAIS
VKEKINGSDPLLVVNDYHYYILSPRENGFSLTPIGTSHPNSAQWKEFQEGFKGANDKEEF
LKKEVANVNKQNIFKKTN
>YTE5_BACAN.1 [29,531]  Q9RMZ0 Hypothetical cell-wall amidas
EKKTFTDVPNWAQQSVNYLMKKALDGKPDGTFSPSEKIDRGSAAKLMAMVLGLQINKQAK
PSFQDAKNHWASPYIAAVEKAGVIYGDGSGNFNPSKDIDRASMASMLVEAYKLNNRIIGD
LPTQFEDLKGHWGAKLANALVALGISKGTGDGWKPNGIVTRAEAVQFIAQTDMKKADTSK
RMYMNRHFITYHQPSLSSGVTSNQHAPQIIVVKEQRADGWIKIVTNIGDKWTPLYEKRET
IHSTFTTYPEASHSSKVLGTHSPQTVTVIEEKGSWIRIRTNAGFQWLDKNQLTLPKKQNN
FLEGKTIIIDPGHGGIDGGHKGIYMNESPVVYDTAVRVQKLFAQKTPFTALLTRDAYSRP
GKNATDSLGKRVEFAKKNKGDIFVSIHANGFNGNAHGTETFYYKAPTQKSNPYVNDSRIL
AEKIQKRLITALQTRDRGVKIGNLYVLRENTMPSVLTELGFVDNKADGKKLDSPEWRQRA
AEAIYAGILDYYEWKGHNMSAYY
>YTMK_BACSU.1 [21,270]  O34852 Probable amino-acid ABC trans
CGAGSQTTGAGQKKVQTITVGTGTQFPNICFIDEKGDLTGYDVELIKELDKRLPHYKFTF
KTMEFSNLLVSLGQHKVDIVAHQMEKSKEREKKFLFNKVAYNHFPLKITVLQNNDTIRGI
EDLKGKRVITSATSNGALVLKKWNEDNGRPFEIAYEGQGANETANQLKSGRADATISTPF
AVDFQNKTSTIKEKTVGNVLSNAKVYFMFNKNEQTLSDDIDKALQEIIDDGTLKRLSLKW
LGDDYSKEQY
>YURO_BACSU.1 [21,422]  O32156 Hypothetical ABC transporter 
CSSQSSSADGKVTLKFFHRWPKEPEKSYFEEVVKEFEKDHPDIDIQIEAVLNDSYKDKIK
VMLGTTSPPDIYFSWSDEFAFKFIRGNKALDLSSYYKNDTDWSSQLVQSQITPFTYENKQ
YGVPWQMDAKSFFYNKDIFQKLNLDPPKTWDELIDVSKKLKEHGYTPISFGTKATWTISH
YIGTLNQRMVDEKTREKDYNAKTGEFTDEGYVKALEKLQELMPYFNKHVNSVDHEYVRQQ
FKSGKSAMIYAETAEIKLVEPVNLGMFPFPEISGQKGSSEALTGAPEGFMISSRTKHPKE
AMEFLQFLTSKRMGEKLVKDVGKYSAVQGTATEENATAIQREAVQHIVDAKSMVPWFDMD
VDVEVADAYLTGVQQMLGGDMTPQQVMKAVQKAAKQVRASAE
>YUSW_BACSU.1 [30,145]  O32189 Hypothetical protein yusW pre
EGENTAVTQLKSVPYSNFSLRVSYGDGEHNRYEGIYTKNGTQEKAEIQDKLSGVNQEGEE
ALDEMKMILSELSVTDQMAETEVIHSVLAAFNLDSHYDHIDLKLKLKDGSIREIKK
>YVAY_BACSU.1 [33,203]  O34344 Hypothetical protein yvaY pre
KENHTFSGEDYFRGLLFGQGEVGKLISNDLDPKLVKEANSTEGKKLVNDVVKFIKKDQPQ
YMDELKQSIDSKDPKKLIENMTKADQLIQKYAKKNENVKYSSNKVTPSCGLYAVCVAAGY
LYVVGVNAVALQTAAAVTTAVWKYVAKYSSSASNNSDLEAAAAKTLKLIHQ
>YVFO_BACSU.1 [22,429]  O07013 Hypothetical family 53 glycos
GYAAAIEKEKHVSELRAEDLFVKKVEGMNKDFIKGADVSSVIALENSGVTFYNTNGKRQD
IFTTLKQAGVNYVRVRIWNHPYDSNGNGYGGGNNDVQKAIEIGKRATANGMKVLADFHYS
DFWADPAKQKVPKAWANLSFEAKKAKLYEYTKQSLQKMIKEGVDIGMVQVGNETTGGFAG
ETDWTKMCQLFNEGSRAVRETNSNILVALHFTNPETAGRYSFIAETLSKNKVDYDVFASS
YYPFWHGTLQNLTSVLKAVANTYGKKVMVAETSYTYTAEDGDGHGNTAPKSGQTLPYPIS
VQGQATAVRDVMEAVANTGKAGLGVFYWEPAWIPVGPKTQIEKNKVLWETYGSGWASSYA
AEYDPEDAGKWYGGSAVDNQALFDFNGHPLPSLQVFQYAESGHIPKKR
>YVGO_BACSU.1 [27,161]  O32211 Stress response protein yvgO 
EENPAPKMSQTTTAGTTAADVGLNVNLDVLGIANQIADAIKSAQNRDGFVKNLMESSFYA
SGQKYNVMVFNLSQEYEDHLNGVQFYGSAVYDGITYGIWVFEDGTFTNKGDGGWINWAFR
GWFDRDGSTVAFHRP
>YWAD_BACSU.1 [32,455]  P25152 Hypothetical peptidase ywaD p
VQISNSERELPFKAKHAYSTISQLSEAIGPRIAGTAAEKKSALLIASSMRKLKLDVKVQR
FNIPDRLEGTLSSAGRDILLQAASGSAPTEEQGLTAPLYNAGLGYQKDFTADAKGKIALI
SRGDLTYYEKAKNAEAAGAKAVIIYNNKESLVPMTPNLSGNKVGIPVVGIKKEDGEALTQ
QKEATLKLKAFTNQTSQNIIGIKKPKNIKHPDIVYVTAHYDSVPFSPGANDNGSGTSVML
EMARVLKSVPSDKEIRFIAFGAEELGLLGSSHYVDHLSEKELKRSEVNFNLDMVGTSWEK
ASELYVNTLDGQSNYVWESSRTAAEKIGFDSLSLTQGGSSDHVPFHEAGIDSANFIWGDP
ETEEVEPWYHTPEDSIEHISKERLQQAGDLVTAAVYEAVKKEKKPKTIKKQMKAKASDIF
EDIK
>YWBL_BACSU.1 [23,481]  P39595 Hypothetical protein ywbL pre
EDDPIAALIQLNKQMIKSVKDGDMDSAQQTFDTFKAKWKKEEPSIKKENLSSHSEMDANI
AMISLSFINQDARKLKTQLEELASHLETYQQAVVLKKTSSGQSRASLTAYIQSLKDTKQF
IEKKQLDEASSAIDNLVTSWLAVEGDVVSQSKEAYTTCHQNLALMKAEIGSHPEKVSKQI
DEMIQLLEPIASSSYSWWDAALIPVREGMEALLVIGALLTMTKKARVTRSSTWIWGGASA
GMAVSLAAGIGVTVLFSSSVFGENNFLLGGVTGVLSAVMLLYVGVWLHRNASMDKWREKI
NIQKSQALKKRSLLSFALIAFLAVVREGLETVIFFIGLVGKLPLTELIGGTAAGLIVLVI
VGVLMIKLGMRIPLKPFFLLSMAVVLYMCVKFLGTGVHSLQLAGILPSDAESWLPSVSVL
GIYPSVYSTIPQMLILLFLLIALVSEAAKHFTNGKELTK
>YWGB_BACSU.1 [25,156]  P71047 Hypothetical UPF0074 protein 
SLTSEAISQRLRVSPSYLKKLMRTLVQAGLAESLPGTKGGFTLTKPLADITLYDVYQAVE
GRGSMYQGKGLLQSVFEGESHCVLETVMAEIEDKWSNLMREESLQHVMDRVGELYDLEKI
DDWVIKQVKGQL
>YWMC_BACSU.1 [24,227]  P70960 Hypothetical protein ywmC pre
AEKTETEAKAPANVAVLLDASGSMAKRIDGVSKFNSAKKEISKFASSLPEGTQVKMSVFG
SEGNNKNSGKVQSCEAIRNVYGFQSFNEQSFLNSLNTIGPTGWTPIAKALNEAKSSFDQL
DAKGEKVVYLLTDGEETCGGNPIKTAKELQKDNITVNVIGFDYKEGYKGQLNAIAKVGGG
EYFPAYTQKDVEKIFTQQSLMLSK
>YWMD_BACSU.1 [24,224]  P70961 Hypothetical protein ywmD pre
AEKQADTNVAVLFDGSGSMVQKTGGERKIDIAKKSVKSFAELLPKDTNLMLRVFGHAGNN
KLSGKALSCSTTETIYGLHPYEGSLFDNSLSELKPTGWTPIAKALADTRKEFEAFDADGK
NVVYLITDGEETCGGDPAAEIEKLRASNVDTIVNIIGFNFDVKGNEEMKQAAVAGGGEYI
SANSADEFEQAWEKEAQKFTE
>YWTC_BACSU.1 [26,55]  P96739 Hypothetical protein ywtC prec
NDQLTDQEKQKIDMEMNKIQQQEEPVNANK
>YXEA_BACSU.1 [16,115]  P54940 Hypothetical protein yxeA pre
VICGLLFFHNDVTDRFNPFIHQQDVYVQIDRDGRHLSPGGTEYTLDGYNASGKKEEVTFF
AGKELRKNAYLKVKAKGKYVETWEEVKFEDMPDSVQSKLK
>YXEB_BACSU.1 [21,319]  P54941 Probable ABC transporter bind
CSGTASKGSSSDSASEKTEMRTYKSPKGNVNIPAHPKRIVTDFYAGELLSVGANVVGSGS
WSFDNPFLKSKLKNVKDVGDPISVEKVMELQPDLIVVMNEENVDKLKKIAPTVVIPYNTA
KNVEDTVSMFGDIAGAKDQAKSFMADFNKKAEAAKKKIAGVIDKDATFGIYENTDKGEFW
VFNDNGGRGGQAVYNALGLKAPEKIEQDVIKKGEMKQLSQEVIPEYAADYMFITDYNPKG
ESKTLDKLENSSIWKNLDAVKHNRVFINDFDSFYPYDPISVSKQVDIITDMLIKRAEEN
>YXEF_BACSU.1 [24,144]  P54945 Hypothetical protein yxeF pre
CQQQKEETPFYYGTWDEGRAPGPTDGVKSATVTFTEDEVVETEVMEGRGEVQLPFMAYKV
ISQSTDGSIEIQYLGPYYPLKSTLKRGENGTLIWEQNGQRKTMTRIESKTGREEKDEKSK
S
>YXEM_BACSU.1 [21,264]  P54952 Probable amino-acid ABC trans
CGNGNSSSKEDDNVLHVGATGQSYPFAYKENGKLTGFDVEVMEAVAKKIDMKLDWKLLEF
SGLMGELQTGKLDTISNQVAVTDERKETYNFTKPYAYAGTQIVVKKDNTDIKSVDDLKGK
TVAAVLGSNHAKNLESKDPDKKINIKTYETQEGTLKDVAYGRVDAYVNSRTVLIAQIKKT
GLPLKLAGDPIVYEQVAFPFAKDDAHDKLRKKVNKALDELRKDGTLKKLSEKYFNEDITV
EQKH
>YXIA_BACSU.1 [20,469]  P42293 Hypothetical protein yxiA pre
LPNSVYAQKPIFKEVSVHDPSIIETNGTFYVFGSHLASAKSNDLMQWQQLTTSVSNDNPL
IPNVYEELKETFEWAQSDTLWAADVTQLADGKYYMYYNACRGDSPRSAMGVAVADNIEGP
YKNKGIFLKSGMEGTSSDGTPYDATKHPNVVDPHTSFDKDGKLWMVYGSYSGGIFILEMN
PKTGFPLPGQGYGKKLLGGNHSRIEGPYVLYNPDTQYYYLYLSYGGLDATGGYNIRVARS
KKPDGPYYDAEGNPMLDVRGKGGTFFDDRSIEPYGVKLMGSYTFETENEKGTGYVSPGHN
SAYYDEKTGRSYLIFHTRFPGRGEEHEVRVHQLFMNKDGWPVAAPYRYAGETLKEVKQKD
ITGTYKLIQHGKDISADIKQTINIQLNKNHTISGEMTGTWRKTGKNTADITLAGKKYNGV
FLRQWDSVREKNVMTFSVLNTSGEAVWGSK
>YXIM_BACSU.1 [26,382]  P42304 Hypothetical protein yxiM pre
AEPKVYQFDFGSGSMEPGYIGVRASDRYDRSKGYGFQTPENMRDVAASGAGVKSDAVEFL
AYGTKSNNTFNVDLPNGLYEVKVTLGNTARASVAAEGVFQVINMTGDGAEDTFQIPVTDG
QLNLLVTEGKAGTAFTLSALKIKKLSDQPVTNRTIYVGGDSTVCNYYPLNSSKQAGWGQM
LPHYIDKHTFQVRNMASGGQIARGFRNDGQLEAILKYIKPGDYFMLQLGINDTNPKHKES
EAEFKEVMRDMIRQVKAKGADVILSTPQGRATDFTSEGIHSSVNRWYRASILALAEEEKT
YLIDLNVLSSAYFTSIGPERTLGLYMDGDTLHPNRAGADALARLAVQELKRQGIAGF
>YXIP_BACSU.1 [19,226]  P42307 Hypothetical protein yxiP pre
ACESEGEAQMFADCDQKTVKQTAAKPMSSKKKQDFQALASDRQLAIVFSSMIQVSEAFDY
GIGNPEYFVRISMTEEEADIAKENLESIKLENKSLKKQNSEAVALLQKTRNQDMSRIEIQ
QLTENRAGFFETADSMIKLINQVTPKNAKKTRQQLDQLKKQYTQYSAESIKIMNSIVKKQ
KADKASFERHLEALLQKQPGQQVRSELY
>YXIT_BACSU.1 [24,80]  P42311 Hypothetical protein yxiT prec
APSLKAVQAKTPTVSTHTYKKIKELTYPQVHHVGNAAFEKKINQELKAYMDNRIRNT
>YYCP_BACSU.1 [28,387]  Q45606 Hypothetical protein yycP pre
HKTVSQQDLRNPDFLDDKEVLLYFSSSADQDAFGGGKNYALFISHDGTLSSFQMKGLELG
SAKVHGDSVMLEDKNTIYTIKNGLRSHKRTYQHTGDSAGFLQNTDGFYTLYNSGYDKKGD
GYRSELYRQMDGEWKKDVIPYYIRASGFHDGAIYALVPTDDGKGYQLLQIQADQKKLTYL
SITEWQYREGASVESQLAVDDQAVYVMVRGQKAHDLYQMVKINKKSGEVELHDIAEYKND
EQTIYSSMPFSFKNSFFPYDGNLYFIDGFGKVHKIDAKTGKTSIVFTLSPDKMKAEFKEI
TQKGSSLYFFTYTYHKPAYIEQYSLKTGKKMKEKEIGKVKDVVTPKSHLKLYDVEVMKRF